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Abstract
The potential of the silver-catalysed cyclisation has been illustrated by the synthesis of furans, 
pyrroles and pyrazole-N-oxides. With yields predominantly being >95%, and ubiquitous high 
purity, the results herein show the compatibility of many substituents including alkyl, aryl and 
silyl, to name but a few. Extended investigations have improved our understanding of reaction 
rates, the effect of stereochemistry and the use of protection strategies as well as identifying a 
handful of limitations.
With the above results in hand, and a desire to recognise the practical advantages of a metal- 
catalysed procedure, we have further described two continuous flow systems for heterocyclic 
synthesis. The first, a trickle-bed reactor, produces heterocycles in excellent yields (>95% except 
where volatile products were produced) and has been shown to exhibit < 1 ppm silver leaching. 
Our understanding of the optimal flow rates, catalyst loading and practical attributes associated 
with such a reactor is then described. The second, a supercritical carbon dioxide : ionic liquid 
system, has been shown to produce furans in excellent yields (>95%), when used in batch mode, 
and in slightly lower yield (>70%) when used in a continuous fashion. Once again silver 
leaching was seen to be <1 ppm. The success of these two systems, and the speed in which their 
success was achieved, clearly demonstrates the ease of working with silver-catalysed 
cyclisations. In a further brief foray, the use of heat and microwave irradiation is discussed in 
view of potential applications to other continuous systems.
Finally, several specific applications of the silver-catalysed cyclisation have been shown. It is 
seen that this procedure is suitable for the synthesis of scented furans and has uses in the 
preparation of heterocyclic substrates, which can be used for bigger and better things. One such 
example, which is described in Chapter 6, is the formation of oxepan-4-ones, oxepin-4-ones and 
oxocins-5-ones from their corresponding furyl alcohols.
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LI: Introduction
Heterocycles (Figure 1) are inherently important in many modem pharmaceuticals, being found 
in >70% of such commercial products. Why heterocycles? One of the prevalent features in a 
heterocycle is the presence of at least one lone pair of electrons {e.g. O, N, S), which provides a 
basis for electronic co-ordination, hydrogen-bonding, reactivity and resonance. Such electronic 
properties are crucial to a heterocycle’s ability to exhibit biological activity. With many aromatic 
heterocycles being electron excessive, these become ideal candidates for coordination and 
electrophilic substitution, a property which is vital to the synthesis of substituted examples. 
Indeed, the presence of heterocycles in many biological systems means their use should 
contribute to providing a therapeutic which is biologically stable.
Figure 1: Heterocyclic compounds.
Many traditional synthetic approaches to heterocycles have been discussed in Comprehensive 
Heterocyclic Chemistry, 1996,1 with many featuring ring closures through the nucleophilic 
addition of a heteroatom to an electron deficient carbon atom. These electron deficient centres 
can be present ‘naturally’ in, for example, carbonyls, nitriles and alkyl halides or can be 
generated in situ from unsaturated linkages by coordination with an intermolecularly-delivered 
electrophilic species. Classical examples of this latter methodology include halo-etherification 
and halo-lactonisation, amongst many others.
2
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1.1.1: Furans
Furans have attracted much interest with particular uses in therapeutics and further applications 
within fragrance chemistry. Industrially, furan itself, 3, a clear colourless oil, is obtained from 
the nickel-catalysed decarbonylation of furfural 2 (Scheme 1), itself a product of the acidic 
dehydration of pentose sugars 1.
OH
1 2 3
Scheme 1: Industrial preparation of furan 3.
A typical synthesis of functionalized furans is the Feist-Benary method.2 Here, a 1,3-dicarbonyl 
compound 5 adds to an a-halo-carbonyl 4 via its enolate 6. The resulting 1,3-dicarbonyl 7 can 
then undergo cyclisation and dehydration to yield a substituted furan 8 in high yield (90%) 
(Scheme 2), but with the requirement for a p-carbonyl substituent in the final product. This latter 
type of cyclisation [7] proceeds in a similar fashion to the Paal-Knorr furan synthesis, in which a 
1,4-dione undergoes acid-catalysed cyclisation.
O
R2
8 > 'R3
4 5 6 8
(X = Cl. Br, I)
Scheme 2: Feist-Benary furan synthesis/
R 2 Base
t> H
With a host of other procedures available, furans including furocoumarins 9, rosefuran 10 3,4 and 
sesquirosefuran 11 4 have been synthesised (Scheme 3).
10 11
Scheme 3: Important furans.
3
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1.1.2: Pyrroles
Another important class of heterocycles, especially in the context of this thesis, are the pyrroles. 
Pyrrole itself, 13, also a clear colourless oil, is held in high regard by synthetic chemists. It too 
has vast numbers of applications in many industries, with particular uses in therapeutics and 
materials science, and has been synthesised from the dry distillation of the ammonium salt of D- 
galactaric acid 12 (Scheme 4).
OH
H4l # S0 2C'   rT
H C02 NH„ ILn'
H 
13
Scheme 4: Industrial preparation of pyrrole 13.
A classic example of a substituted pyrrole synthesis is seen in the Paal-Knorr cyclocondensation 
5,6 of a 1,4-dicarbonyl precursor 14 with ammonia (Scheme 5). Here the nucleophilic lone pair of 
the nitrogen heteroatom ring closes [16] with a carbonyl situated in its y-position to yield a fully 
substituted pyrrole 17.
V yr‘— r!y V — RV s r R' 4 = 5 .  " V C *
14 15 16 17
Scheme 5: Paal-Knorr synthesis 5,6 of pyrroles 17.
A derivative of this procedure is the Knorr pyrrole synthesis, 7 9 where an a-aminoketone 18 
condenses with an a-methylene-ketone 19. The product of the condensation, 20, then undergoes 
intramolecular ring closure [21] to form the aromatic pyrrole 22 (Scheme 6). This reaction 
involves a heteroatom driven carbon-carbon bond formation between an enamine and a ketone.
r 3
Ry > ^ ^ r R3 PT^  Rl^.O ^R3 RS ^ f T R3 PT, RV i v _
R1 NH2 Oy R4 ,H20; R ^ N ^ R 4 R1^ ^ R 4 , H20r  R1 H
18 19 20 21 22
Scheme 6: Knorr synthesis7 9 of pyrroles 22.
4
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Pyrrole rings are found in the therapeutics pyrrolnitrin 23 and zomepirac 24, and in haemoglobin, 
which is based on the tetrapyrrole porphyrin ring system 25 (Scheme 7). They are also used in 
the formation of polypyrrole polymers 26, often referred to as ‘pyrrole blacks’.
Cl
c o 2h
23 24 25
26
Scheme 7: Important pyrroles.
1.1.3: Pyrazoles
The final class of aromatic heterocycles that will be featured during the course of this project are 
pyrazoles 27 (Scheme 8). These too take the form of a 5-membered ring but, unlike furan 3 and 
pyrrole 13, contain two adjacent nitrogen heteroatoms. This arrangement provides pyrazole with 
both a pyrrole-like nitrogen, whose lone pair provides aromaticity, and a pyridine-like nitrogen, 
which has an exposed lone pair giving pyrazole a degree of basicity comparable with tertiary 
amine bases.
rV n2L ^ r1
R2
27
Scheme 8: Pyrazole.
Its electron-rich n system readily undergoes electrophilic substitution, preferably at the 4- 
position, and nucleophilic substitution at the 3 and 5-positions. A typical synthesis of the 
pyrazoles 31a and 31b 10 incorporates the addition of hydrazine 29 to a 1,3-dicarbonyl 28 to give, 
upon cyclisation of 30, good to excellent yields of the regioisomers of the expected pyrazoles 
31a, 31b (Scheme 9). Some regioselectivity can be achieved through the use of appropriate 
substituents, for example through steric bulk.
5
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R3
R2. ^ o hn pt d3 R3
 ► RV 1  n-n
//
30
\\_o1 3 \ _ R1
' y f L y 1 (-h2o) V n n r  (-h2o> r2 - W ^  r2
R D
28 29  31a 31b
Scheme 9: Knorr synthesis 10 of pyrazoles 31a and 31b.
1.2: Aims o f  the project
With the basics of furan 3, pyrrole 13 and pyrazole 27 syntheses having been described, the focus 
of this work now turns towards Knight’s interest in the synthesis of heterocycles.1116 With a 
previous interest in the silver-catalysed synthesis of pyrroles 17 (R3 = H) 17 and furans 3,18 our 
attention turned towards providing a broadly applicable continuous flow system for heterocyclic 
synthesis.
Often, as with all approaches, traditional techniques have their limitations, be it in terms of 
substituent compatibility, regioselectivity or reaction conditions. There is also the problem that 
many of these techniques show subtle differences in their starting materials as well as in their 
conditions. It would therefore be desirable to present a practical approach which can produce 
heterocycles regiospecifically via a common scheme and set of conditions.
6
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Chapter 2: Results and Discussion
2.1: Introduction
There is significant interest in furans and their applications as therapeutics for a range of diseases. 
Therefore a broadly applicable, fast and efficient synthesis is crucial to their successful use. 
Many previous synthetic approaches suffered from low yields, the need for forcing conditions or 
require convoluted synthetic approaches to attain suitable starting materials. The few approaches 
that provide a more practicable mode of synthesis are often extremely good for their desired 
purpose but, like most synthetic procedures, do have significant limitations.19 By drawing 
comparisons with previous literature, it will be shown that we have developed a powerful 
procedure for the synthesis of a broad range of furans from commercially available starting 
materials.
2.1.1: Baldwin’s rules
Almost all cyclisation reactions adhere to a set of rules devised by Baldwin,20"22 often referred to 
as Baldwin’s Rules, (Figure 2 (X=Nuc)). There are several conditions which a transformation 
must usually obey in order to allow a successful reaction. The rules predict the feasibility of a 
cyclisation reaction for a range of sp (digonal) 34, sp2 (trigonal) 35 and sp3 (tetrahedral) 36 
carbon centres (Figure 2). It also accounts for the relative positions of bond formation and 
breakage in relation to a particular carbon centre. If the broken bond is within the newly formed 
ring, then endo 32 attack has ensued whereas if the converse is true, i.e. the bond is broken 
outside the newly formed ring, then exo 33 attack has ensued. The final piece of nomenclature 
deals with the size of the final ring structure, i.e. the number of ring atoms (R). Thus, a number 
of transformations can be written as being R-ew/o/ejco-dig/trig/tet.
32 33 34 35 36
endo exo sp sp2 sp3
Figure 2: Baldwin’s rules for ring closure.20"22
8
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According to Baldwin’s rules, 5-em/o-dig ring closures are favoured and indeed recently there 
has been much activity in this area.16,23 29 One of the most common stoichiometric approaches 
uses iodine to activate the alkyne bond such that a formal 5-era/o-dig cyclisation can proceed. 
Indeed, the Knight group held a previous interest in this field with investigations into the use of 
stoichiometric iodine n’ 15 to effect the cyclisation of 3-alkyne-2-hydroxy-1 -sulfonamides 42. 
Unpublished results 30 showed high conversions which yielded 3-iodopyrroles 43 and, with an 
additional step, pyrroles 44. These results were achieved through the addition of tosyl glycine 
methyl ester 41 to alkynones 40, synthesised from carbonyls 37 (or DMF) and alkynes 38 to yield 
the desired 3-alkyne- 1,2-sulfonamide 42, which is then cyclised to the 3-iodopyrrole 43 (Scheme 
10). Indeed, the success of the technique also found uses in the synthesis of dihydro-3- 
iodopyrroles 45, 31 a complete surprise, of 3-iodofurans 46 15 from 3-alkyne-1,2-diols and of 4-
•yy
iodo-3-isoxazolines 47 (Scheme 11).
R2 o-BuLi, THF TsCI, DCM,
+
40
Ri ° 5 #
I R3
R 1 j  HCOONa R 1 j
n-BuLi, THF l2, DCM^ X | p \ _ R 2 PdCI2(ppfe >2
Me02C NHTs -H2°  Me02C ^ s  d m f .h o ° C  Me02C ^ s  
42 43 44
Scheme 10: Synthesis of 3-iodopyrroles using the iodocyclisation protocol.
Me02C !j*s R1 °  R1
45 46 47
Scheme 11: Dihydro-3-iodopyrroles, 3-iodofurans and 4-iodo-3-isoxazolines.
Although very successful procedures, these iodocyclisations suffer the drawback of occasional 
side-product formation, e.g. 6/s-iodination of the alkyne, and the more serious requirement of 
excess iodine (3 eq). Interest therefore moved towards investigating the use of catalytic variants 
of these cyclisation procedures, especially the possibility of developing a heterogeneous catalyst.
2.1.3: Catalytic synthesis of furans
Chapter 2: Results and Discussion
“72 *)Q 11 A QPrevious literature ‘ ’ had shown the use of several transition metal salts in effecting the 
cyclisation of similar compounds, in both a 5-em/o-dig and 5-exo-dig fashion, but with varying 
yields and sometimes harsh conditions. Indeed, some of the earliest examples saw the use of 
mercury salts, which were employed to effect the cyclisation of 3-alkyne-l,2-diols 48 33 and 1- 
alkynyl-2,3-epoxyalcohols 50 34 to their corresponding furans 49, 51 in good yields (55-85%) 
(Scheme 12).
OH
48 49 50 51
Scheme 12: Mercury-catalysed fiiran synthesis.
More recently, Nishizawa has used mercuric triflate, in the most successful mercury-catalysed 
procedure to date, to effect the cyclisation of l-alkyn-5-ones 52.35 He showed that furans 53 
could be obtained in excellent yields (70-100%), under very mild conditions, when using a 
terminal alkyn-5-one 52 (Scheme 13). There were however several drawbacks with this 
procedure: for instance, side product formation -  the diones 54 - was often observed. More 
significantly, it was also not possible to cyclise aldehydes or non-terminal alkynes and there was 
a need to use benzene as solvent to obtain good yields.
Hg(OTf)2
52 53 54
Scheme 13: Nishizawa’s mercury-catalysed furan synthesis.35
Another general problem which affects all mercury-catalysed procedures is the toxicity of these 
salts, which makes their use very undesirable, especially in industrial preparations.
In the mid-1980s, and again more recently, the trend moved towards the use of palladium in the 
catalytic cyclisation of 3-alkyne-l,2-diols 55,23 (Z)-2-en-4-yn-l-ols 56,36*38 allenyl ketones 57,39’ 
40 O-alkynylphenols 58 25 and alkynones 59 41 (Scheme 14). These procedures were often
10
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coupled with carbonylation, using carbon monoxide, and are distinguished by their ability to 
produce tetrasubstituted furans.
OH
R2
R ^  
R1 OH
55
R2R2>s
R1>"OH RH R1Y d  ^  "OH
56 57 58
Scheme 14: Substrates for palladium-catalysed furan synthesis.
R1 "O
59
These approaches seem ideal at face value, often giving good to excellent yields, and exhibiting 
low toxicity and the potential for broad substitution. In many cases however, they suffer from the 
need for extended reaction times and elevated temperatures, as well as inconsistency, given the 
varied yields which are obtained even with relatively basic substituent alterations. Further 
drawbacks are associated with the use of palladium itself, as it is notoriously expensive, sensitive 
and difficult to remove but, at least, it is usually required only in catalytic amounts.
More recently, a novel 1,2-migration has been shown by Gevorgyan to yield tri- and tetra­
substituted furans by the use of a copper-catalysed cyclo-isomerisation and a silver-catalysed 
sequence respectively.42 The first incorporates a base-assisted propargyl-allenyl isomerisation of 
a-acyloxyalkynones 60 to give allenones 61, which can undergo nucleophilic Adj^-E attack [62] 
to form the furans 63 (Scheme 15).
AcO R2
) — i
R1 O
CuCI
Et3N
60
Scheme 15: Gevorgyan’s copper-catalysed furan synthesis.42
Gevorgyan’s other cyclo-isomerisation procedure sees the use of silver tetrafluoroborate for the 
synthesis of furans via a [3,3]-shift, 1,2-migration and cyclo-isomerisation sequence.42 Addition 
of catalytic silver tetrafluoroborate to a solution of a-acyloxy-P-ketoalkynes 64 in 
dichloromethane promotes the [3,3]-shift and 1,2-migration to yield the acyloxyallenones 65, 
which then readily cyclise to yield tetrasubstituted furans 66 (Scheme 16). The procedure can 
also be used with other hetero-migrating groups such as phosphatyloxy and tosyloxy analogues.
11
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? Ac AaBF, AcO R2 AcO R2
64 65 66
Scheme 16: Gevorgyan’s silver-catalysed furan synthesis.42
Marshall had previously shown that it was possible to effect the cyclisation of P-alkynyl allylic 
alcohols 67, 5-endo-d\g, and y-alkynyl allylic alcohols 69,26, 43 5-exo-d\g, as well as allenones 
71,26’ 44*45 by using various silver salts, to yield the corresponding furans 68, 70 and 72 in 
excellent yields (>86%) (Scheme 17). This was achieved by the addition of commercially 
available 10% w/w silver nitrate on silica gel (henceforth referred to as 10% AgNC>3.SiC>2) to a 
solution of the heterocyclic precursor, to yield furans in excellent yields (up to 96%) within 1 h.
,R2
v \
OH R1 0
67 68
26,43-45Scheme 17: Marshall’s silver-catalysed furan synthesis.
Having found great success with this procedure, Marshall invested time in optimising the reaction 
conditions and understanding the mode of action. He showed that the most efficient cyclisations 
of allenones 71 used 20% AgN0 3 .SiC>2, with acetone as the solvent, to yield furans 72 (90%)
n/-
within 1 h. Further developments saw the improved conversion of alkynyl allylic alcohols 67 
and 69 with 10% AgN0 3 .SiC>2 in hexane, to yield furans 68 and 70 (96%), still within 1 h 26
With this optimisation of the reaction conditions, Marshall then assessed the mode of action of 
the allenone cyclisation (Scheme 18). Using deuterium labelling, he was able to show that allene 
coordination to silver [73] allowed ring closure to proceed via lone pair donation from the 
carbonyl oxygen. Deprotonation of the resulting silver complex followed by Ag+/H+ exchange of 
the silver derivative 74 afforded furan 75 in the usual excellent yields (92%).
' ^ R2 ^  ^  T \ \ r2
R1 O R1" ^ 0  R1> O R1^ 0  R1^ 0
71 73 74 75
Scheme 18: Marshall’s proposed silver cyclisation pathway.
12
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In a final development, more recent interest has focused on the use of gold(III) salts and gold(I) 
complexes.46"48 It was shown by Liu that both gold(III) chloride and the cationic gold(I) complex 
(PPh3)AuCl/AgOTf could be used.46 He successfully cyclised a range of (Z)-2-en-4-yn-l-ols 76 
to yield the corresponding furans 77, or dihydrofurans 79 in the case of tertiary alcohols 78, in 
excellent yields (>83%) (Scheme 19), via a 5-exo-dig pathway.
1mol% Aucat.
R3
1mol% o i ^ O  
(PPh3)AuCI/AgOTf R
77
1moi% Au cat.
OH 1mol% 
(PPh3)AuCI / AgOTf
78 79
R2
5mol% A11CI3 
MeCN, rt
R2
80 81
Scheme 19: Liu’s and Hashmi’s gold-catalysed furan syntheses.
Liu found that these reactions could be performed at room temperature within 3 h when using just 
1 mol% of catalyst, although he did acknowledge that the presence of air did reduce yields 
slightly. Unsurprisingly, his use of silver triflate with the gold(I) catalyst appears to show a 
marked effect. Previously, the best yields (77%) were obtained when using (PPh3)AuCl under 
reflux in acetonitrile for five days. The addition of 1 mol% silver triflate to this catalyst was 
found to not only improved yields (82%) but, more importantly, allow the cyclisations to proceed 
at room temperature within 3 h. This result is perhaps expected given that Marshall had already 
demonstrated the use of silver nitrate, amongst other silver salts, in effecting the cyclisation of 
(Z)-2-en-4-yn-l-ols 69 (Scheme 17).26 The use of silver with gold is interesting and, in view of 
Marshall’s results, it appears that the combination of the two are critical to lowering the required 
amount of catalyst to just 1 mol%.
Hashmi also spent some time investigating the use of gold(III) chloride.48 He found that he could 
catalyse the isomerisation of alkynyl epoxides 80 to furans 81 in moderate to high yields (25- 
85%) under mild conditions (Scheme 19). Tolerating a range of functional groups including 
alkyl, aryl, aryl halide and hydroxyl groups, this work highlighted the strength of gold-catalysed 
cyclisations for the synthesis of furans. With predominantly high yields, its inert nature and the 
successes seen when using low levels of the catalyst, the use of gold is highly attractive.
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Knight had already seen some success with the use of copper and protons 17 in the synthesis of 
pyrroles 83 and, less successfully, furans 85 (Scheme 20) but publications by Marshall inspired 
investigations into the use of silver. Sharland, a previous member of the Knight group, assessed 
the use of 10% AgN0 3 .SiC>2, amongst other transition metal salts, in the cyclisation of a small 
number of 3-alkyne-2-hydroxy-l-sulfonamides 82. Hoping to find a heterogeneous system, he 
found that the addition of 10% AgNC>3.Si0 2  to a solution of 82 screened from daylight, so as not 
to reduce silver(I), yielded the corresponding pyrroles 83 in excellent yields (>95%) and in high 
purity. With this result in hand, Menzies attempted the cyclisation of another class of substrate, 
the 3-alkyne-l,2-diols 84, with 10% AgN0 3 .SiC>2 and found, once again, the formation of furans 
85 to occur in excellent yields (>95%) and in high purity. In view of these early results, it was 
felt that an equally strong procedure for the synthesis of a range of furans 85 from 3-alkyne-l,2- 
diols 84 had been found.
O H ^
10% AgN03Sj0210%AgNO3S«O2
R1 NHR4
82 83 84 85
Scheme 20: Substituted pyrroles 83 and furans 85.
As the above results were very much ‘initial observations’ which had been by no means 
comprehensively investigated, no great effort had been made to optimise the system, and at the 
time it was not known for certain what the best conditions were. It was known that with the 
advent of gold catalysts in this field, a viable competitor had been discovered, however a 
competitor which also suffers a major drawback: gold catalysts act in a homogeneous fashion. 
This renders the use of gold catalysts in continuous synthetic production awkward to say the 
least, given that product contamination was unavoidable and purification often quite difficult. It 
is here where silver could gain some ground.
At the outset of the present project, the silver nitrate system had the great advantage over gold 
catalysts of being heterogeneous and hence much more easily removed. However, leaching of 
silver(I) species into the products was a problem in all systems. There was however a belief that 
the heterogeneous nature of the silver catalysts might provide an opportunity through which 
leaching could be prevented, and a flow system formed. This belief formed a fundamental aim 
for this present project.
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With the isolation of such pure products, it was felt that the silver cyclisation procedure may have 
applications to a range of other heterocycles including dihydrofurans 86, dihydropyrroles 87, 
isoxazolidines 88, isoxazolines 89, 90, 91, isoxazoles 92, pyrazoles 93, pyrazole-N-oxides 94, 
benzofurans 95, indoles 96 and triazoles 97 (Figure 3), all continuing with the 5-ew/o-dig theme. 
Clearly, it may be anticipated that similar 5- and 6-exo-dig versions could also be discovered. It 
was at this point that this work commenced. With research by Song having shown a further 
application in the synthesis of pyrazoles 93,49 the aim of this project became orientated towards 
the synthesis of a comprehensive range of furans 85, pyrroles 83 and pyrazole-N-oxides 94 
through the development of a flow system (Figure 4), once the basic viability of these particular 
cyclisations had been demonstrated.
R2
b
R2 OH
x>O
86
-R3
R2 ? H
' ^ V RS
87
R2
jO
N
R3
88
R1 N
89
R2
N-R3
N
93
R2
N-R3
N©
Cb
94 95
R2
(D 
N 
R3 
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R,C X h R2
R3
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R2
:o
N
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R2
b
N
92
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R 1^
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Figure 3: Possible heterocyclic targets.
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Figure 4: Principle of a continuous flow system.
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2.2.1: a-Hydroxycarbonyl pathway
1 o
Following the work of Menzies and with the use of additional synthetic approaches, a
comprehensive range of 2,4-disubstituted, 2,5-disubstituted and 2,3,5-trisubstituted furans were
performed to complete a thorough assessment of substituent effects and compatibilities. Addition 
of excess alkyne 99 (2.2 eqs), an arguably justified atom efficiency in view of the time and cost 
of using protection strategies (see later; Chapter 2.2.1 -  p 23), to a commercially available a- 
hydroxycarbonyl compound 98, as utilised by Menzies, yielded the desired 3-alkyne-l,2-diols 
lOOa-o. The addition of 10% AgN0 3 .SiO2, commercially available from Aldrich, to a stirred 
solution of the diols lOOa-o in dichloromethane (3-24 h) yielded the pure furans lOla-o (>95%) 
(Scheme 21) (Table 1). It is worth highlighting that the vast majority of the successful 
cyclisation reactions exhibited >95% conversion and isolated yield. Only in a few specific cases 
were isolated yields seen to be lower, at around 50-60%, usually a result of product volatility, a 
likely explanation given that, in all of these instances, conversion remained high at >95%. As 
such, we feel it a fairer reflection to discuss each cyclisation herein with respect to its conversion. 
As a result of the observed high conversions, the purity shown by these cyclisations was seen to 
be outstanding, indeed in the majority of cases, there were no indications of by-product formation 
whatsoever (other than water). The few cases which did exhibit a degree of by-product formation 
are interesting in their own right (Chapters 2.2.1, 2.2.3 and 5.2.4 -  p 24, 32, 97 and 100). Perhaps 
one of the most impressive aspects of this synthetic transformation was the isolation of such pure 
products, as shown by the represented !H NMR spectra (Spectrum 1, 2 and 3).
Further aspects of this project have shown that a successful cyclisation can be attempted even in 
the presence of trace impurities. This, although usually avoided, does hint at the robustness of
synthesised (Table 1 and 2 - p 17 and 30). A few of these results were repeated, from the original 
work of Menzies18 in an attempt to confirm and optimise the overall yields, and many others were
R 3 n-BuLi.THF
OhU^
10% AgN0 3Si02
100 101
Scheme 21: a-Hydroxycarbonyl approach to furans.
the technique, and hence provides greater scope for its practical use. It is worth mentioning that
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when furans 101 are the desired end point, it is recommended that purification is attempted at the 
diol stage. This often simplifies column chromatography given the larger difference in polarity 
observed between many of the alkynes 99 and diols 100, as well as other impurities. Obviously
this recommendation is case-dependent, but for a large number of alkynes it remains true.
Table 1: Silver(I)-catalysed synthesis of furans.
r 2 0 H jT r3  2
10% AgNCb Si02 ► [I />—R
R1 OH °°M R1 O
100,12$ 101,127
3-alkyne-l,2-
diol
R1 R2 R3 Furan Isolated 
Yield (%)
1 0 0 a Me Me Bu 1 0 1a c 67
1 0 0 b Me Me Ph 1 0 1 b 95
1 0 0 c Me Me (CH2)2OTIPS 1 0 1c 63
lOOd Me Me (CH2)3OBn lOld 96
lOOe Ph Ph Bu lO le c 99
lOOf Ph Ph Ph lO lf 95
10 0g Ph Ph t-Bu 1 0 1g 97
1 0 0 b Ph Ph (CH2)2OTIPS 1 0 1 b 96
lOOi Ph Ph (CH2)3OBn lOli 98
lOOj Ph Ph (C=CH2)CH3 101 j 0
1 0 0 k Cy a Bu 1 0 1k c 96
1001 Cy a Ph 1011 95
1 0 0 m Cy a (CH2)3OBn 1 0 1 m 80
lOOn H Me Bu lOln 48
lOOo H Me Ph lO lo c 85
126a Ph H Bu 127ac 83
126b Ph H (CH2)3OTBDMS b 127b b 95
126c Me H (CH2)2OTIPS 127c 98
126d Me H (CH2)3OTBDMS b 127db 94
8 Cy = Fused cyclohexanyl ring. b silyl group was partially removed during cyclisation to yield R3=(CH2)nOH 
(~2:1 in favour o f  proto-desilylated).c confirmation and optimisation o f  yields obtained by M enzies.18
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Spectrum 1: NMR spectrum of diol lOOe (CDCI3) and furan lOle (CDCI3).
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Spectrum 2: *H NMR spectrum of diol 100m (CDCI3) and furan 101m (CDCI3).
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Spectrum 3: ]H NMR spectrum of diol lOOn (CDCI3) and furan lOln (CDCI3).
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Results of particular importance are the elaboration of the bicyclic ring systems 101 k-m, the 2,4- 
disubstituted furans lOln-o and the ability to protect against competing 5-exo-dig ring closures 
(Scheme 25 and 26 -  p 24). By inclusion of a cyclohexanyl moiety, it was possible to synthesise 
tetrahydrobenzofurans which would allow for the inclusion of several fixed stereocentres. This is 
important as it gives the ability to synthesise a range of furanosteroids stereospecifically (Figure 
5); such compounds are known to treat not only common non-life-threatening diseases but also 
rapidly proliferating diseases such as cancer. [S^J-Furanosteroids 0^ are known to act as androgen 
receptor antagonists, which competitively prevent the action of androgen, so can be used to treat 
less threatening diseases such as benign prostatic hyperplasia (BPH) and acne. The coffee 
constituents cafestol and kahweol on the other hand induce the activity of the liver detoxifying 
enzyme glutathione S-transferase51 to increase binding of toxins to glutathione, thereby 
facilitating their excretion.
[3,2] Furanosteroid
Cafestol Kahweol
OH
MeO-
AcQ
MeO
Viridin [4,6] Furanosteroid Wortmannin
Figure 5: Furanosteroids.
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Finally, the [4,6]-furanosteroids52 have perhaps attracted the most interest given their potential to 
act as anti-cancer agents. Traditionally known for their potent anti-inflammatory properties, 
these compounds have recently been shown to selectively block certain intracellular signalling 
pathways associated with cell growth and development, through their irreversible inhibition of 
PI 3-Kinase. One of the most common examples of a PI 3-inhibitor is Wortmannin (Figure 5), 
which is used in cell biology to inhibit DNA repair and cell proliferation.53
Of the other [4,6]-furanosteroids Viridin, which has the same order of activity as 
organomercurials,54 has also attracted much interest, with a recent publication by Jacobi52 
describing a model study of its synthesis (Figure 5). Targeting Jacobi’s model 103 of a viridin 
precursor 102 previously prepared by Sorensen,55 and using some of Jacobi’s previous approach 
work, it seems plausible that 103 can be synthesised from the 2,4-disubstituted furan 104. One 
could perhaps imagine furan 104 being readily synthesised from the 3-alkyne-l,2-diol 105 via 
our silver cyclisation procedure (Scheme 22). The diol itself could be synthesised in a number of 
ways, with one particularly attractive approach featuring an alkynenone ester 106 derived from 
alkynone 107, obtainable from commercially available diethyl phthalate 108, together with ethyl 
acrylate 109 and 1,1-dibromoethene 110.
OTBS
OH
102
5>
OTBS OTBS
EtO
HO.
104
o i-u r o
EtO "O OH EtO 'O
OEt
108
106 X  vEtO ^O
109 110
Scheme 22: Proposed retrosynthetic analysis of model viridin compound 102.
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Traditionally, the synthesis of 2,4-substituted furans has often been troublesome.56'58 Their 
presence in natural terpenoids59 and other natural products60 has generated interest in their 
synthesis yet many previous efforts have failed to be broadly applicable. Knight and Rustidge 
presented one of the first syntheses of 2,4-disubstituted furans, which was of some generality, 
with the use of 4-methyl-2-furyl-lithium but this approach was one which was limited to 4- 
methyl-2-substituted furans.59 Their procedure allowed for the synthesis of a range of 2,4- 
disubstituted terpenoid furans in good yields (50-65%) including the natural sponge metabolite 
pleraplysillin-2 (Scheme 23).
Pleraplysillm-2
Solanofuran
Scheme 23: Naturally occurring 2,4-disubstituted furans.
Using our new approach, it was possible to obtain several 2,4-disubstituted furans in the usual 
excellent conversions (>95%) with the only significant reduction in yield being observed with 2- 
butyl-4-methylfuran lOln (isolated 48%), which can readily explained by extreme product 
volatility. Given the simplicity of this approach, we feel that we have defined a highly efficient 
way to synthesise the troublesome 2,4-disubstituted furans, and one which is truly general. 
Indeed, with silyl protection and deprotection strategies allowing for the use of just one 
equivalent of precious alkynes 113 (Scheme 24), it was possible to synthesise a series of more 
complex 2,4-disubstituted [334; R1 = H] and 2,3,5-trisubstituted 336 furans (Chapter 6.2 -  p 
117). This made it possible to access a range of substituted furans which contained both 
stereogenic centres and olefinic bonds.
p3 p3
r 2 o h ^
R2y O
R1 OH
9® Imidazole
R2 O
Et3N
► R1
R3SiCI
111
OSiR3 
112 ^  
113
n-BuLi, THF TBAF
R3 -78°C R 1 i
Ag* Rs
OSiR3
114
R1 OH 
115
Y V r3
1 ^ 0
334, 336
Scheme 24: Silyl protection during a-hydroxycarbonyl approach to furans 334 and 336.
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The final series of results, which sparked particular interest, centred around the ability to both 
effect and prevent 5-exo-dig ring closures. Attempts to cyclise pentyn-l-ol-based 3-alkyne-l,2-
diols 116 led to a 4:2:1 mixture of the expected “5-endo-dig” furan 117 together with the 
alternative “5-exo-dig” tetrahydrofuran-2-ylidene 118 and dihydrofuran 119, resulting from a 1,4- 
elimination, products (Scheme 25). Spectrum 4 highlights the key peaks between 5.00 and 7.00 
ppm which allude to the proposed structures.
Fortunately, simple masking of the “5-exo” hydroxyl of triol 116, through the application of 
standard protection strategies, allowed for this competitive cyclisation mode to be blocked. 
Examples using both R3 = benzyl 122 (R1 = R2 = Ph) (98%) and R3 = silyl 122 (R1 = Ph, R2 = H) 
(60-98%) protecting groups were both shown to be successful in preventing 5-exo-dig ring 
closure 118, despite their potential lability in the presence of a nearby electrophilic centre. 
Unlike analogous results from the iodocyclisation reaction,61 the desired 5-endo-dig closure 120 
was observed exclusively when using benzyl and silyl protecting groups (Scheme 26). The 
spontaneous deprotection of shorter chain silyl ethers 121 (n < 3) was observed in some cases 
after successful cyclisation; fortunately in these examples, competitive cyclisation was not likely. 
It would appear that this was not the case for longer chain lengths (n > 3) 120, where successful 
prevention of 5-exo-dig ring closures 118 was possible with silyl and benzyl protecting groups.
Scheme 26: Protection strategies allow 5-endo 120,121 and prevent 5-exo 118 ring closures.
OHU2
10% AgNCb.SK^
116 117 118 119
5-endo-dig 5-exo-dlg Dihydrofuran
Scheme 25: 5-endo vs 5-exo ring closures.
120 OhU£ OR3 -oOH
5-endo-dig R3 = SiR3, Bn
(n < 3) R1 OH
122 
R3 * Bn, SiR3
118
5-exo-dig
121
5-endo-dig
24
Spectrum 4: NMR spectrum of possible products from the cyclisation o f unprotected diol 116 (CDCI3).
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The observed competitive 5-exo-dig reaction reveals a potential limitation of this technique but, 
naturally, the very fact that 2 -ylidenetetrahydrofiiran 118 was formed indicates the further 
possibilities of a general procedure for silver(I)-catalysed 5-exo-dig ring closures.
2.2.2: Sonogashira strategy
An alternative procedure for precursor synthesis involved the use of a palladium-catalysed 
Sonogashira coupling reaction62,63 between an alkyne 124 and a vinyl halide 123 (Scheme 27). 
The resulting enynes 125 were then dihydroxylated regiospecifically with catalytic potassium 
osmate, using Sharpless’ dihydroxylation protocol,64-66 to yield the desired 3-alkyne-1,2-diols 
126. These were then cyclised to the furans 127a-d in the usual high yields (>95%) (Table 1).
r 3 p 3
R2 + Pd(PPh3)Cl2  R2y ^  0 s°4 10% AgN03.Si02 RV ^  r 3
R^ X  ^  Cul, Et3N R1J  R ^ O H  DCM ^  R l ^ O
123 124 125 126 127
Scheme 27: Sonogashira, dihydroxylation approach to fUrans.
The advantage which this approach held over the previous nucleophilic addition to an a- 
hydroxycarbonyl centred around the ability to use just one equivalent of precious alkyne without 
the need for protection. This reduced waste and removed the need for column chromatography, 
previously a necessity, which one could consider an extra step given the time required to perform 
such purifications. Another advantage is clear from the ability to control stereochemistry through 
this approach (Scheme 28), by using either a direct asymmetric dihydroxylation 128—>12964~66 or 
an overall dihydroxylation 130—>131, via the epoxide. This allows for the selectivity of the more 
efficient diastereoisomer, in terms of kinetics, the importance of which is discussed later (Chapter 
2.3.2 -  p 37). In both cases, the geometry of the alkene affects the stereochemistry but since this 
geometry is easily known, the final stereochemistry can be chosen. Many concerns with the use 
of osmium can be addressed by using solid-supported osmium catalysts, where toxicity becomes 
less of an issue. The availability of vinyl halides may however be a stumbling block for very 
general applications.
,R3
Os04 CX P NaOHm-CPBA
0  0  R1
Scheme 28: Alternative dihydroxylation procedures.
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A further application of the 5-endo-d\g cyclisation method was aimed at accessing a range of 
furylacetic acids 136, a functionality present in the natural product Plakorsin A,67*70 which itself 
will be discussed in more detail later (Chapter 6.3.2.1 -  p 130). Using a literature procedure 
presented by Lavallee,71 it was possible to regiospecifically add an alkyne 134 to the more 
electrophilic ring carbonyl of 2-acetoxysuccinic anhydride 133, synthesised from malic acid 132, 
since this is also the less hindered site. In situ sodium borohydride reduction was followed by 
sodium hydroxide-induced removal of the acetate group to yield the desired 3-alkyne-l,2-diols 
135a-b (>60%). These diols 135a-b were then directly cyclised under standard conditions to 
yield the target furylacetic acids 136a-b (>95%) (Scheme 29) (Table 2). It can be seen in 
Spectrum 5 that this transformation was effected cleanly once again.
OH OAc OH
JL r n  M AcCI ,— (  n-BuLi, THF 1 10%AgNO3 __
132 133 134 NaOH<3M> 135 136
Scheme 29: Synthesis of furylacetic acids 136a-b.
The lack of literature references surrounding the synthesis of 2-furylacetic acids67*70 alludes to the 
difficulties associated with accessing this class of furans and this result therefore provided a 
major bonus and another beneficial application for the silver(I)-catalysed cyclisation procedure. 
With both alkyl and aryl functionalities being compatible, this procedure formed the basis of our 
attempts to synthesise the natural functionalised furylacetic acid 351 (Chapter 6.3.2 -  p 130).
In a slight modification to the existing procedure, it was also possible to lactonise diols 135a-b 
with /?ara-toluenesulfonic acid in refluxing pyridine to yield a mixture of two cyclic 
diastereomers 137 (Scheme 30).71 Exposure of this mixture to 10% AgNC>3.Si0 2  permitted the 
cyclisation of just one of these (Scheme 31) (Table 2) (Spectrum 6 ). The successful conversion 
of this diastereomer into its cyclic product was found to occur in >95% yield.
10%AgNOj £ y R
136
Scheme 30: Hydroxylactone 137 5-em/o-dig cyclisation.
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Spectrum 5: ]H NMR spectrum of diol 135b (MeOD) and furan 136b (CDCI3).
28
OH Bu OH Bu
138 140
OH
136a 140
, T.F r- T  -.......... r*——**1 ! ’■■ ■ ■ ! ■ —— r-  i ................................—I ■ ■ ■ ,M1 ■ ■ 1—I * ■ * » r * ■ ' ■ I ■ ■ • " > ■" ■ —, ■ ■ —I i r-^  i
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0 5  0.0 ppm
Spectrum 6: !H NMR spectrum of lactone 138 and 140 (CDCI3) cyclising to furan 136a (CDCI3).
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Table 2: Synthesis of furylacetic acids.
PTSA, pyridine
OH
DCMDCMOH
135
OH
136 137
3-alkyne-l,2-
diol
Functional Group R Furan Yield (%)
135a CH2C 02H H Bu 136a 96
135b CH2C02H H Ph 136b 93
137 Lactoine8 Bu 136a a ca. 84 k
a lactone group ring opens during cyclisation to yield R 1=CH2C 0 2H, R2=H. 
b combined yield o f  furan and uncyclised lactone isomer.
It is likely that successful cyclisation occurred with the (5 ^^)-iso m er 138 (Scheme 31), to yield 
furylacetic acid 136 via a m-fused 5/5 bicyclic intermediate 139. These ring systems are less 
strained and, with the presence of the acetoxy leaving group, they form furylacetic acid 136 in 
excellent conversions, >95%. The (&S,570-isomer 140 failed to cyclise altogether, most likely 
due to the need for a trans-515 bicyclic intermediate 141, which would be highly strained. The 
presence of a carbon-carbon double bond and sp2 carbonyl makes this system even less likely to 
form.
10% AgN03 10% AgN03
10% AgN03
r^\w,ur\ j ■ ■
140 141 136a
Scheme 31: Stereoselective furylacetic acid 136a synthesis.
More general diastereomeric observations, applicable to many of the 3-alkyne-l,2-diols lOOa-o, 
126a-d and 136a-b discussed in Tables 1-2, are addressed later (Chapter 2.3.2 -  p 37).
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2.2.4: Limitations
Throughout the course of this project, it has been shown that there are, as with the vast majority 
of synthetic procedures, certain limitations. It had been previously shown that divalent sulfur is 
not compatible with this cyclisation procedure and it is obvious that tetrasubstituted furans are 
unattainable directly through the silver(I)-catalysed cyclisation. Another general observation 
seen previously, and still apparent in these results, was that of silver leaching. It was apparent at 
this stage that a ‘pure’ product could not be obtained without filtration through celite, thus 
preventing the re-use of the silver(I) salt. Investigations into resolving the issue of the 
immobilisation of silver(I) are discussed later (Chapter 5 -  p 81).
Other results of this study highlighted the risk of a competitive 5-exo-dig cyclisation [see 116] in 
appropriate cases, but this has been shown to be avoidable with the implementation of benzyl 
100d,i,m or silyl 100c,h and 126b-d protection strategies (Scheme 32) (Chapter 2.2.1 -  p 24). 
Despite this incurring an additional cost to the procedure, the use of protecting groups often has 
further benefits to the success of other steps, namely in the improved efficiency of addition of 
alkynols 99 (R3 = (CLDnOH) to a-hydroxycarbonyls 98 (Scheme 21 -  p 16).
5-exo
116
5-endo
R1^ O H  (R3 = Bn, SiR3) 
100  and 126
H
R ^O H
142
Scheme 32: Limitations of the silver cyclisation.
OK^
The inability to cyclise diol lOOj also appeared to show a limitation. Addition of 10% 
AgNC>3.SiC)2 to a solution of diol lOOj failed to produce the desired furan lOlj. Instead the 
complex nature of the !H NMR spectrum meant that no firm conclusions could be drawn to as 
what actually did happen. A possible explanation is the nucleophilic addition (by water, or other 
molecules) to the terminus of the exposed enyne system when activated by silver(I). If the 
adjacent hydroxyl were also to be lost, one could envisage cumulene formation. Terminal alkyne 
diols 142 (R = Me or Ph) also failed to cyclise, with only starting material recovered. It is
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however expected that the use of non-terminal alkene substituents 143 may still be compatible 
with the silver(I)-catalysed cyclisation (Scheme 32), in view of a similar result seen with the 
iodocyclisation. 11'15 Indeed, evidence described later suggests that this is the case (Chapter 6.2 -  
p 117) however, an example where the proposed non-terminal alkene substituent is in 
conjugation with the alkyne [143] has not been tested as yet.
A final observation is offered as a caveat. It was seen, particularly in the synthesis of 2,3- 
dimethyl-5-phenylfuran 1 0 1b, that, upon prolonged exposure to 10% AgNC>3.Si0 2 , cyclisation 
produced a second product. With a singlet at 6.75 ppm (J = 1.6 Hz) and a full set of aromatic 
peaks, as well as a fresh pair of methyl singlets at 2.30 ppm and 2.05 ppm (J = 1.6  Hz), it seemed 
plausible that the product was closely related to the furan 101b formed initially. Thus, it was felt 
that the product might be either a “migrated” furan derivative 144->148 or the product of 
oxidation 149 (Scheme 33).
101b 144 145 146 147 148
Ph
Ph
DCM
101b 149
Scheme 33: Methyl migration and oxidation.
Interestingly, there had been some further evidence of such transformations when using either a 
heated flow system (Chapter 5.2.4 -  p 97) and/or microwave irradiation (Chapter 5.2.4 -  p 100).
1 7^Literature H NMR data had suggested that this product may indeed be a furan [e.g. 144]. 
Further investigation into the literature, with particular focus on ,3C NMR data, helped identify 
its true nature. Using the data available,72 and the further evidence from ,3C NMR, it was shown 
that 1,4-dione 149 was the species formed. Therefore, with careful monitoring, it was possible to 
synthesise a clean sample of the desired furan 101b in excellent yield (>95%). Prolonged 
exposure of furan 1 0 1 b to 10% AgN0 3 .Si0 2 , over a period of several weeks, led to the 
observation of a third product at the expense of dione 149. It is felt that this third product may in 
fact be one of the migrated furans 144->148; however, with the lack of literature 13C NMR data, 
these “migrated” structures can only be tentatively proposed.
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In a recent development, with the help of Taheri, the synthesis of pure dione 149 has now been 
robustly achieved. It was shown that microwave irradiation of furan 101b in THF at elevated 
temperature (130°C), in the presence of 10%AgNO3.SiO2 (1 eq), successfully yielded dione 149 
in excellent yields (>95%) within 1 h. Exposure of other furans 101 to the same conditions 
yielded analogous products, but high yields were only observed with furans which contained an 
a-phenyl substituent. As a result of these studies, it can be recommended that care be taken when 
performing the silver(I)-catalysed cyclisations at higher temperatures, and completed reactions 
carried out at ambient temperature should be worked up immediately.
2.3: Silver-catalvsed cyclisation 
2.3.1: Mechanistic elucidation
Given the success of the silver-catalysed cyclisations, efforts were made to try to ascertain how 
and why the cyclisation proceeds. With previous literature having alluded to the “remarkable 
accelerating effect of a propargylic C-0 bond”73 in silver-catalysed cyclisations of other 
acetylenic alcohols, it seemed prudent to investigate the effect of the propargylic C-0 bond on 
our system. Addition of 1-hexyne 151 to 1,2-epoxyhexane 150 yielded the required p-alkynol 
152 in excellent yield (97%) (Scheme 34) .74 Upon addition of 10% AgN0 3 .SiC>2, only starting 
material 152 was recovered.
.Bu
,BU n-BuLi (2.5M) s "  10% AgN03,Si02K |j DULI^.DW l y ' U lU 2
o  ^  — -  r  - 4 4 —  r y - i
BF3 THF complex R u O H  DCM
Bu
B u ^ O H  & u '
150 151 th f , -78°C 152 153
Scheme 34: The importance of propargyl alcohol.
This suggests that the propargylic alcohol functionality is required to instigate a successful 
cyclisation reaction, as suggested by Dalla and Pale (Scheme 35).73, 75 According to their 
rationalisation, it seems likely that the propargylic oxygen coordinates the silver within close 
proximity to the alkyne bond 154, which allows attack by the (3-heteroatom 155 to yield furan 
lOla-o, 127a-d and 136a-b, at least in the case of furan formation when the nucleophile is a 
primary or secondary alcohol.
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HO
Ag
>
R OH 
154
R OH 
155
Rv
1 > R3Rr  O 
101a-o, 127a-d, 136a-b
Scheme 35: Silver co-ordination by propargylic alcohol.
In another approach to determine the driving force of the reaction, the diol p-hydrogens were 
replaced with methyl groups to prevent aromatisation. Addition of 10% AgN0 3 .SiC>2 to a 
solution of the P-gem-dimethyl-l,2-diol 156 in dichloromethane, resulted in no cyclisation, but 
rather yielded an unknown product that might be due to degradation.76 The inability of diol 156 
to cyclise to the dihydrofuran 157 (Scheme 36) suggested that aromatisation is a requirement for 
a successful cyclisation, possibly by providing a thermodynamic ‘sink’ for the furan product.
o k ^ Bu o h
10% AgNOa.SiOs
—X  **
DCM
Scheme 36: P-gemdimethyl-l,2-diol 156 cyclisation.
To test this, a final modification involved the movement of the propargyl alcohol to an exo 
position 161. In this position, the propargyl alcohol would still be present to encourage co­
ordination of the silver to the alkyne bond, but it would not be situated in a position where 
aromatisation could occur, without additional rearrangement. Addition of O-TBDMS-3-butyn-l- 
ol 159 to valeraldehyde 158 (80%), followed by deprotection of the resulting homopropargylic 
alcohol 160, yielded the desired 3-alkyne-l,5-diol 161 (8 8%) (Scheme 37).
OH
Bu
158
O
J
OTBDMS -fBuU.THF.
-78°C
159
OH
Bu
TBAF
OH
161
10% AgN03,Si02
DCM
OTBDMS 
160
c KO OH 
162
Scheme 37: Exo propargyl alcohol 161. 
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Cyclisation with 10% AgN03 .Si0 2 led to the formation o f dihydrofuran 162, containing 
unreacted starting diol 161. Prolonged exposure, in an attempt to achieve complete cyclisation, 
saw decomposition of the initial product 162 to unknown products.76 This observation deserves 
further attention, but clearly is not currently a viable dihydrofuran synthesis. It does however 
suggest that aromatisation may not be critical to a successful cyclisation but may be a 
requirement for robust, stable reaction products.
With the above observations in hand, we propose a mechanistic pathway through which the silver 
cyclisation o f 3-alkyne-l,2-diols proceeds. Starting with the known coordinating abilities o f the 
propargyl alcohol, one would expect the silver to be directed into a position where it bridges the 
alkyne bond through acceptance o f re-electrons into its lowest unoccupied molecular orbital, in 
the case o f  silver, a o-orbital. Molecular orbital theory then suggests that an occupied d-orbital, 
most likely a dxy, dxz or dyz orbital, donates electrons to the empty n*-orbital o f the alkyne to help 
form a stronger interaction. This phenomenon is known as back bonding and is best shown by 
the Dewar-Chatt-Duncanson model (Figure 6).
(2) d-orbital back bonding to alkyne 7t-orbital.(1) 7t-electron donation to metal an-orbital.
(4) d-orbital back bonding to alkyne 7i-orbital.(3) Ti-electron donation to metal d-orbital.
Figure 6: Dewar-Chatt-Duncanson model: Four-bonding interactions o f an alkyne and metal.
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The effect of donation of the alkyne 7t-electrons to the silver o-orbital is to make the alkyne 
electron deficient, which in turn makes it amenable to nucleophilic attack. Attack of the 13- 
heteroatom results in ring closure via a formal 5-endo-dig transformation. Donation of the ring 
heteroatoms’ lone pair into the newly formed cycle allows for elimination of the a-hydroxyl 
group. This results in the formation of an oxonium ion which readily loses a proton to form the 
observed furan (Scheme 38). Finally, it is believed that the silver undergoes Ag+/H+ exchange. 
Although it is not clear when or exactly how this happens, this concept seems plausible given 
both the acidic nature of the support and the presence of the nitrate counter ion, which together 
can be used to abstract the silver atom from the furan intermediate. Further evidence is provided 
by Nishizawa’s investigations into the use of mercury triflate, where he proposed a similar 
exchange concept.35,77
101a-o, 127a-d 
136a-b
H Ag
Ag+ R OH 
10Oa-o, 126a-d
135a-b
A g) r
r”P )
R OH
(-H+) (-H*)
Ag /f-ujAg
-V r
Scheme 38: Proposed silver catalytic cycle.
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Stereochemical control is crucial to many chemical transformations, and is equally true for this
work. As already identified, stereochemistry had an effect not only on the rate of cyclisation, but 
in one particular case, on the ability to cyclise altogether. In the case of the lactone cyclisation, it 
was clear that the required trans-5/5 bicyclic intermediate 141 of the (RS,SR) isomer was too 
strained to permit cyclisation, (Scheme 31 -  p 30). All other general examples lOOa-m, 126a-d, 
135a-b and 137 did not have this large ring strain and thus only their rate of cyclisation, rather 
than their ability to cyclise, was seen to be affected.
Thus, to understand the effects of stereochemistry on the rate of cyclisation, it is first necessary to 
confirm the nature of the major isomer formed. In the case of 3-methylnon-4-yne-2,3-diol 164, a 
68:32 ratio of isomers was observed. Assuming chelation control prevails, a provisional Felkin- 
Anh assessment alluded to the stereochemistry of the major isomer 164a to be syn and the minor 
isomer 164b to be anti (Scheme 39).
In a bid to confirm the above, 3-methylnon-4-yne-2,3-diol 164a was stereoselectively 
synthesised. A Sonogashira coupling of (is)-2-bromobut-2-ene 165 with 1-hexyne 166 yielded an 
enyne 167 (Scheme 40). Sharpless asymmetric dihydroxylation with the (DHQD)2-PHAL ligand 
allowed for isolation of the syn-diol 164a (Scheme 40).64-66
MAJOR
HO?
164b
MINOR
Scheme 39: Felkin-Anh elucidation of stereochemistry - Chelation control.
Pd(PPh3)CI2
Bu Bu w nw Bu
O s04
HO
165 166 167 164a
Scheme 40: Stereoselective approach to sy«-3-methylnon-4-yne-2,3-diol 164a.
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The ;H NMR spectra of the diastereomeric mixture obtained through the addition of lithiated-1- 
hexyne to 3-hydroxybutan-2-one 163 (Scheme 39) showed the presence of two isomers, with the 
2-H proton seen at 3.70ppm for the major isomer and 3.52ppm for the minor isomer. 
Comparison with the *H NMR spectra of the stereoselectively synthesised sy«-3-methylnon-4- 
yne-2,3-diol 164a, where 2-H was seen at 3.70ppm, confirmed the major diastereomer from the 
mixture to be the syn-diol 164a. This result appears to agree with the Felkin-Anh model analysis 
(Scheme 39), if chelation control is indeed true.
Therefore, to test whether this was the case, the effect of protection groups was assessed. One 
would expect that if chelation control is predominant, then the presence of a non-chelating 
protecting group on the a-hydroxy group should change the selectivity of the addition. A good 
example would be the use of a silyl protection strategy. With the direct addition of 1-hexyne to 
benzoin having been seen to be almost stereospecific (99:1) in favour of the presumed syw-type 
diastereomer 169a (OH in place of O-TBDMS = lOOe), a Felkin-Anh model with TBDMS- 
benzoin 168 was used (Scheme 41). This suggests that the previously observed minor anti-type 
isomer 169b would now be favoured over the 5yw-type isomer 169a upon the use of a non­
chelating protecting group. HOPh
Ph y.0
P h ^ o T B D M S
168
Phu Xf>OTBDMS 
M Ph
OH
* W h ,^ V P h  ' 
B u ^  OTBDMS
HOTBDMS
169a
MINOR
PhOH
HOTBDMS 
169b
MAJOR
Scheme 41: Felkin-Anh elucidation of stereochemistry - Non-chelation control.
It was found that addition of 1-hexyne 170 to O-TBDMS-benzoin 168 resulted in the observation 
of the proposed stereochemistry with a ratio of syn- 169a to anti- 169b being 40:60 (Scheme 42).
P h y O
P h ^ u T B D M S
170
Bu
OH^ Bu
Ph OTBDMSOTBDMS
168  169a 169b
40% 60%
Scheme 42: Addition of 1-hexyne 170 onto O-TBDMS-benzoin 168.
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This observation was important as the enforcement of non-chelation control successfully inverted 
the selectivity, of what was a highly selective addition, in favour of the minor isomer. As a 
result, this appears to support the previous concept of chelation control in the formation of 
unprotected 3-alkyne-l,2-diols 164a,b.
Final confirmation came from the successful procurement of an X-ray crystal structure 
(Appendix A) for the major isomer of diol lOOf, obtained via the chelation control pathway. It 
can be seen clearly that, as predicted, the hydroxyl groups are situated syn to one another (Figure 
7). All bond angles and lengths appear normal and there appears to be hydrogen bonding 
between 01 and the hydrogen attached to 02, which has further implications (Scheme 43).
C20
C19
C16, X 17
C I4 '
C13<
[Cl 2
Figure 7: X-ray structure of ^ -diastereom er of diol lOOf.
Having determined the issues of selectivity upon addition to an a-hydroxyketone, it is now 
possible to consider the effect of stereochemistry on the rate of cyclisation. The synthesis of both 
syn- 164a and anti- 164b diastereomers implies two possible cyclisation alignments (Scheme 43).
164a 171a 101a 171b 164b
MAJOR (syn) MINOR (anti)
Scheme 43: Cyclisation of syn- 164a and anti- 164b diastereomers.
It can be seen in Scheme 43 that the more stable conformation of the major syw-isomer 171a, 
where the bulky side groups (2 x Me) reside in equatorial positions, provides the required
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alignment for cyclisation. It also presents a beneficial axial alignment of the propargylic 
hydroxyl, which perhaps aids proton abstraction from the ring closing heteroatom. The minor 
anti-isomer 164b, on the other hand, has a sterically demanding axially aligned substituent in 
both of its alignments 164b and 171b, thus the equilibrium is not as one sided towards the 
beneficial axially aligned hydroxyl groups 171b. With consideration of these factors, one would 
expect the syw-isomer 164a to cyclise faster, particularly when the methyl substituents are 
replaced by larger groups, to give furan 101a.
One of the best ways of assessing the rates of cyclisation is to use continuous monitoring. The 
use of thin layer chromatography (TLC) to qualitatively analyse the cyclisation of 3-alkyne-l,2- 
diols in different solvents (Chapter 2.3.3 -  p 41) was less applicable to this situation since some 
of the diastereomers of interest were inseparable. Fortuitously, silver(I)-catalysed cyclisations 
can be performed in an NMR tube and, with appropriate programming, can be continuously 
analysed at regular time intervals (Figure 8 ). In this way the single diastereomer of diol lOOe and 
the combined diastereomers of diol 100a were observed to cyclise to yield their respective furans 
101a and lOle in excellent yields, within 4 h and without the observation of any intermediates. 
Further spectroscopic data for some other furans can be found in Appendix B and C
100e 101e
b)
Figure 8: Continuous in situ monitoring by *H NMR spectroscopy. 
a)l,2-diphenyloct-3-yne-l,2-diol lOOe (CDCI3). b) 3-methylnon-4-yne-2,3-diol 100a (CDCI3).
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Performing a similar analysis on the mixture of diastereomers of 3 -methylnon-4 -yne-2 ,3 -diol 
100a allowed for the relative rates of cyclisation of the syn- 164a and anti- 164b isomers to be 
continuously monitored (Figure 8b). It was found that in a 2:1 mixture, the major syn- 164a 
isomer cyclised faster than the minor anti- 164b isomer, as expected. Indeed, the cyclisation is 
seen to proceed at approximately twice the rate of the ««//-isomer 164b, a significant time saving.
Thus, with the above results in hand, it can be confirmed that the observed stereochemistry 
occurs as a result of chelation control, except where protection strategies are used. 
Unsurprisingly this has been shown to have important implications on the overall rate of 
cyclisation, and should certainly be considered when choosing whether or not to implement 
protection strategies. It adds purpose to the use of a Sonogashira pathway given the reliability of 
Sharpless dihydroxylation.
2 .3 .3 : Solvent effect
Historically, dichloromethane had been the chosen solvent for these cyclisations. With the 
previous experience of other group members having shown that certain iodocyclisation reactions 
hinged upon solvent choice, it seemed prudent to test the effect of solvent on the silver(I)- 
catalysed cyclisation reactions. Thus, 10% AgN0 3 .SiC>2 (0.2eq) was used to successfully effect 
the cyclisation of l,2-diphenyloct-3-yne-l,2-diol lOOe in acetone, chloroform, dichloromethane, 
ethanol, ethyl acetate, hexane, tetrahydrofuran and toluene to yield furan lOle (Scheme 44). 
Qualitative monitoring using TLC showed both ethanol and hexane to be superior in terms of rate 
to the existing solvent dichloromethane, with hexane effecting cyclisation quantitatively within 
1.5 h. Dichloromethane was third best, being within the standard 4 h timeframe, with chloroform 
and toluene following closely behind with complete cyclisation occurring within 5 h. Indeed, the 
only common solvent used which did not successfully effect the cyclisation was water. This can 
be readily explained by the inability of water to dissolve the substrate.
Bu
10%AgNO3SiO2
"—Bu
OrL^
Ph" 0  
101e
Scheme 44: Synthesis of 5-butyl-2,3-diphenyl furan lOle.
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Additionally, a short time was spent assessing the use of ionic liquids. In preparation for work
7ftwhich was performed with David Cole-Hamilton (Chapter 5.3 -  p 105), the ionic liquids 
[bmim][OS0 2 0 (CH2CH2 0 )2Me] 172 and [bmim][OTf] 173 (Scheme 45) were successfully 
employed for the cyclisation of l,2-diphenyloct-3-yne-l,2-diol lOOe to its corresponding furan 
lOle in similarly essentially quantitative yields (>95%) (Scheme 44).
r^\® r^\® ft r5=^ \®ki- r.i I r
„  ^ N~Bu u M J * * *  u M J * ° *Me ^  Me Q /  @ Me @
0 S 0 20(CH2CH20)2Me OTf NTf2 NTf2
172 173 174 175
Scheme 45: Ionic liquids to effect cyclisation.
The further successful use of [omim][NTf2] 174 and [ompy][NTf2] 175 (Scheme 45) had 
important implications for use in our second novel flow system for heterocyclic synthesis 
(Chapter 5.3- p  105).
2.3.4: Rate studies
At this point, having been able to make some suggestions for the mechanism and the 
stereochemical behaviour, efforts were made to optimise the reaction kinetics using our existing 
dichloromethane system. Using l,2-diphenyloct-3-yne-l,2-diol lOOe as a standard (Scheme 44), 
lOOpL samples were taken at frequent intervals and assayed using *H NMR spectroscopy. The 
data generated allowed an assessment of the effect of both substrate concentration and catalyst 
equivalence on the rate of reaction to be made (Chart 1).
Effect of substrate concentration 
and catafvst equivalence
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Chari 1: Conversion data: Effect of substrate concentration and catalyst equivalence.
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Consideration of the variation in substrate concentration showed that, on the whole, the more 
concentrated the solution and the more catalyst present then the shorter the overall reaction time. 
This can be seen clearly in Chart 1 with complete conversion occurring between 75-150 mins for 
the most concentrated solutions tested. Interestingly the reaction profile of each solution showed 
the expected concentration dependent curve, where maximal conversion is seen early on when 
the substrate is in effect saturating the catalyst.
The impact of catalyst concentration seemed to induce a more dramatic effect, as one might 
expect, given that even a slight increase in catalyst equivalence was enough to accelerate 
cyclisation significantly. In fact, this acceleration was most dramatic between lower catalytic 
boundaries, i.e. between 10 mol% and 20 mol% catalyst use, where the 20 mol% catalytic 
reactions were all seen to achieve completion in less than half the time of the corresponding 10 
mol% reactions. Beyond a catalyst equivalence of 20 mol%, there were marginal improvements 
in rate relative to the increase seen between 10 mol% and 20mol%. Indeed, when using 
stoichiometric AgN0 3 .SiC>2 catalyst, the rate was seen to increase by a factor of two relative to 
the rate shown when using 20 mol% catalyst, yet the molar equivalence of silver had increased by 
a factor of five.
It is of note that any change in concentration appears to be much less significant than a change in 
the equivalence of catalyst, with regard to the rate of reaction. Indeed the data shows an overall 
increase in rate of cyclisation, across the range tested, by a factor of 1.4 for a 10-fold increase in 
substrate concentration compared to a change of 6.7 for a 10-fold increase in the amount of 
catalyst. All of this data boded well for the pursuance of subsequent ideas where the catalyst was 
to be placed in a column or within a similar setup.
2.4: Conclusion
It has been shown that the silver-mediated 5-cra/o-dig ring closure of 3-alkyne-l,2-diols is 
broadly applicable to a range of substituents including alkyl, aryl, carboxyl, hydroxyl and 
substituted vinyl groups. The successful use of three different approach strategies has provided a 
variety of avenues from which to access a series of his- and ^/-substituted furans. Many were 
cyclised overnight to ensure complete cyclisation. However, from the series of rate studies one 
would expect the majority of these to be complete within 4-6 h. In a handful of cases the
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prolonged exposure to 10% AgN0 3 .SiC)2 caused ring opening, and perhaps methyl migration, 
however under standard conditions this was not an issue in the majority of cases.
The observed competitive 5-exo-dig cyclisation reaction is of interest. Although an undesired 
side reaction in the synthesis of furans 127b’, this observed transformation has great potential. 
For instance one could imagine, given appropriate substrates, the use of the silver(I)-catalysed 
cyclisation in the synthesis of a series of 2-alkyl idenetetrahydrofurans 118, and perhaps even a 
series of pyrrolidine-2-ylidenes.
With the effects of stereochemistry and solvent nature having been assessed, as well as substrate 
and catalyst concentration dependence, a range of operation conditions have been identified. It 
appears that optimal cyclisation is observed when using the syn diastereomer as a highly 
concentrated solution in hexane or dichloromethane. The use of 10% AgN0 3 .Si02 in differing 
amounts had a marked effect on the overall rate, with an optimum of 20 mol% perhaps being 
seen as the most efficient relative to the amount of catalyst required. With the above work 
displaying the vast potential of this technique, a solid foundation, from where the rest of this 
project is built, has been laid.
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Synthesis o f Pyrroles
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3.1: Introduction
Like furans, pyrroles 83 are important targets in drug development and elsewhere. They, and 
their derivatives, are used in a range of highly successful therapeutics and are found throughout 
nature, e.g. pyoluteorin 176, kryptopyrrole 177, /?-nicotyrine 178 and the porphyrin ring system 
179 (Scheme 46).
H
176 177 178 179
Scheme 46: Important examples of substituted pyrroles.
Porphyrins 179 and 181, found in haem and chlorophyll derivatives, have long been a target of 
many synthetic chemists. Traditionally, these were synthesised through the condensation of 
dipyrrolic intermediates 180 (Scheme 47),80 but suffered from the need for symmetry in order to 
avoid complex mixtures of isomers.
E t
180
Scheme 47: Classic synthesis of porphyrins 181.
Following this work, Kenner described the stepwise synthesis of unsymmetrically substituted 
porphyrins, via the progressive synthesis of pyrrole 182, 183, 185 and 187, dipyrrole 184 (72%), 
tripyrrole 186 (76%) and tetrapyrrole 188 (89%) subunits.81,82 Cyclisation of tetrapyrrole 188 in 
the presence of copper(H) acetate in DMF yielded the copper(H) complex of porphyrin 189
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(Scheme 48). Demetallation was effected by the addition of trifluoroacetic acid containing 5% 
sulfuric acid to yield porphyrin 190 in moderate yield (30%).
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Scheme 48: Kenner’s porphyrin 190 synthesis.
One of the most significant synthetic applications of a pyrrole functionality in recent years has 
seen its use in atorvastatin 191 (Scheme 49). Like statins 192 and 193, it acts as a competitive 
inhibitor of the enzyme HMG-CoA reductase to help lower levels of LDL-cholesterol in the 
blood.83 Unlike other statins, for example Pravastatin 19284 and Simvastatin 193,85 atorvastatin
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191 is an entirely synthetic compound and in 2005 traded under the name Lipitor to produce 
annual sales of $12.2 billion, making it the largest selling drug in the world that year.83
NH
F
HO'
HOOC OH
191
OH
HO'
HOOC OH
192
O
OH
193
Scheme 49: Atorvastatin 191, Pravastatin 192 and Simvastatin 193.
Despite the importance of pyrroles, there are only a few broadly applicable synthetic strategies 
available to a synthetic chemist. Perhaps the best known of these are the Hantzsch 194-M9786, 
Paal-Knorr 198-M995'6 and Knorr 200-^2037'9 syntheses (Scheme 50). These are classic 
“textbook” reactions, but unfortunately their efficiency and lack of very broad applicability do 
not reflect as kindly as their fame may suggest. A common example of this is that in many 
pyrrole syntheses, there is often a requirement for the inclusion of an ester group around the ring 
as in 197 and 203. It is further seen, in many examples, that precursor synthesis is more of a 
problem than the key reaction itself.
O
O ^ R 3
OEt OEt
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H2N' 'R3 
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Scheme SO: Hantzsch 194-M 97, Paal-Knorr 198-^199 and Knorr 200-^203 pyrrole syntheses.
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Despite its limitations, the reputation of the Paal-Knorr reaction 198->199 means that it still 
attracts much interest. Many have focused on trying to improve the yields of what on paper looks 
like an appealingly straightforward transformation. A good example of this is seen in a recent 
modification presented by Banik.87 He used bismuth nitrate and obviated the need for previous 
modifications which required acid and/or microwave irradiation (Scheme 5 1).88’90
a R 3 BKN03)3 5H20 , R1NH2-----------------XV-R3DCM.n r 2 ^ N R1
204 205
Scheme 51: Banik’s modified Paal-Knorr synthesis of pyrroles 205.
With high yields of pyrroles 205 (70-98%), and mild conditions, this approach has certainly made 
an improvement on many of the previous attempts but still suffers from the major drawback of 
the Paal-Knorr reaction, the relative difficulty in synthesising 1,4-dicarbonyls 204. While there 
are very many routes, atom efficiency is often a problem as well as overall yields. Fortunately, 
there are several less well known synthetic methodologies that are of greater practical interest 
and, as such, these have found use in the synthesis of several important targets.
3.1.1: Iodocyclisation
Knight’s interest in the synthesis of 3-iodofurans 20615 had been extended to the synthesis of 3- 
iodopyrroles 208!2 via the cyclisation of 3-alkyne-2-hydroxy-1 -sulfonamides 207 (Chapter 2.1.2 
-  p 9). Using this method, Singkhonrat was able to successfully synthesise a range of substituted 
3-iodopyrroles 208 in high yields (65-85%), which could further be converted into the analogous 
pyrroles 209 using one of the many Pd 0 catalysed coupling reactions now available (Scheme 
52).91
R2 J  R R1 I  HCOONa R 1 ,R3
y W  X  Jl525-  X V r2 p^ 3)2 y V r2
R1 0  Me02C NHTs Me02C ^s dmf, no°c Me02C ^s
206 207 208 209
Scheme 52: Synthesis of 3-iodopyrroles 208 using the iodocyclisation protocol.
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With complete regioselectivity and high yields, this technique certainly provided a useful 
approach to a series of synthetically useful pyrroles 208 and 209. Unfortunately, there were some 
limitations with this technique, with the need for three equivalents of iodine being of particular 
concern. There was therefore still a reliance on other techniques for the synthesis of many other 
substituted pyrroles 209.
3.1.2: Catalytic synthesis of pyrroles
As with furans, there are a variety of catalysed procedures for the synthesis of pyrroles. Both 
copper92, 94 and palladium93, 94 salts are good examples of this but, as with most synthetic 
approaches to pyrroles, their success is often restricted to only a handful of examples. For 
instance, Takeya has described a palladium-catalysed oxidation of hydroxy-enamines 210 to 
keto-enamines 211, which then yielded polysubstituted pyrroles 212 in mixed yields (36-84%) 
(Scheme 53).93
Ck
P~  R?
^  r 2  MsBr, K2C 0 3
2 h
212
Scheme 53: Takeya’s synthesis of polysubstituted pyrroles 212.
With the need for elevated temperatures (150°C), the required p-ester substituent and the 
‘moderate’ yields, this procedure has severe limitations. Despite allowing for the inclusion of a 
range of substituents, the overriding limitations prevent this technique from being widely used.
Gabriele has investigated the copper- and palladium-catalysed cycloisomerisation of (Z)-2-en-4- 
yn-1 -amines [213; R3/ H].94 In a similar transformation to that featuring the previously discussed 
(Z)-2-en-4-yn-l-ols 5626, 26~38’43 (Chapter 2.1.3 -  p 10), the corresponding amines 213 undergo 
cyclisation to yield polysubstituted pyrroles [214; R3/ H] (Scheme 54).
Cu cat.
DMA 25-100°C R2 N
R1
214
Scheme 54: Gabriele’s copper-mediated synthesis of poly-substituted pyrroles [214; R3/ H].
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The conversions in many of these copper-catalysed transformations were found to be excellent 
(often 100%), however isolation was a problem with somewhat lower yields (63-91%) often 
being obtained. Alkyl, substituted vinyl and /-butyl substituents were all compatible with this
or KC1, were not as efficient as their copper counterparts with pyrroles [214; R3 / H] being 
isolated in usually moderate yields (25-80%) (Scheme 55).
Scheme 55: Gabriele’s palladium-mediated synthesis of polysubstituted pyrroles [214; R3 = HJ.
Unlike the copper-catalysed cyclisation, it was found that the palladium-catalysed system was far 
more suited to enynes [213; R3 = H]. In such cases, conversions were excellent (~100%) and 
isolated yields only fell slightly to 82-87%. With this proven ability to synthesise 2-substituted, 
2,4-disubstituted and both 2,3,4- and 2,3,5-trisubstitued pyrroles [214; R3 = H], these approaches 
present a system which has the potential for very broad applications. The variable yields are 
perhaps somewhat of an issue, but this work marks a significant contribution in a difficult field.
The final significant contributions, regarding the catalysed synthesis of pyrroles, have been 
described by Knight and Sharland. They successfully cyclised several 3-alkyne-2-hydroxy-l- 
sulfonamides 215 (R’ = Ts) with copper(I) (6 h), palladium(II) (5 h) and mercury(II) (16 h) salts 
to give 3-hydroxy dihydropyrroles 216a and pyrroles 216b in good yields (76-84%), often with 
selectivity leaned towards the 3-hydroxy dihydropyrroles 216a (Scheme 56).16 These reactions 
were carried out in pyridine-ether mixtures at reflux.
cyclisation but there was a requirement in each example that R3 could not be a proton. The same 
palladium-catalysed transformations of enynes [213; R3 / H], in the presence of a co-salt e.g. KI
DMA 25-100°C
R1
213 214
215 216a 216b
Scheme 56: Metal-catalysed synthesis of pyrrole-2-carboxylates 216.
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Following this work, they successfully employed 10% AgNC>3.SiC)2 in the synthesis of a series of 
pyrrole-2-carboxylates 216b, which were obtained in excellent yields (>95%) (Scheme 56). Not
work performed towards the synthesis of the furans lOla-o 127a-d and 136a-b (Chapter 2.2 -  p 
16). With the high yields came high purity: the only observed side product was water.
synthesis of furans lOla-o, 127a-d and 136a-b, the reaction itself was very robust and has the 
potential to be manipulated by temperature, solvent and a range of other variables. With few 
limitations, and without as strong a competitor as gold in this field, generalisation of this 
synthesis of pyrroles has the potential to make a considerable impact.
3.13: Nitriles in pyrrole synthesis
As a final point of discussion for the synthesis of pyrroles, nitriles and isonitriles are well known 
for their uses in cycloaddition reactions. Containing both nucleophilic and electrophilic 
functionalities, they are involved in two bond-forming transitions, which ultimately results in the 
formation of a nitrogen-containing heterocycle. They have traditionally found applications in the 
synthesis of pyrazoles but more recently they have also been used in the synthesis of pyrroles.
With there being such an interest in developing a simple and broadly applicable synthesis of 
pyrroles, several groups have looked to utilise nitriles or isonitriles. A good example, presented 
by Bullington,95 incorporates the use of isocyanoacetates 218. Here, an a,p-unsaturated nitrile 
217 is coupled with methyl isocyanoacetate 218, in the presence of potassium /-butoxide, to yield 
a 2,3,4-trisubstituted pyrrole 219 (51-60%) (Scheme 57).
only were pyrroles 216b formed selectively but the reaction no longer required pyridine and it 
proceeded successfully at ambient temperature within 4 h. This was the first example of a silver- 
catalysed cyclisation of a 3-alkyne-2-hydroxy-l -sulfonamide 215 and formed the basis of the
Furthermore, the reaction conditions were mild and, as has been shown by the work towards the
Ar
COOMe
Ar
Ar f-BuOK Ar
COOMe217
O H
O
218
219
Scheme 57: Bullington’s methyl isocyanoacetate [2,3] strategy.
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Addressing perhaps one of the most difficult tasks in the synthesis of pyrroles, that of 
regioselectivity, this technique does have its advantages. Many others require quite varied and 
convoluted approaches to obtain the desired regioisomers. Despite this, and the simplicity, there 
is still an untested limitation with the use of only non-enolisable aryl a,p-unsaturated nitriles 217. 
The generation of potassium cyanide is of course another concern, one which could limit this 
technique to preparative scales.
One of the most successful syntheses, which utilises isonitriles, is the Barton-Zard reaction. This 
reaction has generated much interest and as a result there have been several publications which 
are based around this reaction. First reported in 1990,96 Barton and Zard described the synthesis 
of pyrroles 223 in good yield (55-97%) from nitroalkenes 221 and a-isocyanoacetate esters 220 
using a procedure which is now widely regarded as one of the most competitive pyrrole syntheses 
(Scheme 58).
base N C  N 0 2 *****
C N ^ o 2n .
+ X *  -
R 10 ^ 0 H 'A r 2
220 221 2 2 3
R 10 2C  l f  R 3 
R 2 
222
Scheme 58: The Barton-Zard synthesis of pyrroles
Having shown compatibility with alkyl, aryl and hydroxyl substituents, this procedure has broad 
applications towards the synthesis of substituted pyrroles 223. Further successes of the Barton- 
Zard reaction include its use in the synthesis of ^ -substituted porphyrins 22797 and the synthesis 
of pyrrole[2,3-&]indole ring systems 230 (Scheme 59).98
0 2 Nv . R 2  p o r p h y r in
R1 OAc
+ 1 1 m C N
C N
2 2 5 2 2 6
RING SYSTEMS
2 2 4    2 2 7
N O 2
\  N C  base
N + ^ C 0 2E t
S 0 2P h
2 2 8  2 2 9
Scheme 59: Synthesis of substituted porphyrins 227 and pyrrole[2,3-£]indoles 230.
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The alternative procedure exemplifying the use of nitriles, presented by Pagenkopf," utilises both 
nitriles 233 and a,P-unsaturated nitriles 217 in combination with cyclopropanes 232 in a [2,3]- 
cycloaddition (Scheme 60). He showed that pyrroles 234 could be synthesised, via a novel 
cascade [2,3]-dipolar cycloaddition, dehydration and tautomerisation sequence, in often 
respectable yields (52-93%).
1 ^ 1 r 3 r 2R O ^ R 3 R1<X /K h  d4 J
T  N;CHC0;EI>  J x V  E ♦ f p > - R 3
R2 C u o rR h ca t. R2 C02Et N MeNOz r4 n
231 232 233 234
Scheme 60: Pagenkopf s synthesis of pyrroles.
This sequence allows for the inclusion of aryl, alkyl and substituted vinyl groups around the ring 
system. With further regioselectivity, this procedure has all the makings of an approach which 
can be used for the efficient synthesis of a vast array of substituted pyrroles. There are of course 
occasional examples which are not as efficiently synthesised but, even with these in mind, this 
procedure is perhaps another major competitor in the field of substituted pyrrole synthesis.
3.2 Silver-catalvsed synthesis o f pyrroles
3.2.1: Aim
Given the broad successes of the furan cyclisations, it was felt that similar efforts could be made 
to secure the synthesis of a broad range of pyrroles. As shown previously, the Knight group had 
applied two different 5-endo-dig cyclisations to the synthesis of pyrroles: the iodocyclisations 
investigated by Singkhonrat,91 and the silver(I)-catalysed cyclisation, described briefly by 
Sharland.17 With much of the work by Sharland having been focused around syntheses of the 
substituted pyrrole-2-carboxylates 216b (Scheme 56), it seemed prudent to attempt to prepare a 
more expansive series of alkyl, aryl and N-protected pyrroles 239 (Scheme 61). It was also of 
interest to assess the effect of protecting groups1008 and stereochemistry,1006 with the aim of 
forging a compatibility with both acid- and base-sensitive approach strategies, as well as 
determining their compatibility with the cyclisation itself.
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Following on from the approach work to 3-alkyne-l,2-diols lOOa-o, 126a-d and 135a-b (Chapter
2.2 -  p 16), a simple approach was devised, one in which an alkyne would be coupled to an a- 
aminocarbonyl compound 237. With nitrogen being trivalent there came a further requirement to 
use a protection strategy. Coupled with the fact that commercially available a-aminocarbonyls 
237 (R’ = H) are few and far between, it meant that, unfortunately, this strategy had to be taken 
back to a synthetically early stage with the addition of two extra steps (Scheme 61).
R V OH R V 0H PCC. N.OAC R V °  R2^  10%A9 N O ,SC 2 R 2
AR1 NH2 R1 NHR' DCM R1 NHR'"'BuU thf R1 NHR‘ r 1 n
R'
235 236 237 238 239
Scheme 61: a-Aminocarbonyl approach to protected pyrroles.
The first step incorporates protection of the more nucleophilic nitrogen of a commercially 
available 1,2-aminoalcohol 235 to yield the protected amine derivative 236 (>95%). Overnight 
PCC oxidation, with purification through a flash column, yielded the desired protected a- 
aminoketones 237 in excellent yields (>80%). Next, w-BuLi-mediated alkyne addition (2.2 eqs) 
yielded the corresponding protected-3-alkyne-2-hydroxyamines 238, the key cyclisation 
precursors. Starting with a tosyl protected a-aminocarbonyl 237a (R1 = Me, R2 = Ph, R’ = Ts), 
several alkynes were successfully employed to yield a series of tosyl-3-alkyne-2- 
hydroxysulfonamides 238a-d (Table 3).
Table 3: Synthesis of tosyl protected-3-alkyne-2-hydroxyamines.
Protected a- 
aminocarbonyl
R 1 R2 R3 Protecting 
Group (Rf)
Protected-3-alkyne-
2-hydroxyamine
Yield
(%)
237a Me Ph Bu Ts 238a 82
237a Me Ph Ph Ts 238b 80
237a Me Ph TMS Ts 238c a 22 8
237a Me Ph H Ts 238d * 18 8
a Obtained from the same crude mixture. Y ields reflect contribution in crude composition.
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Where TMS-acetylene 238c,d (R3 = TMS) was used, it was found that two products were 
isolated, the TMS-alkyne 238c (R3 = TMS) and the deprotected terminal alkyne 238d (R3 = H). 
With a combined isolated yield of ~40%, this addition was not as efficient as previous examples, 
but provided two tosy 1-3-alkyne-2-hydroxy sulfonamides 238c and 238d, both suitable candidates 
for cyclisation.
In view of the ease of work-up associated with the use of 1 -hexyne, the synthesis of a series of 
protected-2-aminonon-4-yn-3-ols 238a-h (R1 = Me, R2 = Ph, R3 = Bu) was targeted. Protection of 
the a-amino group and concurrent oxidation were found to be equally successful in the cases of 
the precursors 237b-d having 4-nosyl, Moc and Boc protecting groups respectively (Scheme 62). 
P h ^ O  P h ^ O
^ N H N s  ^ N H C 0 2Me ^ N H C 0 2f-Bu
237b 237c 237d
Scheme 62: Protected a-aminoketones.
Addition of 1-hexyne to the respective protected a-aminoketones 237b-d yielded the desired 
protected-2-aminonon-4-yn-3-ols 238e-h (65-83%) (Table 4), with any stereochemical 
implications of the protecting groups being discussed later (Chapter 3.2.4 -  p 64). It was found 
that when using Moc 237c and Boc 237d protecting groups, there was a requirement to modify 
the work-up procedure upon the addition of 1-hexyne to the protected a-aminoketone 237c-d 
(Scheme 63).
Bu
Ph
>=0KH2P0 4  pH7 buffer
240
NHR'
237c-d Phn-BuLi, 1-hexyne 
-78°C
NHR’
conc. HCI, -78°C
238f-g
Scheme 63: Modified work-up procedure for Moc and Boc protection strategies.
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This modification was required given the electrophilic nature of the carbamate functionality. If 
not used, then it was found that a significant amount of oxazolidin-2-one 240 was formed when 
quenching with the usual aqueous phosphate buffer, upon warming to room temperature. This 
was still the case even when this quench was carried out at -78°C, probably a result of the frozen 
water not providing a sufficient proton source. Thus, the decision was taken to add concentrated 
hydrochloric acid (few mL) at -78°C to ensure an immediate termination to the reaction (Scheme 
63). It was found that the products of this reaction contained only the desired 3-alkyne-2- 
hydroxy-1-aminocarbonyls 238f-g, which were obtained in high yield (65-83%). Importantly, 
despite the presence of concentrated acid, the Boc protecting group remained in place.
With the above series of 3-alkyne-2-hydroxyamines 238a-h in hand, 10 mol% silver nitrate on 
silica gel was added to a solution of each in dry dichloromethane, screened from daylight using 
aluminum foil. Reaction times between 3 and 24 h cleanly delivered the expected pyrroles 239a- 
g, in mostly excellent yields (>95%) (Table 4) and in high purity (Spectrum 7 and 8).
Table 4: Silver(I)-catalysed synthesis of pyrroles.
2 OK^ R3 2
10% AgN03 .Si02
 ► I t—R3
R1 NHR' DCM R1 N
R'
238a-h 239a-g
Protected-3-
alkyne-2-
hydroxyamine
R 1 R2 R3 Protecting
Group
(R*)
Pyrrole Yield
(%)
238a Me Ph Bu Ts 239a 94
238b Me Ph Ph Ts 239b 97
238c Me Ph TMS Ts 239c* 95
238d Me Ph H Ts 239d 100
238e Me Ph Bu Ns 239eb 96
238f Me Ph Bu C 02Me 239f 98
238g Me Ph Bu C 02/-Bu 239g 90
238h Me Ph /-Bu Ns 239h X
* TMS group was removed during cyclisation to yield R3=H 
b Dihydrohydroxypyrrole 244 formed en route to the corresponding pyrrole.
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Spectrum 7: *H NMR spectrum of amine 238a (CDCI3) and pyrrole 239a (CDCI3).
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Spectrum 8: 'H NMR spectrum of amine 283c (CDCI3) and pyrrole 239c (CDCI3).
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The only amine which failed to cyclise was 3-alkyne-2-hydroxyamine 238h. In hindsight this 
result was not that surprising, this given the strain associated with the steric repulsion of the 4- 
nosyl protecting group trying to ring close against the bulky /-butyl substituent attached to the 
alkyne. It is expected, in view of the successful analogous ring closure to synthesise furan lOlg, 
that cleavage of the nosyl protecting group will allow for ring closure to give the desired pyrrole.
It was found that the range of protection strategies tested were successfully accommodated. 
Conversions were, as in the synthesis of furans (Table 1 and 2 -  p 17 and 30), excellent (>95%) 
with no undesired side product formation and isolated yields remaining high (>90%). 
Substituents including alkyl, aryl and silyl, as well as a terminal alkyne, were all shown to be 
compatible with the cyclisation step (Table 4). Again, as in the case of furans, silver leaching 
was still observed in unfiltered samples. This is discussed in further detail in Chapter 5.
Of particular interest was the synthesis of the 2,3-disubstituted pyrrole 239c,d. It was found that 
silyl alkyne 238c could be cyclised to yield 2-methyl-3-phenylpyrrole 239c (>95%), through the 
apparent spontaneous removal of the TMS substituent (Scheme 64). It is however unclear when 
this TMS substituent is lost but, given the successful isolation of amine 238c and the apparent 
absence of amine 238d in this reaction, one would assume that this occurred at some stage during 
the cyclisation.
.TMS
IQttAgNOySiOz R*
OhU$
R 1" ^ N H R ’ DCM R 1 N
R'
238c 239c
Scheme 64: Synthesis of 2,3-disubsituted pyrroles 239c.
This result by itself was important as it highlighted that the unsuccessful cyclisation of 3- 
methylpent-4-yne-2,3-diols 242 (Chapter 2.2.4 -  p 31) may be resolved through the inclusion of a 
silyl group 243 (Scheme 65). This would allow for the synthesis of 2,3-disubstituted furans 241.
o h . h  0 h t ^TMS
R \ ^ x  10% AgNOs S1O2  R \ U ^  Cu(I),TMEDA r 2\ L > ^  10%AgNO3 SiO2 R \ - \
> - x —  --------- — -  T >
O dcm  R1 OH R3S1CI. ioo°c r 1 ^ q h  ° ° m r 1 O
241 242 243 241
Scheme 65: Proposed synthesis of 2,3-disubstituted furans 241.
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This proposal was somewhat discredited with the observation that the terminal 3-alkyne-2- 
hydroxyamine 238d was successfully cyclised to the same 2-methyl-3-phenylpyrrole 239d in 
equally high yields (>95%) (Scheme 66).
,H
10%AgNO3SiO2
R1^ N H R‘ DCM
238d
N
k
239d
Scheme 66: Synthesis of 2,3-substituted pyrrole 239d.
Given the success of this cyclisation, and the failure of the 3-methylpent-4-yne-2,3-diol 242 
cyclisations, no effort was made to synthesise and cyclise silyl diol 243 (Scheme 65). By no 
means a proven fact, but perhaps the nucleophilicity of the nitrogen was the driving force in the 
successful cyclisation of the terminal alkyne 238d to its corresponding pyrrole 239d.
32 3 :  3-Hydroxy-2,3-dihydropyrroles
A final observation from the above series of results was directly related to the nature of the 
protecting group. It was seen that there was significant evidence for the formation of a 3-hydroxy 
dihydropyrrole intermediate 244, en route to the corresponding pyrrole 239e, in the cyclisation of 
protected 3-alkyne-2-hydroxy-l-amine 238e. In this instance, a nosyl protecting group was used, 
but there is also some evidence that Moc protection strategies act in a similar way (Scheme 67).
Bu HOPh 10%AgNOaSiO2 Ph
DCMNHR’ NHR'
238e
Ph
Ph (OH
Bu STABLE
N
R*
Bu
Bu
244
Ph Ph
N 3 
R’
x>— Bu STABLE 
R’
239e
Scheme 67: 3-Hydroxy dihydropyrrole intermediate 244 formation.
61
Ph
NHNs
238e
OH
Ns Ns
239e 244
Ns
2 39e
9.5 8.0 8.5 8.0 7.5 7 JO 6.5 6.0 5.5 5.0 4.5 4.0 3.6 3.0 2£  2.0 1.5 1.0 0.5 0.0 ppm
Spectrum 9: H NMR spectrum of amine 238e (CDCI3), 3-hydroxydihydropyrroIe 244 (CDCI3) and pyrrole 239e (CDCI3).
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Unlike any case from the synthesis of furans, there was clear evidence for the presence of such an 
intermediate 244, at least when using a 4-nosyl protecting group. Indeed, the central plot of 
Spectrum 9, obtained by in situ lH NMR, clearly shows the formation of 3-hydroxy 
dihydropyrrole 244 with the presence of both the 4- and 2-H ring protons at 5.05 and 3.88 ppm 
respectively. Together with the presence of a new set of aromatic peaks, it is clear that the 3- 
hydroxydihydropyrrole 244 has been observed in situ. Although no attempts were made to 
isolate this intermediate, given its formation as a mixture with the corresponding pyrrole 239e, 
Sharland had presented similar evidence for the formation of such a compound. Interestingly, 
our own data show that the formation of such an intermediate is possible when the cyclisation is 
performed in dichloromethane using either A-Nosyl or A-Moc protecting groups, whereas all of 
Sharland’s examples used A-tosyl in diethyl ether.17 As a result of the above observations, it 
would be fair to assume that, at least in the case of A-Nosyl and N-Moc cyclisations in 
dichloromethane, aromaticity is not the only driving force in the synthesis of the target pyrroles 
239. Indeed, it appears that the electron withdrawing nature of the 4-nosyl nitro group renders 
the attacking nitrogen heteroatom less nucleophilic, perhaps slowing down the overall 
transformation (Scheme 68). The nitrogen is, however, still nucleophilic enough for cyclisation 
to occur, but seemingly somewhat electron deficient that expulsion of the p-hydroxyl is slow via 
the proposed iminium ion formation (Scheme 67).
10% AgNOa Si02
238e 244 239e
(EWG « 4-nosyl)
Scheme 68: Synthesis of 3-hydroxydihydropyrrole 244.
It is felt that this observation has important implications as it may provide a handle with which it 
might be possible to access a new series of substituted 3-hydroxydihydropyrroles 244, which one 
would expect to have some considerable synthetic potential.
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Stereochemistry has an important effect on the synthesis of furans (Chapter 2.3.2 -  p 37). It was 
shown that the stereochemistry of the major isomers 164a could be altered upon introduction of a 
protection strategy such that the major isomer became anti 169b (Scheme 69).
,) cP  H OH
Li
)
' h
163
6 h^ ' B u
MAJOR
PhOH
b> PH t ° TBDM S "  = >
Bu OTBDMS Bu^ HOTBDMS
168 169b
MAJOR
Scheme 69: a) Chelation and b) non-chelation control in diol synthesis.
This had important implications on the cyclisation reaction as the syw-isomer 164a was shown to 
cyclise faster, given it exhibited the required alignment of the attacking heteroatom, which was 
aided by hydrogen bonding with the adjacent axial propargyl alcohol (Scheme 43 -  p 39). In the 
case of pyrroles, the major isomers were also expected to be the syw-isomers 246a, a result of 
chelation control100b given nitrogen anion formation (Scheme 70).
Lii \
6/NR’ u OH HOPh
--------  pHh^
Ph R’HN ^ B u  B u ^  H NHR'
245 246a
MAJOR
Scheme 70: Chelation control in protected 3-alkyne-2-hydroxy-l -amine 246a synthesis.
Indeed, the NMR spectra of all the protected 3-alkyne-2-hydroxy-l -amines 238a-h suggest 
the presence of just one isomer, which one could assume to be the syw-isomer 246a. As a result 
of the use of mono-protected amines, no assessment of the effect of non-chelation control was 
made for this model. However, one would expect the preference for the syw-isomer 246a to cross 
over in favour of the anti-isomer 246b if 6/s-protection strategies were used.
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With the presence of primarily only one isomer, it was difficult to assess the rate of cyclisation of 
such isomers. It can only be assumed that, as in the case of diols 246a, the s>7*-isomer would 
cyclise faster, given the further stability seen with all bulky substituents being equatorial in the 
desired hydrogen bonded alignment, including the protecting group (Scheme 71). Interestingly, 
in the example below, the difference in rate may be very small given the preference of the phenyl 
group of the antf-isomer 246b to lie equatorially.
Bu Bu Bu
4  ' _ /  —  /
Ph HHO...H
239a-g
MAJOR syn MINOR anti
Scheme 71: Cyclisation of syn- 246a and anti- 246b diastereomers.
3.2.5: Limitations
As already stated, the silver-catalysed cyclisation of 238f-g (R’ = Moc and Boc) proceeded with 
normal efficiency; however attempts to cyclise oxazolidin-2-one 240 were unsuccessful, not 
surprising given the misalignment of the nitrogen heteroatom and alkyne (Scheme 72).
Bu
n
-O. 10%AgNO3SjO2 Ph'Ph.
N DCM
H 'n C02H
240 247
Scheme 72: Cyclisation of oxazolidin-2-one 240.
The use of acetyl protection [248->249] and the oxidation of A-methylephedrine [250->251] 
were also unsuccessful (Scheme 73), although no great effort was made to optimise these systems 
as the above four protection strategies appeared to provide an adequate choice. It is felt that with 
further effort, there should be no problems implementing these two other protection strategies.
P h v ^ O H  AcCI^PyridineP ^ P h v ^ O H  PCC^NaOAc 
^ N H 2 dmap ^ N H A c  ^ N H M e  oin ^ N H M e  e  /
248 249 250 251
Scheme 73: Acetyl protection 249 and attempted oxidation of A-methylephedrine 250.
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3.3: Conclusions
In conclusion, it has been shown that it is possible to use alkyl, aryl and silyl substituents in the 
silver-catalysed synthesis of pyrroles. With the successes seen in the synthesis of furans, and 
previous work having been performed in this field, a representative series of pyrroles has been 
synthesised using silver(I). The successful implementation of a range of protection strategies has 
helped broaden the applications of this procedure, with both acid- and base-labile protecting 
groups being accommodated in the approach strategy. Problems observed with the use of acetyl 
and methyl protecting groups are thought to be easily solved with further investigations.
The observed increase in rate of reaction, relative to the cyclisation of diols lOOa-o, 126a-d and 
136a-b, is of interest. It is felt that the increased nucleophilicity of nitrogen is responsible, which 
hints towards the fact that ring closure may be the rate limiting step. Indeed, this may well be the 
case in view of the infrequent observations of the 3-hydroxy dihydropyrrole intermediates 244 
which, given their absence in most of the ‘crude’ products, appear to aromatise to the target 
pyrrole 239 with great ease. Further evidence is provided by the highly successful cyclisation of 
the amine 238d (R = Me, R = Ph, R = H), where the nitrogen heteroatom successfully ring
I ^
closed onto a terminal alkyne, a transformation which was not possible with diol 142 (R = R = 
Ph, R3 = H), to give a 2,3-disubstituted furan. With the greater nucleophilicity of the nitrogen 
being a significant factor in the success of this cyclisation, it would seem be fair to conclude that 
nitrogen nucleophilicity is responsible for both the rate and success of pyrrole 239 formations.
The discovery of the 3-hydroxy dihydropyrrole 244 is very encouraging. Importantly, it suggests 
that our proposed mechanism is feasible, since allene formation would not allow for such 
intermediates to be formed. It further draws our attention to the possibility of accessing a series 
of 3-hydroxy dihydropyrroles, perhaps themselves valuable synthetic intermediates.
With the limited commercial availability of a-aminocarbonyl compounds, future work could see 
the use of Sharpless aminohydroxylation chemistry, which would allow for the selective 
formation of the more efficient, in terms of the parent cyclisation, syw-isomer. Although the 
desired ^-stereochem istry is apparently attainable using our current protected approach, 
Sharpless’ methodology would, more importantly, allow access to a wider range of substituted 
pyrroles.
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4.1: Introduction
Pyrazoles 251 are important heterocyclic targets and their synthesis is by no means trivial. 
Although not being known to occur naturally, they are highly prized for their therapeutic activity. 
With derivatives including dihydropyrazoles 252-254, tetrahydropyrazoles 255 and pyrazole-A- 
oxides 256 (Scheme 74), there is much interest in a broadly applicable, fast and efficient 
synthesis of this class of heterocycles.
251 252 253 254 255 256
Scheme 74: Pyrazole derivatives.
Many methods for the synthesis of this class of compounds suffer in terms of regioselectivity, 
with several being limited in their general applications. The key structural feature of pyrazole is 
seen to be the presence of two adjacent nitrogen ring atoms. This provides a very specific handle 
from which one can design a synthesis, with many approaches taking advantage of readily 
available hydrazines.101 105
4.1.1: Hydrazine-based synthesis of pyrazoles
Procedures which use hydrazine are exposed to the possibility of regioisomer formation {e.g. 
Chapter 1.1.3 -  p 5). Often, when used as a general procedure, the outcome of such approaches 
is extremely dependent on the nature of the substrate substituents. However, despite such 
complications, hydrazines have found broad uses in accessing these heterocycles. One such 
approach sees the 2+3 addition of hydrazines 257 to an a,p-unsaturated carbonyl 258.106, 107 
Subsequent dehydrogenation of the dihydropyrazole intermediates 259 and 260 yields the 
corresponding pyrazoles 261 and 262 (Scheme 75).
1 H R’ R1
rJ nh,  9  R' n n hn' n r' n n n - n .
H * ‘ ^  * RIJ ^
257 258 259 260 261 262
Scheme 75: Synthesis of pyrazoles 261 and 262.
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Unfortunately, the drawback of this simple transformation is seen in its susceptibility to 
regioisomer formation when using unsymmetrical reagents. In the above example, this results in 
a mixture of 1,3- 262 and 1,5- 261 disubstituted pyrazoles, and with regioisomers being difficult 
to separate, this is quite problematic. It means that this procedure is limited primarily to 
symmetrical reagents and, perhaps most importantly, it cannot therefore be used as a generic 
approach.
Another stoichiometric approach which employs hydrazine has been reported by Deng and 
Mani.105 They coupled monosubstiuted hydrazines 257 with aldehydes 263 to produce 
hydrazones 264. Addition of a substituted nitro-olefin 265 permitted regioselective formation of 
the substituted pyrazoles 267 in low to high yields (26-92%) (Scheme 76). They propose that this 
reaction proceeds via ‘a key nitropyrazolidine intermediate’ 266, which appears to account for 
the observed regioselectivity, and is believed to result from the reversible cycloaddition of a 1,3- 
dipolar intermediate, generated in situ.
RV NH2 .  0
257
h V
263
MeOH
ft, 1h
r i 
H
R1'N'N NC> 2  air rV ni V -R 2
H ^ R 2
+ R3^ A R4 rt24h* r3V -
r 4 N02
R1
R2
266264 265
Scheme 76: Deng and Mani’s pyrazole 267 synthesis.
R4 
267
This one-pot approach, given some higher yields (26-92%) and the observed regioselectivity, 
means the method has the potential to make a significant impact. Its ability to produce 
tetrasubstituted pyrazoles 267 means that it could well have applications in parallel synthesis. 
However, there is evidence that this cycloaddition occurs in competition with the irreversible 
conjugate addition of the more nucleophilic secondary amine centre of hydrazone 264. The 
product of the conjugate addition is known not to undergo cyclisation and as a result resides as a 
contaminant in the isolated product. The toxic nature of nitro compounds, and the limited 
availability of nitro-olefins 265, highlight some further limitations.
Of the catalysed hydrazine additions, palladium has been employed in a four-component coupling 
reaction for the synthesis of pyrazoles 270 and isoxazoles. Very recently, Mori showed the use 
of 1-5 mol% PdCl2(PPh3)2, in the presence of 2 mol% Cul, in successfully coupling hydrazine
69
Chapter 4: Results and Discussion 
257, a terminal alkyne 268, an aryl iodide 269 and carbon monoxide (Scheme 77).103 He showed 
that pyrazoles 270 could be synthesised in good yields (59-93%) at ambient temperatures and 
pressures.
1 - 5 mol% PdCl2 (PPh3 ) 2  
2 mol% Cul
rV nRV NH2 * ^ R2 * r *   00(1 ami> > V-Ar
H
T H F /H 20 ( 1 : 1 ) R2
r.t., 2 4  - 3 6  h
257 268 269 270
Scheme 77: Palladium-catalysed synthesis of pyrazoles 270.
Proceeding via the palladium-catalysed coupling of an aryl iodide 269 with carbon monoxide and 
an alkyne 268, the resultant propargyl ketone readily reacts with hydrazine 257, which 
subsequently cyclises to form a substituted pyrazole 270. As a result, this procedure benefits 
from being one-pot and catalytic, but it does also produce large quantities of waste given the need 
for excess hydrazine 257 (3 eq). Furthermore, with the need for prolonged reaction times and the 
compatibility with only aryl iodides, there are limitations to its broad applicability. Finally, the 
need for carbon monoxide and the use of hydrazines, which have a limited availability, is not 
desirable given issues of containment and toxicity.
4.1.2: Pyrazole-A^-oxides
One of the key derivatives of pyrazoles 271 are the pyrazole-N-oxides 272. They are an 
important class of compounds, and are themselves useful in the synthesis of substituted 
pyrazoles. Despite the demand for an efficient synthesis, there are few reports of such 
approaches to pyrazole-A-oxides 272. Often these are derived from the oxidation of pyrazoles
i nit271 (Scheme 78), but in these reactions, yields are usually low (<20%), with the presence of 
electron withdrawing ring substituents preventing any oxidation.
0
®P
h 2 0 2 . A cO H
r.t.-60°C
271 272
Scheme 78: Oxidation of pyrazoles 271.
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Another approach, reported by Gilchrist, sees the cyclisation of l-imino-2-nitrosoalkenes 274 to 
yield pyrazole-A-oxides 275 (Scheme 79) .109
0O
p1  r 1 d 1 © '
N RtCN+O- NO H20 2,Ac0 H N'Nv o
» r V § " - ---------- •  r A A *
273 274 275
(R1 = Ph. CehU-p-NOz)
Scheme 79: Gilchrist’s synthesis of pyrazole-N-oxides 275.
In a different tactic to those described before, Gilchrist, and others since, utilised a N-N bond 
forming step. Prepared from ylides 273, l-imino-2-nitrosoalkenes 274 undergo successful 
cyclisations in mixed yields (9-75%), with the electron-poor N-oxide 275 (R1 = C6H4-P-NO2, R2 
= CC^Et) being formed in the highest yield (75%). In fact, it appears that there is a requirement 
to have electron withdrawing groups in both positions around the ring. This procedure is further 
limited to the synthesis of 3,5-disubstituted pyrazole-A-oxides 275 and attempts to extend the 
range of A-substituents were unsuccessful.
Following this work, Begtrup et a l synthesised a series of 4-hydroxylamino-l-azabuta-l,3-dienes 
279 from commercially available 1,1,3,3-tetramethoxypropane 276.110,111 He was able to cyclise 
these dienes 279 to yield 2-substituted pyrazole-N-oxides 280 (Scheme 80).
1)RNH2
OMe p-tolutdine. EtOH [ f ^ N T o l  r t | 2 0 h  f f ^ N R
( I   ►  M
aq. HCIO4  NHTol 2 ) NaH NHR
r.t., 1 h r-t- 1 2  h
277 278
H2NOSiR3  fj^NOTBDMS CuS04, pyridine [ f \ | - o
\   roflnv O h © ©-------------------------- ^  |  ^  j y jr.t., 24 h NHR reflux, 0.5 h N® 0
R
279 280
(R * Me, Bn)
Scheme 80: Begtrup’s synthesis of pyrazole-A-oxides 280.
Although providing access to pyrazole-A-oxides 280, the yields of the key cyclisation were 
always low (3-36%) and often resulted in mixtures being obtained. There was however some
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evidence of the potential to use these //-oxides 280 to access a range of alkyl and aryl substituted 
pyrazole-A-oxides 281-285 (Scheme 81), however yields were low once again.
[ V o  A Vo T V  o T V o
® © ® ® N ® ® N ® ®i i i i
Ar Ar Ar Bn
281 282 283 284
(X = Br. NO2 )
Scheme 81: Begtrup’s other pyrazole-JV-oxides 281-285. 
4.13: Synthesis of substituted pyrazoles from pyrazole-TV-oxides
' ©  0
Pyrazole-N-oxides e.g. 261, 262 and 270, as stated above, can be used in the synthesis of 
substituted pyrazoles 286-^288, via the use of a deoxygenation procedure. Recent literature 
points towards the use of deoxygenation, following alkylation and halogenation reactions, in the 
synthesis of 1,3-, 1,5- and 1,3,5-substituted pyrazoles 286-288 (Scheme 82).112
R2 R2
XN J p N  P n
NR1 R2 ^ N R 1 fV n R1
286 287 288
Scheme 82: Substituted pyrazoles 286-288.
A good example of such a transformation has been presented by Vedso and Begtrup. 112 They 
synthesised a range of l-alkyl-5-halopyrazoles 289 regiospecifically using phosphorus 
oxychloride and phosphorus oxybromide in high yield (70-98%) (Scheme 83).
POX3, o°c ^
fi n - 0  -------------------► [I N
N ® 0  50°C, 2.5 h X N
R R
280 289
Scheme 83: Synthesis of l-alkyl-5-halopyrazoles 289.
Proceeding via POCI3 activation of the N -0 bond, the halide ion, generated in situ, attacks at the 
5-position to effect deoxygenation. With the opportunity to apply palladium chemistry, and the 
ability to selectively alkylate at the 5-position, this procedure becomes of synthetic importance to 
the synthesis of a range of substituted pyrazoles 286-288 (Scheme 82).
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With the above work in mind, and with the silver-mediated cyclisation in hand, Knight and Song 
recently assessed the silver-catalysed synthesis of pyrazoles 297.113 Starting with the addition of 
a 1-alkyne 292 to imine derivatives 291 of aldehydes 290, they formed a series of 
propargylamines 293. Nitrosation of these with nitrous acid yielded A-nitroso propargylamines 
294, which in turn were reduced to propargyl hydrazines 295 with LLAIH4. Addition of 
stoichiometric 10% AgN0 3 .SiC>2 successfully effected cyclisation to the pyrazoles 297 in 
excellent yields (>95%), via the oxidation of their corresponding dihydropyrazoles 296 by 
silver(l) (Scheme 84).
n  R 2NH2 R* n  r 3  oBuLi (2.5M) R2"N H  N a N 0 2> conc. HCI R^ m 'NO
0 ------------------ X  + <0? " "
2 h R1^ H
290 291 292
R1 H  H B F3.TH F R 1 0°C , o /n
-7 8 °C , 3  h
LJAIH4 R ^ N N H 2  1 0 % A g N O 3 S iO 2 R ^ N " N \  ,  1 0 % A g N O 3 S iO 2 R ^ N ' N \  ,
XV-R 3 ----------------► i y—R3
0°C , 2 4  h  R 1" > ^  DCM , 5  h  r I ^ ^ 7  DCM , 1 9 h
^ R 3
295 296 297
Scheme 84: Silver-catalysed synthesis of pyrazoles 297.
With the usual attributes of high yields, cleanliness and speed, this work showed yet another 
application of the silver-mediated cyclisation reaction, with the necessary regiospecificity 
displayed by this approach being a key strength. Interestingly, it was expected that 
dihydropyrazoles 296 would be the end point of these silver(I)-catalysed cyclisations, not the 
observed pyrazoles 297. The use of catalytic 10% AgNC>3.Si0 2  did however often lead to the 
preparation of a mixture of pyrazoles 297 and dihydropyrazoles 296. The subsequent oxidation 
to pyrazoles appeared to be catalytic in the presence of silver(I) with N-alkyl substituents, but did 
not proceed at all with A^-COR substituents. This observation does however highlight the greater 
potential of this transformation. There were however two prevailing limitations to this technique: 
A-nitroso propargylamines 294 are known to be highly toxic and their reduction is often 
somewhat low yielding. Nonetheless, perhaps most importantly, this procedure is unrivalled in 
terms of efficiency and regioselectivity.
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4.2: Silver-catalvsed synthesis o f  pyrazole-N-oxides
4.2.1: N-Nitroso propargylamine pathway
We wondered if a change of order would be possible i.e. cyclisation prior to reduction. Thus, 
during further investigations into the field of pyrazoles 297, an opportunity arose to test this 
possibility. With the help of a project student, Pickering, and using Song’s approach work, it was 
found that 10% AgN0 3 .SiC>2 successfully induces the cyclisation of N-nitroso propargylamines 
294a-f to yield the corresponding pyrazole-N-oxides 298a-f in excellent yield (>95%) (Table 5). 
As with pyrroles and furans, silver leaching was observed in unfiltered products.
Table 5: Silver(I)-catalysed synthesis of pyrazole-N-oxides.
©q
RVN0 1 0 %AgNO3 SIO2  RV \  3I  ► I
DCM R ^
^ R 3
294a-f 298a-f
N-nitroso
propargylamine
R 1 R2 R3 Pyrazole-
N-oxide
Yield
(%)
294a /-Bu CH2Ph Bu 298a >95
294b /-Bu CH2Ph Ph 298b >95
294c /-Bu CH2Ph (CH2)2OTBDPS 298c >95
294d Ph Pr Bu 298d >95
294e Ph Pr Ph 298e >95
294f /-Bu CH2CH=CH2 Ph 298f >95
Given the toxicity of the products, these cyclisations were carried out in NMR tubes and the 
quoted yields are therefore a reflection of the conversion seen by ‘H NMR analysis (Spectrum 
10). Both 13C NMR and mass spectrometry were used in conjunction with the above data to 
confirm the successful formation of the pyrazole-N-oxides 298a-f. Mass spectrometric data for 
the N-nitroso propargylamines 294a-f were inconclusive, with each N-nitroso propargylamine 
appearing to form some sort of unknown dimer. In the case of amine 294b, a [2M-NO] dimer 
appeared to form (M = 552), however in the case of some of the other amines e.g. 294d, there 
was no tangible explanation for the observed high molecular weight fragment (M = 516).
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Spectrum 10: !H NMR spectrum o f N-nitrosoamine 294d (CDCI3) and pyrazole-TV-oxide 298d (CDCI3).
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There was therefore a reliance on the characteristic 'H NMR signals of the rotameric N-nitroso 
propargylamines 294a-f to confirm their successful formation. Indeed, their replacement by a 
single set of peaks consistent with the cyclic pyrazole-N-oxides 298a-f, upon the addition of 10% 
AgNC>3.Si0 2 , in turn provided confirmation of successful cyclisation. As with many previous 
examples, these transformations were successfully effected in high yield and in complete purity. 
Utilising the best parts of the approach work to pyrazoles 297 (Scheme 84), this procedure, which 
avoids the need for LiAlFU reduction, benefits from overall high yields of up to 70%. 
Mechanistically, this transformation presumably proceeds in a similar fashion to that of the 
synthesis of pyrazoles 297 with an additional reorganisation step, however in this sequence no 
intermediates were observed, given the presence of an electron sink in the form of the nitrone 
functionality (Scheme 85).
DCM, o/n
2 9 4
©
A g: H
exchange
2 9 8
Scheme 85: Silver-catalysed cyclisation of N-nitroso propargylamines 294a-f.
Of the results themselves, the ability to accommodate a range of substituents, including alkyl 
294a, aryl 294e, allyl 294f and protected hydroxyl groups 294c, was very important. As in the 
synthesis of furans and pyrroles, this series of substituents provides a good foundation towards 
the synthesis of a library of pyrazole-N-oxides 298. For instance, given the previously observed 
silyl cleavage (Chapter 3.2.2 -  p 60), one could imagine the use of TMS-acetylene in the 
synthesis of 2,3-substituted pyrazole-N-oxides 298 (R3 = H). Unlike in the synthesis of 
pyrazoles 297 (Scheme 84), but as expected, there was no observation of any intermediate(s). 
The major limitation is, of course, the inability to incorporate 4-substituents, a necessary 
limitation with the silver-catalysed cyclisations but one which may be overcome through similar 
work to that of Nozaki.23 However, with the vast commercial availability of amines, aldehydes 
290 and terminal alkynes 292, this procedure is still of probable synthetic importance. Indeed,
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given the cyclisation proceeds in excellent yields (>95%), this transformation is arguably the best 
pyrazole-N-oxide 298 synthesis to date, in terms of yield, compatibility and cleanliness. Finally, 
a further benefit is seen with the use much milder conditions, i.e. ambient temperatures, in the 
key cyclisation step.
4.2.2: Synthesis of pyrazoles
Following this work, and with literature alluding to the use of phosphorus trichloride for the 
deoxygenation of pyrazole-N-oxides 298, it became apparent that it would also be possible to 
access substituted pyrazoles 297 from this approach (Table 6 ) .112,114
Table 6: Synthesis of pyrazoles.
0
p2 © ^  p2
Y L r j  p c ^ c h c ^  Y V r3
reflux , 2  h
298a,c 297a,b
Pyrazole-N-oxide R 1 R2 R3 Pyrazole Yield (%)
298a /-Bu CH2Ph Bu 297a 99
298c /-Bu CH2Ph (CH2)2OTBDPS 8 297b 8 92
8 silyl group was removed during deoxygenation to yield R3=(CH2)2 0 H.
It was found that deoxygenation could be effected in excellent yields (92-99%), with the isolation 
of pyrazole 297a,b (Spectrum 11). Having avoided the need for UAIH4 reduction, which was at 
times low yielding, this synthesis of pyrazoles 297a-b provided a further improvement on the 
overall yields of the original approach to these heterocycles. 113 Interestingly, where a silyl- 
protected hydroxyl substituents were used [e.g. 298c], deprotection was observed, yielding the 
free hydroxyl pyrazole derivative 297b. This was perhaps not very surprising given the harsh 
conditions used to deoxygenate the pyrazole-N-oxide 298c.
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Spectrum 11: !H NMR spectrum of pyrazole-A^-oxide 298a (CDCI3) and pyrazole 297a (CDCI3).
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As with the previous cyclisations, we held an interest in assessing the rate of cyclisation of N- 
nitroso propargylamines 294. Continuous monitoring by NMR allowed for a rate profile of 
the cyclisation of N-nitroso propargylamine 294e to be obtained (Figure 9).
N NO
Ph"
Ph
294e
7i 7J U U U U 1J YJ OS &0
Figure 9: ’H NMR profile of N-nitroso propargylamine 294e (CDCI3) cyclisation.
It can be seen, given the hourly readings (Figure 9), that cyclisation proceeds at a similar rate to 
that of the synthesis of furans (Chapter 2.3.2 -  p 40), with the observation of small amounts of 
starting material 294e after 4 h. Interestingly, it can be seen that the addition of 10% 
AgNC>3.SiC)2 appears to resolve the spectrum such that only one rotamer is observed, suggesting 
the inducement of a rigid activation alignment. This is probably a result of the coordination of 
silver to the alkyne bond, and is therefore a good indication of the mode of action.
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4.3: Conclusions
A novel approach to the synthesis of pyrazole-A-oxides 298 has been developed. Being effected 
in high yields (>95%), this procedure is thought to be a class leader in the regiospecific synthesis 
of substituted pyrazole-A-oxides 298. With a proven high yielding deoxygenation step (92- 
99%),114 it can also be used in an alternative approach to pyrazoles 297, which allows one access 
to an analogous library of substituted pyrazoles 297. Indeed, the reported use of POX3, in a
119tandem C-5 regioselective halogenation and nitrogen deoxygenation reaction, may further 
allow access to a range of pyrazoles 297 via a series of halopyrazole 289 intermediates. With this 
in mind, the procedure presented above has important applications to the field of pyrazoles 297, 
and has broad applications to the synthesis of such compounds. Although silver leaching was 
still apparent at this stage, the issue as a whole is addressed in Chapter 5.
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5,1: Introduction
Traditionally, the manufacturing industry has used batch processing as the chosen method of 
synthesis in a range of procedures. Favoured for the production of a broad range of different 
compounds on both small and large scales, and because these lend themselves to the development 
of new catalytic procedures, batch processes have found frequent uses. Recently however, with 
the desire and need for industry to improve productivity, increase safety and lower wastage, there 
has been much focus on the use of continuous processes. With the advantage of decreased 
downtime, risk and spatial requirements coupled with an increase in efficiency, turnover and 
safety, these systems are seen by many to be the future of the manufacturing industry. With the 
common limitation of batch process being single sample fixation, there has been an even greater 
desire to develop continuous processes which have much broader applications.
There are many non-commercial and commercially used continuous flow reactor systems which 
are utilised in a bid to achieve continuous processing. Often, continuous processing is used in 
bulk chemical processing, primarily within petrochemical industries. The complexity and greater 
demands associated with pharmaceutical processes has, until recently, presented a difficult hurdle 
to overcome for the applications of this technique to the pharmaceutical industry. Indeed, only 
some are accepted as being truly continuous but these can be found in many processes worldwide 
today; others however are still subject to scrutiny surrounding the role they might play in 
continuous processing.
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One type of continuous flow system is known as a continuous stirred tank reactor (CSTR), which 
is closely related to a batch reactor (Figure 10). They use conjoined series of batch reactors, into 
which the reactants are added at the same rate as the partially reacted material is removed. 115-116
Substrate
In
Catalyst
Replacement
20%
40%
60%
Conversion Product
Out80%
100%
Figure 10: Continuous stirred tank reactor.115*116
For example, if each reactor contains catalyst, a progressive increase in product formation is 
achieved which ultimately results in high levels of conversion. Unfortunately there is a major 
drawback associated with this technique when fine powder catalysts are used. Often in cases such 
as these, the effluent passing between reactors contains catalyst as well as partially reacted 
material, which has the effect to reduce the activity of each sequential reactor over time. This 
problem can be eliminated by using a coarser catalyst contained within a ‘basket’ but this 
removes the advantages gained by having a large surface area exposed.
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Given the problems associated with the use of CSTRs, there has been much more emphasis on 
the use of fixed bed reactors, the most common of which is arguably the trickle-bed reactor 
(Figure l l ) . 117' 119 In its crudest form, this comprises of a tube containing catalyst which can 
effect the transformation of a stream of reactant into the desired product. With the potential for 
use with both gaseous and liquid reagents, this system has found many applications. A good 
example is its application in a three phase reaction such as a hydrogenation. 120,121 With the use 
of a baffled thermocouple, it is possible to control temperatures reliably such that both vapour 
and liquid phase reactions can be performed. The only limiting factor to this reactor is particle 
size: if too small, there comes a requirement to use high pressures which, although manageable, 
are often preferably avoided. Thus, surface area is usually slightly compromised in the interests 
of reducing pressures whilst still maintaining the required flow rate. Many have found 
applications for this system due to its major strength: simplicity.
S u b stra te
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i
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Out
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Out
Figure 11: Three-phase trickle-bed reactor.
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5.2: Silver-catalysed flow system for heterocyclic synthesis
5.2.1: Silica gel flow system
With the overwhelming success of the batch silver cyclisation reactions, which had been 
observed when using commercially available 10% w/w AgNC>3.Si0 2  as the catalyst, it was felt 
that it would be possible to apply this catalyst to a continuous flow reactor system. Using the 
trickle-bed model (Figure 11), 10% AgN0 3 .SiC>2 catalyst was packed in a foil-lagged glass 
column (18 x 0.5 inches), with a bed volume of 10 inches and a protecting sand layer of 0.5 inch, 
with dichloromethane as the mobile phase (Figure 12). The flow was maintained with the 
application of positive pressure from an air line into the solvent reservoir.
P u m p
Silica-gel
 S u p p o rted
C ata ly s t
S o lven t
R eservo ir
P ro d u c t
O ut
Figure 12: Trickle-bed flow system (10% w/v AgN0 3 .Si0 2  catalyst).
Given the polarity of the silica-gel, it was apparent that a polar diol 100 would progress through 
the column at a slower rate than the derived non-polar furan 101 (Scheme 8 6 ), providing a 
potential advantage by increasing the contact time of the diol 100 with the catalyst. Thus, a 10% 
w/v solution of diol lOOe in dichloromethane (1 mL) was loaded onto the column and mobilised 
with a dichloromethane wash (50-100 mL). In this way, furan lOle was prepared over the course 
of 1 h by passage of the solution of diol lOOe through the column at a flow rate of ~1 mL/min.
1O%A0NO3 SjO2
100e 101e
Scheme 86: Synthesis of 5-butyl-2,3-diphenylfuran lOle.
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Analysis of the residue after evaporation of the filtrate showed the isolation of product in high 
yields (>95%) and complete conversion into the desired furan lOle. Unfortunately, there was 
one major drawback with this particular catalyst: relatively high levels of silver were seen to have 
leached with the product. This was clear from the fact that a stark silver mirror was deposited 
upon exposure of the product to light. Incorporation of an additional bed of silica gel beneath the 
10% AgNC>3.Si0 2  catalyst contained within the glass column, designed to reduce silver leaching, 
failed to have any affect, which was very disappointing.
With this result in hand, it had been shown that although it was possible to effect cyclisation 
using our standard catalyst, 10% AgN0 3 .Si0 2 , embedded within a trickle-bed reactor, it was not 
possible to prevent leaching of the catalyst. The alternative option to remove silver by passage 
through a separate celite column, as shown in the batch reactions, was not a viable solution. Not 
only would this detract from the advantages of this method, but it would merely treat the 
symptoms of the issue instead of the cause, and further lead to a short operational lifetime.
5.2.2: Studies towards a flow system for heterocyclic synthesis
It seemed that the fundamental success of the cyclisations within a trickle-bed reactor did warrant 
its continued use, but the inability to completely retain silver questioned the use of our current 
catalyst. An understanding of why the catalyst was leaching silver was required. Either the 
interaction between the AgNC>3 salt and silica support or the ionic bond between Ag+ and its NO3' 
counter-ion, which itself interacts with silica, were weak enough to allow silver to leave the 
system.
To address the first scenario, a cofactor was used in an attempt to “glue” the silver salt to the 
silica support. Serendipitously, it had been seen that in the failed cyclisation of a mixture of the 
3-alkene-l,2-diols 299a-b in the presence of the precursor 3-alkyne-l,2-diol 100, it was possible 
to isolate pure furan 101. This purification was achieved with the decantation of the organic 
solution from the 10% w/w AgN0 3 .Si0 2 . It appeared that this left all unreacted 3-alkene-1,2- 
diols 299a-b behind, adsorbed on the catalyst (Scheme 87), given their absence in the *H NMR 
spectra of the evaporated organic solution. Furthermore, it seemed as though the unreacted diols 
299a-b had an affinity for the 10% w/w AgNC>3.SiC)2 catalyst, to the extent that there was a 
visible reduction in silver leaching into the product 1 0 1 , this given the absence of a silver mirror.
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Scheme 87: Reaction of 3-alkyne-l,2-diols 100 and 3-alkene-1,2-diols 299a-b.
As it is well established that silver(I) interacts with alkenes (Figure 13),122'123 it seemed most 
likely that the catalyst was interacting with the substituted allylic alcohol functionality. This 
interaction arises from donation of re-electrons from the alkene into the a-orbital of the metal, and 
is further strengthened by d-orbital back donation into the alkenes’ re*-orbital (Figure 13). Thus, 
addition of equimolar 3-penten-2-ol, relative to the silver(I)-catalyst, a commercially available 
substituted allylic alcohol and clearly NOT a cyclisation precursor, appeared to reduce silver 
leaching when performing the same simple decantation. Unfortunately, it was found that the use 
of such a cofactor within the trickle-bed reactor seemed impractical as varying amounts were 
often observed to be admixed with the reaction products obtained (despite the initial observations 
-  see above). Other alcohols were tested, including allyl alcohol itself (10 mol%), but once again 
product contamination was an issue, despite this additive having a much lower boiling point.
cr-donation
Figure 13: Dewar-Chatt-Duncanson model: Two-bonding interactions of an alkene to metal.
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Given the impracticality of using a co-factor, further efforts were targeted towards assessing the 
ionic interaction. With the availability of a range of commercial silver salts, it seemed easier to 
attempt to improve the ionic interaction between the silver(l) and its counter-ion, and thus silica. 
The best way to do this was to substitute the nitrate anion for a more polar anion. Prior to their 
use in a flow system, it was necessary of course to show that such alternative salts were able to 
effect the cyclisation of the diols 100 in the same manner as the AgNC>3 system. Thus, a range of 
silver salts were prepared as admixed 10% w/w catalysts on silica gel. These catalysts were then 
screened in parallel using diol lOOe, with continuous monitoring by thin layer chromatography, 
where it was shown that several of these salts successfully effected the cyclisation (Table 7).
Table 7: Silver cyclisation of diol lOOe using a range of silver salts in CH2CI2.
Silver Salt Support Cyclisation Completion 
Time (h)
AgNC>3 Silica ✓ 4
Ag2C0 3 Silica ✓ 18
Agl Silica X >48 (0%)
AgBF4 Silica ✓ 6
AgOTf Silica ✓ 4
It was clear from this simple screen that silver tetrafluoroborate and silver triflate gave 
comparable rates of cyclisation to the previously used silver nitrate catalyst. Silver iodide was 
not expected to permit cyclisation as silver halides are not very soluble in organic solvents. 
Interestingly, a side study showed that silver carbonate on celite did not induce cyclisation, 
probably due to the use of neutral celite, which is used to remove silver from the cyclisation 
solutions. It should be noted that at this stage we were most interested in activity and thus 
leaching was not quantified.
Having shown that other silver salts exhibit cyclisation activity, we proposed that it may be 
possible to combine and manipulate the greater polarity of some of these salts with the use of 
commercially available ion exchange resins. Ion exchange resins are known for their scavenging 
abilities, often being used in water purification, and have been frequently used to support a wide 
range of catalysts. 124-127 Some, such as Amberlite 1RC748, are even known for their ability to 
scavenge silver from photographic solutions. Thus, the large range of resins available allows for 
almost any catalyst to be accommodated, and as such many reactions have been seen to be
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performed in the presence of such resins. Hence, as a starting point, it was proposed that an ion- 
exchange resin could be used as a pad at the bottom of our existing column in a bid to scavenge 
any leaching silver (Figure 12 -  p 85). The thought then occurred that the silver cations, when 
bound to an ion-exchange resin, could themselves be effective in inducing cyclisation, but 
without leaching. The mode of action is as follows. Many resins present surface areas covered in 
a wide range of simple anions or cations, which are attracted to an immobilised charged site of 
opposite charge. These charged sites can be readily exchanged to remove an appropriately 
charged ion from a reaction medium (Table 8 ).
Table 8: Amberlite ion exchange resins.
Resin Surface ion Counter ion Classification
Amberlite IRC50 r c o 2* Yf Weakly acid
Amberlite 1RC748 RN(CH2C 02')2 Na+ Weakly acid
Amberlite 200C r s o 3' Na+ Strongly acid
Amberlite IRA95 r n h 2 free base Weakly basic
Amberlite IRA400 r n h 3+ c r Strongly basic
Known as scavenging, this exchange is pH dependent, therefore to absorb a cationic metal, a 
resin must present a negative charge. 115 To ensure efficient absorption, the pH of the 
impregnating solution has to be controlled. Thus, it was possible to impregnate the acidic 
amberlite 1RC50, 1RC748 and 200C supports by percolation of an acidic aqueous silver nitrate 
solution (pH 3.5-5), through a column of the solid resin (Table 9).
Table 9: Silver cyclisation using a range of support conditions.
Resin Active Surface Cyclisation Cost (£/kg)
Silica Si02 ✓ 122
No supporta X 0
Celite Si02, Fe20 3, Al20 3 X 14
Amberlite 1RC50 r c o 2* V 46
Amberlite IRC748 RN(CH2C 0 2-)2 S 55
Amberlite 200C r s o 3- ✓ 27
P h ^
Ph^O H
100e
Bu
a When using silver nitrate by itself in DCM it was found that cyclisation did not proceed.
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The results from a screen o f these silver impregnated resins, and those o f other supports, showed 
effective cyclisation in the expected cases, i.e. in cases where an acidic, but non-retentive, 
support is present.
An unfortunate consequence o f the above ‘wet impregnation’ is that solution concentration, salt 
nature, solvent and contact time can all affect the distribution o f  the catalyst on the support 
(Figure 14).115 These distributions are further effected by the nature of the support used and as 
such allow for the formation o f several, very different, types o f supported catalyst, each o f  which 
can present slightly different activities.
Figure 14: Different modes o f catalyst distribution (catalyst in grey) 115 
(a) Uniform (b) Egg shell (c) Egg white (d) Egg yolk.
Uniform distributions, formed by saturation o f the support with catalyst solution, allow for 
increased contact time between the reagent and the catalyst. This increases the likelihood o f side 
reactions occurring, and as such they are only used in specialised cases.115 For the silver 
cyclisation, one may expect an ‘egg shell’ distribution to be most appropriate. This would allow 
the alkyne access to the active metal, but minimise contact time, allowing for the furan to be 
readily displaced without the threat o f undergoing side reactions. So how does one go about 
forming such a distribution? ‘Egg shell’ distributions are often seen when using strongly 
absorbing resins, for instance strongly acidic resins such as amberlite 200C. Such resins absorb 
the metal on their surface first and then as all the surface sites become occupied the resin 
gradually impregnates towards its core. Thus, both the concentration o f the impregnating 
solution and contact time can then be adjusted to determine how thick this shell becomes. In the 
case o f this system, the decision was taken to pack the resin within a stainless steel column, to 
form a light-free environment, and to then flush saturated aqueous silver nitrate quickly through 
the column five times. It was felt that this would have the effect o f lowering contact time, to 
ensure mainly surface absorption, but at the same time would provide enough silver to ensure that 
this surface became sufficiently impregnated.
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With the assessment of counter-ions and supports having been performed, and in an attempt to 
mimic the triflate counter-ion, amberlite 200C, the cheapest resin tested, was chosen to act as 
both the counter-ion and support. With strongly acidic resins having an isoelectric point far 
below pH 7, it was expected that this resin would load with the most efficiency and desired 
distribution. It was found that amberlite 200C, in its sodium form, packed in a stainless steel 
column (8  x 0.5 inches) (Figure 16) and with a bed volume of 50 cm3, successfully exchanged 
Ag+ from an aqueous solution of silver nitrate (Figure 15). In practice 50 mL of a 10% w/v 
aqueous solution of silver nitrate was passed through the column three times prior to the washing 
sequence. Repeated washing with water, methanol, diethyl ether and then dichloromethane 
conditioned the column for use.
AgN03 + H20
l
Ag*
i
Na* 0 3S H < V
Na
Ag OjSH
i
Na*
i
NaNO, + H20
Figure 15: Silver exchange by an ion exchange resin.
Analysis of silver content on this resin, by ICPMS, showed there to be 7.65% w/w silver on this 
column, with very little difference between the top and bottom of the column. With the dry 
weight of the impregnated resin being 8 .8  g, it can be calculated that there was a total of 0.67 g of 
silver contained within the column, which would be equivalent to 1.05 g of AgNC>3. 
Unfortunately we were not able to obtain data surrounding the % loading of sodium on the parent 
resin, but it is thought that the desired ‘egg shell’ distribution was at least partly achieved given 
the short contact time associated with the passage of aqueous silver nitrate solution down the 
amberlite packed column.
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Figure 16: A flow system for heterocyclic synthesis.
As before, passage of a 10% solution of diol lOOe through the column (Figure 16, Appendix D) at 
a flow rate of lmL/min, with N2 pressure being set to 1 bar, yielded pure furan lOle (Scheme 8 6 ) 
in excellent yields (>95%). Over a 30 min run this equated to the preparation of > 2.67 g of furan 
lOle from 3 g of diol lOOe. This formed our first truly effective ‘Flow System for Heterocyclic 
Synthesis’. The major advantage observed with this new column was the complete absence of 
silver leaching. Analysis of metal content in a range of product samples, determined by ICPMS 
at an independent GSK facility, showed silver content to be <1 ppm in all cases. This is a strong 
indication that minimal silver leaching, if any, is observed from this new amberlite 200C 
supported silver column. Indeed, the strictest FDA limit for any transition metal in an active 
pharmaceutical is 5 ppm for oral doses, a figure applied to platinum, palladium, iridium, rhodium, 
ruthenium and osmium.128 The consistency of the column was also very high, with the same 
result being repeated in the proceeding two experiments, as well as 6  months later, even after 40, 
quite varied, runs in between. Such was the success of the system that it was able to form part of 
the patent129 which was secured for the broader applications of the silver cyclisation procedure.
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5.2.4: Optimisation
Having proven the concept of a successful flow system for heterocyclic synthesis, efforts were 
then made to optimise several parameters. Perhaps the easiest parameter to adjust was the flow 
rate, thus the flow rate of a known concentration of diols 100a, lOOe was increased until NMR 
analysis showed that complete cyclisation to the furans 101a, lOOe was not being attained 
(Scheme 8 8 ).
100a,e 101a,e
(R * Me. Ph)
Scheme 88: Synthesis of 5-butyl-2,3-disubstituted furans 101a, lOle.
It was shown that at flow rates of 0.5 < 1.5 mL/min, cyclisation of a 10% w/v solution of diol 
lOOe went through to completion (Figure 17). Above 1.5 mL/min, cyclisation did not go to 
completion, with NMR showing the presence of some unreacted starting material in the case of a 
2mL/min experiment, where conversion was 48%.
1 0 %AgNO3 SIO2
— — 1 0 %  W v  D i o l  
S o l u t i o n
Conversion vs Flow Rate
0.5 1 1.5 2
Flow Ret* (mL/min)
Figure 17: Effect of flow rate on amberlyst-supported silver cyclisations.
The above observations relate to the fact that given the 5 mL liquid capacity of the column, one 
would expect there to be in the region of 0.5 g of diol 100 contained within the column at any one 
time. With it being known that the column contains 0.67g silver, this equates to 365 mol% silver 
being present in the case of l,2-diphenyloct-3-yne-lv2-diol lOOe and 211 mol% silver in the case 
of 3-methylnon-4-yne-2,3-diol 100a. This amount is more than enough to effect cyclisation 
quickly provided an adequate contact time is allowed, which is what a flow rate of < 1.5 mL/min 
appears to provide.
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In view of these results, and their reproducibility, a standard protocol was developed. This took 
the form of a programmed HPLC pump timetable, where the substrate was introduced for 5 mins, 
followed by a dichloromethane wash for 15 mins and then finally reconditioning with methanol 
then dichloromethane, for 5 mins each. For the first 20 mins, a conservative flow rate of 1 
mL/min was maintained, which equates to a resonance time of around 5 mins, before the flow 
rate was increased to 5 mL/min during the reconditioning period. This protocol formed the basis 
of an automated system where 5 mL samples of a 10% w/v solution of any heterocyclic precursor 
could be consistently cyclised.
To test this claim, a series of different heterocyclic precursors were passed through the column as 
10% w/v solutions and the above protocol used. These precursors included 3-alkyne-l,2-diols 
100 (R1 = R2 = Ph, Me, H, R3 = Bu), 3-alkyne-2-hydroxy-l -sulfonamides 238a-f (R1 = Me, R2 = 
Ph, R3 = Bu, PG = Boc), /V-nitroso propargylamines 294 (R1 = Bn, R2 = /-Bu, R3 = Bu) and O- 
propargylhydroxylamines 301130 (R1 = H, R2 = /-Bu, R3 = Bu) (Scheme 89).
p 3  p 3  p 3  p 3
r 2 o h ^  r 2 o h ^  Ry ^ R
R 1 OH R1 NHPG R 1' N'N O  0 vNHR1
100 238 294 301
Scheme 89: Some of the many heterocyclic precursors.
In the vast majority of cases tested, cyclisation proceeded to completion in excellent yield 
(>95%), with the only exceptions being those which produced volatile products. In these cases, 
the isolated yield of furan 101 [R1 = H, R2 = Me, R3 = Bu; R1 = R2 = Me, R3 = Bu] were lower 
(60-66%), but directly comparable to their equivalent batch reactions, and one would expect to 
obtain yields of >95% when handled with appropriate equipment. Pleasingly, the difficult O- 
propargylhydroxylamines 301 appeared to form isoxazolines 302a and did not oxidise to the 
corresponding isoxazoles 302b (Scheme 90), a common side reaction known to occur in the 
presence of silver nitrate on silica gel. 130
R3
10%AgNO^SlOj R \ - ^ \  10%AgNO3SiO2 R2'N ^ ^ \
O 'N H R 1 15mlns (0.1eq) R o/n(1.1eq) O ^ N R
R 1
301 302a 302b
Scheme 90: Oxidation of O-propargylhydroxylamines 301 to isoxazoles 302b.
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In a further experiment, one which was designed to test the competitive nature of these 
cyclisations, a mixture of three different diols 100b, lOOe and lOOn was cyclised (Scheme 91). 
All three substrates were successfully transformed into their corresponding furans 101b, lOle and 
lOln, and there was no suggestion of the formation of any side products.
O H^OKU2
100b 101b 100e 101e 100n 101n
Scheme 91: Silver-catalysed cyclisation of a mixture of diols 100b, lOOe and lOOn.
This is an important result as it gives an indication of the robustness of this technique and of the 
potential to use just a single column to cyclise a variety of different substrates, without the risk of 
side product formation with any contaminants. Important commercial implications can be drawn 
from this result, given that it allows for the possibility of a “general use column” to be sold for 
standard laboratory research use.
Another avenue of investigation, in view of the successful use of several substrates, sought to test 
a range of substrate concentrations. Given the varying physical form of many of these substrates 
it was clear that, in the case of liquid precursors e.g. 1 0 0a, it may not be necessary to use a 
solvent at all. In the case of solids e.g. lOOe, it was felt that it may be possible to use more 
concentrated solutions, after all 10% was originally chosen arbitrarily. Thus, to test this, a neat 
sample of 3-methylnon-4-yne-2,3-diol 100a (Scheme 92) was passed through a column (8  x 1/8 
inches) at a flow rate of 0.5 mL/min for 15 mins. Analysis of the product showed complete 
conversion to the furan 101a in excellent yield (85%), higher than had been previously seen when 
using solvent, a result of there not being a need to remove any solvent, with attendant loss of 
product through volatilisation.
O H ^
10% AgNQjSiC^ 10% AgN03 Si02
100a 101a 100e 101e
Scheme 92: Synthesis of 5-butyl-2,3-dimethylfuran 101a and 5-butyl-2,3-diphenylfuran lOle.
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The above observation was based upon a one-off result where the column contained minimal 
amounts of dichloromethane. Given the narrower dimension of the column used, one can be 
fairly confident that passage of the substrate through the system for 15 mins allows for the 
majority, if not all, of the dichloromethane to be removed. With cyclisation still proceeding to 
completion, it is reasonable to state that solvents are not required for the reaction to occur, 
although granted they are still needed to clean the column afterwards. This result has therefore 
provided an improvement on the system, for this particular compound, since this time there was 
not the requirement for solvent during the reactive stage.
Having already shown the positive effect of more concentrated solutions of l,2-diphenyloct-3- 
yne-l,2-diol lOOe (Scheme 92) in increasing the rate of cyclisation (Chapter 2.3.4 -  p 42), it 
seemed prudent to test more concentrated solutions through the flow system. Thus a 20% w/v 
solution in dichloromethane was prepared. Passage of the 20% w/v solution at a flow rate of 
< 1.5 mL/min allowed for complete cyclisation to the furan (> 95%) with incomplete cyclisation 
(67%) being observed for a flow rate of 2 mL/min (Figure 18).
C o n v e r s i o n  v »  F l o w  R a t e
100
80
0.5 1.5
Flow Rata (mL/min)
Figure 18: Effect of flow rate on amberlyst-supported silver cyclisations.
Although the results in Figure 18 are comparable to the results seen with the 10% w/v solutions, a 
subtle increase in conversion with the more concentrated 20% solution was observed. This 
suggested that concentration may contribute towards a minor improvement in the efficiency of 
cyclisation in our continuous flow system. This difference appears to be only very small and 
needs further investigation to understand its actual significance. For instance, a more detailed 
study with more sample points may be considered.
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The final optimisation centred around studies into thermal influences on the flow system. This 
work also incorporated investigations into the use of microwave irradiation, given the findings 
described in recent literature articles.131'136 Previous operations of the flow system had been 
successfully performed under ambient conditions. It was recognised therefore, that there was a 
clear opportunity to assess the affect of higher temperatures on the function of this system.
*70&Preliminary studies by John using heated batch reactions showed there to be an acceleration in 
rate upon an increase of temperature, as one would expect. Indeed, these studies showed that 
when using 2 0  mol% of 10% AgNC>3.SiC>2, it was possible to effect the cyclisation of a 10% w/v 
substrate solution in 1/6* of the time at 40°C. This positive result prompted the preparation of a 
‘U* shaped column (Figure 19) with which it was possible to assess such affects on continuous 
flow production.
Substrate Product
In Out
JL 1r
1
t t  T t HEAT T T T T
Figure 19: Thermally influenced flow system.
With the help of Knight,796 a 10% w/v solution of diol lOOe was passed through this column at 
different flow rates whilst it was maintained at 30°C (Spectrum 12). It was found that under 
continuous flow conditions, at a flow rate of 0.5 mL/min, consumption of the diol lOOe was 
successfully achieved. However, unfortunately, under these conditions a mixture of furan lOle 
(Scheme 92) and a suspected ring opened adduct were obtained, this in view of similar previous 
observations (Chapter 2.2.4 -  p 32). At faster flow rates, incomplete cyclisation became 
apparent, with a flow rate of 2 mL/min effecting only slight cyclisation (3%). This was likely to 
be a result of there having been too short a contact time between the substrate and the catalyst in 
this smaller column. A flow rate of 1 mL/min did show some conversion to the furan lOle but 
equal quantities of ring opened product were also observed. These results provided a reference 
point from which to work.
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Spectrum 12: 'H NMR spectrum comparison o f flow rates of the cyclisation o f diol lOOe to furan lOle at 30 °C (in CDCI3).
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Spectrum 13: ]H NMR spectrum comparison of flow rates of the cyclisation of diol lOOe to furan lOle at 50 °C (in CDCI3).
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Using the results from these 30 °C cyclisations it was possible to assess the effect o f increased 
temperature. It was found shown that at 50 °C (Spectrum 13), a flow rate o f 0.5 mL/min gave not 
only both furan 101 e (24%) and its oxidised product 303 (46%) but also a third product (17%) as 
well as some residual diol lOOe (13%) (Scheme 93). Faster flow rates, 1 mL/min, saw more 
selectivity for the desired furan lO le (45%), without less formation o f  the acyclic product (25%), 
however at a flow rate o f 2 mL/min. only a small degree o f  conversion to furan lO le (15%) was 
observed.
.Bu
Ph^ S>H
10% AgNQ3 SiP2  
heat
♦ Ph
Ptl °
Ph O
Bu
MIGRATION
PRODUCTS
100e 101e 303
Scheme 93: Thermally influenced continuous silver-cyclisations.
With Bagley’s interest in microwave continuous flow chemistry,132 the opportunity was taken to 
investigate the effect o f microwave irradiation on the silver cyclisation procedure. Microwaves 
had been previously shown to increase the rates o f a wide range o f reactions.136 Based on this 
work, and that o f his own, Bagley commissioned the first truly successful continuous flow cell
I ^
within a microwave (Figure 20).
sand
M* O
CO,Et
■
BOjCY ^
MT^ N^ Ph
Figure 20: Continuous microwave reactor. 132
Thus, with a view to future work, some time was invested in understanding whether there were 
any benefits in using microwave irradiation in this system. Using a monomodal microwave 
synthesiser in batch mode, 10 mL solutions o f l,2-diphenyloct-3-yne-l,2-diol lOOe were 
irradiated under a range o f conditions. By applying microwave radiation at a range o f  
frequencies for 0.5 h (10-100W), it was possible to assess any effect on the rate o f reaction.
1 0 0
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Given the potential thermal contribution o f microwaves, control measures had to be introduced to 
ensure that we were truly assessing the effect o f the microwave radiation. These took the form of  
continuous temperature control and use o f  a standardised sample to act as a reference point from 
which to judge the success o f any microwave irradiation. The standardised 2% w/v solution o f  
diol lOOe was fully cyclised with 0.5 equivalents o f 10% AgN03.Si02 catalyst at 40°C within lh 
and without any influence from microwave irradiation (Chapter 5.2.4 -  p 97).
With the standardised result in mind, the continuous control o f the temperature was then used to 
create an environment where only the irradiative properties could have been responsible for a 
change in rate. The results compiled by John 798 (Figure 21) showed that the same diol lOOe, also 
as a 2% w/v solution, could be fully cyclised to furan lOle at ambient temperature (external 
vessel temperature maintained by air cooling) within lh when using 50W microwave irradiation. 
Irradiation of the same solution with 30W microwave radiation effected the cyclisation o f diol 
lOOe in 98% conversion. This suggests that the optimum wattage lies around 30W, a reasonable 
improvement on the use o f elevated temperatures, but still quite energy demanding. Further 
studies into the use o f a 1% w/v solution o f diol lOOe proved to be less effective with 100W 
irradiation being required to effect complete cyclisation. Further problems were also seen with 
this 1% w/v solution given its apparent susceptibility to ring opening, with the product o f a 30W 
experiment containing the previously observed acyclic product 303 (8%).
E f f e c t  o f  m i c r o w a v e  I r r a d i a t i o n  a t  
a m b i e n t  t e m p e r a t u r e *
100
Figure 21: Effect o f adjusting wattage on degree o f conversion (%) (lh  reaction time).
It would appear from the data shown in Figure 21 that microwave irradiation does produce a 
positive influence on the speed o f the silver cyclisation reaction for batch cyclisations. Further 
studies are needed to assess the true influence o f such irradiation but on the basis o f this study the 
results look promising. However, given the apparent problem o f  ring opening when applying
1 0 1
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heat to our ion-exchange continuous flow system, it would seem that early indications o f a 
similar transformation resulting from microwave irradiation may just complicate an already 
efficient system. The further expense and effort required when using such a system, when 
compared to an established and simple flow system, is perhaps not worth the trouble. It should o f  
course be recognised that if a robust synthesis o f  the ring opened products can be achieved, then 
the use o f microwaves may be pivotal to their continuous synthesis.
5.2.5: Discussion
With all o f the above optimisations in hand, it seemed prudent to draw a series o f reasonable 
comparisons. This was achieved using a “design space” representation (Figure 22). Correlation 
o f three variables, concentration, flow rate and catalyst loading, allowed an overall perspective to 
be drawn. Temperature was not a chosen variable given the observed ring opening.
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Figure 22: Design space for synthesis o f 5-butyl-2,3-diphenylfuran lOle.
It had already been shown that when using a 7.65% wAv catalyst at a flow rate o f l .5 mL/min, it 
was possible to repeatedly produce quantitative yields. Using the largest flow system, (8 x 0.5 
inches), we went about assessing the chosen design space. The results o f this study highlighted 
that at reduced flow rates, conversion is often very low (< 25%). This is an expected 
consequence o f the reactor design as it is felt that at flow rates < 0.5mL/min, the diol fails to 
bridge the initial cotton wool plug efficiently. Thus, the comparatively high conversion (50%) 
seen when using a 0.5mL/min flow rate at 10% concentration and 7.65% w/w catalyst loading, is 
most likely to be representative o f the inconsistencies attributed to passage through such a plug o f  
cotton wool.
1 0 2
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At flow rates above 1.5 mL/min, the degree o f conversion was seen to drop, as expected; this a 
result o f a decrease in contact time. Indeed, the degree o f reduction in conversion allows us to 
view another previously formed conclusion regarding concentration more clearly. It had been 
suggested that the 20% w/v solution was slightly more efficient beyond its optimal flow rate than 
its 10% w/v counterpart (Chapter 2.3.4 -  p 43). This can now be seen clearly with just a 28% 
drop in activity when using a 20% solution at higher flow rates, as opposed to the 47% drop seen 
with the more dilute solution.
The final area o f interest enables an assessment o f the effect o f catalyst loading to be made. 
Given the time taken to obtain ICPMS data, a decision was taken to assess catalyst loading by 
replacing half o f  the catalyst present in the tube with non-impregnated amberlite 200C. To 
ensure consistency, the retained half o f the column resin was thoroughly dry blended with the 
fresh amberlite 200C to ensure even distribution. This repackaged resin was then used as a 50:50 
distribution o f 7.65% w/w impregnated and 0% w/w impregnated resin to mimic the action o f a 
3.83% w/w impregnated resin (Figure 23).
7.65%  w/w  3.83%  w /w  3.83%  w /w
Mimic
Figure 23: Catalyst distribution o f the 3.83% w/w mimic catalyst.
The effect that this mimicked catalyst had can clearly be seen in Figure 22, where conversions 
were down by up to 35%. With evidence from the batch reactions showing that marked changes 
in reaction time occur upon alteration o f the catalyst molar equivalence, this result seems 
reasonable.
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Overall, it was confirmed that silica had a potential use as a support in a continuous flow system 
with excellent yields (> 95%) of furan lOle. However, despite our best efforts, we were unable 
to control silver leaching from this system, which gave the catalyst a distinctly finite lifetime and 
gave the added requirement of a separate product purification step. With investigations focusing 
on the causes of this leaching, our attention was turned down another avenue, the use of 
alternative supports. It was found that use of the ion exchange resin amberlite 200C provided a 
solution to the silver leaching, with quantification of product metal content showing the presence 
of < 1 ppm silver. Not only had silver leaching been prevented but the excellent product yields 
(> 95%) were maintained. This was a truly remarkable result, with further successes including 
the use of a range of other heterocyclic precursors; even neat diol 101a could be cyclised 
uneventfully. To date, we have neared 100 experimental runs over the course of a year and the 
system appears to be functioning as well as ever. An approximate turnover number of between 
20 and 35 mmol/g has been calculated, per gram of loaded resin, a number which is still 
improving with every result that is run. With mixed results from thermal and microwave 
investigations, there may be further scope for development of this system but as it stands, it forms 
a very powerful and novel flow system for heterocyclic synthesis, one which may have industrial 
applications. And with these views in mind, one would propose the use of a shorter but wider 
column. This would allow for maximal flow rates to be achieved, providing correct substrate 
distribution, given that there would be a far greater surface area of catalyst upon first contact of 
the substrate.
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5.3: scCOi continuous extraction from ionic liquids
5.3.1: Introduction
On the back of the interest in continuous synthesis, there have recently been determined efforts to 
incorporate and develop novel continuous extraction systems. A key example originates from 
investigations into the uses of supercritical carbon dioxide (SCCO2) and ionic liquids (ILs) in 
hydroformylation,137' 143 hydrogenation144-146 and oxidation147-151 reactions (Scheme 94). As a 
result of the robustness, high yields and in some respects environmental advantages, recent 
interest has turned to expanding the applications of such systems. In view of this, it was felt that 
there may be an application of the silver chemistry in such a combined scC0 2 :IL system. 
Discussions with Prof. David Cole-Hamilton,78,143 University of St Andrews, led us to believe 
that our proposal was reasonable.
70°C, 80bar
a) + C O . H, H;'CO,.R-h(CO> ^ c) ft V2 scCO*. [bmimKPFeJ +
b) + H2-------- ----bfcPjgfc—  ^ F T ^ - n
2 [Et4NISnCI3]
OH O
C) JL TPAP, NMO J
R1 R2 [emimKPFel R1 R2
H2O2. PdC>2
SCCO2. [bmlmJIPFe]
Scheme 94: a) Hydroformylation,141 b) hydrogenation144 and c) oxidation in SCCO2.147-151
Supercritical carbon dioxide belongs to a class of solvents known as supercritical fluids (SFs), 
which are formed at and above the critical point of a compound. This critical point consists of a 
critical temperature (Tc) and a critical pressure (Pc) at which the compound exhibits gas- and 
liquid-like properties. This gives the SF a unique advantage, since SFs are usually gases in their 
natural state, they can be readily removed from a system upon simple decompression. With 
SCCO2 having a Tc of 31.1°C and a Pc of 73.8 bar (Figure 24), it is possible to remove any CO2 
from the product under atmospheric pressure and at ambient temperature.152,153
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Carbon Dioxide Phase Diagram
Solid
I
8 Liquid
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Figure 24: Phase diagram of scCC>2 and effect of temperature and pressure on density.
By adjusting both the temperature and pressure of the system, it is possible to alter the solvation 
power of the SCCO2. As a general rule of thumb, it can be seen that an increase in temperature 
causes density to lower and an increase in pressure causes density to increase (Figure 24), 
although beyond a certain point the effect of pressure becomes less significant.
The non-polar nature of SCCO2 makes it formally immiscible with an IL as a liquid, allowing for 
a two phase system (Figure 25). Its gaseous properties on the other hand allow it to partially mix 
with, but not to dissolve anything ionic.
Figure 25: Phase photographs of CO2 transforming into SCCO2.
In tandem with the polar nature of the ILs, it has been broadly shown that transition metal 
catalyst leaching can therefore be kept to a minimum,137,143,152,153 with ICPMS figures often seen 
to be <100ppb. As a result of these findings, it has been shown that it is possible to cleanly 
extract organic matter from a metal-catalysed reaction carried out in an IL. Indeed, the relative 
ease in maintaining a continuous flow of SCCO2 also makes it is possible to extract continuously,
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a result of the stable two-phase system where the IL sits securely at the bottom of the reactor. It 
is this ability to continuously extract and be so easily removed which makes SCCO2 such an 
appealing solvent. With further reports of the recyclability of scCC>2 (> 99.95%), the chemistry 
would also appear to show some degree of environmental empathy. However, with mixed views 
as to whether or not ILs are potential green solvents, given evidence alluding to their toxicity, 
some caution over their use needs to be taken. Despite this, their low-volatility, non-flammability 
and seemingly complete containment within the autoclave chamber, does still make their use in 
this procedure very attractive.
To comprehend the function of such a system, it is best to first understand previous 
hydroformylation reactions. The nature of this reaction meant that elevated pressures and 
temperatures were a requirement. As a result, this procedure employed a rig which consisted of 
the SCCO2 generator, a HPLC pump, an autoclave and a decompression chamber (Figure 26).143,
154,155
S u b s tra te
S tirre r
P r e s s u r e
, C o n tro l 
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scC O j
g e n e ra to r
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H e a te rP ro d u c t O ut
Figure 26: SCCO2 : IL reactor.
The system is operated by a series of pressure regulators, which can be manipulated to accurately 
control the pressure of individual compartments whilst maintaining a continuous flow of mobile 
phase. This allows for continuous decompression of the SCCO2 such that CO2 (g> is vented off to 
leave behind the organic product. It is here that the inherent complexity of these 
hydroformylation reactions raises an issue of desired product retrieval, this given that the polarity 
of the product is greater than the starting material. To be successful, the system is required to act 
counter intuitively i.e. the scCC>2 is being asked to extract the more polar species, something it is 
not set up to do. By manipulating both pressure and temperature, and choosing the correct IL, it
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is possible to give the SCCO2 a helping hand. Thus, it was found that application of elevated 
temperatures (100 °C) and pressures (200 bar) allowed for an efficient reaction where the product
The highest yields were obtained when using l-alkyl-3-methylimidazolium 
bis(trifluoromethanesulfonyl)amides, for example [omim][NTf2],
With the knowledge that furan products are generally considerably less polar than their starting 
diols, it was expected that extraction would present little difficulty. This was expected to allow 
for an efficient extraction under more moderate conditions than those required for 
hydroformylation. The objective of this part of the project was therefore to effect a successful 
silver-catalysed cyclisation in such a continuous extraction system. All of the following 
experiments were carried out during a two week period at St Andrews University.
53.2: SCCO2 batch silver cyclisation
It had been previously proven (Chapter 2.3.3 -  p 42) that 3-alkyne-l,2-diols 100 could be 
successfully cyclised when using an ionic liquid as a solvent. With such a variety of 
commercially available ILs, the question arose as to which would be the best one to use in this 
continuous system. Clearly, given the nature of the reaction, a water stable IL was necessary. It 
was suggested by the Cole-Hamilton group that the ILs [ompy][NTf2] 304 and [omim][NTf2] 305 
(Scheme 95) may be suitable candidates. These had previously been used in their own 
hydroformylation reaction156 and had been shown to be both thermally stable and water tolerant. 
An initial assessment of the ability of these ILs to solvate a handful of silver salts revealed that 
silver triflate dissolved better than silver nitrate. It was found that of the two, [ompy][NTf2] 
solvated silver better, so this IL was used in the model system (Figure 26).
was formed rapidly and continuous extraction occurred with good isolated yields (76%).143
N~Oct N-Oct
304 305
Scheme 95: [ompy][NTf2] 304 and [omim][NTf2] 305 ionic liquids.
To first understand the proposed process, the autoclave chamber was charged with [ompy][NTf2] 
(12 mL) containing 10 w/w % silver triflate and to this 3-methylnon-4-yne-2,3-diol 100a (1 g)
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was added (Scheme 96). The chamber was then heated to 50 °C and pressurised, in three separate 
experiments, with scCC>2 to 100, 130 and 200 bar. The mixture was stirred for lh and then 
continuously extracted with a flow of scCC>2 for 30 min.
10 %  A g O T fin  IL
1 0 0 -2 0 0 b a r ,  4 0 -7 5 ° C  / " O
100a 101a
Scheme 96: Synthesis of 5-butyl-2,3-dimethylfuran.
The resultant oil was identified as the expected furan 101a and found to contain no trace of 
[ompy][NTf2] 304 in all cases, as determined by NMR analysis. Yields were excellent in 
view of product volatility with the best result, from this set of batch experiments, achieved at 
200bar (> 95%). Given the one-off nature of each experiment, as a result of limited time and 
starting diol 100a availability, these provisional results were entirely unoptimised and were used 
only as an indication of the success of the proposed principle.
5.3 J : scC02 Continuous flow system for heterocyclic synthesis
With the optimised batch results in hand, efforts were focused on the use of this catalyst under 
continuous flow conditions. Optimal pressurisation and heating of the stirred autoclave chamber, 
charged with just the 10% IL-silver catalyst solution (12 mL), primed the system for use. 
Opening to the HPLC pump allowed for a controlled flow of the substrate 100a to be introduced 
at a rate of 0.05-0.2 mL/min. Coupled with the steady release of SCCO2 from the system 
(1 mL/min), furan 101a was successfully extracted every 0.25 h in good yields (> 70%) under 
conditions of 150bar, 50°C and at a substrate flow rate of 0.1 mL/min. As with the batch 
procedure, 'H NMR analysis showed there to be no presence of diol 100a or [ompy][NTf2] 304 
as contaminants in the extracted product. Further analysis was carried out by GC, which showed 
that all samples obtained from the cyclisation contained only furan 101a. Analysis for silver 
content by 1CPMS showed there to be < lppm silver in every sample assayed, which was 
comparable to the ion exchange resin method and repeatable once again.
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With continuous sampling for 1.5 to 2 h, it was possible to show that consistent levels of furan 
were extracted once the observed start-up time had been completed (Figure 27). This start-up 
time was set as the point at which product was first extracted and is seen to be both pressure and 
temperature dependent, ranging between 0.25 and 0.75 h.
(a) *cC02 continuous •xtrscWon (O.OSmUmin)
15
025 OS 075
Figure 27: SCCO2 continuous extraction time lines for (a) 0.05 mL/min (b) 1 mL/min flow rates.
It can be seen from the data displayed in Figure 27 that there is an approximate trend, which is 
dependent on both pressure and temperature, even when using different flow rates: as pressure 
increases, the start-up time of the extraction decreases. It was also found, not surprisingly, that 
an increase in temperature had a similar effect. This observation is illustrated by the profile of 
the reaction run at 175 bar and 75 °C, the reaction being comparable to that of the 200 bar and 50 
°C reaction, despite the drop in pressure (Figure 27a). It is worth noting that with the emphasis 
on identifying ‘candidate’ reaction conditions, given the tight time restrictions, these results of 
course show a degree of experimental error. It is clear however that a general trend has been 
identified, where an improvement in start-up time occurs when both pressure and temperature 
increase. At the same time, it can also be seen that pressure and temperature have an effect on 
the overall efficiency of the reaction. Temperature increases have already been used to improve 
profiles of lower pressure runs, as shown in Figure 27a, such that they match the profiles of their 
higher pressure counterparts. Pressure effects are best represented by a 50 bar increase in 
pressure, from 100 to 150 bar, seen in Figure 27b, where overall yields are seen to increase by 
nearly three fold.
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Having assessed the effect of temperature and pressure, efforts then focused on the effect of diol 
100a flow rates, given the previous variations found in the ion exchange system. It was shown 
that doubling the flow rate at 100 bar and 50 °C, and again at 150 bar and 50 °C, decreased the 
start-up time (Figure 28) by up to 20mins.
Effect of flow
Figure 28: Effect of flow rate on scCC>2 continuous extraction time-line.
Such an improvement is interesting, although the precise reasons behind this induction period are 
not clear; perhaps the concentration of diol 100a within the IL has a marked affect. If this is true, 
then it is possible to draw comparisons with the effects of concentration observed in the 
dichloromethane batch reactions (Chapter 2.3.4 -  p 42). Previously, it had been observed that in 
these standard batch reactions, a higher concentration of diol 100a had the effect of increasing the 
rate of cyclisation. Therefore, it would be reasonable to assume that the observed improvements 
in start-up time resulted from an increase in flow rate which may be linked to a concentration 
dependency.
A final area of investigation saw the effect of the IL volume being assessed. In previous runs, 
silver triflate (1.36 g) dissolved in [ompy][NTf2] 304 (12 mL) was used. Using conditions of 150 
bar and 50 °C at a flow rate of 1 mL/min, it has been found that halving the amount of silver 
triflate and [ompy][NTf2] 304, causes a lower conversion rate (Figure 29), not surprisingly.
Figure 29: Effect of IL volume on SCCO2 extraction time line.
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It was also clear that an improved start-up time of 20 mins was apparent when using reduced 
volumes of [ompy][NTf2] 304, an improvement on the previous time of 40 mins. Indeed, this 
improvement was also observed when using 125 bar pressure. The reason for this reduction in 
start-up time may be as follows. When using lower volumes of IL, the diol 100a concentration 
can increase much faster and the extraction of furan 101a is arguably easier with less stationary 
phase present. Increased concentrations are already known to improve reaction efficiency, as 
seen with the studies into the effect of flow rate in this system, and therefore improve furan 
production. Together with the improved extraction ability of scCC>2 when reduced amounts of IL 
are present, given the decreased ‘sponge’ volume, early extraction would be expected to occur. 
A limiting factor then prevails where overall output is regulated by the physical amount of 
catalyst present, i.e. although a 10 w/v % catalyst concentration has been maintained, the 
equivalence of silver in the system has still been halved.
5 J.5: Operational considerations
The main difficulty observed was associated with the control of SCCO2 decompression. With the 
large change in pressure came problems of evaporative cooling, which in time led to 
crystallisation of furan 101a within the decompression regulator valve. With intermittent 
blockages forming in this valve, it was difficult to control SCCO2 flow rate at times and, as a 
result, the efficiency of extraction was affected. To counteract this, the regulator was heated, 
quite vigorously, with heating tape. This solved the problem of crystallisation, but led to the loss 
of some of the highly volatile product, 5-butyl-2,3-dimethylfuran 101a. Crude cooling (0 °C) 
beyond the regulator did improve yields (>70%), however a degree of product evaporation was 
still observed even with this cooling in place. It is expected that the addition of a condenser to 
the rig should allow the product to re-condense more efficiently.
53,6: Use of alternative substrates
With the successful synthesis of 5-butyl-2,3-dimethylfuran 101a in hand, attempts were made to 
cyclise another substrate. l-(Hex-l-ynyl)cyclohexane-l,2-diol 100k (2.5 g) (Scheme 97) was 
dissolved in the 10% silver triflate [ompyJfNTfz] catalyst (6 mL), and held under 150 bar 
pressure at 50 °C for 2 h. A flow of SCCO2 was then applied for 30 mins so as to extract the
1 1 2
Chapter 5: Results and Discussion 
product 101k. This reaction was run in batch mode due to the limited quantity of diol 100] that 
had been prepared for the visit.
B u
10% AgOTf, lompyJNTfj]
 "  I jT  /  ^ U150bar, 50°C, 2h
100k 101k
Scheme 97: Synthesis of 2-butyl-4,5,6,7-tetrahydrobenzofuran 101k.
It was found that 2-butyl-4,5,6,7-tetrahydrobenzofuran 101k could be isolated cleanly and in high 
yields (80%). Extraction did not present any problems and *H NMR analysis showed there to be 
no contamination by either the starting diol 100k or the IL [ompy][NTf2] 304.
5.3.7: scC02 Conclusions
In summary, it has been shown that a scCC>2 continuous extraction system, with an appropriate 
ionic liquid, can be successfully employed for the novel continuous synthesis of 5-butyl-2,3- 
dimethylfuran 101a and 2-butyl-4,5,6,7-tetrahydrobenzofuran 101k. Yields were high (>70%) 
and conditions were optimised to a system which uses a 10% w/w silver [ompy][NTf2] catalyst 
under conditions of 150bar and 50°C. A range of substrate flow rates were successfully 
employed with optimal yields being obtained when using a 0.1 mL/min flow. Further benefits 
were seen through the removal of organic solvents and the quantification of silver leaching as 
being < lppm. With possible environmental benefits and much interest from industry, this 
procedure may contribute a great number of synthetic procedures. The anticipated ability to 
selectively extract the much less polar furan product had clearly been shown to be correct.
It is believed that there is plenty of scope for the synthesis of pyrroles, pyrazoles and isoxazoles 
in the future, but these will perhaps be limited to non-polar examples. Furthermore, with the 
successes of this procedure having been based on partially optimised conditions, given the short 
timeframe available, a promising foundation has surely been laid.
O H ^
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5,4: Conclusions
Investigations into the immobilisation of silver have led us to discover two novel flow systems 
for heterocyclic synthesis. The first, a more traditional trickle-bed reactor, takes the form of a 
simplistic and low expense approach, with advantages of high yields (>95%) and seemingly no 
silver leaching. Indeed, the robust nature of this first system, as shown by its continuous use over 
the past 18 months, attests to the attractiveness of such a simple system. The alternative 
scCC>2:IL system provides a more intricate and expensive approach, but one which is potentially 
more lucrative, and like its counterpart, benefits from only trace silver leaching and the observed 
high, if unoptimised yields (>70%). The further potential for the use of alternative flow rates, 
substrate concentrations, solvents, supports, ionic liquids, pressures and temperatures in these 
systems make both of their discoveries all the more important. Perhaps the overriding factor in 
the choice comes from the pharmaceutical sector’s interest in new technologies, where there may 
well be more of a demand for the SCCO2 system. With this in mind, the immediate future interest 
would lie in the optimisation of the scCC>2 process, with the further application of alternative 
mobile phases, of differing polarities. Some work on the effect of the use of industrially 
proportioned, short and fat columns for the trickle-bed system should also be undertaken.
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6.1: Synopsis
Discussions up to this point have primarily been focused on core aspects of this project. It has
been shown that a range of furans, pyrroles and pyrazole-A-oxides have been successfully 
cyclised via a formal silver-mediated 5-endo-d’ig ring closure. Yields were high (>95%) in the 
vast majority of cases and further developments saw the successful use of both amberlite 200C
The next step was to illustrate the strength of these results by applying our findings to the 
synthesis of several target compounds. Given the identification of several approaches to the 
silver-catalysed synthesis of substituted furans, we identified a series of targets, which contained 
a furan moiety at their core. These targets included a range of potentially scented furans 307 to 
311 and the natural products plakorsin A [312; and B [313; R=Ci6H33] (Figure 30).
and ionic liquid-immobilised catalysts in novel flow systems for heterocyclic synthesis.
6.1.1: Aim
\
307 308
309 310 311
CO2M8
312 313
Figure 30: Targeted compounds
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315
6.2: Scented furans
6.2.1: Introduction
In the past, there has been much interest in the synthesis of “scented furans”,3,4,157 159 so classed 
due to their possession of quite distinct aromas. This aroma is often highly prized and together 
with the tuneable nature of each scent, this draws attention to their potential use as fragrances. 
Indeed, the more succulent of these fragrances are seen to omit odours which are suitable for use 
within the cosmetics industry, the best examples being rosefuran 314 and sesquirosefuran 315 
(Scheme 98).
314
Scheme 98: Rosefuran 314 and sesquirosefuran 315.
Rosefuran 314, a colourless oil with a boiling point of just 39-40 °C at ImmHg, presents an 
aroma not too dissimilar to roses, as its name might suggest. Sesquirosefuran 315, also a 
colourless oil, displays a slightly heavier scent than rosefuran, reminiscent of geraniol, as one 
might expect. Their synthesis has been widely studied, as highlighted by Salerno,3 with recent 
efforts focused towards an improved synthesis of rosefuran, given its commercial interest.
One of the first syntheses160 saw the use of mercuric chloride and sodium thiosulfate to 
decarboxylate 3-methyl-2-furoic acid 316 and then produce the corresponding difurylmercury 
dimer 317. Transmetalation with lithium yielded 2-lithio-3-methylfuran 318 which was alkylated 
with l-bromo-3-methyl-2-butene 319 to yield rosefuran 314 in relatively low yields (35%) 
(Scheme 99). Being a simple approach, it has its attractions, however the toxicity of mercury 
salts and the low yield make this approach unacceptable for use in large scale production.
■°/ —COOH y 2-  r y - H g   R'U » ( f y - L i  * /  „ /
O NaaSzOa O O J O
316 317 318 319 314
Scheme 99: Buechi’s mercury chloride-based synthesis of rosefuran 314.
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Subsequent contributions saw gradual improvements with Pattenden’s mercury-free approach 
providing the foundations for other successes.4 He showed that 4-methylfuran-2-one 320 acts as 
a better nucleophile, via its enolate 321, for l-bromo-3-methyl-2-butene 319 to yield a (1:2) 
mixture of the separable regioisomers 322a,b (60%) (Scheme 100), together with smaller 
amounts of fo's-alkylated adducts. Reduction of 322b with DIBAL-H at -30°C, followed by 
acidification, yielded rosefuran 314 (80%).
DIBAL-H
then H30 +
322a 322b 314
Scheme 100: Pattenden’s synthesis of rosefuran 314.
Using the above procedure, it was also possible to synthesise the homologous compound 
sesquirosefuran 315, however it too had overall yields of just 32-34%, comparable to those 
observed in Buechi’s synthesis. It was clear that these yields were being affected by the 
formation of undesired mono- and 6/s-alkylated regioisomers. It was not until 1983 that this 
approach showed its true potential when Hoffmann161 was able to limit the ftw-alkylation and 
improve regioselectivity through the use of tetramethylethylenediamine (TMEDA), a sterically 
encumbered metal ligand. Hoffmann found that when using his modified procedure, it was 
possible to isolate rosefuran 314 in greater yields (up to 80%) (Scheme 101).
TMEDA
320 321 319 314
Scheme 101: Hoffmann’s synthesis of rosefuran 314.
More recently, with much interest in metal catalysed procedures, palladium has been used to 
catalyse a cycloisomerisation of (Z)-2-en-4-yn-l-ols 56,36*38 as previously discussed in Chapter 
2.1.3. One such case reported by Salerno3 has highlighted the use of this isomerisation procedure
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for the synthesis of rosefuran 314. This group have shown that it is possible to cycloisomerise 
(Z)-3,7-Dimethylocta-2,6-dien-4-yn-1 -ol 325, obtained in 78% yield from (Z)-enynol 323, to 
yield rosefuran 314 in an overall yield of 60% (Scheme 102).
Br , Pd(PPh3)2 Cl2 I K2 Pdl4
Cul, Et2NH
324 325 314
Scheme 102: Salerno’s synthesis of rosefuran 314.
Given the volatility of rosefuran 314, it should be acknowledged that yields such as those 
reported by Salerno and Hoffmann are quite acceptable. Thus, given these optimisations have 
provided efficient syntheses of rosefuran 314, one which is equally applicable to the synthesis of 
sesquirosefuran 315,162 our efforts turned to the synthesis of several analogues in the hope of 
generating potential perfume components.
6.2.2: Synthesis of /so-sesquirosefuran
Having already addressed one of the greatest difficulties associated with the synthesis of 2,4- 
disubstituted furans (Chapter 2.2.1 -  p 23), it was proposed that it would be possible to synthesise 
a range of 2,4-disubstituted, potentially scented, furans using the silver-catalysed cyclisation 
procedure. Using sesquirosefuran as our model, one could imagine using an a-hydroxyketone 98 
combined with geraniol 326 or citronellol 327, as core building blocks (Scheme 103). This 
would further test the silver-catalysed method in the presence of a non-terminal but potentially 
labile alkene.
R1 OH
98 326 327
Scheme 103: Core building blocks for synthesis of /^-sesquirosefuran analogues.
With the help of undergraduates Haynes, Petherbridge and Williams, efforts were made to 
synthesise the targeted scented furans. Early attempts to mimic an /so-form of sesquirosefuran 
315 were troubled. The required synthesis of geranyl acetylene 329 from geranyl iodide 328163 
(itself synthesised in high yield (97%) from geraniol 326 by exposure to iodine, imidazole and 
triphenylphosphine) was unsuccessful for reasons unknown (Scheme 104). Significantly, geranyl
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acetylene 329 is not recorded in the literature, a sign, perhaps, that it is in some way unstable or 
difficult to prepare.
I } f2, Imidazole, I I Li-^-H.EDA
MU PPh3, rt 1
0°C
326 328 329
Scheme 104: Synthesis of geranyl acetylene 329.
To test this conclusion, lithium acetylide-ethylene diamine complex was added to a solution of 
citronellyl iodide 330,163 synthesised from commercially available racemic citronellol 327 in 
excellent yields (97%). Using the same procedure, the citronellyl acetylene 331 was successfully 
isolated as an oil in 78% yield. Deprotonation using w-BuLi allowed for successful addition to a 
slight excess of TBDMS-acetol to yield crude propargyl alcohol 332 (97%). Addition of TBAF 
(1M in THF) to a solution of the crude alcohol 332 in THF allowed for the isolation of crude diol 
333. Any excess TBDMS-acetol from the original mixture was also deprotected in this step to 
yield acetol, a water soluble component which was successfully washed out during a standard 
aqueous work-up. Column chromatography of the crude mixture allowed for further purification 
to yield pure diol 333 in lower than expected, but unoptimised, yields of 37-55%. Addition of 
10% AgN0 3 .SiC>2 successfully induced cyclisation of diol 333 to yield furan 334 in excellent 
yield (95%) (Scheme 105).
‘ ' Li-=-H.EDAl2, Imidazole, 
PPIb. rt 0°C
327 330 331
n-BuLi, THF 
-78°C
TBDMS-acetol OTBDMS
332
TBAF, THF 
o/n
OH
333
334
10% AgNOsSiC^ 
DCM
Scheme 105: Synthesis of 4-methyl-2-(3,7-dimethyloct-6-enyl)furan 334.
It is significant that this cyclisation proceeded cleanly, given the presence of a sensitive prenyl 
group in citronellyl. Overall yields for this approach were moderate (43%) but it is expected that
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with further optimisation of this procedure these yields would increase. The aroma which this 
furan 334 displayed is best described as being fresh lemon in nature, perhaps expected given that 
citronellol smells of lemons.
With the above result in hand, efforts were made to test the effect of furan substituents. Addition 
of citronellyl acetylene 331 to 0-TBDMS-3-hydroxybutan-2-one 335, followed by deprotection, 
purification and cyclisation yielded the corresponding furan 336 (Scheme 106). The key 
cyclisation step once again proceeded cleanly and in excellent yield (93%).
* 1 °^OTBDMS
331 335 336
Scheme 106: Synthesis of 2,3-dimethyl-5-(3,7-dimethyloct-6-enyl)furan 336.
Again, lower than expected overall yields (28%) were observed but the high yields resulting from 
the key cyclisation were very encouraging. This furan 336 displayed a heavier aroma, more 
reminiscent of an earthy lemon scent. Given the trisubstituted nature of this furan 336, it is 
perhaps not surprising that a more subtle aroma was detected, given the decreased volatility 
associated with increased substitution.
The final scented furan to be synthesised used benzoin 337 as the source of substituents. Here 
citronellyl acetylene 331 was used to synthesise furan 338 in high yield (95%) (Scheme 107).
P h ^ O
Ph
Ph 338
Ph^OTBDMS '
331 337
Scheme 107: Synthesis of 2,3-diphenyl-5-(3,7-dimethyloct-6-enyl)furan 338.
In this instance, furan 338 displayed what can be described as a mild, heavy, smokey lemon 
scent, perhaps not unexpected given the presence of two bulky aryl substituents. With this result 
we had again moved away from the more inviting and purer scent of furan 334. Overall it can be 
said that these results have shown a successful foray into the field of the synthesis of potential 
fragrances. From this provisional work we saw an opportunity to assess the formation of an 
enantiomerically pure furan.
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Based on detailed reviews on the effect of stereochemistry on aroma,158 our final investigation in 
this field sought the implementation of fixed stereochemistry. Unsurprisingly, numerous 
examples have shown that stereochemistry can have a marked effect on the aromas of a broad
'tn i
range of compounds. For example, the isomers of Hedione 339 are renowned for their floral 
jasmine fragrance and have been used in Christian Dior’s Eau Sauvage ™. Other examples
include Ambrox ™ 340, Dihydromyrcenol ,IVI 341 and Galaxolide 1M 342 (Scheme 108), all of 
which contain crucial stereogenic centers that can be used to tailor the overall scent.
TM TM
339 340 341
Scheme 108: Hedione ™ 339, Ambrox ,iyi 340, Dihydromyrcenol 1M 341 and Galaxolide IM 342.TM
OH
TM
342
TM
A more generic ingredient in perfumes is sandalwood oil, a complex mixture of scented organic 
compounds.157' 159 With its wide use and composition of multiple active ingredients, there has 
been much interest in identifying its key odorant. In 1990 Krotz and Helmchen identified (Z)-(-)- 
/?-santalol 346, which contributes up to 25% of the weight of the oil, as the major sandalwood 
odour. They synthesised enantiomerically pure (Z)-/?-santalol 346, together with the minor 
constituents (£)-/?-santalol 345 and /?-santalene 347, from enantiomerically pure 3-methyl-2- 
norbomanones 343 and 344 (Scheme 109).164
345
O 
343
O
H
344 346
347
Scheme 109: Synthesis of enantiomerically pure sandalwood oil components.
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It was found that (->-346 displayed a scent reminiscent of sandalwood oil, whereas (+)-346 was 
shown to be odourless. As for the enantiomers of (-£)-/?-santalol 345 and /?-santalene 347, it was 
found that only (->-345 displayed an odour similar to (-)-346, but notably milder. Remarkably all 
of the other enantiomers prepared, (+)-345 and (+/-)-347, were found to be odourless (Scheme 
110).
HOOH
HO
(+)-346
OH
(-)-347 (+)-347
Scheme 110: Isomers of (£)-/?-santalol 345, (Z)-/?-santalol 346 and /?-santalene 347.
Interestingly, some view (Z)-(+)-a-santalol 348 (Scheme 111), which contributes some 47% to 
the composition of sandalwood, as key to the displayed aroma; however, this view is still open to 
debate.159
OH
348
Scheme 111: (Z)-(+)-a-sanatol 348.
Prior to the acceptance of (Z)-(-)-/?-Santalol 345 as the main odour, many others looked at some 
of the other components in sandalwood oil. Naipawer165 showed that Ebanol ™ 349 displayed a 
relevant odour, with a racemic mixture of diastereomers 349a-h presenting the strongest odour 
ever reported at the time (Scheme 112). Bajgrowicz166 later showed that of the eight possible 
isomers of Ebanol ™ 349, only two exhibited the desired lucrative aroma attributed to 
sandalwood oil. These were the (VS, 2S, 3R)- 349b and (1 2S, 3R)~ 349e isomers.
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349a 349b 349c 349d
349e 349f 349g 349h
Scheme 112: The eight stereoisomers of Ebanol ™ 349.
All of the above examples, just a small number from what is a vast library of compounds, 
illustrate the powerful effect which stereochemistry can have on the aroma of a compound. 
Citronellol contains a stereogenic centre at its core and therefore has two possible enantiomeric 
forms, the (/?)-enantiomer (Jf)-327 and the (*S)-enantiomer (S)-327 (Scheme 113).167 With the 
change from geraniol to citronellol introducing this stereochemical feature, the opportunity was 
taken to assess any stereochemically related changes in the aroma of furans 334 and 336.
HO" ^  ^  ^ HO"
(R)-327 (S)-327
Scheme 113: (R)- and (Sy citronellol 327.
With the help of Williams,168 commercially available enantiomerically pure (/?)- and (S)- 
citronellyl bromide was used to synthesise pure (R)- and (5)-citronellyl acetylene 331 (71%). 163 
With the yields being a little low, the decision was made to take a step back and synthesise (R)- 
and (S)-citronellyl iodide 330 (Scheme 114) from enantiomerically pure (R)- and (S)- citronellol 
327 (Scheme 113). The corresponding (R)- and (S)-citronellyl acetylenes 331 were obtained in 
marginally improved yields (79%). Addition to both TBDMS-acetol and TBDMS-3- 
hydroxybutan-2-one 335, which were used in excess once again, yielded the corresponding 
propargyl (R)- and (S)- silyl ethers 332a,b which were successfully deprotected to give the diols 
333a,b which were finally cyclised to yield the (R)- and (S)- forms of both furans 334 and 336 in 
excellent yields (>90%). Spectra 14 and 15 show the (S)-enantiomers of furans 334 and 336 and 
their respective (S)-diols 333a and 333b. The purity of each furan can be seen clearly from their 
respective images (Spectrums 14 and 15), and given [a]D291 values of +6.3° and +11.4° for the
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furans (*S)-334 and (5)-336, and -7.8° and -8.9° for the furans (R)-334 and (R)-336, it appears that 
enantiomeric selectivity/purity has been maintained.
Lh*-H.EDA
0°C
R1 OTBDMS
R1 OTBDMSn-BuLi, THF -78°C
(R)~330 (R)-331 (R)-332
a) R1 *H, R2  ■ Me
b) R1 * R2 = Me
TBAF, THF 
o/n
10% AgNOjSiOa 
DCM 
o/n
(R)-333
334 R1 =H, R2  -  Me (91%) 
336 R1 = R2 = Me (92%)
R1 OTBDMS R2.
n-BuLi, THF 
-78°C
0°C 1 OTBDMS
(S)-330 (S)-331 (S)>332
a) R1 =H, R2  = Me
b) R1 = R2  = Me
TBAF, THF 
o/n
10% AgN03 S1O2 
DCM 
o/n
(S)-333
334 R1 “H, R2  = Me (90%) 
336 R 1 = R 2 = Me (95%)
Scheme 114: Synthesis of enantiomerically pure (R)- and (S)- furans 334 and 336.
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333a
334
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Spectrum 14: H NMR spectrum of (S)-diol 333a (CDCI3) and (S)-furan 334 (CDCI3).
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Spectrum IS :'H NMR spectrum o f (S)-diol 333b (CDCIj) and (S)-furan 336 (CDCIj).
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Overall yields were varied (24-43%), but importantly each furan (R/Sy334 and (R/S)-336 shows 
the defined optical activity. Interestingly, it was found that there were noticeable differences in 
the aroma of each enantiomer. Both furans (Ry334 and (lf)-336 were found to display weak 
lemon scents whereas the alternate enantiomers (5)-334 and (5)-336 had much stronger and more 
distinct aromas. Indeed, (5)-2-(3,7-dimethyloct-6-enyl)-4-methylfuran (5)-334 emitted a sharp 
tar-like aroma with ‘earth and wood’ overtones where as (S)-2,3-dimethyl-5-(3,7-dimethyloct-6- 
enyl)furan {Sy336 displayed a smoother citrus and flower scent (Scheme 115). Although the 
aromas are perhaps not ground-breaking, these observations are interesting in that they highlight 
the use of this approach to synthesise enantiomerically pure fragrances, a lucrative niche within 
the cosmetics market. Furthermore, as a result of the use of a relatively polar diol, it is 
reasonable to be confident that any aroma displayed is derived from the furans 334, 336. This is 
true since potentially significant competing non-polar aromas, i.e. the alkyne 331, are readily 
removed through column chromatography at the diol stage.
(S)-334 (S)-336
Scheme 115: (S)-4-methyl-2- 334 and (S)-2,3-dimethyl-5- 336 furans.
6.2.4: Summary
It has been shown that it is possible to use the silver-catalysed cyclisation procedure to synthesise 
a range of scented furans. 169 By manipulating the core strengths of the cyclisation procedure, it 
has been possible to synthesise enantiomerically pure (R)~ and (5)- 2,4- 334 and 2,3,5- 336 di- 
and tri-substituted furans with definitively controlled regiochemistry. With the observed greater 
potency of the (5)-enantiomers over the (i?)-enantiomers, we have further identified the 
importance of stereochemistry and as a result presented a powerful tool for the synthesis of 
enantiomerically pure scented furans. Although current overall yields are moderate at best, there 
is clear potential for optimisation. Indeed, through the course of our investigations, we have 
addressed some of the practical aspects with the avoidance of allylic halides and the preferential 
use of iodide over bromide as a leaving group. One can further imagine the possible use of Lewis 
acids to improve the efficiency of the addition step. In summary, it would be fair to say that the 
successes shown here have the potential to impact, in some way, on the field of fragrances.
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6.3: Plakorsin A and B
6.3.1: Introduction
With much of the focus in synthetic organic chemistry having been, and still being, orientated 
towards the synthesis of natural products, there has been a growth in the number of naturally 
occurring targets. These targets can range in complexity from simple, non-stereogenic motifs to 
complex scaffolds containing multiple stereogenic centers. At first sight, Plakorsin A 350 and 
Plakorsin B 351 would appear to be amongst the easiest of natural products to synthesise, given 
their simplicity and lack of stereogenic centers (Scheme 116). Their use in the synthesis of 
m an zamenones,67-68 which are known to inhibit DNA-polymerase, makes them particularly 
desired targets. The lack of research around this area however uncovers the truth, particularly in 
the case of Plakorsin B 351: furylacetic acids are not easy to synthesise.
Previous attempts to synthesise Plakorsin A 350 and Plakorsin B 351 are sparse with the only
Friedel-Crafts acylation with palmitoyl chloride 354 yielded furyl ketone 355 (98%), which was 
reduced using a Wolff-Kishner reaction to yield Plakorsin B 351 (60%). Esterification of acid 
351 with TMS-diazomethane yielded Plakorsin A 350 in good yields (72%) (Scheme 117). Such 
decent yields were obtained only after extensive optimisations.
C O ^e
C16H33' C16H33'
350 351
Scheme 116: Plakorsin A 350 and Plakorsin B 351.
significant studies undertaken by Whitehead.67'70 His group synthesised both Plakorsin A 350 and 
Plakorsin B 351 from 2-(furan-2-yl)acetonitrile 352.67 Addition of sodium hydroxide then TMS- 
diazomethane in MeOH yielded the methyl ester 353 of 2-furanylacetic acid in variable yields.
C02M6
NaOH
TMSCHNj. MeOH
O 3 5 5
C 02Me
352 353 354
c o 2h C02Me
H2NNH2. NaOH tm sch n2,
HOCH2CH2OH C 1 6 H 3 3  
72 h 351
MeOH, rt Ci6H33^
350
Scheme 117: Whitehead’s synthesis of Plakorsin A and B 350 and 351.
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This procedure was effective for the synthesis of both Plakorsin A and B 350 and 351, taking on 
a 4-step approach, with the overall yields of Plakorsin B 351 (59%) being respectable, although 
lower for Plakorsin A 350 (42%). A recent modification has since improved the yield of 
Plakorsin A 350 (43-58%), with the use of DCCI to improve esterification of Plakorsin B 351.69 
With applications to the synthesis of other important products,67'70 Whitehead should be given 
credit for having successfully tackled this difficult synthetic target, perhaps best appreciated by 
the six years taken to optimise this procedure to its current level.
63.2: New approaches towards Plakorsin A and B.
With the silver-catalysed cyclisation procedure in hand, it seemed that it might be possible to 
synthesise both Plakorsin A 350 and Plakorsin B 351 (Scheme 118) via two of our approach 
strategies. It was clear that the chemistry involved in some of our previous approaches (Chapter 
2.2.2 and 2.2.3) lent itself to the synthesis of these two targets.
6.3.2.1: 2-Acetoxysuccinic anhydride approach to Plakorsin B.
Having shown the use of 2-acetoxysuccinic anhydride 133 (Chapter 2.2.3 -  p 27), synthesised 
from malic acid 132 (98%),169 as a starting point for the synthesis of furylacetic acids 136a-b 
(>57% overall yields), it seemed that we held a competitive solution to the above targets. Thus, 
using our standard procedure (Scheme 118),71 «-BuLi was added dropwise to a solution of 
commercially available 1-octadecyne 356 in THF. After stirring for 0.5h, this solution was then 
added dropwise to a solution of 2-acetoxysuccinic anhydride 133 in THF, and then treated with 
sodium borohydride in ethanol and deprotected with sodium hydroxide solution (2M). A yellow 
wax was obtained, which was identified as 1-octadecyne 356.
OAc OH .
h o 2c - ^ y C° 2H acci f > °   ^ Y Cl6h33 "-BuU,(25M> HOfi
OH O 0  * ^  ”  OH
132 40°C 2'’ 133 356 NaBH< E,0H' Na0H 357
C O 2H C 0 2M e
10%  A q N Q jS J ^  JL ' ------ TM SC H N 2, J L  / -----
C16H33 O MeOH, rt ^16^33 ^
351 350
Scheme 118:2-Acetoxysuccinic anhydride 133 approach to Plakorsin A and B 350 and 351
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This result was disappointing to say the least, especially since there had not been any previous 
problems with this type of addition. In a bid to counteract this setback, we implemented a range 
of addition strategies, which included the use of Lewis acids, co-solvents and Grignard regents. 
Indeed, a brief foray into the compatibility of cerium trichloride with our additions to a- 
hydroxycarbonyls had shown that addition was able to proceed as normal. It was therefore felt 
that application of this methodology might aid the addition of 1-octadecyne 356 to the anhydride 
133; however, once again, only 1-octadecyne 356 was recovered. Reference to the literature 
highlighted the use of other Lewis acids such as boron trifluoride,171 silver iodide172 and zinc 
triflate,173 but as with cerium chloride, each attempt was unsuccessful. Changing tack slightly, 
isopropylmagnesium chloride was used to form octadecylmagnesium chloride. Grignard 
reagents174 are known to have good affinity for anhydrides and it was felt that this may provide 
the best hope for this addition. Unfortunately, this Grignard reagent was equally unsuccessful.
With the above observations in hand, perhaps the problem was not related to the addition itself 
but possibly to the formation of micelles, given the fatty nature of 1-octadecyne 356. To rule out 
such a problem, DMPU was used in a (1:6) mixture with THF,175 to evenly distribute the chains 
throughout the solution such that their anions were more exposed. Yet again, successful addition 
was not observed.
At this juncture, we terminated this approach, citing the use of extended alkynes as a limitation to 
our furylacetic acid synthetic procedure, and instead focused our efforts on our alternative 
approach using the Sonogashira pathway.
6.3.2.2: Sonogashira approach to Plakorsin B.
This previously defined approach (Chapter 2.2.2 -  p 26) featured the synthesis of conjugated 
enynes 360 using a Sonogashira coupling reaction,61-63 followed by osmium-catalysed 
regiospecific Ms-hydroxylation.64-66 Substituents including alkyl, aryl and silyl ethers were all 
accommodated in this approach. It was further shown that this procedure was successful with 
TBDMS protected 3-butyn-l-ol 359a to produce 5-substituted-2-furylalcohols 361 (Scheme 119).
— ►. X V ^ 0H
OTBDMS R
358 359a 360 361
Scheme 119: Synthesis of 5-substituted-2-furylalcohols 361.
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With this in mind, it was felt that it should be possible to oxidise the 2 -furylethanol 361 (R = 
C16H33) using one of the very many literature oxidation procedures.176'190 Having performed a 
comprehensive review of the literature, there appeared to be little, if anything, in the field of 2 - 
furylethanol 361 oxidation. A broader review identified a number of general oxidation 
procedures 362, some leading directly to the desired carboxylic acid 364176"180,184*190 and others 
pausing at the aldehyde stage 363181'183,186 (Scheme 120). We were particularly attracted to the 
use of PDC in DMF, 185 Jones reagent, 176"178 regarded by many as an “all or nothing” reagent
1 ftOgiven its strength, and the equally effective but milder oxidants TPAP, potassium 
permanganate187, 188 and 1BX.186 Other oxidants including PCC183 and the Swem protocol182 
stood out given that they could be combined with sodium chlorite184 to promote a 2 -step 
oxidation to the acid 364.
e.g. Swem, _  NaOCI ^
R ^O H  ........................... R ^ °   ^ R ^ f °
H OH
362 363 364
j_____________________e.g. Jones, TPAP,_______________________|
KMn04. IBX
Scheme 120: Oxidation procedures.
Thus, 1-octadecyne 356 was treated with catecholborane and iodine to yield 1-iodooctadec-l-ene 
365 (46%). Sonogashira coupling with 359b then yielded enyne 366 in good yield (79%), which 
was converted into the corresponding diol 367 by selective 6 /5-hydroxylation. Cyclisation with 
10% AgN0 3 .Si0 2  successfully yielded furan 368 in excellent yield (95%) (Scheme 121).
C i6H33 C^ o i bon.ne + /^ O T B S  C16H33
^  NaOH, l2  X ^  Cul, Et3N
356 365 359b 366
10% AgNCbSiOa
TBAF, THF
C16H33'
369 351
Scheme 121: Sonogashira approach to Plakorsin B 351.
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At this point, with a small amount of furan 368 in hand and the expected greater stability of the 
furan with the silyl group still present, it was felt that a previously prepared model compound 
should first be used to determine suitable oxidative conditions. This model, 5-phenyl-2- 
furylethanol 371, was synthesised from p-bromostyrene 370 and 0-TBDMS protected 3-butyn-l- 
ol 359a (Scheme 122).
OTBDMS
370 359a 371
Scheme 122: Synthesis of 5-phenyl-2-furylethylalcohol 371.
With this model compound 371, the decision was made to attempt to carry out a direct oxidation 
to give furan 136b, an alternative synthesis of which has been previously described in Chapter 
2.2.3. Given the highly acidic nature of Jones reagent, and the sensitivity of furans to strong 
acids, some of the alternative oxidative procedures were implemented first. It was found that 
TPAP,189 basic potassium permanganate187'188 and PDC in DMF185 were all unsuccessful with 
each yielding an array of unexpected products in the presence of starting material 371. Despite 
some reservations, Jones’ reagent176*178 was also used in the interest of completeness. Although a 
potentially risky strategy, given the sensitivity of furans, Jones oxidations are usually easy to 
perform and can often be highly effective. It was found that the addition of a few drops of Jones 
reagent to a solution of furylethanol 371 in acetone failed to effect the desired oxidation to the 
corresponding furylacetic acid 136b (Scheme 123).
^  , OH Jones Reagent 0 ^ 2^
y s  ------ ^ ► fi > /
P h ' 0  PIT °
371 136b
Scheme 123: Oxidation of 5-phenyl-2-furylethylalcohol 371.
Attempts to perform a two step oxidation via the mild conditions of a Swem oxidation182 
provided yet another set-back. Yet again, we had been unsuccessful in obtaining the desired 
furylacetic acid 136b. Instead, what had become apparent, at this stage, was the presence of an 
unidentified product in the mixtures produced from the PDC, Jones and Swem oxidation 
procedures. Indeed Jones reagent appeared to provide a remarkably clean passage to this 
unknown product.
133
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With the difficulties encountered in our attempts to oxidise a furylethanols 361 we stumbled upon 
a quite remarkable transformation. To our surprise, addition of a slight excess of Jones reagent 
(120 mol%) to a solution of 5-phenyl furan-2-ethanol 371 in acetone at 20 °C had in fact produced 
2,3-dihydro-7-phenyloxepin-4(5H)-one 372 in moderate yield (50%) (Scheme 124).
OH Jones Reagent
Acetone
20°C
371
Scheme 124: Synthesis of 2,3-dihydro-7-phenyloxepin-4(5H)-one 372.
The enclosed *H NMR data (Spectrum 16) suggested that the product formed is cyclic, this given 
the nature of the signals between 4.50 and 2.00 ppm. Careful interpretation of the coupling 
constants provided confidence in the proposed structure given the grouping of the apparent ring 
protons into one group of three, the 5- and 6-H ’s, and one group of four, the 2- and 3 -H ’s. 
Further structural confirmation was achieved through the use of COSY (Figure 31) and HMBC 
analysis (Figure 32), and with the determination of the molecular weight of 188, consistent with 
structure 372. Infrared spectroscopy further showed the presence of a carbonyl and enol ether 
peak at 1756 and 1686 cm'1. Yields were later optimised (81%) by cooling to 0 °C and 
improving the work-up protocol.
j
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Figure 31: COSY analysis of 2,3-dihydro-7-phenyloxepin-4-one 372.
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Spectrum 16:] H NMR spectrum of oxepin-4-one 372 (CDCI3).
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Figure 32: NMR assignments o f  oxepin-4-one 372.
In Figure 31 it can clearly be seen that there is a relation between the masked 6-H at 4.10ppm and 
the 5-CHaHb system, adjacent to the carbonyl, which shows a chemical shift o f 3.55 and 
3.30ppm. The second relation occurs between the 2-CHaHb and 3-CHaHb systems, which have 
chemical shifts o f 4.30 and 4.05ppm, and 2.70 and 2.50ppm respectively. Such relations suggest 
there to be a divide between the two sets o f  protons, for which a carbonyl group and ether oxygen 
are perfect candidates, especially given the concurrent chemical shifts. Figure 32 provides 
further evidence with the observed proximity between the ortho proton o f the phenyl ring and the 
enol ether quaternary carbon at 197.7ppm, which itself displays further proximity to the 6-H and 
5-CHaHb protons.
Further discussions surrounding the potential o f this technique and a detailed introduction to this 
field are presented in the next section (Chapter 6.4 -  p 137).
6.3.4: Summary
Both attempts to synthesise Plakorsin B 35167'70 were disappointingly unsuccessful. Despite 
having what seemed an attractive approach to furylacetic acids, with the use o f 2-acetoxysuccinic 
anhydride 133,71 it was shown that it is not possible to incorporate long chain alkynes into this 
procedure. When turning to our second approach, the Sonogashira pathway, everything seemed 
to be running smoothly but as before an insurmountable obstacle formed, in this case the 
oxidation stage. Despite trying a range o f  oxidative conditions,176-178, 182, 185, 187 , 89 we were 
unable to synthesise the desired furylacetic acid 136b and 351 using this approach. In hindsight
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perhaps the literature had a hidden message, given the lack of reports of the successful oxidation 
of furylethanols 361. Had it not been for this stumbling block, then we believe that an efficient 
synthesis of Plakorsin B 351 would have been identified. Despite these set backs, the pleasing, 
but completely unexpected, formation of 2,3-dihydro-7-phenyloxepin-4(5H)-one 372 had been 
realised.
6.4: Synthesis o f cyclic ethers - oxeDin-4-one. oxepan-4-one and oxocin-5-one 
6.4.1: Introduction
Oxepanes 373 and oxocanes 374 are 7- and 8-membered oxygen-containing heterocycles 
(Scheme 125). They are known to have important practical and medicinal applications and can 
be functionalised further with unsaturated bonds to give oxepins 375 and oxocins 376, as well as 
with carbonyl groups to give oxepinones 377 and oxocinones 378.
O  Q  O  6  " O
374 375 376 377 378
Scheme 125: Functionalised and non-functionalised oxepanes 373 and oxocanes 374.
With the relative ease of synthesis of non-functionalised cyclic lactone derivatives, there have 
been some industrial preparations with perhaps the best example being the use of e-caprolactone 
as monomer for the production of poly-e-caprolactone.191 Whilst there have been successes in 
this area, the synthesis of more functionalised derivatives is by no means trivial. The synthesis of 
oxocanes 374 is particularly troublesome given the required energies to permit cyclisation.
Many synthetic approaches to oxepanes 372 incorporate either a displacement reaction, with 
elimination of an activated leaving group, or a ring expansion reaction such as a Beckmann 
rearrangement.192 Indeed, one of the best approaches to a functionalised oxepane involves the 
rearrangement of a 6/s-epoxidized furan 381, obtained from the epoxidation of a substituted furan 
379 with m-CPBA.193 Here it is seen that epoxidation occurs in two stages 380 and 381, with the 
latter epoxidation activating ring expansion to the oxepanone 382 (Scheme 126). Yields for this
373
137
Chapter 6: Results and Discussion 
transformation are high (>95%) and furthermore successfully exemplify the effectiveness of 
using heterocyclic substrates.
~ m-CPBA m-CPBA
O
379 380 381 382
Scheme 126: Synthesis of (Z)-2-(7-oxooxepan-2-ylidene)propanal 382.
Approaches to functionalised oxocanes 385 tend to be fixed to ring expansion reactions, and 
often result in low yields. One of the few cyclisation procedures uses lead tetraacetate to effect 
ring closure of A7-octene-l-ol 383,194 however yields of the 2-substituted oxocanes isomers 384, 
385 are low (10-11%) and contain mixtures of alternative products (Scheme 127).
PtXOAc)4 f7  ^  ^
,OH . "  L 0A - OAc + V _ 0A ^ ° " (C H 2)6CH=CH2
383 384 385
Scheme 127: Synthesis of 2-substituted oxocanes from A7-octene-l-ol 383.
Finally, a high yielding ring expansion has also been described by Closson.195 In this procedure, 
cycloheptanone 386 was reacted with peroxytrifluoroacetic acid to yield oxocan-2-one 387 in 
good yields (72%) (Scheme 128).
h o o c c f3 /  N
o  ---------- '  ^
386 387
Scheme 128: Closson’s synthesis of oxocan-2-one 387.
All in all, the literature around the synthesis of these compounds is quite varied, with the best 
results reported through ring expansion procedures,195_196 with a significant proportion of these 
ring expansions seeing the synthesis of oxepan-2-ones 382 and oxocan-2-ones 387. Although a 
little limited, it is possible to convert oxepane-2-ones 388 into the corresponding 2-substituted 
cyclic ethers, through a series of simple transformations. Indeed, Murai has shown that it is 
possible to convert oxepan-2-one 388 into a substituted cyclic ether 391 via the formation of its 
enol triflate 389.197 Thus, addition of lithium hexamethyldisilazide, HMPA and A-phenyl 
triflimide to a solution of oxepane-2-one 388 in THF successfully yielded the enol triflates 389 in
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excellent yields (89-95%). These enol triflates 389 could then be coupled with lithium 
dialkylcuprates to give the 7-substituted tetrahydrooxepines 390 in good yields (58-72%). Further 
functionalisation was shown with hydroboration and oxidation to yield the p-hydroxyoxepane 
391 in low yields (30%) (Scheme 129).
0 - *  uhmds» r y R’ r y Ri r y *
X - O  HMPA. PhNTf2  Cut 2) H2 ° 2 > NaOH HO'
^  -78°C -> 0°C -50°C -> 0°C R 2
388 389 390 391
Scheme 129: Functionalisation of oxepane-2-ones 388.
Murai’s work shows the potential manipulations of oxepan-2-ones 388 and, provides access to 
‘various marine natural products with cyclic ether ring systems’197 e.g. hemibrevetoxin B.198
6.4.2: Synthesis of oxepin-4-ones and oxepan-4-ones
In view of the successful synthesis of 2,3-dihydro-7-phenyloxepin-4(5H)-one 372 from 5- 
phenylfuran-2-ethanol 371 (Scheme 124), we looked to assess the need for deprotection prior to 
this transformation. Further investigations into the effect of protection strategies saw the 
successful transformation of the O-TBDMS-protected 2-furylalcohol 392 into the (Z)-oxepin-4- 
one 372 (Scheme 130).
O
OTBDMS Jones Reagent
Acetone y -"0
o°c ^
392 372
Scheme 130: Synthesis of 2,3-dihydro-7-phenyloxepin-4(5H)-one 372.
In this one-off experiment, yields were lower (15%), as purification was required to remove 
traces of silyl residues, but it had been shown that separate deprotection of the protected 2- 
furylalcohol 393 was not essential and can be replaced by in situ removal of the silyl group. This 
allows the number of steps in this sequence to be reduced to five. It also lowers time and wastage 
as, in this case, deprotection required overnight stirring in the presence of 400 mol% TBAF to 
ensure complete cleavage.
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With these results in hand, and in an effort to optimise the reaction conditions, the components of 
Jones reagent were tested individually. Addition of 25% sulfuric acid to a solution of furan 371 
in acetone failed to induce the transformation, and somewhat surprisingly had no effect on furan 
371 as this starting material was recovered, even after exposure to the acidic solution for 1 h. 
The use of concentrated sulfuric acid did have an effect, but once again did not yield the now 
expected oxepinone 372. Instead, the acid sensitive furan 371 had undergone a Friedel-Crafts 
alkylation at its ^-position. The highly acidic conditions had allowed for the addition of acetone, 
traditionally used as the solvent, to yield trisubstituted furan 393a, seemingly regioselectively but
HO OH
OH OH
Ph Ph'
371 393a 393b
Scheme 131: p-acylation of furylethanol 371.
NOESY correlations provided some evidence that the regioselective addition of acetone had 
occurred at the 3-position of furan 371, this given the distinct absence of any overlap between the 
newly incorporated gem-dimethyl group and the existing phenyl ortho-protons. Although not 
definitive, this evidence does provide our best estimate of the correct regiochemistry, and the 
addition itself confirmed through further elucidation with a second transformation to the 
corresponding oxepin-4-one 394. With the regiochemistry tentatively proposed a second 
curiosity is obviously the presence of an apparently acid-stable tertiary alcohol. It would be 
normal for such an “allylic” tertiary alcohol to undergo easy elimination, forming a conjugated 3 - 
vinylfuran, especially with the furan heteroatom being perfectly aligned to activate this. Instead 
this alcohol remains intact.
The addition of Jones reagent to this modified furyl alcohol 393 then yielded oxepan-4-one 394 
(27%) (Scheme 132). Interestingly, the image presented in Spectrum 17 appears to suggest that 
this product consisted of both diastereoisomers in a 4:1 ratio.
HQ
OH cone. H2 SO4  f—\ x _ y  Jones Reagent
Acetone Acetone
0°C 0°C
371 393
Scheme 132: Synthesis of 7-hydroxy-5-(2-hydroxypropan-2-yl)-7-phenyloxepan-4-one 394.
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Spectrum 17:] H NMR spectrum of furan 393 and oxepan-4-one 394 (CDCI3).
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It appeared that water has not been eliminated from the product, despite the acidic conditions. 
This seemed strange to say the least, especially given that the newly formed tertiary 7-hydroxyl 
group o f the hemiacetal, a perfect leaving group for enol ether formation, also appeared to not 
undergo elimination. Infrared spectroscopy shows the presence of a particularly broad OH 
absorbance centred around 3450cm'1, 13C NMR displays the presence o f three CH2 groups at 
61.6, 42.2 and 33.8ppm. Further evidence is provided with the use o f COSY (Figure 33) and 
HMBC (Figure 34) analyses.
o  0
u 44 3. 4 2 4
Figure 33: COSY analysis of 7-hydroxy-5-(2-hydroxypropan-2-yl)-7-phenyloxepan-4-one 394.
Figure 34: HMBC analysis o f 7-hydroxy-5-(2-hydroxypropan-2-yl)-7-phenyloxepan-4-one 394.
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Figure 33 shows coupling between the 2-CHaHb system, with a chemical shift of 4.10 and 3.83 
ppm, and the 3-CHaHb system, which has a chemical shift of 2.73 and 2.30 ppm. It also shows a 
separate series of couplings between the signals at 3.50, 3.35 and 2.50 ppm, which appear to 
belong to the 5-H and 6 -CHaHb protons. With reference to Figure 34, it can be seen that the clear 
Ji coupling of the proton at 3.35ppm to the CH carbon at 56.2 ppm, pinpoints this peak as the 5- 
CH group. The further Jj coupling of the 3.50 and 2.50ppm signals to the 6 -CH2 carbon at 33.8 
ppm adds further weight to the presence of a CH2 group at the 6 -position. Finally, close 
interpretation of the signals at 207.4 and 197.7 ppm appears to show that the 5-CH group couples 
only to the carbonyl signal at 207.4 ppm. The 6 -CH2 protons on the other hand couple to both the 
carbonyl signal at 207.4 ppm and the 7-C at 197.7 ppm, suggesting closer proximity of the CH2 
group to the 7-C than the CH. The mass spectrometric data were somewhat ambiguous. A 
molecular weight of 246 was identified, corresponding to M-H2O, but given the harsh conditions 
within the mass spectrometer, it would certainly not be unexpected for water to be eliminated 
from such a sensitive compound.
With the above evidence in hand, it seems fair to suggest that the proposed transformation to 7- 
hydroxy-5-(2-hydroxypropan-2-yl)-7-phenyloxepan-4-one 394 is reasonable. It also brings the 
tally of compounds synthesised via this new procedure to two, with the apparent formation of 
both an oxepin-4-one 372 and an oxepan-4-one 394 (Scheme 133).
Ph OH
394
Scheme 133: Synthesised oxepin-4-one 372 and oxepan-4-one 394.
Finally, reverting back to our original aim, our next optimisation in the synthesis of our oxepin-4- 
one 372, saw the use of C1O 3 on its own. It was observed that the desired transformation to the 
oxepin-4-one 372 occurred once again and in a somewhat cleaner fashion, but at a much slower 
rate. Thus, in view of the benefits of a slower reaction, Jones reagent was added dropwise to a 
cooled (0 °C) solution of furylethanol 371 in acetone. The introduction of a neutralisation step, 
using saturated aqueous potassium carbonate, allowed for the isolation of pure product in 
excellent yield (81%) and with time optimisations, presented a system which effected the 
transformation to oxepinone 372 in just 0.5 h when using just a slight excess of Jones reagent.
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With the above results in hand, it was then proposed that it would be possible to synthesise an 
oxocin-5-one 397. With die compatibility of silyl protection groups having already been shown, 
it was possible to use our standard synthetic approach (Chapter 2.2.1 -  p 24) to synthesise 
0-TBDMS protected 5-phenylfuran-2-propanol 396 (60%) from p-bromostyrene 370 and 
O-TBDMS protected 4-pentyn-l-ol 395. Addition of Jones reagent (120 mol%) to this protected 
5-phenyl furan-2-propanol 396 yielded a mixture of products containing oxocin-5-one 397, dione 
398 and the carboxylic acid derivative of furan 396 as the major products in a ratio of 5 : 2 : 25. 
This result was more reflective of a traditional Jones oxidation, given the predominant formation 
of the furyl acid, however interestingly we were able to form at least some of the targeted 8 - 
membered ring. Column chromatography led to the isolation of 3,4-dihydro-8-phenyl-2H- 
oxocin-5(6H)-one 397 (10%) in a 3:2 mixture with the ring opened product 398 (6 %) of furan 
396 (Scheme 134).
Ph^ v Br OTBDMS
/  Jones Reagent370 ------- ^ ^
Acetone
^ ^ ^ O T B D M S
395 396 397 398
Scheme 134: Synthesis of 3,4-dihydro-8-phenyl-2H-oxocin-5(6H)-one 397.
Although product formation did not occur as cleanly as in the previous example, a columned 
yield of 10% did provide a satisfactory starting point. The 'H NMR data (Spectrum 18) shows 
clearly that there are two distinct compounds, including the oxocins-5-one 397 with what are now 
characteristic cyclic signals between 4.50 and 2.00ppm and the dione 398 with its acyclic CH2 
groups at 3.73, 2.50 and 1.79 ppm in the presence of the c/s-alkene signals at 6.50 and 5.62 ppm. 
Together with the evidence from COSY (Figure 35) and HMBC (Figure 36) analyses, it seems 
likely that the suggested structure of 3,4-dihydro-8-phenyl-2H-oxocin-5(6H)-one 397 may indeed 
be correct. Mass spectrometry showed two major molecular ions, one with a mass of 202, which 
corresponds to the proposed oxocin-5-one 397, and the other with a mass of 218, which correlates 
with the ring-opened and oxidised dione 398.
+ Ph
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Spectrum 18: *H NMR of oxocin-5-one 397 (CDC13).
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Figure 35: COSY analysis o f 3,4-dihydro-8-phenyloxocin-5-one 397.
Figure 36: HMBC analysis o f 3,4-dihydro-8-phenyloxocin-5-one 397.
Once again it can be seen that the required correlations for the proposed 8-membered ring 397 are 
present. Figure 35 shows coupling between the 7-CH at 4.41 ppm and the 6-CHaHb system, 
which has chemical shifts o f 3.55 and 3.25ppm. It can be further seen that there is coupling 
between the 2-, 3- and 4-CHaHb protons at 4.01, 3.83, 2.63, 2.48, 2.18 and 2.04ppm. The HMBC
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profile presented in Figure 36 shows the peak at 4.41ppm to display a J1 correlation with the CH 
carbon at 79.6ppm and J2 couplings with the 6 -CH2 and 8-C carbons at 39.3 and 196.8ppm.
Further evidence is seen with the peak at 2.28ppm displaying the expected J2 couplings to the 2- 
CH2 and 4 -CH2 carbons at 38.0 and 6 6 .6 ppm respectively.
The above data also allow some conclusions to be drawn about the nature of the other isolated 
product 398, particularly given that the lH NMR data appeared to suggest that this second 
product is acyclic. It can be seen in Figure 35 that there is an apparent trans-coupling between 
what are seemingly alkene peaks at 6.52 and 5.62ppm. There is also further long range coupling 
between the 3-CH and 5-CH2 groups at 5.62 and 2.50ppm respectively. This suggests that the 
other product is indeed the proposed dione 398. Reference to Figure 36 shows further proof of 
this proposed structure with typical J 1 and J2 couplings of the 2-CH carbons and characteristic J 1 
and J2 couplings for the 5-, 6 - and 7 -CH2 carbons.
With further investigation, and the exposure of the unprotected derivative of 396 to the same 
conditions, perhaps an improved synthesis of 3,4-dihydro-8-phenyl-2H-oxocin-5(6H)-one 397 
can be realised, particularly given the number of possible experimental variables.
6.4.4: Proposed mechanism
Interestingly Jones reagent was not the only oxidising agent to effect the transformation of 5- 
phenylfuran-2-ethylalcohol 371 into 2,3-dihydro-7-phenyloxepin-4(5H)-one 372 (Scheme 124). 
Our earlier efforts to synthesise furylacetic acids (Chapter 3.2.2 -  p 131) had shown the same 
transformation to occur in trace amounts when performing a Swem oxidation, and significant 
amounts were observed in the product of the PDC oxidation. This seemed to suggest that either 
some sort of oxidation was occurring or the oxidising agent was acting as an electrophilic 
activating group. On the face of it, no formal oxidation is required to form the proposed product 
372, thus the chromium- and DMSO-derived species present in such reagents must be involved in 
activating ring closure. To this effect, it is proposed that the following happens (Scheme 135):
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y —QH Electrophile , <- H+) ^ \ J E
Ph'WT Ph-^ ^jV Ph(^ °/NH®
(E = Jones, Swem ... etc)
371 403 404
HOE
(+ H*)
405 406 372
Scheme 135: Electrophile-mediated synthesis of 7- and 8 -membered cyclic ethers.
It seems plausible that the addition of an electrophile at the 2-position [403], perhaps assisted by 
ethyl alcohol co-ordination, would allow for ring closure by the 2 ’-hydroxyl substituent and 
newly formed oxonium ion to form a bicyclic intermediate 404. This intermediate does not 
contravene Bredt’s rule as there are no bridgehead double bonds and one could imagine oxonium 
ion formation [405], elimination [406] and tautomerisation to occur to yield oxepin-4-one 372. 
Given the possibilities for the addition of water at various stages throughout this mechanism it 
would not be so unsurprising to observe related hemi-acetal derivatives, as seen in the synthesis 
of oxepane-4-one 394.
6.4.5: Alternative Pathway
Recently, it has been proposed that this reaction may proceed via an alternative pathway, one 
which produces a different product. It is suggested that the 5-phenylfuran-2-ethanol 371 
undergoes oxidation to dione 407, which then cyclises using the 2’-hydroxyl substituent to form a 
substituted tetrahydropyran-4-one 409 (Scheme 136).
Q
0
OH
\ __ /  Jones, Swem... 1 *- H0
Ph" ' °  ~  p A >  p A >
371 407 408 409
Scheme 136: Alternative oxidative-transformation of 5-phenylfuran-2-ethanol 371.
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Whilst this mechanism does incorporate a formal oxidation, the data available does not 
conclusively fit the proposed structure. Mass spectrometry does give a molecular ion of 227, 
which could correspond to the sodium adduct o f409, and both *H- and 13C-NMR can relate to the 
above, with the lower chemical shift of the 2-CH group now attributable to its alkylic nature. The 
infra-red spectrum is less conclusive with signals at 1686 and 1756cm*1 being perhaps too low 
given the presence of two ketone functionalities. The alternative structures for the transformation 
of furans 393 and 3%  are shown in scheme 137.
H O ./  .OH
r Y
H O /
f i r OH
PhA o
Jones, Swem
393
piA > °
410
rr°
o^ A ^ oh
piA o
411
OTBDMS
Ph
396
OH (TBDMS)
Jones, Swem...
412
P lA o
Scheme 137: Alternative oxidative-transformation products.
The data for these products is less conclusive. The *H- and 13C-NMR suggest the presence of 
three CH2 functionalities and one CH for the proposed formation of dihydropyran-4-one 411 
from furan 393, where as there are only two CH2 groups in the above structure. For the 
transformation of furan 396 there are two potential products, oxepan-4-one 413 and 
dihydropyran-3-one 414, for which there is a molecular ion (M+H^ of 219. The JH- and 13C- 
NMR data show agreement with both of the proposed structures, with the intermediate dione 412 
showing !H-NMR signals at 6.50 and 5.62ppm. Reference to the HMBC (Figure 36) highlights 
that oxepane-4-one 413 is the more likely of these two given the observed coupling of the 2-CH 
proton to the aryl ketone at 196.8cm*1, yet this would be perhaps the least favoured on first sight. 
The final piece of data available is the infra-red, which shows two signals at 1639 and 1748cm*1. 
The lower of these signals is perhaps too low for a ketonic functionality and again draws a degree 
of uncertainty over such a transformation.
Whilst this proposal presents an alternative pathway, which produces potentially more viable 
products 409, 411 and 414, the data available does not completely agree with the proposal.
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Tetrahydropyran-4-one 409 appears plausible however dihydropyran-4-one 411 appears to lack a 
CH2 group and dihydropyran-3-one 414 appears not to be formed. Clearly an X-ray crystal 
structure will answer this question once and for all however a disruption to departmental facilities 
have meant that the data has not been obtainable. Once the proposed data is available then a firm 
conclusion should be drawn on the precise nature of this transformation.
6.4.6: Summary
The transformation of 5-phenylfuran-2-ethanol 371 into 2,3-dihydro-7-phenyloxepin-4(5H)-one 
372 was a pleasant surprise. The cleanliness and high yields of the reaction hinted towards the 
discovery of a novel synthetic methodology. Thus, with further experimentation, it was also 
shown that other 7- and 8-membered cyclic ethers 394 and 397 could be synthesised through the 
use of this procedure. Unfortunately the yields of these reactions were lower (27% and 10%) 
than in the synthesis of 2,3-dihydro-7-phenyloxepin-4(5H)-one 372 (83%), and in the case of the 
8 -membered ether 397, a competitive reaction was observed, to yield what is thought to be a ring 
opened furan derivative 398.
With the potential to use 5-alkylfurylalcohols 127 and tri-substituted furylalcohols 101, there is 
great scope for this technique. There are still several avenues for optimisation and much work 
which still needs doing, but the results from this brief study are promising. Indeed, with 
optimised conditions in hand, one could imagine accessing a large library of other 7- and even 8 - 
membered heterocycles, and perhaps even a series of 9-membered ring systems. If this can be 
achieved then a significant synthetic procedure would have been formed.
6.5: Conclusions
The work in this Chapter has shown the potential of the silver-catalysed cyclisation. Despite the 
mixed successes in achieving the overall outcomes it was found, that in all cases where the 
cyclisation procedure had been used to synthesise furans (±)-334, (±)-336, 371 and 396 were 
obtained in high yields. Indeed the most successful result saw the synthesis of a series of 
enantiospecific scented furans 0-334 and 0-336 (>95%), which displayed a mixed array of 
aromas. With the vast range of substituents accommodated by the silver cyclisation, one could 
imagine the compilation of an extensive library of scented compounds from this technique alone.
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The attempted syntheses of Plakorsin A and B were unsuccessful. With the implementation of 
two quite different synthetic approaches there was great hope in obtaining the desired products. 
Unfortunately, despite best efforts, the unsuccessful addition of 1-octadecyne 356 onto 2- 
acetoxysuccinic anhydride 133 proved a stumbling block. The insurmountable problems found 
when oxidising substituted furylethanols 361 further meant that progress towards the synthesis of 
Plakorsin A and B became stalled. With the above failings in mind, we were able to highlight the 
importance of our existing approach to fiirylacetic acids 136 (Chapter 2.2.3 -  p 27), be it with the 
limitation of not being able to use fatty alkyne chains. Ominously there is sparse literature 
around the synthesis of furylacetic acids 136, and therefore the simplicity and high yields of our 
approach certainly has its merits.
The unsuccessful oxidation of furan 371 did however identify an unforeseen use for the products 
of the silver-catalysed cyclisation reactions. It was shown that Jones reagent, specifically 
chromium(VI) trioxide although slow by itself, can be used to effect the synthesis of substituted 
oxepin-4-ones 372 and 394 and oxecin-5-ones 397. With the potential synthesis of a series of 
substituted cyclic ethers, via the preparation of required substrates through the use of the silver 
cyclisation, it is felt that this procedure may have important applications. Although yields are 
varied (10-83%), there is much hope for the optimisation of this procedure through further 
investigation.
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7.1 Conclusions
The silver(I)-catalysed synthesis of furans, pyrroles and pyrazole-A-oxides has been described. It 
has been shown that all are formed from their respective substrates with excellent conversions 
(>95%), and isolated yields are equally high (>95%) in the majority of cases. The few 
observations of an impurity can be clearly related to the purity of the starting material or, in a 
handful of cases, further but preventable side reactions.
In the scope of this project, the procedure was successfully used to synthesise a series of 2,4-,
2.5- and 2,3,5-substituted furans, which included the troublesome furylacetic acids and 2,3- and
2.3.5-substituted pyrroles, pyrazole-JV-oxides and pyrazoles. Through this work it was shown 
that there is compatibility with a range of substituents including alkyl, allyl, aryl, hydroxyl and 
silyl groups, as well as a series of protecting groups, which include alkyl, benzyl and silyl for 
hydroxyl groups and Boc, Moc, 4-nosyl and tosyl groups for amines. Many of these substituents 
appear to be broadly applicable to each heterocycle; this has important future implications, as it is 
likely that this will be the case for the many other possible heterocyclic targets which are 
attainable through this kind of approach.
Efforts to understand the mode of reaction, including stereochemistry, key functionalities and in 
situ NMR studies, have helped to elucidate the proposed mechanism. From the evidence in 
hand, we can be reasonably confident in our conclusions and go some way towards optimising 
the overall procedure. Of particular note was the observation that the sryw-isomer cyclises the 
faster, a result which may influence the choice of approach towards a chosen heterocyclic target, 
be it chelation or non-chelation control or the use of an appropriate stereoselective approach.
As with all procedures there are of course limitations; fortunately in this instance, there have only 
been a handful of such constraints identified thus far. These include the use of allylic alkenes, 
divalent sulfur, unprotected propyl alcohol substituents and the synthesis of dihydrofurans. Some 
of these issues have been resolved and it is believed that with further work will help to address 
many of the others in time. Interestingly in the case of propyl alcohol substituents, competitive 
5-exo, and possibly 6-endo, transformations were observed. Although a limitation in the 
synthesis of the required furan, this observation is in fact of great interest as it highlights the 
possibility of using the silver(I)-catalysed method for the synthesis of other heterocyclic products.
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With the above results in hand, and with a view towards the continuous use of the silver(I) 
catalyst, it was possible to engineer a flow system for heterocyclic synthesis. Early attempts 
using the existing catalyst, 10% AgN03.Si02, although high yielding (>95%), were troubled by 
silver leaching. By considering what was known about the chemistry, and further assessing the 
active state of the catalyst, amberlite 200C was identified as a candidate for catalyst support. The 
results from this supported catalyst were remarkable. By placing the supported catalyst in a 
stainless steel column, we were able to successfully synthesise a series of furans, pyrroles, 
pyrazole-jV-oxides and isoxazoles in high yield (>95%). Quantification of the levels of metal 
within the products obtained from this column, showed silver content to be <lppm in all samples 
tested. Furthermore, the highly repeatable nature of the results and large number of runs to date 
are an indication of the robustness of the column, and show the potential value of such a simple 
piece of equipment. Finally, in another positive move, it has been shown that the column can be 
operated without solvents when using liquid diols. This is important as it means the turnover 
from such a column greatly increases and processing is kept to a minimum.
With the help of David Cole-Hamilton, investigations into the use of a second flow system 
proved to be equally fruitful, with it being shown that this chemistry can be applied to a scC0 2 :IL 
continuous flow system. It was possible to contain the silver catalyst within a polar ionic liquid 
such that upon application of a continuous feed of diol, cyclisation could proceed. Using a 
second continuous feed of SCCO2, and by manipulating its gas and liquid-like properties, it was 
possible to continuously extract the newly prepared non-polar furan cleanly and in high yield 
(>70%). Yields were a little lower than the existing flow system but this can confidently be put 
down to product volatility, given the upstream condensation of the product. With the high 
recyclability of CO2 and there not being a specific need for organic solvents, this process has 
great potential and is seen by many as part of the future of continuous manufacturing.
Finally, having achieved our original aims, we were able to demonstrate specific uses of the 
silver(I)-catalysed cyclisation procedure. As part of this work the individual enantiomers of the 
sesquirosefuran analogues 334 and 336 were successfully prepared, with the key cyclisation step 
proceeding in high yield (>90%). Having taken measures to ensure the removal of competing 
aromas, it was shown that the (5)-isomers of both furans 334 and 336 presented the most pleasant 
scent. Indeed, given the range of compatible substituents, and the successful development of our 
flow system, one could imagine the preparation of a library of similarly scented compounds.
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Further work towards the applications of the silver(I)-catalysed cyclisation saw the attempted 
synthesis of the natural products Plakorsin A and B. Unfortunately, in this instance, it was not 
possible to synthesise the desired targets however, with regard to the silver(I) cyclisation, these 
approaches were successful. Instead these approaches failed as a result of the unsuccessful 
nucleophilic addition of 1-octadecyne and the failure to oxidise the furyl ethyl alcohol to the 
desired furyl acetic acid. The results of the oxidation did however highlight our final synthetic 
transformation, the synthesis of 7- and 8-membered cyclic ethers. It was shown that several 
oxidising agents successfully effected the transformation of furyl alcohols to their corresponding 
7- or 8 -membered cyclic ether. By far the best of these was Jones reagent, with oxepin-4-one 372 
being obtained in high yield (81%). Using this procedure, it was also possible to synthesise the 
larger 8-membered cyclic ether, oxocin-5-one 397.
Future work should expand the range of heterocycles prepared by the silver(I)-catalysed 
cyclisation. With there being evidence for competitive 5-exo ring closures, as well as the 
formation of dihydrohydroxy pyrroles, it seems prudent to investigate these areas in particular. 
Given the range of compatible substituents, it may be of interest to attempt the synthesis of other 
natural products, perhaps the furanosteroids. Finally further investigations are required into the 
synthesis of 7- and 8 -membered cyclic ethers using Jones reagent. With the provisional 
successes in hand there is potential to expand and optimised this field still further, perhaps into 
the synthesis of 9-membered rings.
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8.1: General Details
All non-aqueous reactions, unless otherwise stated, were conducted in oven- or flame-dried 
glassware under an atmosphere of dry nitrogen with magnetic stirring. Solid carbon dioxide and 
an acetone bath (-78 °C) or an ice-water bath (0 °C) were used to obtain low temperatures. 
Heated reactions were conducted in a stirred oil bath heated on a magnetically stirred hotplate.
Dried: Refers to addition of dried magnesium sulfate (MgS0 4 > to remove trace amounts
of water.
Filtered: Refers to removal of MgSC>4 by filtration of organic solutions through filter paper.
Evaporated: Refers to the distillation of solvent using a Buchi rotary evaporator, typically
between 20 and 40 °C.
Overnight: 18-24hrs.
When required, solvents were dried and purified prior to use. Tetrahydrofuran was distilled from 
sodium. Dichloromethane and toluene were distilled from calcium hydride. Triethylamine, 
diisopropylamine, pyridine and Hunigs base were distilled over sodium hydroxide containing 4A 
molecular sieves. Diethyl ether was distilled from sodium benzophenone ketyl. All solutions of 
crude products were dried by brief exposure to dried magnesium sulfate (MgS0 4 ), unless 
otherwise stated, then filtered and evaporated under reduced pressure (Buchi rotary evaporator 
attached to a 20 L Charles Austen pump and using a warm water bath). Column chromatography 
was carried out over matrix silica gel (35-70 pm mesh), sourced from Biotage, as the stationary 
phase, and with an elution gradient of ethyl acetate: petrol (40-60 °C) solutions (ranging from 2.5 
- 30% ethyl acetate). All reactions, where appropriate, were monitored by tic using Merck silica 
gel 60 F254 precoated aluminium backed plates, which were visualised with ultraviolet light or 
ammonium molybdenate. Retention factor values (Rf) are reported in the appropriate solvent 
system.
All melting points (mp °C) were determined using a Gallenkamp melting point apparatus and are 
uncorrected. Infrared spectra were obtained using a Perkin Elmer 1600 series Fourier Transform
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Infrared Spectrometer, as liquid films on sodium chloride plates [film], as a solution in 
dichloromethane [DCM] or as nujol mulls on sodium chloride plates [nujol].
Proton (]H) NMR spectra were recorded on a Bruker DPX 400 instrument at 400 MHz, unless 
otherwise stated, in which case they were performed on a Bruker DPX 250 or 500 instrument 
operating at 250 and 500 MHz respectively. Spectra were obtained as dilute solutions in 
deuteriochloroform, unless otherwise stated. The chemical shifts are recorded relative to residual 
chloroform (7.17 ppm) as an internal standard. Abbreviations used for the multiplicities are s 
(singlet), d (doublet), t (triplet), q (quartet), bs (broad singlet), m (unresolved multiplet), app. 
(apparent) or as a combination of these multiplicities. All coupling constants (J) are recorded in 
Hertz (Hz). Carbon (,3C) spectra were recorded on the same instruments, but were operated at 
100, 62.5 and 125 MHz respectively. Chemical shifts are reported relative to residual chloroform 
(77.0 ppm) as an internal standard. Assignments were made on the basis of chemical shift and 
coupling constant data using DEPT-90, DEPT-135, COSY, NOESY and HMBC experiments 
where required.
Mass spectra were recorded on a Varion Platform II Quadrupole low resolution instrument using 
electron ionisation [El], atmospheric pressure chemical ionisation [APCI] and electrospray 
techniques [ES]. m/z values are reported with the percentage abundance in parentheses. 
Accurate high resolution mass spectrometric data were determined using the HRMS Service, 
Cardiff University, with the molecular formula corresponding to the observed signal using the 
most abundant isotopes of each element. All molecular formulae are given as values quoted as 
either molecule (M), molecule + hydrogen (M+H)+, molecule + potassium (M+K)+, molecule + 
sodium (M+Na)+ or molecule -  water (M-H2O).
A literature reference associated with title of compound means it is not a novel compound and 
any data recorded in this thesis matches well with those reported in the associated references, 
unless otherwise stated.
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Alkvne additions to a-h vd r oxvca r bon vis: 18
n-BuLi (2.5 -  250 mmol of a 2.5M solution in hexanes, 2.2 eq) was added dropwise to a solution 
of 1-alkyne (2.5 - 250 mmol, 2.2 eq) dissolved in THF (10 mL g'1) maintained at -78 °C. The 
solution was stirred for 0.5 h before being transferred dropwise to a second flask containing an a- 
hydroxyketone (1.1-113 mmol, 1 eq) dissolved in THF (10 mL g’1), which was also maintained 
at -78°C for the first 3 h. After overnight stirring, with slow warming to ambient temperature, the 
mixture was quenched by the addition of aqueous 0.1M KH2PO4 pH 7 buffer, and any emulsion 
broken up by the dropwise addition of 2M hydrochloric acid. The product was extracted with 
diethyl ether (3 x 25 mL g*1) and the combined organic layers washed with water (1 x 50 mL g '1) 
then brine (1 x 50 mL g'1). The ether layer was then dried, filtered and evaporated, with any 
excess 1-alkyne being removed through column chromatography when necessary, to give the 
diol.
Sonogashira couplings: 61-63
Palladium(II) 6/s-(triphenylphosphine)dichloride (0.3 mmol, 0.05 eq), copper iodide (0.6 mmol, 
0.1 eq) and a vinyl halide (6 mmol, 1 eq) were suspended in dry diisopropylamine (10 mL g 1). 
The mixture was heated to 50°C for 5 mins. Upon cooling to ambient temperature, a 1-alkyne (6 
mmol, 1 eq) was added and the solution left to stir overnight. The metal content was removed by 
filtration through silica with hexane (3 x 50 mL g 1) and the filtrate washed with 2M hydrochloric 
acid (25 mL g'1), water (100 mL g*1) and brine (100 mL g'1) then dried, filtered and carefully 
evaporated to yield the enyne.
Dihvdroxvlation of envnes: 64-66
Potassium ferricyanide (1.2 -  9.3 mmol, 3 eq), potassium carbonate (1.2 -  9.3 mmol, 3 eq) and 
DHQD2-PHAL (30 - 170 pmol, 0.01 eq) were dissolved in a 1:1 mixture of /-butanol and water 
(10 mL g*1). To this mixture, an enyne (0.4 -  3.1 mmol, 1 eq) was added followed by potassium 
osmate (VI) dihydrate (6 -  30 jimol, 0.002 eq). The resulting solution was stirred overnight then 
quenched with sodium sulfite (0.1 g m L 1), with stirring for 0.5 h. The product was extracted
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with ethyl acetate (3 x 25 mL g*1) and the combined organic layers washed with water (1 x 50 mL 
g'1) and brine (1 x 50 mL g*1). The ethyl acetate layer was then dried, filtered and evaporated to 
yield the diol.
Cvclisations using 10% AgNCh.SiO?: 18
In a foil-wrapped flask, 10% w/w silver nitrate on silica gel (0.01 -  0.66 mmol, 0.1 - 0.5 eq) was 
added to a stirred solution of a 3-alkyne-l,2-diol (0.06 — 1.32 mmol, 1 eq) in dichloromethane (10 
mL g"1). The resulting suspension was stirred for 3-48 h then filtered through celite and the 
solvent evaporated to yield the furan.
Experiments and Data
(RSJiS)- and (J?S,5J?)-3-Methylnon-4-yne-2,3-diol (100a)18
X
Using the general procedure, 1-hexyne (28.7 mL, 0.250 mol) was added to 3-hydroxybutan-2-one 
(lOg, 0.113 mol) to give the diol 100a as a colourless oil (18.498g, 96%), containing a ratio of 
68:32 of diastereomers: Rf 0.21 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3396, 
2958, 2211, 1457, 1372, 1075, 929; SH 3.70 (0.68H, q, J 6.4, 2-H), 3.52 (0.32H, q, J 6.4, 2-H), 
2.16 (1.36H, t, J 7.0, 5-CH2), 2.12 (0.64H, t, J 6.1, 5-CH2), 1.50-1.38 (2H, m, 6-CH2), 1.38-1.26 
(2H, m, 7-CH2), 1.34 (0.96H, s, 3-Me), 1.33 (2.04H, s, 3-Me), 1.21 (0.96H, d, J 6.4, 1-Me), 1.15 
(2.04H, d, J 6.4, 1-Me), 0.85 (0.96H, t, J 7.2, 9-Me), 0.84 (2.04H, t, J 7.2, 9-Me); 5C minor 85.8 
(4-C), 80.7 (5-C), 74.3 (2-CH), 71.9 (3-C), 30.7 (6-CH2), 24.9 (3-Me), 21.9 (7-CH2), 19.5 (1- 
Me), 18.3 (9-Me), 18.2 (8-CH2); 5C major 85.2 (4-C), 82.3 (5-C), 73.7 (2-CH), 71.0 (3-C), 30.6 
(6-CH2), 23.1 (3-Me), 21.9 (7-CH2), 18.2 (8-CH2), 16.8 (1-Me), 13.6 (9-Me); m/z (El) 152 ([M] - 
H20) 27%, 125 (100), [Found ([M]-H20), 152.1197. C,0H16O requires M-H20 , 152.1201]. All 
data obtained matched that previously reported in the literature.
OH
100a
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100a 101a
Using the general procedure (3 h), 10% AgNC^.SiCh (0.25g, 0.147 mmol) was stirred with a 
solution of diol 100a (0.05g, 0.294 mmol) in dichloromethane to yield the furan 101a as a pale 
yellow oil (0.030g, 67%): Rf 0.74 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 2927, 
2863, 1643, 1578, 1457, 1386, 1263, 1225, 1161, 1129, 1081, 992, 950, 796, 739, 629; 5H 5.67 
(1H, s, 4-H), 2.41 (2H, t, J 7.6, P- CH2), 2.09 (3H, s, 2-Me), 1.79 (3H, s, 3-Me) 1.50 (2H, m, 2’- 
CH2), 1.30 (2H, m, 3’-CH2), 0.83 (3H, t, J 7.3, 4’-Me); 8C 153.5 (C), 145.1 (C), 114.1 (C), 107.7 
(4-CH), 30.4 (P-CH2), 27.7 (2’-CH2), 22.3 (3’-CH2), 13.9 (4’-Me), 11.3 (2-Me), 9.9 (3-Me); m/z 
(APCI) 153 [M+H]+ 100%. All data obtained matched that previously reported in the literature.
(RSJIS)- and (J?i5ySJ?)-3-Methyl-5-phenylpent-4-yne-2r3-diol (100b)
100b
Using the general procedure, phenylacetylene (6.85 mL, 62.4 mmol) was added to 3- 
hydroxybutan-2-one (2.5g, 28.4 mmol) to give a crude oily solid (6.913g). This was purified by 
column chromatography (10:90 ethyl acetate - petroleum ether) to give the diol 100b as a yellow 
solid (5.4g, 100%, mp = 56-57 °C), containing a ratio of 69:31 of diastereoisomers: R f 0.21 (30 : 
70 ethyl acetate -  petroleum ether); Umax/cm1 (DCM) 3382, 2980, 2247, 1598, 1488, 1372, 1265, 
1070, 938, 756, 691; 8H 7.39-7.33 (2H, m, 2 x Ar-H), 7.28-7.21 (3H, m, 3 x Ar-H), 3.85 (0.69H, 
qd, J 6.4 and 2.7,2-H), 3.64 (0.31H, dq, 7.0 and 6.3, 2-H), 2.91 (0.31H, bs, OH), 2.41 (0.69H, bs, 
OH), 2.30 (0.69H, bs, OH), 1.97 (0.31H, bs, OH), 1.46 (0.93H, s, 3-Me), 1.45 (2.07H, s, 3-Me), 
1.31 (0.93H, d, J 6.3, 1-Me), 1.23 (2.07H, d, J 6.4, 1-Me); 8C minor 131.8 (2 x Ar-CH), 128.5 (2 x 
Ar-CH), 128.3 (Ar-CH), 122.3 (C), 89.6 (4-C), 85.3 (5-C), 74.6 (2-CH), 72.4 (3-C), 25.8 (3-Me),
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16.8 (1-Me); 6C major 131.7 (2 x Ar-CH), 128.6 (2 x Ar-CH), 128.3 (Ar-CH), 122.2 (C), 91.1 (4- 
C), 84.7 (5-C), 73.7 (2-CH), 71.5 (3-C), 31.0 (3-Me), 18.6 (1-Me); m/z (APCI) 173 ([M+H]+ - 
H20) 100%;
2,3-Dimethyl-5-phenylfuran (101b)199
Ph
i -------------   Y V *
^ T > H / O
100b 101b
Using the general procedure (24 h), 10% AgNOj.SiC^ (0.224 g, 0.132 mmol) was stirred with a 
solution of diol 100b (0.25g, 1.32 mmol) in dichloromethane to yield the furan 101b as a pale 
yellow oil (0.213 g, 95%): R f 0.80 (30 : 70 ethyl acetate -  petroleum ether); Omax/cm'1 (film) 
2921, 1601, 1554, 1487, 1447, 1149, 1072, 936, 759, 691; SH (125MHz) 7.59 (2H, dd, J 8.2 and 
1.2, 2 x Ar-H), 7.33 (2H, dd, J 8.2 and 7.5, 2 x Ar-H), 7.19 (1H, tt, J 7.5 and 1.2, Ar-H), 6.44 
(1H, s, 4-H), 2.27 (3H, s, 2-Me), 1.97 (3H, s, 3-Me); 8C (125MHz) 150.9 (C), 147.4 (C), 131.3 
(C), 128.6 (2 x Ar-CH), 126.6 (Ar-CH), 123.2 (2 x Ar-CH), 116.3 (C), 108.4 (4-CH), 11.5 (2- 
Me), 10.0 (3-Me); m/z 172 [M] 100%, 157 (26), 128 (36), 77 (21). All data obtained matched 
that previously reported in the literature.
(RSJRS)- and (Jt£*S&)-7-(Triisopropylsilyloxy)-3-methylhept-4-yne-2,3‘diol (100c)
OTIPS
Using the general procedure, O-TIPS-3-butyn-l-ol (2.8g, 12.5 mmol) was added to 3- 
hydroxybutan-2-one (0.5g, 5.67 mmol) to give the diol 100c as a crude yellow oil (2.958g), 
containing a ratio of 57:43 of diastereoisomers, which was purified by column chromatography 
(30:70 ethyl acetate -  petroleum ether) to yield the diol 100c as a pale yellow oil (1.152g, 65%), 
containing a ratio of 54:46 of diastereoisomers: Umax/cm*1 (film) 3399, 2941, 2242, 1639, 1464,
OKU2
100c
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1383, 1334, 1258, 1211,1106, 1013, 996, 920, 882, 792, 737, 683, 659; Sh 3.76-3.66 (2.54H, m,
6-CH2 and 2-H), 3.52 (0.46H, dq, J 6.3 and 2.0,2-H), 2.71 (0.46H, bs, OH), 2.41 (0.92H, t, J 6.9,
7 -CH2), 2.39 (1.08H, t, J 6.9, 7-CH2), 2.24 (0.54H, bs, OH), 2.11 (0.54H, s, OH), 1.89 (0.46H, 
bs, OH), 1.34 (1.38H, s, 3-Me), 1.33 (1.62H, s, 3-Me), 1.21 (1.38H, d, J 6.3, 1-Me), 1.15 (1.62H, 
d, J 6.4, 1-Me), 1.02-0.98 (21H, m, TIPS); 5C major 83.3 (4-C), 82.6 (5-C), 73.8 (2-CH), 71.2 (3- 
C), 61.9 (7-CH2), 23.4 (3-Me), 23.1 (1-Me), 18.0 (TIPS-Me), 11.9 (TIPS-CH); 5C minor 83.2 (4- 
C), 81.6 (5-C), 74.6 (2-CH), 72.1 (3-C), 62.0 (7-CH2), 25.6 (3-Me), 23.2 (1-Me), 18.0 (TIPS- 
Me), 11.9 (TIPS-CH).
(2-(4,5-Dimethylfuran-2-yl)ethoxy)triisopropylsilane (101c)
OTIPS
100c 101c
Using the general procedure (16 h), 10% AgN0 3 .Si0 2 (0.287g, 0.169 mmol) was stirred with a 
solution of diol 100c (0.5g, 1.69 mmol) in dichloromethane to yield the furan 101c as a pale 
yellow oil (0.298g, 63%): Rf 0.81 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 2943, 
2893, 1642, 1577, 1541, 1464, 1385, 1367, 1249, 1224, 1105, 1069, 1013, 995, 909, 883, 804, 
735, 678; Sh 5.76 (1H, s, 3-H), 3.80 (2H, t, J 7.3,2’-CH2), 2.72 (2H, t, J 7.3, l ’-CH2), 2.07 (3H, s, 
5-Me), 1.81 (3H, s, 4-Me), 1.00-0.96 (21H, m, OTIPS); 5C 150.0 (C), 145.5 (C), 114.3 (C), 109.3 
(3-CH), 62,3 (2’-CH2), 32.1 ( l ’-CH2), 18.0 (5-Me), 17.7 (TIPS-Me), 12.3 (TIPS-CH), 12.0 (4- 
Me); m/z (El) 296 [M] 1%, 253 (4), 131 (61), 103 (71), 75 (100), [Found ([M]-/Pr), 253.1615. 
Ci4H25 0 2Si requires M-iPr, 253.1624].
(RS>RS)- and (/£5,5/f)-8-(Benzyloxy)-3-inethyloct-4-yne-2,3-diol (lOOd)
lOOd
Using the general procedure, O-benzyl-4-pentyn-1 -ol (1.09g, 6.24 mmol) was added to 3- 
hydroxybutan-2-one (0.25g, 2.84 mmol) to give a crude yellow oil (1.022g), containing a ratio of
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55:45 of diastereoisomers, which was purified by column chromatography (20:80 ethyl acetate -  
petroleum ether) to yield the diol lOOd as a yellow oil (0.258g, 35%), containing a ratio of 66:34 
of diastereoisomers: Rf 0.23 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3416, 
3055, 3033, 2983, 2935, 2869, 2241, 1453, 1367, 1268, 1105, 1077, 928, 738 700: SH 7.39-7.31 
(4H, m, 4 x Ar-H), 7.31-7.27 (1H, m, Ar-H), 4.51 (2H, s, Bn-CH2), 3.72 (0.66H, q, J 6.4, 2-H), 
3.56 (0.34H, q, J 6.1, 2-H), 3.54 (2H, t, J 6.0, 8-CH2), 2.35 (0.68H, t, J 7.0, 6-CH2), 2.33 (1.32H, 
t, J 7.0, 6-CH2), 1.86-1.76 (2H, m, 7-CH2), 1.37 (1.02H, s, 3-Me), 1.36 (1.98H, s, 3-Me), 1.24 
(1.02H, d, J 6.1, 1-Me), 1.19 (1.98H, d, J 6.4, 1-Me); 5C minor 138.3 (C), 128.4 (2 x Ar-CH),
127.7 (2 x Ar-CH), 127.7 (Ar-CH), 85.2 (4-C), 81.0 (5-C), 74.5 (2-CH), 72.9 (Bn-CH2), 72.0 (3- 
C), 68.7 (8-CH2), 28.8 (6-CH2), 25.9 (3-Me), 16.6 (1-Me), 15.6 (7-CH2); 5C major 138.3 (C),
128.4 (2 x Ar-CH), 127.7 (2 x Ar-CH), 127.7 (Ar-CH), 84.7 (4-C), 82.7 (5-C), 73.8 (2-CH), 72.9 
(Bn-CH2), 71.1 (3-C), 68.7 (8-CH2), 28.7 (6-CH2), 23.4 (3-Me), 18.4 (1-Me), 15.6 (7-CH2); m/z 
(El) 244 ([M] - H20) 3%, 173 (100), [Found ([M]-H20), 244.1465. C16H20O requires M-H20, 
244.1463].
5-(3-(Benzyloxy)propyl)-2,3-diinethylfuran (lOld)
O  P h
lOOd lOld
Using the general procedure (24 h), 10% AgNC>3.Si02 (0.2g, 0.118 mmol) was stirred with a 
solution of diol lOOd (0.05g, 0.191 mmol) in dichloromethane to yield the furan lOld as a yellow 
oil (0.045g, 96%): Rf 0.76 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 2923, 2859, 
1673, 1636, 1454, 1364, 1273, 1104, 945, 807, 736, 698; SH 7.35-7.15 (5H, m, 5 x Ar-CH), 5.63 
(1H, s, 4-H), 4.42 (2H, s, Bn-CH2), 3.42 (2H, t, J 6.4, 3’-CH2), 2.52 (2H, t, J 7.5, l ’-CH2), 2.07 
(3H, s, 2-Me), 1.89-1.80 (2H, m, 2’-CH2), 1.83 (3H, s, 3-Me); Sc 152.6 (C), 145.4 (C), 138.6 (C),
128.4 (2 x Ar-CH), 127.7 (2 x Ar-CH), 127.6 (Ar-CH), 114.2 (C), 109.2 (4-CH), 72.9 (PhCH2),
69.5 (3’-CH2), 28.3 ( l ’-CH2), 24.7 (2’-CH2), 11.3 (2-Me), 9.9 (3-Me).
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(RSJtSy- and («5^«)-U-Diphenylact-3-yne-l,2-diol (100e)18
O H ^ BuPh
Ph OH Ph OH
lOOe
Using the general procedure, 1-hexyne (28.7 mL, 0.250 mol) was added to benzoin (24. lg, 0.113 
mol) to give the diol lOOe as a pale yellow solid (32.020g, 96%), containing a ratio of 99:1 of 
diastereoisomers. Recrystallisation from methanol : water yielded the diol lOOe as a fluffy pale 
yellow solid (30.1 llg , 90%, mp = 95-97°C): R f 0.30 (30 : 70 ethyl acetate -  petroleum ether);
CH2), 22.1 (6-CH2), 18.6 (7-CH2), 13.6 (8-Me); m/z (El) 276 ([M] - H20 ) 100%. All data 
obtained matched that previously reported in the literature.
0-(/-Butyldimetbylsilyl)benzoiii (168)200
/-Butyldimethylsilyl chloride (0.7lg, 4.71 mmol, 2 eq), imidazole (0.64g, 9.42 mmol, 4 eq) and 
DMAP (0.03g, 0.24 mmol, 0.1 eq) were added to a solution of benzoin (0.5g, 2.36 mmol, 1 eq) in 
dry dichloromethane (20 mL). The resulting solution was then stirred at ambient temperature 
overnight before being transferred to a separating funnel containing saturated aqueous sodium 
hydrogen carbonate (20 mL) and petroleum ether (20 mL). The mixture was shaken and 
separated and the aqueous layer was extracted with petroleum ether (2 x 20 mL). The combined 
organic layers were washed with water (50 mL) and brine (50 mL), then dried, filtered and 
evaporated to yield TBDMS-benzoin 168, as a pale yellow oil (0.77g, 100%): Dmax/cm'1 (film)
Umax/cm*1 3443, 2958, 1652, 1457, 1372, 1129, 929; §H 7.40-7.30 (2H, m, 2 x Ar-H), 7.25-7.00 
(8H, m, 8 x Ar-H), 4.80 (1H, d, J 3.1, 1-H), 2.65-2.60 (2H, m, 2 x OH), 2.25 (2H, t, J 7.1, 5-CH2), 
1.54-1.44 (2H, m, 6-CH2), 1.40-1.31 (2H, m, 7-CH2), 0.86 (3H, t, J 7.3, 8-Me); 8C (125MHz)
140.5 (C), 137.7 (C), 128.1 (2 x Ar-CH), 128.0 (Ar-CH), 128.0 (Ar-CH), 127.7 (2 x Ar-CH),
127.3 (2 x Ar-CH), 126.7 (2 x Ar-CH), 89.0 (3-C), 81.2 (1-CH), 80.8 (4-C), 76.4 (2-C), 30.6 (5-
OTBDMS
168
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3170, 2850, 2830, 1680, 1600, 1450, 1225, 1120, 1070, 865, 835, 780, 695; 8H 8.03-8.00 (2H, m, 
2 x Ar-H), 7.55-7.51 (2H, m, 2 x Ar-H), 7.48-7.43 (1H, m, Ar-H), 7.37-7.31 (4H, m, 4 x Ar-H),
7.28-7.22 (1H, m, Ar-H), 5.74 (1H, s, 1-H), 0.89 (9H, s, /-Bu Me), 0.00 (6H, s, Si-Me); 8C 199.2 
(C=0), 138.9 (C), 134.4 (C), 132.9 (Ar-CH), 130.0 (2 x Ar-CH), 128.7 (2 x Ar-CH), 128.1 (2 x 
Ar-CH), 127.7 (Ar-CH), 125.7 (2 x Ar-CH), 80.4 (1-CH), 25.8 (/-Bu Me), 18.2 (C), -4.9 (Si-Me); 
mlz (APCI) 327 [M+H]+ 8%, 211 (100), [Found [M+H]+, 327.1770. C2oH2702Si requires M+H, 
327.1780]. All data obtained matched that previously reported in the literature.
(RSJIS)- and (/f5yS'i?)-l^!-Diphenyl-2-hydroxy-l-6>-(r-butyldimethylsiIyl)oct-3-yne (169a 
and 169b)
P h ^ O
Ph^OTBDMS
168
OH^
Ph OTBDMS 
169a
Ph OTBDMS 
169b
Using the general procedure, 1-hexyne (0.1 mL, 0.842 mmol, 1.1 eq) was added to TBDMS- 
benzoin 168 (0.25g, 0.766 mmol, 1 eq) to give propargylic alcohols 169a,b as a pale yellow oil 
(0.262g, 84%) and a 39:61 mixture of diastereoisomers: 8h 7.57-7.21 (8.78H, m, 18 x Ar-H), 
7.18-7.12 (1.22H, m, 2 x Ar-H), 4.78 (0.39H, s, 1-H), 4.75 (0.61H, s, 1-H), 3.49 (0.61H, bs, OH),
3.01 (0.39H, bs, OH), 2.38 (0.78H, t, J 7.0, 5-CH2), 2.32 (1.22H, t, J 6.9, 5-CH2), 1.69-1.44 (4H, 
m, 6- and 7-CH2), 0.99-0.95 (8.49H, m, 2 x 8-Me and /-Bu Me), 0.93 (3.51H, s, /-Bu Me), 0.16 
(1.83H, s, Si-Me), 0.00 (1.83H, s, Si-Me), -0.12 (1.17H, s, Si-Me), 0.23H (1.17H, s, Si-Me); 8C 
minor 141.6 (C), 139.6 (C), 128.5 (Ar-CH), 128.3 (2 x Ar-CH), 127.6 (Ar-CH), 127.3 (2 x Ar- 
CH), 127.1 (2 x Ar-CH), 126.9 (2 x Ar-CH), 91.8 (3-C), 85.4 (4-C), 82.3 (1-CH), 76.4 (2-C),
30.7 (5-CH2), 25.7 (/-Bu Me), 22.1 (6-CH2), 18.5 (7-CH2), 18.1 (C), 13.4 (8-Me), -4.9 (Si-Me), -
5.6 (Si-Me); 8C major 141.4 (C), 139.2 (C), 130.2 (Ar-CH), 128.3 (2 x Ar-CH), 127.6 (Ar-CH),
127.3 (2 x Ar-CH), 127.0 (2 x Ar-CH), 126.9 (2 x Ar-CH), 94.7 (3-C), 88.3 (4-C), 82.3 (1-CH),
77.2 (2-C), 30.5 (5-CH2), 25.8 (/-Bu Me), 21.9 (6-CH2), 18.6 (7-CH2), 18.2 (C), 13.6 (8-Me), -4.8 
(Si-Me), -5.4 (Si-Me); m/z (El) 390 ([M] - H20 ) 37%.
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{RSyRS)~ and (U5ySi?)-l,2-Diphenyloct-3~yne-l,2-diol (lOOe)
OI-U5
Ph OHPh OTBDMS Ph OH
169a-b lOOe
Tetrabutylammonium fluoride (0.16 mL of a 1M solution in THF, 0.538 mmol, 1.1 eq) was 
added to a solution of propargylic alcohol 169a,b (0.2g, 0.489 mmol, 1.1 eq) in tetrahydrofuran 
(5 mL) and the resulting solution stirred overnight at ambient temperature. The mixture was 
diluted with water (25 mL) and extracted with diethyl ether (3 x 25 mL). The combined organic 
layers were washed with water (100 mL) and brine (100 mL), then dried, filtered and evaporated 
to give the diol lOOe as a pale yellow solid (0.135g, 94%), containing a 39:61 mixture of 
diastereoisomers: 6H 7.42-7.32 (2H, m, 4 x Ar-H), 7.28-7.05 (8H, m, 16 x Ar-H), 4.83 (0.39H, s,
1-H), 4.75 (0.61H, s, 1-H), 3.04 (0.39H, bs, OH), 2.93 (0.61H, bs, OH), 2.67 (0.61H, bs, OH), 
2.29 (0.78H, t, J 7.1, 5-CH2), 2.27 (1.22H, t, J 7.0, 5-CH2), 1.58-1.31 (4H, m, 6- and 7-CH2), 0.90 
(1.17H, t, J 7.2, 8-Me), 0.89 (1.83H, t, J 7.3, 8-Me); Sc minor 140.5 (C), 137.9 (C), 128.1 (2 x Ar- 
CH), 128.0 (Ar-CH), 128.0 (Ar-CH), 127.7 (2 x Ar-CH), 127.3 (2 x Ar-CH), 126.7 (2 x Ar-CH),
89.3 (3-C), 81.2 (1-CH), 80.8 (4-C), 76.4 (2-C), 30.6 (5-CH2), 22.1 (6-CH2), 18.5 (7-CH2), 14.2 
(8-Me); Sc major 141.0 (C), 135.0 (C), 129.9 (Ar-CH), 128.0 (Ar-CH), 127.9 (2 x Ar-CH), 127.8 
(2 x Ar-CH), 127.2 (2 x Ar-CH), 126.8 (2 x Ar-CH), 89.0 (3-C), 81.7 (1-CH), 79.3 (4-C), 77.6 
(2-C), 30.5 (5-CH2), 22.0 (6-CH2), 18.5 (7-CH2), 13.6 (8-Me). All other data collected was in 
accord with that previously obtained from the direct addition of 1-hexyne to benzoin.
5-Butyl-23-diphenylfuran (lOle) 18,201
Ph OH
PhYVBu
PIT 0  
lOle
Using the general procedure (4 h), 10% AgNC>3.Si02 (1.5g, 0.675 mmol) was stirred with a 
solution of diol lOOe (0.5g, 1.75 mmol) in dichloromethane to yield Juran lOle as an orange oil
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(0.463g, 99%): R f 0.76 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3451, 2931, 
2250, 1671, 1450, 1380, 1266, 1181, 1060, 903, 734; 8H 7.46-7.41 (2H, m, 2 x Ar-H), 7.36-7.31 
(2H, m, 2 x Ar-H), 7.30-7.24 (2H, m, 2 x Ar-H), 7.23-7.16 (3H, m, 3 x Ar-H), 7.15-7.09 (1H, m, 
Ar-H), 6.09 (1H, s, 4-H), 2.63 (2H, t, J 7.5, 1’- CH2), 1.69-1.59 (2H, m, 2’- CH2), 1.43-1.32 (2H, 
m, 3’-CH2), 0.86 (3H, t, J 7.3, 4’-Me); 8C 155.1, 146.3, 132.2, 128.4, 126.2, 125.2, 122.5, 108.8, 
31.7, 30.2, 30.0, 29.3, 27.8, 26.0, 22.6, 22.3, 14.1, 13.9; m/z (El) 276 [M]+ 100%, [Found [M]+, 
276.1499. C 2oH 2oO  requires A/, 276.1515]. All data obtained matched that previously reported in 
the literature.
(RSyRS)- and (Jl5ySll)-l,2,4-Triphenylbut-3-yne-l,2-diol (lOOf)
p h ^ Ph
P h ^ O H  
lOOf
Using the general procedure, phenylacetylene (0.57 mL, 5.18 mmol) was added to benzoin (0.5g,
2.36 mmol) to give the diol lOOf as a yellow solid (0.704g, 95%, mp = 138-140°C), containing a 
ratio of 87:13 of diastereoisomers: R f 0.5 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm' 1 
(DCM) 3442, 2100, 1643, 1489, 1450, 1175, 1060, 930, 729; 6H 7.48-7.39 (4H, m, 4 x Ar-H), 
7.30-7.16 (11H, m, 11 x Ar-H), 4.91 (0.87H, d, J 3.4, 1-H), 4.80 (0.13H, d, J 3.9, 1-H), 3.25 
(0.13H, s, OH), 2.98 (0.13H, d, J 3.9, OH), 2.83 (0.87H, s, OH), 2.64 (0.87H, d, J 3.4, OH); 5C 
(125MHz) 140.1 (C), 137.6 (C), 131.8 (2 x Ar-CH), 128.9 (Ar-CH), 128.4 (2 x Ar-CH), 128.3 (2 
x Ar-CH), 128.1 (2 x Ar-CH), 127.9 (2 x Ar-CH), 127.5 (2 x Ar-CH), 126.8 (2 x Ar-CH), 122.1 
(C), 89.5 (3-C), 87.9 (4-C), 81.2 (1-CH), 77.0 (2-C); m/z (APCI) 297 ([M+H]+-  H20 ) 100%.
2,3>5-Triphenylfuran (lOlf)202
p h ^ Ph
Ph^O H  
lOOf
Using the general procedure (4 h), 10% AgN0 3 .Si0 2 (0.2g, 0.118 mmol) was stirred with a 
solution of diol lOOf (0.05g, 0.159 mmol) in dichloromethane to yield the furan lO lf as a oil
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(0.045g, 95%): Rf 0.85 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm’1 (film) 3060, 2248, 
1949, 1882, 1810, 1675, 1593, 1488, 1449, 1146, 1073, 1054, 1026, 953, 909, 816, 762, 736, 
695; 5h 7.65 (2H, d, J 8.56,2 x Ar-CH), 7.52 (2H, d, J 8.2,2 x Ar-CH), 7.37 (2H, d, J 8.0, 2 x Ar- 
CH), 7.35-7.10 (9H, m, 9 x Ar-CH), 6.73 (1H, s, 4-H); Sc 152.6 (C), 147.9 (C), 134.3 (C), 131.1 
(C), 130.5 (C), 128.8 (2 x Ar-CH), 128.7 (4 x Ar-CH), 128.5 (2 x Ar-CH), 127.6 (Ar-CH), 127.6 
(Ar-CH), 127.4 (Ar-CH), 126.2 (2 x Ar-CH), 124.6 (C), 123.9 (2 x Ar-CH), 109.5 (4-CH); m/z 
(APCI) 297 [M+Hf 100%, [Found [M+H]+, 297.1327. C22H27O requires M+f f ,  297.1301]. All 
data obtained matched that previously reported in the literature.
(RSyRS)- and (i?5,*£l?)-5,5-Diinethyl-l,2-diphenylhex-3-yne-l,2-diol (lOOg)
P h ^ O
Ph"X>H Ph OH
Using the general procedure, 3,3-dimethyl- 1-butyne (0.63 mL, 5.18 mmol) was added to benzoin 
(0.5g, 2.36 mmol) to give the diol lOOg as a pale yellow solid (0.619 g, 89%, mp = 126-127 °C), 
containing a ratio of 91:9 of diastereoisomers: Umax/cm*1 (DCM) 3487, 3065, 2971, 2232, 1682, 
1449, 1363, 1265, 1173, 1058, 939, 889, 739, 697; 5H 7.40-7.34 (2H, m, 2 x Ar-H), 7.25-7.05 
(8H, m, 8 x Ar-H), 4.78 (0.91H, d, J 3.2, 1-H), 4.68 (0.09H, d, J 4.2, 1-H), 2.95 (0.09H, s, OH), 
2.89 (0.09H, d, J 4.2, OH), 2.57 (0.91H, d, J 3.2, OH), 2.55 (0.91H, s, OH), 1.21 (8.19H, s, /-Bu), 
1.18 (0.81H, s, /-Bu); 8C minor 141.3 (C), 138.0 (C), 128.2 (2 x Ar-CH), 128.0 (Ar-CH), 127.9 
(Ar-CH), 127.6 (2 x Ar-CH), 127.2 (2 x Ar-CH), 127.0 (2 x Ar-CH), 97.5 (2-C), 81.7 (1-CH),
77.9 (3-C), 76.1 (4-C), 30.9 (/-Bu Me), 25.6 (/-Bu C); 8C major 140.5 (C), 137.8 (C), 128.2 (Ar- 
CH), 128.0 (Ar-CH), 128.0 (Ar-CH), 127.6 (Ar-CH), 127.2 (Ar-CH), 127.0 (Ar-CH), 97.1 (2-C),
81.1 (1-CH), 79.3 (3-C), 76.2 (4-C), 30.9 (/-Bu Me), 27.6 (/-Bu C); m/z (APCI) 277 ([M+H]+ - 
H20) 100%, [Found ([M+Hf - H20), 277.1588. C20H2iO requires [M+HJ - H2Q, 277.1592].
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5-terr-Butyl-2,3-dipheiiylfuran (lOlg)
Ph 'OH
Ph
Ph r * *
lOlg
Using the general procedure (24 h) 10% AgN0 3 .Si0 2 (0.031g, 0.018 mmol) was stirred with a 
solution of diol lOOg (0.053g, 0.180 mmol) in dichloromethane to yield the furan lOlg as a 
yellow oil (0.050g, 97%): tW c m ’1 (film) 2965, 1601, 1552, 1501, 1444, 1362, 1258, 1143, 
1070, 962, 762, 694; 8h 7.47-7.42 (2H, d, J 7.6, 2 x Ar-H), 7.36-7.32 (2H, d, J 7.5, 2 x Ar-H),
7.28-7.22 (2H, m, 2 x Ar-H), 7.22-7.16 (3H, m, 3 x Ar-H), 7.15-7.08 (1H, m, Ar-H), 6.09 (1H, s,
4-H), 1.32 (9H, s, r-Bu-Me); 8C 163.3 (C), 146.3 (C), 134.9 (C), 131.7 (C), 128.7 (2 x Ar-CH),
128.6 (2 x Ar-CH), 128.3 (2 x Ar-CH), 127.0 (Ar-CH), 126.9 (Ar-CH), 125.9 (2 x Ar-CH), 122.7 
(C), 106.7 (4-CH), 32.8 (r-Bu C), 29.1 (r-Bu-Me); m/z (APCI) 277 [M+H]+ 100%, [Found 
[M+H]+, 277.1583. C20H21O requires M+H, 277.1592],
(RSJRS)- and C&S,5i?)-6-(Triisopropylsilyloxy)-l,2-diphenylhex-3-yne-l,2-dioI (100b)
O H ^ '° TIPS
Ph^O  Ph*
Ph^OTMS Ph' OH
Using the general procedure, TIPS-3-butyn-l-ol (0.8g, 3.52 mmol, 1 eq) was added to TMS- 
benzoin (lg, 3.52 mmol) to give the diol 100b as a yellow oil (1.101 g), containing a ratio of 
80:20 of diastereoisomers. The residue was purified by column chromatography (20:80 ethyl 
acetate -  petroleum ether) to yield the major anti-diol 1 0 0 b as a yellow wax (0.158g, 10%): 
W c m ’1 (DCM) 3435, 3062, 3032, 2943, 2867, 2245, 1494, 1450, 1385, 1192, 1109, 1058, 910, 
882, 733, 698; 6H 7.37-7.33 (2H, m, 2 x Ar-H), 7.22-7.03 (8H, m, 8 x Ar-H), 4.78 (1H, d, J 3.3,
1-H), 3.78 (2H, dt, J 7.1 and 1.3, 6 -CH2), 2.71 (1H, d, J 3.3, OH), 2.68 (1H, s, OH), 2.49 (2H, t, J 
7.1, 5-CH2), 1.00-0.95 (21H, m, OTIPS); 5C (125MHz) 140.3 (C), 137.5 (C), 128.0 (3 x Ar-CH),
128.0 (Ar-CH), 127.7 (2 x Ar-CH), 127.3 (2 x Ar-CH), 126.7 (2 x Ar-CH), 85.8 (3-C), 82.0 (4-
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C), 81.2 (1-CH), 61.9 (6-CH2), 23.4 (5-CH2), 18.0 (TIPS-Me), 12.0 (TIPS-CH); m/z (El) 420 
([M] - H20) 4%, 377 (59), 287 (47), 105 (100), 77 (72).
(2-(4,5-Diphenylfuran-2-yI)ethoxy)triisopropy!silane (101 h)
.OTIPSO H ^ OTIPS
Using the general procedure (16 h), 10% AgN03.Si02 (0.047g, 0.027 mmol) was stirred with a 
solution of diol 100b (0.12g, 0.274 mmol) in dichloromethane to yield the furan 101 h as a pale 
yellow oil (0.1 lg, 96%): aW cm '1 (film) 3062, 2942, 2865, 1672, 1601, 1502, 1464, 1383, 1365, 
1249, 1218, 1176, 1107, 1071, 995, 953, 911, 882, 763; 8H 7.42 (2H, dd, J 7.2 and 1.5, 2 x Ar-H), 
7.34-7.10 (8H, m, 8 x Ar-H), 6.18 (1H, s, 3-H), 3.94 (2H, t, J 6.9, 2’-CH2), 2.89 (2H, t, J 6.9, 1’- 
CH2), 1.00-0.95 (21H, m, OTIPS); 8C 152.6 (C), 146.9 (C), 134.7 (C), 131.5 (C), 128.6 (2 x Ar- 
CH), 128.6 (2 x Ar-CH), 128.3 (2 x Ar-CH), 127.1 (Ar-CH), 126.9 (Ar-CH), 126.0 (2 x Ar-CH),
123.1 (C), 110.9 (3-CH), 62.0 (2’-CH2), 32.1 (U-CH2), 18.0 (TIPS-Me), 12.0 (TIPS-CH); m/z 
(APCI) 421 [M+H]+ 12%, 263 (52), 255 (100), 198 (59), 115 (71), [Found [M+H]+, 421.2583. 
C27H3702Si requires M+H, 421.2563].
(RSJIS)- and (AS,5j?)-7-(Benzyloxy)-l,2-diphenylhept-3-yne-l,2-diol (lOOi)
lOOi
Using the general procedure, O-benzyl-4-pentyn-l-ol (0.45g, 2.59 mmol) was added to benzoin 
(0.25g, 1.18 mmol) to give the diol lOOi as a crude red oil (0.519g). This was purified by column 
chromatography (10:90 ethyl acetate -  petroleum ether) to yield the diol lOOi as a pale orange 
wax (0.217g, 48%) containing only one diastereoisomer: R f 0.33 (30 : 70 ethyl acetate -  
petroleum ether); tW c m '1 (DCM) 3395, 3027, 2867, 2246, 1493, 1450, 1366, 1195, 1026, 697; 
8h 7.40-7.05 (15H, m, 15 x Ar-H), 4.78 (1H, s, 1-H), 4.47 (2H, s, Bn-CH2), 3.52 (2H, t, J 6.1, 7-
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CH2), 3.03 (1H, s, OH), 2.99 (1H, bs, OH), 2.40 (2H, t, J 7.0, 5-CH2), 1.88-1.78 (2H, m, 6-CH2); 
5C 140.5 (C), 138.3 (C), 137.8 (C), 128.5 (2 x Ar-CH), 128.1 (2 x Ar-CH), 127.9 (Ar-CH), 127.9 
(Ar-CH), 127.8 (2 x Ar-CH), 127.7 (Ar-CH), 127.7 (2 x Ar-CH), 127.3 (2 x Ar-CH), 126.8 (2 x 
Ar-CH), 88.0 (3-C), 81.5 (4-C), 81.2 (1-CH), 76.3 (2-C), 73.0 (Bn-CH2), 68.8 (7-CH2), 28.7 (5’- 
CH2), 15.9 (6’-CH2); m/z (APCI) 369 ([M+H+] -  H20 ) 100%, 278 (27).
5-(3-(Benzyloxy)propyl)-2,3-diphenyIfuran (101 i)
O Ph
Ph OH
lOOi
Ph
Ph
Ph
lOli
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.2g, 0.118 mmol) was stirred a solution 
of diol lOOi (0.05g, 0.129 mmol) in dichloromethane to yield the furan lOli as a yellow oil 
(0.047g, 98%): Rf 0.82 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 3061, 2926, 
2855, 1703, 1600, 1557, 1502, 1448, 1364, 1271, 1216, 1103, 1026, 910, 813, 763, 734, 696; SH 
7.41 (2H, d, J 8.6, 2 x Ar-CH), 7.35-7.05 (13H, m, 13 x Ar-CH), 6.08 (1H, s, 4-H), 4.43 (2H, s, 
Bn-CH2), 3.49 (2H, t, J 6.3, 3’-CH2), 2.74 (2H, t, J 7.5, l ’-CH2), 1.95 (2H, dt, J 7.5 and 6.3, 2’- 
CH2); 8c 154.9 (C), 146.8 (C), 138.5 (C), 134.7 (C), 131.5 (C), 128.6 (2 x Ar-CH), 128.6 (2 x Ar- 
CH), 128.5 (2 x Ar-CH), 128.4 (2 x Ar-CH), 127.8 (2 x Ar-CH), 127.6 (Ar-CH), 127.1 (Ar-CH),
127.0 (Ar-CH), 126.0 (2 x Ar-CH), 123.0 (C), 109.7 (4-CH), 73.0 (PhCH2), 69.4 (3’-CH2), 28.2 
( l ’-CH2), 24.8 (2’-CH2); m/z (APCI) 369 [M + H]+ 92%, 277 (95), 134 (54).
(RSJtS)- and (&SVS'/?)-5-Methyl-l,2-diphenylhex-5-en-3-yne-l,2-diol (lOOj)
p ^y 0
Ph^ S)H
Ph
PIT "OH 
lOOj
Using the general procedure, freshly distilled 2-methyl-l-butene-3-yne (0.7 mL, 7.26 mmol) was 
added to benzoin (0.7g, 3.30 mmol) to give the diol lOOj as a crude yellow solid (0.72lg) in a
172
Chapter 8: Experimental
ratio of 99:1, which was purified by column chromatography (10:90 ethyl acetate -  petroleum 
ether) to yield the diol lOOj as a yellow solid (0.50g, 54%, mp 110-111 °C): R f 0.45 (30 : 70 ethyl 
acetate -  petroleum ether); iW c m '1 (DCM) 3442, 2145, 1709, 1494, 1364, 1288, 1228, 1092, 
1058, 904, 845, 703; 5h 7.41-7.36 (2H, m, 2 x Ar-H), 7.25-7.20 (4H, m, 4 x Ar-H), 7.18-7.10 
(4H, m, 4 x Ar-H), 5.31 (1H, dq, J 1.9 and 1.0, 6-H), 5.24 (1H, dq, J 1.9 and 1.5,6-H), 4.83 (1H, 
d, J 3.2, 1-H), 2.69 (1H, s, OH), 2.56 (1H, d, J 3.2, OH), 1.86 (3H, dd, J 1.5 and 1.0, 5-Me); Sc
140.1 (C), 137.6 (C), 128.1 (2 x Ar-CH), 128.0 (2 x Ar-CH), 127.8 (2 x Ar-CH), 127.4 (2 x Ar- 
CH), 126.8 (2 x Ar-CH), 126.0 (5-C), 123.0 (6-CH2), 89.0 (3-C), 88.5 (4-C), 81.1 (1-CH), 76.6 
(2-C), 23.3 (6-Me); m/z (El) 260 ([M] - HzO) 1%, 229 (42), 171 (100), 105 (92), 77 (93), [Found 
([M ] - H20), 260.1189. CuHisO requires M-H2 0 , 260.1201],
23-Diphenyl-5-(prop-l-en-2-yl)furan (101 j)
Ph
Ph
lOlj
Using the general procedure (24 h), 10% AgN0 3 .SiC>2 (0.12g, 0.072 mmol) was stirred with a 
solution of diol lOOj (0.2g, 0.72 mmol) in dichloromethane to yield an unidentified product.
(RSJIS)- and (AS,5J?)-l-(Hex-l-ynyl)cyclohexane-l,2-diol (100k)18
O H ^ Bu
OH 
100k
Using the general procedure, 1-hexyne (1.1 mL, 9.64 mmol, 4.4 eq) was added to 2- 
hydroxycyclohexanone dimer (0.5g, 2.19 mmol) to give the diol 100k as a crude yellow oil 
(0.333g), containing a ratio of 64:36 of diastereoisomers. The two diastereoisomers were 
separated by column chromatography (20:80 ethyl acetate -  petroleum ether) to give the major 
syw-isomer as a colourless solid (0.103g, 12%, mp = 65-66 °C): R f 0.21 (30 : 70 ethyl acetate -  
petroleum ether): iW c m '1 (DCM) 3150, 2936, 1446 and 1060; 8H 3.32 (1H, dd, J 11.2 and 4.3,
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2-H), 2.19 (2H, t, J 7.1, 3’-CH2), 1.98-1.92 (1H, m, 6-H), 1.87-1.80 (1H, m, 3-H), 1.70-1.50 (2H, 
m, 3- and 6-H), 1.50-1.10 (8H, m, 4-, 5-, 4 ’- and 5’-CH2), 0.85 (3H, t, J 7.2, 6’-Me); 5C 88.3 (1’- 
C), 79.4 (2’-C) , 77.2 (2-CH), 74.1 (1-C), 37.9 (6-CH2), 32.2 (3-CH2), 30.8 (3’-CH2), 24.2 (5- 
CH2), 23.3 (4-CH2), 22.0 (4’-CH2), 18.4 (5’-CH2), 13.6 (6’-Me); m/z (El) 178 ([M] - H20) 3%, 
[Found ([M] - H20), 178.1359. Ci2HigO requires M-H2O, 178.1358]; and the minor awtf-isomer 
as a colourless solid (0.088g, 10%): R f 0.26 (30 : 70 ethyl acetate -  petroleum ether); Sh 3.61 
(1H, dd, J 7.9 and 3.8, 2-H), 2.36-2.22 (1H, m, 6-H), 2.15 (2H, t, J 7.0, 3’-CH2), 1.97-1.87 (1H, 
m, 3-H), 1.75-1.15 (9H, m, 3- and 6-H; 4-, 5-, 4’- and 5’-CH2), 0.84 (3H, t, J 7.3, 6’-Me); 8C 85.4 
( l ’-C), 82.5 (2’-C), 74.1 (2-CH), 70.2 (1-C), 35.5 (6-CH2), 30.7 (3’-CH2), 28.6 (3-CH2), 21.9 (4’- 
and 5-CH2), 21.6 (4-CH2), 18.3 (5’-CH2), 13.6 (6’-Me); m/z (El) 178 ([M] - H20 ) 5%, 165 (45), 
93 (48), 79 (100), [Found ([M]-H20), 178.1359. C,2H180  requires Af-H20 , 178.1358]. The 
remainder of the compound was isolated as a white solid (0.120g, 15%) containing a mixture of 
both isomers. All data obtained matched that previously reported in the literature.
2-Butyl-4,5,6,7-tetrahydrobenzofuran (101 k)18
OKU2
100k 101k
Using the general procedure (3 h minor isomer, 16 h major isomer), 10% AgN0 3 .Si0 2 (0.22g, 
0.127 mmol) was stirred with a solution of diol 100k (0.05g, 0.255 mmol) in dichloromethane to 
yield the Juran 101k as a pale yellow oil (0.043g, 96%): R f 0.75 (30 : 70 ethyl acetate -  
petroleum ether); iw /c m ’1 (film) 3558, 3054,2939, 1603, 1422, 1061, 896; 8H 5.68 (1H, s, 3-H), 
2.43 (4H, m, 4-CH2 and 7-CH2) 2.29 (2H, tt, J 6.0 and 1.8, 1’- CH2), 1.78-1.68 (2H, m, 6-CH2), 
1.67-1.59 (2H, m, 5-CH2), 1.56-1.47 (2H, m, 2’- CH2), 1.34-1.24 (2H, m, 3’-CH2), 0.83 (3H, t, J 
7.3,4’-Me); 8C (125MHz) 154.2 (C), 148.6 (C), 117.1 (C), 105.4 (3-CH), 30.5 ( l ’-CH2), 27.9 (2’- 
CH2), 23.3 (4-CH2), 23.2 (7-CH2), 23.1 (5-CH2), 22.4 (6-CH2), 22.2 (3’-CH2), 13.9 (4’-Me); m/z 
(APCI) 179 [M+Hf 100%, [Found [M+H]+, 179.1432. C |2H190  requires M, 179.1434], All data 
obtained matched that previously reported in the literature.
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(RSJIS)- and (JW*£R)-l-(2-PlienyletIiynyl)cyclohexane-l,2-diol (1001)
O H ^
1001
Using the general procedure, phenylacetylene (0.26mL, 2.41 mmol) was added to 2- 
hydroxycyclohexanone dimer (0.25g, 1.10 mmol) to give the diol 1001 as a crude yellow oil 
(0.212g), in a ratio of 63:37 of diastereoisomers. The two isomers were separated by column 
chromatography (10:90 and 20:80 ethyl acetate -  petroleum ether) to give the major syw-isomer 
as a yellow oil (0.058g, 12%): Rf 0.23 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 
3419, 2939, 2246, 1645, 1495, 1451, 1378 1070, 756; 8H 7.39-7.33 (2H, m, 2 x Ar-H), 7.27-7.20 
(3H, m, 3 x Ar-H), 3.77 (1H, dd, J 7.9 and 3.8, 2-H), 2.58 (1H, bs, OH), 2.38 (1H, bs, OH), 2.08-
2.00 (1H, ddd, J 13.3, 7.0 and 3.7, 6-H), 1.85-1.20 (7H, m, 6-H; 3-, 4- and 5-CH2); 8C 131.8 (2 x 
Ar-CH), 128.5 (Ar-CH), 128.3 (2 x Ar-CH), 122.4 (C), 91.3 ( l ’-C), 84.6 (2’-C), 74.1 (2-CH),
70.7 (1-C), 35.5 (6-CH2), 28.6 (3-CH2), 21.7 (5-CH2), 21.3 (4-CH2); and the minor awfi-isomer as 
a yellow oil (0.063g, 13%), which was successfully recrystallised from ethyl acetate : petroleum 
ether to yield the anti-diol as a white solid (0.050g, mp = 93-94 °C): R f 0.27 (30 : 70 ethyl acetate 
-petroleum ether); W c m * 1 (film) 3388, 2937, 2244, 1490, 1444, 1371, 1060, 756; 8H 7.39-7.35 
(2H, m, 2 x Ar-H), 7.21-7.16 (3H, m, 3 x Ar-H), 4.02 (1H, bs, OH), 3.44 (1H, dd, 11.0 and 3.2, 
2-CH), 3.04 (1H, bs, OH), 2.08-2.01 (1H, m, 6-H), 1.88-1.78 (1H, m, 3-H), 1.64-1.40 (5H, m, 3-, 
4- and 6-H; 5-CH2), 1.20-1.04 (1H, m, 4-H); 8C 131.9 (2 x Ar-CH), 128.5 (Ar-CH), 128.3 (2 x 
Ar-CH), 122.5 (C), 88.7 ( l ’-C), 87.4 (2’-C), 76.9 (2-CH), 74.5 (1-C), 37.9 (6-CH2), 32.1 (3- 
CH2), 24.2 (5-CH2), 23.3 (4-CH2); m/z (ES) 239 [M+Na]+ 91%, 199 (100).
2-Phenyl-4,5,6,7-tetrahydrobenzofuran (lOli)203,204
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Using the general procedure (6 h), 10% AgN0 3 .SiC>2 (0.05g, 0.03 mmol) was stirred with a 
solution of diol 1001 (0.02g, 0.06 mmol) in dichloromethane to yield the furan 1011 as a yellow 
oil (0.018 g, 95%): R f 0.82 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 1600, 1485,
24.0, 23.8, 22.8; m/z (El) 198 [M] 100%. All data obtained matched that previously reported in 
the literature.
(RSyRS)- and (/?5,5/?)-l-(5-(Benzy!oxy)pent-l-ynyl)cyclohexane-l,2-diol (100m)
Using the general procedure, O-benzyl-4-pentyn-l-ol (0.42g, 2.41 mmol) was added to 2- 
hydroxycyclohexanone dimer (0.25g, 1.10 mmol) to give the diol 100m as a crude yellow oil 
(0.275g), containing a ratio of 60:40 of diastereoisomers. The two isomers were separated by 
column chromatography (20:80 ethyl acetate -  petroleum ether) to give the major .yyw-isomer as a 
pure yellow wax (0.023g, 4%): R f 0.30 (20 : 80 ethyl acetate -  petroleum ether); Umax/cm'1 
(DCM) 3419, 3056, 2306, 1644, 1422, 1265, 1114, 896, 738 and 705; 5H 7.29-7.25 (4H, m, 4 x 
Ar-H), 7.25-7.20 (1H, m, Ar-H), 4.44 (2H, s, Bn-CH2), 3.56 (1H, dd, J 8.0 and 3.8, 2-CH), 3.48 
(2H, t, J 6.3, 5’-CH2), 2.35 (1H, bs, OH), 2.28 (2H, t, J 6.9, 3’-CH2), 1.93-1.83 (1H, m, 6-H), 1.74 
(2H, tt, J 6.9 and 6.3, 4’-CH2), 1.70-1.20 (7H, m, 6-H; 3-, 4- and 5-CH2); 5C 138.4 (C), 128.4 (2 x 
Ar-CH), 127.7 (2 x Ar-CH), 127.6 (Ar-CH), 84.7 (U-C), 82.9 (2’-C), 74.3 (2-CH), 73.0 (Bn- 
CH2), 70.2 (1-C), 68.7 (5’-CH2), 35.6 (6-CH2), 29.3 (3-CH2), 28.8 (3’-CH2), 28.5 (5-CH2), 21.3 
(4-CH2), 15.7 (4’-CH2); m/z could not be obtained; and the minor anti-isomer as a pure yellow oil 
(0.018g, 3%): Rf 0.32 (20 : 80 ethyl acetate -  petroleum ether); 5H 7.29-7.25 (4H, m, 4 x Ar-H), 
7.25-7.20 (1H, m, Ar-H), 4.45 (2H, s, Bn-CH2), 3.50 (2H, t, J 6.2, 5’-CH2), 3.28 (1H, dd, J 11.2 
and 4.2, 2-CH), 2.84 (1H, bs, OH), 2.32 (2H, t, J 7.0, 3’-CH2), 1.96-1.79 (2H, m, 6- and 3-H), 
1.77 (2H, tt, J 7.0 and 6.2, 4’-CH2), 1.70-1.10 (6H, m, 3- and 6-H; 4- and 5-CH2); Sc 138.3 (C),
128.4 (2 x Ar-CH), 127.7 (2 x Ar-CH), 127.7 (Ar-CH), 87.5 ( l ’-C), 79.9 (2’-C), 77.2 (2-CH),
1440, 1300; 8h 7.52 (2H, d, J 8.4 Ar-CH), 7.26 (2H, app. t, Ar-CH), 7.13 (2H, t, J 7.2, Ar-CH), 
6.38 (1H, s, 3-H), 2.54 (2H, t, J 6.2, 7-CH2), 2.37 (2H, t, J 6.0 and 1.7, 4-CH2), 1.82-1.75 (2H, m,
6-CH2), 1.70-1.64 (2H, m, 5-CH2); 8C 152.3, 151.5, 132.1, 129.2, 127.2, 123.9, 119.6, 106.7,
O H ^
100m
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74.0 (1-C), 73.0 (Bn-CH2), 68.8 (5’-CH2), 37.7 (6-CH2), 32.1 (3-CH2), 28.9 (3’-CH2), 24.2 (5- 
CH2), 23.3 (4-CH2), 15.8 (4’-CH2); m/z could not be obtained.
2-(3-(Benzyloxy)propyI)-4,5,6,7-tetrahydrobeiizofuran (101m)
101m
Ph
OH
100m
Using the general procedure (24 h), 10% AgNC>3.Si02 (0.012g, 0.007 mmol) was stirred with a 
solution of jyn-diol 100m (0.020g, 0.070 mmol) in dichloromethane to yield the furan 101m as a 
yellow oil (0.015g, 80%): R f 0.82 (20 : 80 ethyl acetate -  petroleum ether); Sh (125MHz) 7.29- 
7.26 (4H, m, 4 x Ar-CH), 7.24-7.19 (1H, m, Ar-CH), 5.71 (1H, s, 3-H), 4.43 (2H, s, Bn-CH2), 
3.45 (2H, t, J 6.4, 3’-CH2), 2.61 (2H, t, J 7.5, l ’-CH2), 2.46 (2H, t, J 6.2, 7-CH2), 2.28 (2H, td, J
6.0 and 1.8, 4-CH2), 1.83 (2H, dt, J 7.5 and 6.4, 2’-CH2), 1.76-1.70 (2H, m, 6-CH2), 1.65-1.60 
(2H, m, 5-CH2); 5c (125MHz) 153.3 (C), 148.9 (C), 138.6 (C), 128.4 (2 x Ar-CH), 127.7 (2 x Ar- 
CH), 127.5 (Ar-CH), 117.5 (C), 105.9 (3-CH), 72.9 (PhCH2), 69.5 (3’-CH2), 29.7 ( l ’-CH2), 28.4 
(2’-CH2), 23.2 (7-CH2 and 5-CH2), 23.1 (4-CH2), 22.1 (6-CH2); m/z (APCI) 271 [M+H]+ 100%, 
179 (12), [Found [M+Hf, 271.1686. Ci8H230 2 requires M+//, 271.1698].
2-MethyIoct-3-yne-l,2-diol (lOOn)205
OI-U>
lOOn
Using the general procedure, 1-hexyne (1.89 mL, 16.4 mmol) was added to acetol (0.5 mL, 7.48 
mmol) to give the diol lOOn as a colourless oil (0.82g, 70%): R f 0.17 (30 : 70 ethyl acetate -  
petroleum ether); Umax/cm'1 (film) 3374, 2956, 2244, 1640, 1458, 1377, 1052, 949; Sh 3.54 (1H, 
d, J 11.0, 1-Ha), 3.39 (1H, d, J 11.0, 1-Hb), 2.14 (2H, t, J 7.1, 5-CH2), 1.47-1.38 (2H, m, 6-CH2),
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1.37 (3H, t, 2-Me), 1.36-1.26 (2H, m, 7-CH2), 0.84 (3H, t, J 7.3, 8-Me); 8C 85.4 (3-C), 81.5 (4-C),
70.9 (1-CH2), 68.7 (2-C), 30.7 (5-CH2), 25.6 (2-Me), 22.0 (6 -CH2), 18.3 (7-CH2), 13.6 (8-Me); 
m/z (El) 138 ([M] - H20) 1%, 130 (100), [Found ([M]-H20), 138.1043. C9H14O requires M-H20 , 
138.1045]. All data obtained matched that previously reported in the literature.
2-Butyl-4-methylfuran (lOln)205
lOOn lOln
Using the general procedure (3 h), 10% AgNC>3.Si0 2 (0.054g, 0.032 mmol) was stirred with a 
solution of diol lOOn (0.05g, 0.320 mmol) in dichloromethane to yield the furan lOln as a pale 
yellow oil (0.021 g, 48%): R f 0.73 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 2958, 
2872, 1619, 1552, 1459, 1379, 1269, 1122, 947, 914, 799, 739 and 602; 5H (125MHz) 6.91 (1H, 
s, 5-H), 5.72 (1H, s, 3-H), 2.43 (2H, t, J 7.6 1’- CH2), 1.85 (3H, s, 4-Me), 1.52-1.42 (2H, m, 2’- 
CH2), 1.29-1.18 (2H, m, 3’-CH2), 0.79 (3H, t, J 7.3, 4 ’-Me); 8C (125MHz) 156.6 (C), 137.2 (5- 
CH), 120.4 (C), 107.4 (3-CH), 30.2 ( l ’-CH2), 27.8 (2’-CH2), 22.3 (3’-CH2), 13.8 (4’-Me), 9.8 (4- 
Me); m/z (El) 138 [M] 100%. All data obtained matched that previously reported in the 
literature.
2-Methyl-4-phenylbut-3-yne-l,2-diol (IOO0 )18,206
.0
OH
Ph
OH
lOOo
Using the general procedure, phenylacetylene (0.88 mL, 8.03 mmol) was added to acetol 
(0.25mL, 3.65 mmol) to give a crude yellow solid (0.359). This residue was purified by column 
chromatography (30: 70 ethyl acetate -  petroleum ether) to yield diol lOOo as a yellow solid 
(0.145g, 23%, mp 88-90 °C) (lit. mp. = 85-86 °C): R f 0.14 (30 : 70 ethyl acetate -  petroleum 
ether); tW c m '1 (DCM) 3399, 2247, 1651, 1376, 1283, 1050, 908, 733; 5H 7.39-7.33 (2H, m, 2 x
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Ar-H), 7.27-7.21 (3H, m, 3 x Ar-H), 3.70 (1H, d, J 11.0, 1-Ha), 3.51 (1H, dd, J 11.0 and 3.4, 1- 
Hb), 2.71 (1H, bs, OH), 2.14 (1H, bs, OH), 1.49 (3H, s, 2-Me); Sc (125MHz) 131.8 (2 x Ar-CH),
128.6 (Ar-CH), 128.3 (2 x Ar-CH), 122.2 (C), 90.3 (3-C), 84.5 (4-C), 70.8 (1-CH2), 69.1 (2-C),
25.4 (2-Me); m/z (El) 158 [M -  H20] 100%. All data obtained matched that previously reported 
in the literature.
4-Methyl-2-phenylfuran (lOlo)18,207
lOOo lOlo
Using the general procedure (3 h), 10% AgN0 3 .Si0 2 (0.029g, 0.017 mmol) was stirred with a 
solution of diol lOOo (0.03g, 0.17mmol) in dichloromethane to yield furan lOlo as a pale yellow 
oil (0.023g, 85%): R f 0.70 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 1597, 1538, 
1484, 1445, 914, 763; SH (125MHz) 7.58 (2H, d, J 7.1, 2 x Ar-CH), 7.31-7.27 (2H, m, 2 x Ar- 
CH), 7.19-7.14 (2H, m, Ar-CH and 5-H), 6.43 (1H, s, 3-H), 2.00 (3H, d, J 1.0, 4-Me); 6C 
(125MHz) 153.9(C), 138.9 (5-CH), 131.1 (C), 128.6 (2 x Ar-CH), 127.1 (Ar-CH), 123.7 (2 x Ar- 
CH), 122.0 (C), 107.7 (3-CH), 9.9 (4-Me); m/z (El) 158 [M] 100%, [Found [M], 158.0728. 
CnHioO requires M, 158.0727], All data obtained matched that previously reported in the 
literature.
(^^£)-l-Phenyloct-3-yne-U-diol(126a)18
125a 126a
Using the general procedure, (£)-1 -phenyloct-1 -en-3-yne208 125a (0.182g, 1 mmol) was 
dihydroxylated with potassium osmate (VI) dihydrate (5mg, 19.8 pmol) to yield the diol 126a as 
a yellow-brown oil (0.144g, 67%): Rf 0.24 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1
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(film) 3404, 3033, 2958, 2872, 2249, 1548, 1494, 1454, 1380, 1227, 1260, 1198, 1142, 1057, 
909, 842, 734, 700, 649; 8H 7.36 (2H, d, J 7.4, 2 x Ar-H), 7.33-7.20 (3H, m, 3 x Ar-H), 4.61 (1H, 
d, 6.9, 1-H), 4.31 (1H, dt, J 6.9 and 2 .0 ,2-H), 2.75 (1H, bs, OH), 2.26 (1H, bs, OH), 2.09 (2H, td, 
J 7.2 and 2.0, 5-CH2), 1.40-1.30 (2H, m, 6-CH2), 1.29-1.17 (2H, m, 7-CH2), 0.80 (3H, t, J 7.3, 8- 
Me); 8C 139.4 (C), 128.2 (2 x Ar-CH), 127.1 (Ar-CH), 123.3 (2 x Ar-CH), 88.1 (3-C), 77.8 (4-C),
77.7 (1-CH), 67.7 (2-CH), 30.4 (5-CH2), 21.8 (6-CH2), 18.3 (7-CH2) and 13.6 (8-Me); m/z 
(APCI) 219 [M+H]+ 89%. All data obtained matched that previously reported in the literature.
2-Butyl-5-phenylfuran (127a)18
Ph OH
V bu
P h ^ O
126a 127a
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.2g, 0.115 mmol) was stirred with a 
solution of diol 126a (0.05g, 0.230 mmol) in dichloromethane to yield furan 127a as an orange 
oil (0.038g, 83%): Rf 0.73 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3019, 2926, 
1448, 1215, 755, 669; 8H 7.56 (2H, d, J 7.6, 2 x Ar-H), 7.25 (2H, t, J 7.6, 2 x Ar-H), 7.17-7.11 
(1H, m, Ar-H), 6.47 (1H, d, J 3.2, 4-H), 5.97 (1H, d, J 3.2, 3-H), 2.61 (2H, t, J 7.6, 1’- CH2),
1.65-1.56 (2H, m, 2’- CH2), 1.40-1.29 (2H, m, 3’-CH2), 0.86 (3H, t, J 7.3, 4’-Me); 8C 156.5 (C),
152.1 (C), 131.3 (C), 128.6 (2 x Ar-CH), 126.7 (Ar-CH), 123.3 (2 x Ar-CH), 106.9 (3-CH), 105.7 
(2-CH), 30.3 ( l ’-CH2), 27.9 (2’-CH2), 22.3 (3’-CH2), 13.9 (4’-Me); m/z (El) 200 [M]+ 97%, 
[Found [M], 200.1195. C14H16O requires My 200.1201]. All data obtained matched that 
previously reported in the literature.
(E)- and (Z)-(7-Phenylhept-6-en-4-ynyIoxy)(terf-butyl)dimethylsilane (125b)
.Br ^ ^ ^ O T B D M S
J  — - rn
125b
Using the general procedure, O-TBDMS-4-pentyn-l-ol (3.1 g, 15.6 mmol) was added to p- 
bromostyrene (2 mL, 15.6 mmol) to give the enyne 125b as a crude yellow oil (4.76 g),
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containing a ratio of 96:4 of isomers: R f 0.25 (5 : 95 ethyl acetate -  petroleum ether); omax/crrf! 
(film) 2953, 2856, 2213, 1651, 1492, 1471, 1447, 1388, 1361, 1255, 1105, 1006, 953, 836, 777, 
747, 691, 664; SH 7.78 (0.08H, d, J 7.6, 2 x Ar-H), 7.32-7.15 (4.92H, m, 8 x Ar-H), 6.79 (0.96H, 
d, J 16.3, 7-H), 6.48 (0.04H, d, J 11.9, 7-H), 6.07 (0.96H, dt, J 16.3 and 2.1, 6-H), 5.62 (0.04H, 
dt, J 11.9 and 2.4, 6-H), 3.66 (1.92H, t, J 6.0, 1-CH2), 3.60 (0.08H, t, J 6.0, 1-CH2), 2.45 (0.08H, 
dt, J 7.0 and 2.4, 3-CH2), 2.38 (1.92H, dt, J 7.0 and 2.1, 3-CH2), 1.77-1.62 (2H, m, 2-CH2), 0.84- 
0.82 (9H, s, /-Bu), 0.00 (6H, s, Si Me); 8C 140.1 (7-CH), 136.5 (C), 128.7 (2 x Ar-CH), 128.3 (Ar- 
CH), 126.1 (2 x Ar-CH), 108.8 (6-CH), 92.5 (5-C), 79.9 (4-C), 61.7 (1-CH2), 31.8 (3-CH2), 26.0 
(/-Bu Me), 18.4 (C), 16.1 (2-CH2), -5.3 (Si Me) (minor isomer was not observed by ,3C-NMR); 
m/z (El) 300 [M] 2%, 243 (96), 141 (71), 89 (100) [Found [M], 300.1916. Ci9H28OSi requires A/, 
300.1909].
(i?5^?5)-7-((/err-Butyl)dimethylsilyIoxy)-l-phenyIhept-3-yne-l^-diol (126b)
OTBDMS
125b
OTBDMSHO.
126b
Using the general procedure, enyne 125b (4g, 13.3 mmol) was dihydroxylated with potassium 
osmate(VI) dihydrate (8mg, 30 pmol) to yield crude diol 126b as a yellow oil (3.842g, 94%) 
containing a ratio of 96:4 of isomers, which was purified by column chromatography (20:80 ethyl 
acetate -  petroleum ether) to give the diol 126b as a pale yellow oil (3.842g, 86%) and as a single 
isomer: Rf 0.26 (30 : 70 ethyl acetate -  petroleum ether); iW c m '1 (film) 3372, 2953, 2896, 
2857, 2234, 1672, 1599, 1495, 1471, 1389, 1361, 1326, 1255, 1198, 1104, 1065, 968, 836, 776; 
5h 7.39 (2H, dd, J 7.8 and 1.3, 2 x Ar-H), 7.36-7.26 (3H, m, 3 x Ar-H), 5.04 (1H, bs, OH), 4.63 
(1H, d, J 7.2, 1-H), 4.34 (1H, dt, J 7.2 and 1.8,2-H), 3.54 (2H, t J 6.0, 7-CH2), 2.21 (2H, dt, J 1.8 
and 7.2, 5-CH2), 1.65-1.55 (2H, m, 6-CH2), 0.86 (9H, s, f-Bu), 0.00 (6H, s, Si Me); 8C 139.3 (C),
128.2 (Ar-CH), 128.2 (2 x Ar-CH), 127.1 (2 x Ar-CH), 87.7 (3-C), 77.8 (4-C), 77.6 (1-CH), 67.6 
(2-CH), 61.5 (7-CH2), 31.4 (5-CH2), 25.9 (t-Bu Me), 18.3 (C), 15.1 (6-CH2), -5.3 (Si Me).
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(3-(5-Phenylfuran-2-yl)propoxy)(ter/-butyl)dimethylsilane (127b)
OTBDMSOTBDMS
Using the general procedure (48 h), 10% AgN0 3 .Si0 2  (2 g, 1.20 mmol) was stirred with a 
solution of diol 126b (2 g, 5.98 mmol) in dichloromethane to yield the furan 127b as a pale 
yellow oil (1.799g, 95%): Rf 0.77 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 3335, 
3054, 2955, 2857, 1667, 1597, 1548, 1471, 1448, 1389, 1265, 1102, 1017, 974.8, 837, 778, 740, 
704; SH 7.57 (2H, d, J 7.2, 2 x Ar-H), 7.32-7.26 (2H, m, 2 x Ar-H), 7.14 (1H, t, J 7.3, Ar-H), 6.48 
(1H, d, J 3.3, 4-H), 6.00 (1H, d, J 3.3, 3-H), 3.63 (2H, t, J 6.2, 3’-CH2), 2.70 (2H, t, J 7.6, 1’- 
CH2), 1.89-1.80 (2H, m, 2’-CH2), 0.85 (9H, s, t-Bu), 0.00 (6H, s, Si-Me); 8C 155.8 (C), 152.2 (C),
131.2 (C), 128.6 (2 x Ar-CH), 126.8 (Ar-CH), 123.3 (2 x Ar-CH), 107.1 (4-CH), 105.7 (Ar-CH),
62.2 (3’-CH2), 31.4 (U-CH2), 26.0 (/-Bu Me), 24.6 (2’-CH2), 18.4 (C), -5.2 (Si-Me); m/z (El) 316 
[M] 5%, 259 (100), [Found [M], 316.1873. Ci9H280 2Si requires M  316.1859].
3-(5-Phenylfuran-2-yl)propan-l-ol (117)
OTBDMS
Tetrabutylammonium fluoride (15 mL of a 1M solution in THF, 14.7 mmol, 4.4 eq) was added to 
a solution of furan 127b (l.lg, 3.35 mmol, 1 eq) in dichloromethane (20 mL). The resulting 
solution stirred overnight at ambient temperature, then diluted with water (50 mL) and extracted 
into dichloromethane (3 x 50 mL). The combined organic layers were washed with water (200 
mL) and brine (200 mL), then dried, filtered and evaporated to give a brown oil (1.105g), which 
was purified twice by column chromatography (30:70 ethyl acetate -  petroleum ether) to yield 
the furan 117 as a yellow oil (0.166g, 25%) containing an apparent decomposition product: Rf
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0.28 (30 : 70 ethyl acetate -  petroleum ether): bn furan 7.54 (2H, d, J 7.2, Ar-H), 7.28-7.24 (2H, 
m, Ar-H), 7.14 (1H, t, J 7.1, Ar-H), 6.48 (1H, d, J 3.2, 4-H), 6.02 (1H, dt, J 3.2 and 0.8, 3-H), 
3.66 (2H, t, J 6.4, 3’-CH2), 2.72 (2H, t, J 7.4, l ’-CH2), 1.89 (2H, tt, J 7.4 and 6.4, 2’-CH2), 1.39 
(1H, bs, OH); bcfuran 162.7 (C), 151.1 (C), 142.4 (C), 128.6 (2 x Ar-CH), 126.9 (Ar-CH), 123.4 
(2 x Ar-CH), 107.3 (4-CH), 105.7 (3-CH), 62.2 (3’-CH2), 31.1 ( l ’-CH2) and24.5 (2’-CH2).
(£)- and (Z)-7-PhenyIhept-6-en-4-yn-l-ol (125b’>
Ph
Br OH
Ph
125b’
Using the general procedure, 4-pentyn-l-ol (1.45 mL, 15.6 mmol) was added to 0-bromostyrene 
(2 mL, 15.6 mmol) to give the enyne 125b’ as a crude red oil (3.12 g), containing a ratio of 96:4 
of isomers. Pure sample recovered as a result of purification in the following step (20:80 ethyl 
acetate -  petroleum ether) (0.223g): R f 0.30 (30 : 70 ethyl acetate -  petroleum ether): Umax/cm*1 
(film) 3350, 3027, 2948, 2211, 1952, 1597, 1492, 1447, 1326, 1179, 1055, 955, 930, 844, 787, 
749, 692; 8H 7.77 (0.08H, d, J 7.4, 2 x Ar-H), 7.31-7.15 (4.92H, m, 8 x Ar-H), 6.80 (0.96H, d, J 
16.3, 7-H), 6.50 (0.04H, d, J 11.4, 7-H), 6.07 (0.96H, dt, J 16.3 and 2.3, 6-H), 5.61 (0.04H, dt, J
11.8 and 2.5, 6-H), 3.71 (1.92H, t, J 6.2, 1-CH2), 3.66 (0.08H, t, J 6.2, 1-CH2), 2.49 (0.08H, dt, J
6.9 and 2.5, 3-CH2), 2.43 (1.92H, dt, J 7.0 and 2.3, 3-CH2), 1.79-1.70 (2H, m, 2-CH2), 1.65 
(0.96H, bs, OH); 8C E-isomer 140.4 (7-CH), 136.4 (C), 128.7 (2 x Ar-CH), 128.4 (Ar-CH), 126.1 
(2 x Ar-CH), 108.5 (6-CH), 91.9 (5-C), 80.3 (4-C), 61.8 (1-CH2), 31.4 (3-CH2), 16.3 (2-CH2); 8C 
Z-isomer 137.2 (7-CH), 135.9 (C) 128.4 (2 x Ar-CH), 128.2 (Ar-CH), 126.1 (2 x Ar-CH), 106.6 
(6-CH), 91.9 (5-C), 80.3 (4-C), 61.8 (1-CH2), 31.3 (3-CH2), 16.5 (2-CH2); m/z (El) 186 [M] 40%, 
141 (67), [Found [M], 186.1039. Ci3H140  requires M, 186.1045].
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Using the general procedure, enyne 125b’ (lg, 5.37 mmol) was dihydroxylated with potassium 
osmate(VI) dihydrate (3mg, 10 pmol) to yield a crude mixture (1.629g) containing diol 116, 
enyne 125b’ and /-butanol. The residue was purified by column chromatography (30:70 ethyl 
acetate -  petroleum ether) to yield the diol 116 as a yellow oil (0.133g), comprising solely of the 
syn-diol 116: Rf 0.25 (40 : 60 ethyl acetate -  petroleum ether): Umax/cm*1 (film) 3419, 2930, 2251, 
1640, 1496, 1263, 1143, 1056, 909, 733, 700; SH 7.36-7.23 (5H, m, 5 x Ar-H), 4.68 (1H. bs, OH), 
4.60 (1H, d, J 7.0, 1-H), 4.32 (1H, dt, J 7.0 and 1.8, 2-H), 3.55 (2H, t, J 6.0, 7-CH2), 2.20 (2H, dt, 
J 6.8 and 1.8, 5-CH2), 1.71 (1H, bs, OH), 1.64-1.56 (2H, m, 2-CH2), 1.48 (1H, bs, OH); 8C 139.3 
(C), 128.3 (Ar-CH), 128.3 (2 x Ar-CH), 127.1 (2 x Ar-CH), 87.2 (3-C), 77.6 (1-CH), 77.2 (4-C),
67.5 (2-CH), 61.5 (7-CH2), 30.8 (5-CH2), 15.3 (6-CH2); m/z (El) 202 ([M] -  H20 ) 5%, 105 (89), 
77 (100), [Found ([M]-H20), 202.1000. C13Hi40 2 requires M-H2Q, 202.0994].
Cyclisation of (R54W)-l-phenylhept-3-yne-l^,7-triol (116)
R n
OH OH
3
117
R 1 OH 
118
R2r t >R1^ O H W
119
Using the general procedure (24 h), 10% AgN03.Si02 (0.077 g, 0.045 mmol) was stirred with a 
solution of the syw-diol 116 (0.1 g, 0.454 mmol) in dichloromethane to yield a crude mixture of 
products as a pale yellow oil (0.088g) containing the furan 117 (57%), 5-exo diol 118 (29%) and 
dihydrofuran 119 (24%). Key selected data: bw furan 6.48 (1H, d, J 3.1, 4-H), 6.03 (1H, d, J 3.1,
3-H), 3.66 (2H, t, J 6.3, 3’-CH2), 2.73 (2H, t, J 7.2, l ’-CH2), 1.89 (2H, tt, J 7.2 and 6.3, 2’-CH2); 
5h 5-exo diol 6.02 (1H, dd, J 5.8 and 1.7, 3’-H), 5.80 (1H, m, 1 ’-H), 5.74 (1H, dd, J 5.8 and 2.3, 
2’-H); 8» dihydrofuran 6.87 (1H, dd, J 15.8 and 5.1, 2’-H), 6.38 (1H, dd, J 15.8 and 1.7, l ’-H),
6.08 (1H, dd, J 5.1 and 1.7, 3’-H), 5.31 (1H, m, 3-H).
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(£>(Hept-5-en-3-ynyloxy)(/e/t-butyI)diphenylsilane (125c)
OTBDPS
Using the general procedure, O-TBDPS-3-butyn-1 -ol (1.7g, 6.01 mmol) was added to 
bromoprop-l-ene (0.5 mL, 6.01 mmol) to give a yellow oil (1.538g), which was purified by 
column chromatography (10:90 ethyl acetate -  petroleum ether) to yield the enyne 125c as a 
yellow oil (1.258g), containing residual OTBDPS-3-butyn-l-ol. The product 125c showed: Rf 
0.30 (5 : 95 ethyl acetate -  petroleum ether); Umax/cm*1 (film) 2931, 2857, 2327, 1510, 1428, 
1112, 813, 765, 702; 6H enyne 7.66-7.52 (4H, m, Ar-H), 7.39-7.22 (6H, m, Ar-H), 5.80 (1H, dq, J
10.7 and 6.8, 6-H), 5.35 (1H, d, J 10.7, 5-H), 3.67 (2H, t, J 6.8, 1-CH2), 2.41 (2H, t, J 6.8, 2-CH2), 
1.74 (3H, d, J 6.8, 7-Me), 0.97 (9H, s, /-Bu); Sc (125MHz) enyne 137.5 (5-CH), 133.7 (C), 135.7 
(4 x Ar-CH), 133.5 (C), 129.7 (2 x Ar-CH), 127.8 (4 x Ar-CH), 110.3 (6-CH), 78.3 (4-C), 74.6 
(3-C), 62.7 (1-CH2), 26.9 (/-Bu Me), 23.8 (2-CH2), 19.3 (C), 15.9 (7-Me).
(l?5»i?5)-0-(/cr/-ButylphenylsilyIoxy)-hept-4-yne-2^-diol (126c)
OTBDPS
HO
OH
126c
OTBDPS
125c
Using the general procedure, crude enyne 125c (lg, 3.12 mmol), containing 0.7g of O-TBDPS-3- 
butyn-l-ol, was dihydroxylated with potassium osmate(Vl) dihydrate (2mg, 6 pmol) to give a 
yellow oil (0.997g), which was purified by column chromatography (20:80 ethyl acetate -  
petroleum ether) to yield the diol 126c as a yellow oil (0.175g, 54%): R f 0.29 (30 : 70 ethyl 
acetate -  petroleum ether); W a n '1 (film) 3385, 2931, 2342, 1472, 1428, 1390, 1112, 910, 823, 
735, 702; 8H 7.60-7.56 (4H, m, 4 x Ar-H), 7.32-7.24 (6H, m, 6 x Ar-H), 4.16 (1H, dt, J 3.5 and 
1.9, 3-H), 3.71 (1H, dq, J 6.4 and 3.5,2-H), 3.67 (2H, t, J 6.9, 7-CH2), 2.38 (2H, dt, J 6.9 and 1.9,
6-CH2), 1.09 (3H, d, J 6.4, 1-Me), 0.96 (9H, s, (-Bu Me); 8C (125MHz) 135.6 (4 x Ar-H), 133.4 (2
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x C), 129.8 (2 x Ar-CH), 127.8 (4 x Ar-CH), 84.8 (4-C), 78.6 (5-C), 70.3 (3-CH), 67.3 (2-CH),
62.3 (7-CH2), 26.8 (/-Bu Me), 22.9 (6-CH2), 19.2 (1-Me), 18.3 (C).
(3-(5-Methylfuran-2-yl)ethoxy)(ter/-butyl)diphenylsilane (127c)
-OTBDPS
HO OTBDPS
OH
126c 127c
Using the general procedure (48 h), 10% AgN0 3 .Si0 2 (0.088g, 0.052 mmol, 0.2 eq) was stirred 
with a solution of diol 126c (O.lg, 0.261 mmol) in dichloromethane to yield the furan 127c as a
Furan 127c (0.093g, 0.250 mmol, 1 eq) was dissolved in THF (10 mL). TBAF (1.3 mL of a 1M 
solution in THF, 1.20 mmol, 4.8 eq) was added and the resulting solution stirred overnight, then 
poured into a mixture of dichloromethane (25 mL) and water (25 mL). The separated aqueous 
layer was extracted with dichloromethane (2 x 25 mL) and the combined organic layers washed 
with water (100 mL), then dried, filtered and evaporated to give a  yellow oil (0.109g), which was 
purified by column chromatography (20:80 ethyl acetate -  petroleum ether) to yield the furan 
127c* as a yellow oil (0.004g, 12%): R f 0.39 (20 : 80 ethyl acetate -  petroleum ether); Umax/cm'1
yellow oil (0.093g, 98%): 5H 7.58-7.53 (4H, m, 4 x Ar-H), 7.38-7.26 (6H, m, 6 x Ar-H), 5.84 
(1H, d, J 2.8, 4-H), 5.77 (1H, d, J 2.8, 3-H), 3.80 (2H, t, J 6.8, 2’-CH2), 2.77 (2H, t, J 6.8, 1’- 
CH2), 2.16 (3H, s, 5-Me), 0.95 (9H, s, /-Bu Me); 8C (125MHz) 151.4 (C), 150.4 (C), 135.6 (4 x 
Ar-CH), 133.8 (2 x C), 129.6 (2 x Ar-CH), 127.6 (4 x Ar-CH), 106.9 (4-CH), 105.9 (3-CH), 62.6 
(2’-CH2), 31.7 ( l ’-CH2), 26.8 (/-Bu Me), 19.2 (C), 13.5 (5-Me).
2-(5-methylfuran-2-yl)ethanol (127c*)
OTBDPS
127c 127c’
(film) 3413, 2925, 1646, 1046, 909, 733; 6H 5.91 (1H, d, J 2.8, 4-H), 5.81 (1H, d, J 2.8, 3-H), 
3.78 (2H, t, J 6.2, 2’-CH2), 2.78 (2H, t, J 6.2, l ’-CH2), 2.19 (3H, s, 5-Me), 1.69 (1H, bs, OH); 5C
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151.2 (C), 151.1 (C), 107.3 (4-CH), 106.1 (3-CH), 61.2 (2’-CH2), 31.7 ( l ’-CH2), 13.6 (5-Me); 
m/z (El) 126 [M] 22%, 95 (100), [Found [M], 126.0683. C7Hi0O2 requires M, 126.0681].
(E)- and (Z)-Oct-6-en-4-ynyloxy)(ter/-butyI)dimethylsilane (125d)
. Br
1  + ^ ^ ^ O T B D M S
OTBDMS
125d
Using the general procedure, O-TBDMS-4-pentyn-1 -ol (1.64g, 8.27 mmol) was added to 1- 
bromoprop-l-ene (lg, 8.27 mmol) to give a yellow solid (1.207g), containing a ratio of 77:23 of 
the trans : cis isomers. This mixture was then purified by column chromatography to yield the 
enyne 125d as a pale yellow oil (0.123g, 6%), containing a ratio of 69:31 of the trans : cis 
isomers: tw /c m '1 (film) 2954, 2929, 2857,2206, 1673, 1471, 1388, 1255, 1106, 972, 837, 777, 
735; 8h 5.99 (0.69H, dq, J 15.7 and 6.7, 2-CH), 5.83 (0.31H, dq, J 10.6 and 6.8,2-CH), 5.40 (1H, 
app. doubled hextet, J 15.7 and 1.8,3-CH), 3.66 (0.62H, t, J 6.0, 8-CH2), 3.64 (1.38H, t, J 6.0, 8- 
CH2), 2.38 (0.62H, dt, J 7.0 and 2.0 ,6-CH2), 2.31 (1.38H, dt, J 7.0 and 1.8, 6-CH2), 1.79 (0.93H, 
dd, J 6.8 and 1.6, 1-Me), 1.70 (2.07H, dd, J 6.7 and 1.8, 1-Me), 1.71-1.61 (2H, m, 7-CH2), 0.84 
(9H, s, (-Bu), 0.00 (6H, s, Si-Me); 8C trans 138.1 (3-CH), 111.0 (2-CH), 88.0 (4-C), 79.3 (5-C),
61.7 (8-CH2), 31.8 (6-CH2), 26.0 (t-Bu-Me), 18.5 (1-Me), 18.4 (C), 15.7 (7-CH2), -5.3 (Si-Me); 
8c cis 137.0 (3-CH), 110.3 (2-CH), 94.4 (4-C), 88.0 (5-C), 61.7 (8-CH2), 31.9 (6-CH2), 26.0 ((-Bu 
Me), 18.5 (1-Me), 18.4 (C), 16.0 (7-CH2), -5.3 (Si-Me).
{RSJIS)- and (/?5VSl?)-8-((ter/-Butyl)dimethylsilyIoxy)-oct-4-yne-2,3-diol (126d)
OTBDMS OTBDMS
Using the general procedure, enyne 125d (O.lg, 0.42 mmol) was dihydroxylated with potassium 
osmate (VI) dihydrate (2mg, 6 pmol) to give the diol 126d as a yellow oil (0.109g, 96%), 
containing a ratio of 69:31 of diastereoisomers: Umax/cm1 (film) 3375, 2928, 2857, 2233, 1576,
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1471, 1362, 1326, 1255, 1154, 1106, 975, 837, 777, 738, 662; 8H 4.23 (0.31H, d, J 3.5, 3-H), 4.03 
(0.69H, dt, J 6.9 and 1.8, 3-H), 3.79 (0.31H, dq, J 6.2 and 3.5, 2-H), 3.71 (0.69H, app. quintet, 2-
H), 3.63 (0.62H, t, J 6.0, 8-CH2), 3.62 (1.38H, t, J 6.0, 8-CH2), 2.31-2.22 (0.62H, m, 6-CH2), 2.26 
(1.38H, dt, J 7.2 and 1.8, 6-CH2), 1.70-1.61 (2H, m, 7-CH2), 1.21 (2.07H, d, J 6.2, 1-Me), 1.20 
(0.93H, d, J 6.2, 1-Me), 0.84 (9H, s, /-Bu), 0.00 (6H, s, Si-Me); 8C syn 112 (4-C), 74.9 (5-C),
71.4 (3-CH), 67.7 (2-CH), 61.5 (8-CH2), 43.5 (1-Me), 31.5 (6-CH2), 26.0 (/-Bu Me), 18.5 (C),
15.1 (7-CH2), -5.3 (Si-Me), 8C anti 76.8 (4-C), 73.6 (5-C), 70.4 (3-CH), 67.3 (2-CH), 61.6 (8- 
CH2), 43.6 (1-Me), 31.6 (6-CH2), 26.0 (/-Bu Me), 18.4 (C), 15.2 (7-CH2), -5.3 (Si-Me); m/z (El) 
141 ([M] - TBDMS - H20 ) 46%, 169 (99), 95 (52), 75 (100).
(3-(5-Methylfuran-2-yI)propoxy)(/er/-butyl)dimethylsilane (127d)
OTBDMSOTBDMS
126d 127d
Using the general procedure (48 h), 10% AgNC>3.Si02 (0.062g, 0.037 mmol) was stirred with a 
solution of diol 126d (O.lg, 0.367 mmol) in dichloromethane to yield the furan 127d as a pale 
yellow oil (0.087g, 94%): iW c m '1 (film) 2927, 2856, 1571, 1463, 1362, 1255, 1103, 1020, 965, 
910,837, 777, 735; 8H 5.80 (2H, bs, 3- and 4-H), 3.60 (2H, t, J 6.3 ,3’-CH2), 2.59 (2H, t, J 7.6, P- 
CH2), 2.20 (3H, s, 5-Me), 1.78 (2H, m, 2’-CH2), 0.85 (9H, s, /-Bu), 0.00 (6H, s, Si-Me); 8C 154.2 
(C), 150.2 (C), 105.8 (4-CH), 105.3 (3-CH), 62.3 (3’-CH2), 31.2 ( l ’-CH2), 26.0 (/-Bu Me), 24.4 
(2’-CH2), 18.4 (C), 13.5 (5-Me), -5.3 (Si-Me).
2,3-Dimethylnon-4-yiie-2,3-diol (156)
O H ^
156
Using the general procedure, 1-hexyne (0.5 mL, 4.31 mmol) was added to 3-hydroxy-3- 
methylbutan-2-one (0.21 mL, 1.96 mmol) to give the diol 156 as a clear oil (0.194g, 53%):
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iW cm "1 (film) 3434, 2935,2873,2245, 1639, 1460, 1370, 1266, 1083, 959, 915, 851, 794, 735; 
6h 2.49 (1H, s, OH), 2.15 (2H, t, J 7.0, 6-CH2), 1.97 (1H, s, OH), 1.48-1.30 (4H, m, 7- and 8- 
CH2), 1.37 (3H, s, 2-Me), 1.30 (3H, s, 1-Me), 1.20 (3H, s, 3-Me), 0.84 (3H, t, J 7.2, 9-Me); 8C
85.5 (4-C), 82.2 (5-C), 75.3 (3-C), 74.1 (2-C), 30.7 (6-CH2), 25.7 (1-Me), 24.5 (2-Me), 22.7 (3- 
Me), 22.0 (7-CH2), 18.3 (8-CH2), 13.6 (9-Me), m/z (El) 184 [M] 100%.
Attempted cyclisation of 2,3-dimethylnon-4-yne-2,3-dioI (156)
O K ^
156 157
Using the general procedure (24 h), 10% AgN0 3 .Si0 2  (0.184g, 0.11 mmol) was stirred a solution 
of diol 157 (O.lg, 0.54 mmol) in dichloromethane to yield an unidentified product.
(RSyRS)- and (RSjSR)- 3-Methylpent-4-yne-2,3-diol (142a)
142a
Using the general procedure, TMS-acetylene (0.7 mL, 4.99 mmol) was added to 3-hydroxybutan- 
2-one (0.2g, 2.27 mmol) to give the diol 142a as a pale yellow oil (0.074g). The residue was 
purified by column chromatography (20:80 ethyl acetate -  petroleum ether) to yield the diol 142a 
as a clear oil (0.027g, 11%), containing a ratio of 69:31 of diastereoisomers: Umax/cm*1 (film) 
3350, 3297, 2985, 2359, 1640, 1450, 1375, 1069, 1009, 935, 874; 6H 3.77 (0.69H, q, J 6.2, 2-H),
3.57 (0.31H, app. quintet, J 6.0, 2-H), 3.22 (0.69H, bs, OH), 2.84 (0.69H, bs, OH), 2.72 (0.31H, 
bs, OH), 2.44 (1H, s, 5-H), 2.40 (0.31H, bs, OH), 1.37 (0.93H, s, 3-Me), 1.36 (2.07H, s, 3-Me), 
1.24 (0.93H, d, J 6.4, 1-Me), 1.17 (2.07H, d, J 6.2, 1-Me); 8C major and minor 86.2 (5-CH), 84.6 
(5-CH), 74.2 (2-CH), 73.4 (2-CH), 72.8 (4- and 3-C), 71.8 (3-C), 70.8 (4-C), 25.6 (3-Me), 23.1 
(3-Me), 18.3 (1-Me), 16.6 (1-Me).
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Attempted cyclisation of 3-methylpent-4-yne-2,3-diol (142a)
O K ^
Using the general procedure (24 h), 10% AgNC>3.Si02 (0.7g, 0.45 mmol) was stirred a solution of 
diol 157 (O.lg, 0.90 mmol) in dichloromethane. Starting material was recovered.
(Jt£,AS)-l,2-DiphenyIbut-3-yne-l,2-diol (142b)18
D . O H ^ "H 
P h ^ O  Ph
Ph^O H  Ph OH
142b
Using the general procedure, TMS-acetylene (0.72 mL, 5.18 mmol) was added to benzoin (0.5g,
2.36 mmol) to give the diol 142b as a yellow solid (0.673g), which was purified by column 
chromatography (20:80 ethyl acetate -  petroleum ether) to yield the diol 142b as a yellow solid 
(0.235g, 42%, mp 114-115 °C) and as an apparent single diastereoisomer: Umax/cm1 (DCM) 3435, 
3326, 3055, 2962,2137, 1641, 1494, 1450, 1421, 1265, 1192, 1089, 1053, 846, 738; 6H 7.24-7.18 
(2H, m, 2 x Ar-H), 7.10-6.92 (8H, m, 8 x Ar-H), 5.65 (1H, d, J 2.9, 1-H), 2.55 (1H, s, 4-H), 2.46 
(1H, d, J 2.9, OH), 1.34 (1H, s, OH); 5C 139.8 (C), 137.9 (C), 132.3(2 x Ar-CH), 128.9 (Ar-CH),
128.7 (Ar-CH), 128.7 (2 x Ar-CH), 127.7 (2 x Ar-CH), 127.0 (2 x Ar-CH), 84.7 (3-C), 80.8 (4- 
CH), 76.3 (2-C), 76.1 (1-CH); m/z (APCI) 239 (M+H)+ 100%. All data obtained matched that 
previously reported in the literature.
Attempted cyclisation of 1,2-diphenylbut-3-yne-1,2-diol (142b)
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Using the genera! procedure (24 h), 10% AgN0 3 .Si0 2  (0.142g, 0.08 mmol) was stirred a solution 
of diol 157 (O.lg, 0.42 mmol) in dichloromethane. Starting material was recovered.
2-Acetoxysuccinicanhydride (133)209
OAc
ho2c ^ y c ° 2h ------------- - r V o
OH o ^ O
133
Racemic malic acid (lOg, 75 mmol) was dissolved in acetyl chloride (37 mL) and the resulting 
solution heated to 40°C for 2 h, then, using a water pump, acetic acid and any excess acetyl 
chloride were removed under reduced pressure. The viscous residue obtained was recrystallised 
from ethanol-free chloroform to yield 2-acetxoysuccinic anhydride 133 (10.686g, 91%, mp = 55- 
57 °C (lit. mp. (S) = 54-56 °C209; (R) = 56-58 “C209)): 8H 5.47 (1H, dd, J 9.6, 6.4, 2-H), 3.32 (1H, 
dd, J 18.9 and 9.6, 3-H.), 2.97 (1H, dd, J 18.9 and 6.4, 3-Hb), 2.13 (3H, s, Me). All data obtained 
matched that previously reported in the literature.
{RSyRS)- and (/LS’^ S/?)-3,4-Dihydroxydec-5-ynoic acid (135a)
UMtOAc 
O
H0 2C
133
w-BuLi (2.5 mL of a 2.5M solution in hexanes, 6.32 mmol, 1 eq) was added dropwise to a 
solution of 1-hexyne (0.72 mL, 6.32 mmol, 1 eq) in THF (10 mL) and maintained at -78°C. 
The solution was stirred for 0.5 h before being transferred dropwise to a second flask containing a 
stirred solution of 2-acetoxysuccinic anhydride 133 (1.00 g, 6.32 mmol, 1 eq) in THF (10 mL), 
which was also maintained at -78 °C. After stirring for 0.5 h, sodium borohydride (0.25 g) in 
ethanol (5 mL) was added to the solution which was then stirred for a further 0.25 h. Aqueous 
1M sodium hydroxide (6 mL) was added and the solution warmed to 0 °C. After stirring for 1 h, 
sufficient 2M hydrochloric acid was added carefully to acidify the solution to pH 4. The product
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was extracted with ethyl acetate (3 x 25 mL) and the combined organic layers washed with water 
(50 mL) and brine (50 mL) then dried, filtered and evaporated to yield a yellow wax, the diol 
135a (0.73g, 58%), which was of suitable quality for all proceeding transformations and 
contained a mixture of two diastereomers in a 51:49 ratio. Recrystallisation of a small portion 
(0.1 g) from methanol yielded pure diol 135a as a colourless solid (0.09g): Rf 0.10 (40 : 60 ethyl 
acetate -  petroleum ether); Umax/cm*1 (nujol) 3422, 2962, 2930, 2864, 2234, 1710, 1460, 1420, 
1398, 1318, 1266, 1156, 1062, 1020, 972, 932, 736, 700; 5H 5.06 (0.49H, dt, J 4.0 and 2.0, 4-H), 
4.95 (0.51H, dt, J 3.4 and 1.8, 4-H), 4.48 (0.51H, ddd, J 5.7, 3.4 and 1.7, 3-H), 4.41 (0.49H, ddd, 
J 5.3, 4.0 and 2.2, 3-H), 2.86 (0.51H, dd, J 17.8 and 5.7, 2-Ha), 2.66 (0.49H, dd, J 17.7 and 5.3, 2- 
Ha), 2.58 (0.49H, dd, J 17.7 and 2.2, 2-Hb), 2.45 (0.51H, dd, J 17.8 and 1.7, 2-Hb), 2.25 (0.98H, 
dt, J 7.1 and 2.0, 7-CH2), 2.15 (1.02H, dt, J 7.0 and 1.8, 7-CH2), 1.55-1.25 (4H, m, 8- and 9-CH2), 
0.89-0.81 (3H, m, 10-Me); 8C major 176.6 (C), 90.7 (5-C), 77.5 (4-CH), 73.9 (6-C), 73.5 (3-CH), 
36.9 (2-CH2), 30.2 (7-CH2), 21.9 (8-CH2), 18.4 (9-CH2), 13.6 (10-Me); 5C minor 174.6 (C) 93.7 
(5-C), 75.3 (4-CH), 71.1 (6-C), 68.5 (3-CH), 37.2 (2-CH2), 30.5 (7-CH2), 22.0 (8-CH2), 18.4 (9- 
CH2), 13.6 (10-Me); m/z (El) 182 ([M] - H20 ) <1%, 111 (100) [Found ([M]-H20), 182.0948. 
C,oH,4 0 3 requires M-H20 , 182.0943].
2-(5-Butylfuran-2-yl)acetic acid (136a)
r v - B u  
ho2c^ A 0
136a
Using the general procedure (4 h), 10% AgN03.Si02 (0.2lg, 0.125 mmol) was stirred with a 
solution of diol 135a (0.05g, 0.25 mmol) in dichloromethane to yield the furan 136a as an orange 
oil (0.044g, 96%): iw /c m '1 (film) 3422, 2960, 2873, 1716, 1566, 1466, 1420, 1232, 1015, 906, 
733, 650; SH 6.06 (1H, d, J 3.0, 3-H), 5.85 (1H, d, J 3 .0 ,4-H), 3.62 (2H, s, l ’-CH2), 2.52 (2H, t, J 
7.6, 1” -CH2), 1.58-1.48 (2H, m, 2” -CH2), 1.36-1.24 (2H, m, 3” -CH2), 0.85 (3H, t, J 7.3, 4” - 
Me); 8C 175.6 (C), 156.5 (C), 144.8 (C), 108.9 (3-CH), 105.5 (4-CH), 33.9 ( l ’-CH2), 30.1 (1” - 
CH2), 27.7 (2” -CH2), 22.3 (3” -CH2) and 13.8 (4” -Me); m/z (El) 182 [M] 50%, 137 (100), 
[Found [M], 182.0946. C |0H|4O3 requires M, 182.0943],
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(J?£ySK)-3,4-Dihydroxy-6-pheiiylhex-5-ynoic acid (135b)71
w-BuLi (2.5mL of a 2.5M solution in hexanes, 6.32 mmol, 1 eq) was added dropwise to a solution 
of phenylacetylene (0.7 mL, 6.32 mmol, 1 eq) in THF (10 mL) maintained at -78 °C. The 
solution was stirred for 0.5 h before being transferred dropwise to a second flask containing a 
stirred solution of 2-acetoxysuccinic anhydride 133 (1 g, 6.32 mmol, 1 eq) in THF (10 mL), 
which was also maintained at -78°C. After stirring for 0.5 h, sodium borohydride (0.25 g) in 
ethanol (5 mL) was added and stirring continued for a further 0.25 h. Aqueous 1M sodium 
hydroxide (6  mL) was added and the solution warmed to 0 °C. After stirring for 1 h, sufficient 
2M hydrochloric acid was added carefully to acidify the solution to pH 4. The product was 
extracted with ethyl acetate (3 x 25 mL) and the combined organic layers washed with water (50 
mL) and brine (50 mL) then dried, filtered and evaporated to yield the diol 135b (0.216 g) as a 
mixture of diastereomers in a 1:2 ratio. The product was recrystallised from chloroform to yield 
the diol 135b as a yellow solid (0.216g, 16%, mp =103-105 °C), which contained a single 
diastereoisomer: Rf 0.10 (0 : 60 ethyl acetate -  petroleum ether); Umax/cm'1 (nujol) 3409, 1703, 
1490, 1176, 1101, 1039; 5H (MeOD) 7.37-7.34 (2H, m, 2 x Ar-H), 7.27-7.20 (3H, m, 3 x Ar-H), 
4.41 (1H, d, J 4.9, 4-H), 4.05 (1H, ddd, J 9.0, 4.9 and 3.8, 3-H), 2.67 (1H, dd, J 15.7 and 3.8, 2- 
Ha), 2.42 (1H, dd, J 15.7 and 9.0, 2-Hb); 6C (125MHz) (MeOD) 178.1 (C), 135.2 (Ar-CH), 132.1 
(Ar-CH), 132.0 (Ar-CH), 126.7 (C), 91.3 (6 -C), 89.1 (5-C), 75.0 (4-CH), 69.0 (3-CH), 41.2 (2- 
CH2); m/z (APCI) 243 [M+Naf 100%, 221(15), [Found [M+Na]+, 243.0644. Ci2Hi20 4Na 
requires M+Na, 243.0633]. All data obtained matched that previously reported in the literature.
2-(5-Phenylfuran-2-yl)acetic acid 210 (136b)
> - P h
ho2c^ o
136b
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Using the general procedure (24 h), 10% AgN0 3.SiC>2 (0.012g, 0.007 mmol) was stirred with a 
solution of diol 135b (0.015g, 0.25 mmol), as a 2:1 mixture of diastereoisomers, in 
dichloromethane to yield the furan 136b as a colourless solid (0.013g, 93%, mp = 78-79°C): Rf 
0.35 (30 : 70 ethyl acetate -  petroleum ether); Sh (MeOD) 7.57 (2H, d, J 8.3, 2 x Ar-H), 7.31-7.25 
(2H, m, 2 x Ar-H), 7.17 (1H, tt, J 7.4 and 1.1, Ar-H), 6.53 (1H, d, J 3.3, 4-H), 6.27 (1H, d, J 3.3,
3-H), 3.74 (2H, s, l ’-CH2); Sc (125MHz) (MeOD)179.1 (C), 153.8 (C), 146.6 (C), 130.7 (C),
128.6 (2 x Ar-CH), 127.3 (Ar-CH), 123.7 (2 x Ar-CH), 110.6 (4-CH), 106.0 (3-CH), 30.9 (1’- 
CH2); m/z (APCI) 203 [M+H]+ 100%, 157(37), [Found [M+H]+, 203.0714. C12H ,,0 3 requires 
M+H, 203.0708]. All data obtained matched that previously reported in the literature.
(RSJtS)- and (RiS'^S'l?)-5-(Hex-l-ynyI)-dihydro-4-hydroxyfuran-2(3H)-one (138 and 140)
In a dry flask, diol 135a (0.1 g, 0.5 mmol, 1 eq) and ^ara-toluenesulfonic acid (few crystals) 
were dissolved in toluene (10 mL) at ambient temperature and the resulting solution warmed to 
50°C for 1.5 h. Upon cooling, pyridine (2.25 mL) was added and the mixture then washed with 
saturated copper sulfate (25 mL), water (25 mL) and brine (25 mL) then dried, filtered and 
evaporated to yield the lactones 138 and 140 (0.063g, 69%) as a colourless oil, in a ratio of 
51:49: W o n ' 1 (film) 3434, 1787, 1642, 1156; SH 5.05 (0.51H, dt, J 4.0 and 2.0, 5-H), 4.92 
(0.49H, dt, J 2.0 and 1.9, 5-H), 4.49 (0.49H, app. dt, J 5.8 and 1.9,4-H), 4.40 (0.51H, ddd, J 5.1,
4.0 and 2.4, 4-H), 2.87 (0.49H, dd, J 17.7 and 5.8, 3-Ha), 2.65 (0.51H, dd, J 17.6 and 5.1, 3-H,),
2.58 (0.51H, dd, J 17.6 and 2.4, 3-Hb), 2.42 (0.49H, dd, J 17.7 and 1.9, 3-Hb), 2.25 (1.02H, dt, J
7.1 and 2.0, l ’-CH2), 2.16 (0.98H, dt, J 7.0 and 2.0, l ’-CH2), 1.55-1.25 (4H, m, 2’- and 3’-CH2), 
0.86 (1.53H, t, J 7.4, 4’-Me), 0.84 (1.47H, t, J 7.4, 4’-Me); 5, major and minor 174.9 (C), 90.7 
( l ’-C), 80.0 (2’-C), 77.3 (5-CH), 73.6 (4-CH), 36.9 (3-CH2), 30.2 (3’-CH2), 21.9 (4’-CH2), 18.4 
(5’-CH2) and 13.6 (6 -Me).
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Using the general procedure (24 h), 10% AgNC>3.Si0 2 (0.233g, 0.137 mmol) was stirred with a 
solution of lactones 138 and 140 (0.05g, 0.274 mmol) in dichloromethane to yield a 1:1 mixture 
offuran 136a and uncyclised (RS,SR) isomer 140, as an orange oil (0.042g, ca. 84%): The data 
obtained was identical to the respective preparations detailed above.
Dodec-7-yn-5-oI (152)
152
H-BuLi (4.43 mL, 11.1 mmol of a 2.5M solution in hexanes) was added dropwise to a solution of 
1-hexyne (1.27 mL, 11.1 mmol) dissolved in THF (10 mL) maintained at -78 °C. After stirring 
for 15 mins, boron trifluoride-THF complex (1.28 mL, 11.6 mmol) was added slowly and the 
solution stirred for a further 15 mins. The solution was then transferred dropwise to a second 
flask containing 1,2-epoxyhexane (1 mL, 8.31 mmol) dissolved in THF (10 mL), which was also 
maintained at -78°C. After 3 h at this temperature, saturated aqueous ammonium chloride (20 
mL) was added and the resulting mixture allowed to warm to ambient temperature. The product 
was extracted into ethyl acetate (3 x 50 mL) and the combined organic layers washed with water 
(75 mL) and brine (75 mL), then dried, filtered and evaporated to give the p-hydroxy-alkyne 152 
(1.458g, 97%), as a pale yellow oil: SH 3.62 (1H, ddt, J 12.7, 6 .8  and 4.5, 5-H), 2.34 (1H, ddt, J
16.5, 4.5 and 2.4, 6 -Ha), 2.20 (1H, ddt, J 16.5, 6 .8  and 2.4, 6 -Hb), 2.11 (2H, tt, J 6.9 and 2.4, 9- 
CH2), 1.50-1.20 (10H, m, 2-, 3-, 4-, 10- and 11-CH2), 0.87-0.81 (6 H, m, 1- and 12-Me); m/z (El) 
164 ([M] - H20 ) 100%. All data obtained matched that previously reported in the literature.
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f ^  
OH
x
152 153
Using the general procedure (3 h), 10% AgN0 3 .SiC>2 (0.466g, 0.27 mmol) was stirred with a 
solution of the p-hydroxy alkyne 152 (O.lg, 0.55 mmol) in dichloromethane. Unreacted /?- 
hydroxy alkyne 152 (0.097g, 97%) was recovered as a pale yellow oil.
/er/-Butyl(but-3-ynyloxy)dimethylsilane (159)
/-Butyldimethylsilyl chloride (3.98g, 26 mmol), imidazole (3.60g, 53 mmol) and DMAP (0.161g,
1.3 mmol) were added to a solution of 3-butyn-l-ol (1 mL, 13 mmol) in dry dichloromethane (20 
mL). The resulting solution was then stirred at ambient temperature overnight before being 
transferred to a separating funnel containing saturated aqueous sodium hydrogen carbonate (2 0  
mL) and petroleum ether (20 mL). The mixture was shaken and separated and the aqueous layer 
extracted with petroleum ether (2 x 20 mL). The combined organic extracts were washed with 
water (50 mL) and brine (50 mL), then dried, filtered and evaporated to yield O-TBDMS-3-butyn-
[M] 87%, 69 (100). All data obtained matched that previously reported in the literature.
TBDMSO
159
l-ol 159 (2.39g, 98%), as a colourless oil: 6H 3.67 (2H, t, J 7.2, 1-CH2), 2.33 (2H, dt, J 7.2 and
2.8, 2-CH2), 1.89 (1H, t, J 2.8, 4-H), 0.82 (9H, s, /-Bu Me), 0.00 (6 H, s, Si-Me); 6C 81.5 (3-C),
69.3 (1-CH2), 61.7 (4-CH), 25.9 (/-Bu Me), 22.9 (2-CH2), 18.4 (C), -5.1 (Si-Me); m/z (El) 184
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/e/t-Butyl(5-hydroxynon-3-ynyloxy)dimethylsilane (160)211
TBDMSO TBDMSO
«-BuLi (2.17 mL, 5.42 mmol of a 2.5M solution in hexanes) was added dropwise to a solution of
O-TBDMS-3-butyn-1 -ol 159 (lg, 5.42 mmol) in THF (10 mL) maintained at -78 °C. The 
solution was stirred for 0.5 h before being transferred dropwise to a second flask containing 
pentanal (0.58 mL, 5.42 mmol) dissolved in THF (10 mL), which was also maintained at -78°C. 
After overnight stirring, with slow warming to ambient temperature, the mixture was quenched 
with the addition of aqueous KH2PO4 pH 7 buffer (10 mL). The product was extracted with 
diethyl ether (3 x 25 mL) and the combined organic layers washed with water (50 mL) then brine 
(50 mL). The ether layer was then dried, filtered and evaporated to give propargylic alcohol 160 
(1.17g, 80%), as a pale yellow oil: SH 4.27 (1H, tt, J 6.4 and 1.9, 5-H), 3.64 (2 H, t, J 7.3, 1-CH2),
2.36 (2H, dt, J 7.3 and 1.9, 2-CH2), 1.67-1.52 (2H, m, 6 -CH2), 1.40-1.20 (4H, m, 7- and 8 -CH2), 
0.84 (3H, t, J 7.2, 9-Me), 0.82 (9H, s, /-Bu Me), 0.00 (6 H, s, Si Me); 6C 82.5 (3-C), 69.3 (4-C),
62.6 (5-CH), 61.9 (1-CH2), 37.8 (2-CH2), 27.4 (6-CH2), 25.9 (/-Bu Me), 23.1 (7-CH2), 22.4 (8- 
CH2), 18.3 (C), 14.0 (9-Me), -5.3 (Si-Me). All data obtained matched that previously reported in 
the literature.
Non-3-yne-l,5-dioI (161)
TBDMSO
Tetrabutylammonium fluoride (4.07 mL of a 1M solution in THF, 4.07 mmol) was added to a 
solution of propargylic alcohol 160 (0.25g, 0.924 mmol) in tetrahydrofuran (10 mL) and the 
resulting solution stirred overnight at ambient temperature. The mixture was diluted with water 
(25 mL) then extracted with diethyl ether (3 x 25 mL). The combined organic layers were 
washed with water (150 mL) and brine (150mL) then dried, filtered and evaporated to give the
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diol 161 as a colourless oil (0.126g, 8 8%): Sh 4.27 (1H, dt, J 6 .6  and 1.8, 5-H), 3.63 (2H, t, J 6.2,
1-CH2), 2.40 (2H, dd, J 6.2 and 1.8, 2-CH2), 1.65-1.52 (2H, m, 6 -CH2), 1.37-1.13 (4H, m, 7- and 
8 -CH2), 0.82 (3H, t, J 7.2, 9-Me). All data obtained matched that previously reported in the 
literature.
l-(4,5-Dihydrofuran-2-yl)pentan-l-ol (162)76
rV <------------------►  ► DECOMPOSITION
161 162
In a foil wrapped NMR tube, 10% w/w AgNC>3 on silica gel (0.033g, 0.019 mmol) was added to a 
solution of diol 161 (0.015g, 0.096 mmol) in deuteriochloroform (1 mL), and the resulting 
suspension monitored over a period of 24 h with occasional shaking. The solution was analysed 
by !H NMR spectroscopy periodically to show the formation of dihydrofuran 162 (33%) in the 
presence of diol 161, followed by decomposition. The dihydrofuran 162 was identified by Sh 
dihydrofuran 4.74 (1H, t, J 2.5, 3-H), 4.10-4.04 (1H, m, l ’-H), 3.61-3.54 (2H, m, 5-CHaHb), 2.57 
(1H, ddd, J 12.0, 9.3, and 1.2, 4-Ha), 2.55 (1H, ddd, J 12.0, 9.5 and 1.0, 4-Hb), 1.64-1.55 (2H, m, 
2’-CH2), 1.35-1.20 (4H, m, 3’- and 4’-CH2), 0.88 (3H, t, J 7.4, 5’-Me).
Amino alcohol protection
Triethylamine (6  - 88  mmol, 1.1 eq) was added slowly to a solution of an amino-alcohol (5 - 80 
mmol, 1 eq) dissolved in dichloromethane (10 mL g 1) at 0 °C. After stirring for 0.5 h, DMAP 
(few crystals) and the desired protecting group precursor (6  - 88  mmol, 1.1 eq) were added and 
the solution left to stir overnight at ambient temperature. The resultant mixture was neutralized 
with aqueous 2M hydrochloric acid and the product extracted into dichloromethane (3 x 25 mL g'
l). The combined organic layers were washed with water (1 x 50 mL g '1) and brine (1 x 50 mL g' 
') then dried, filtered and evaporated, with any excess protecting group being removed through 
column chromatography when necessary, to give the protected amino alcohol.
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Protected amino-alcohol oxidation
A protected amino-alcohol ( 2 - 5  mmol, 1 eq) was dissolved in dichloromethane (10 mL g'1) 
containing 4 A molecular sieves (0.1 g ml*1). Upon cooling to 0 °C, sodium acetate (0.6 -  1.4 
mmol, 0.3 eq) and PCC (3 -  7.2 mmol, 1.5 eq) were added and the resulting mixture left to stir at 
ambient temperature overnight. The metal content was then removed by filtration through silica 
gel, using dichloromethane (100-250 mL) to wash through the organic product, and the filtrate 
was then evaporated to yield the protected-a-aminocarbonyl.
Alkyne addition onto a 4-nosvl or tosvl protected-a-aminocarbonvl
w-BuLi (1 -3 .6  mmol of a 2.5M solution in hexanes, 2.2 eq) was added dropwise to a solution of 
a 1-alkyne (1 -  3.6 mmol, 2.2eq) in THF (10 mL g'1) maintained at -78 °C. The solution was 
stirred for 0.5 h before being transferred dropwise to a second flask containing a protected-a- 
aminocarbonyl (0.4 -  1.6 mmol, 1 eq) dissolved in THF (10 mL g '1), which was also maintained 
at -78 °C for the first 3 h. After overnight stirring at ambient temperature, the mixture was 
quenched with the dropwise addition of aqueous 0.1M KH2PO4 pH 7 buffer, and any emulsion 
broken up by the addition of 2M hydrochloric acid. The product was extracted with diethyl ether 
(3 x 25 mL g*1) and the combined organic layers washed with water (1 x 50 mL g 1) then brine (1 
x 50 mL g'1). The ether layer was then dried, filtered and evaporated to yield 3-alkyne-2- 
hydroxy-1-sulfonamide. Any excess 1-alkyne, and other impurities, were removed through 
column chromatography when necessary.
Alkvne addition onto a Moc or Boc protected-a-aminocarbonvl
w-BuLi (1.9 -  5.3 mmol of a 2.5M solution in hexanes, 2.2eq) was added dropwise to a solution 
of 1-alkyne (1.9 -  5.3 mmol, 2.2eq) in THF (10 mL g '1) maintained at -78 °C. The solution was 
stirred for 0.5 h before being transferred dropwise to a second flask containing protected-a- 
aminocarbonyl (0.8 -  2.4 mmol, leq) in THF (10 mL g 1), which was also maintained at -78 °C. 
After stirring for 3 h the mixture was quenched by the dropwise addition of concentrated 
hydrochloric acid at -78 °C (2 mL g 1). After 10 mins stirring, the resulting solution was allowed
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to warm to ambient temperature and the product then extracted into diethyl ether (3 x 25 mL g'1). 
The combined organic layers were washed with water (1 x 50 mL g 1) and brine (1 x 50 mL g'1) 
then dried, filtered and evaporated to yield 3-alkyne-2-hydroxy-l -amide. Any excess 1-alkyne, 
and other impurities, were removed through column chromatography where necessary.
Cyclisation 17
In a, foil-wrapped flask 10% w/w silver nitrate on silica (0.003 -  0.05 mmol, 0.1 eq) was added 
to a stirred solution of a 3-alkyne-2-hydroxy-l-amide or sulfonamide (0.03 -  0.5 mmol, 1 eq) in 
dichloromethane (10 mL g'1) with stirring. The resulting suspension was stirred for 3-48 h then 
filtered through celite and the solvent evaporated to yield a pyrrole.
(1 j?,2S)-l -Pheny l-2-(tosy lamino)propan-l -ol (236a)212
Ph^O H  
^ nh2
Using the general procedure, tosyl chloride (16.8 g, 88 mmol) was added to (l/?,25)-norephedrine 
hydrochloride (15 g, 80 mmol) to give the tosyUamino alcohol 236a as a colourless solid 
(19.645g, 80%, mp = 93-95°C (lit. mp = 93-95°C212): tw /c m '1 (KBr) 3504, 3257, 1591, 1457, 
1324, 1160; 8h 7.77 (2H, d, J 8.3, 2 x Ar-H), 7.33-7.29 (7H, m, 7 x Ar-H), 5.16 (1H, d, J 8.8, 1- 
H), 4.79 (1H, d, J 3.4, NH), 3.58-3.52 (1H, m, 2-H), 2.86 (1H, bs, OH), 2.41 (3H, s, Ts-Me), 0.82 
(3H, d, J 6.8, 3-Me); 8C 143.6 (C), 140.0 (C), 137.7 (C), 129.8 (2 x Ar-CH), 128.4 (2 x Ar-CH),
127.8 (Ar-CH), 127.0 (2 x Ar-CH), 126.1 (2 x Ar-CH), 75.7 (1-CH), 54.8 (2-CH), 21.6 (Ts-Me),
15.0 (3-Me); m/z (ES) 328 [M+Naf 34%, 288 (100), 155 (90), 133 (50), [Found [M+Na]+, 
328.0968. Ci6Hi9NNa0 3 S requires M+Na, 328.0963]. All data obtained matched that previously 
reported in the literature.
Ph^O H
^ N H T s
236a
2 0 0
(S)-l-Phenyl-2-(tosylamino)propan-l-one 213 (237a)
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Ph^O H
^ N H T s  
236a
Using the general procedure, PCC (0.611 g, 3 mmol) and sodium acetate (0.05 g, 0.6 mmol) were 
added to tosyl-amino alcohol 236a (0.647 g, 2 mmol) to yield the N-tosyl-a-aminoketone 237a as 
a colourless solid (0.547g, 85%, mp = 103-104°C (lit. mp = 100-101°C213)): Rf 0.76 (30 : 70 ethyl 
acetate -  petroleum ether); Umax/cm'1 (DCM) 3315, 3054, 2986, 1687, 1598, 1343, 1165, 1093, 
970, 896, 815, 704; 8H 7.70 (2H, d, J 7.2, 2 x Ar-H), 7.63 (2H, d, J 8.2, 2 x Ar-H), 7.53 (1H, m, 
Ar-H), 7.38 (2H, m, 2 x Ar-H), 7.09 (2H, Ar-H, J 8.2, 2 x Ar-H), 5.71 (1H, d, J 7.9, NH), 4.84 
(1H, dq, J 7.9 and 7.2, 2-H), 2.27 (3H, s, Ts-Me), 1.32 (3H, d, J 7.2, 3-Me); 8C 198.1 (C), 148.7 
(C), 143.5 (C), 137.0 (C), 134.1 (Ar-CH), 129.7 (2 x Ar-CH), 128.9 (2 x Ar-CH), 128.5 (2 x Ar- 
CH), 127.1 (2 x Ar-CH), 53.4 (2-CH), 21.5 (Ts-Me), 21.2 (3-Me); m/z (APCI) 304 [M+H]+ 48%, 
155 (100), 148 (100). All data obtained matched that previously reported in the literature.
(25,3‘S)-3-Phenyl-2-(tosylamino)non-4-yn-3-ol (238a)
NHTs NHTs
237a 238a
Using the general procedure (4 h), 1-hexyne (0.42 mL, 3.63 mmol) was added to the A-tosyl-a- 
aminoketone 237a (0.5 g, 1.65 mmol) to give the 3-alkyne-2-hydroxy-l-sulfonamide 238a as a 
beige solid (0.635 g, 82%, mp = 79-80 °C) and as a single isomer: R f 0.52 (30 : 70 ethyl acetate -  
petroleum ether); tw /cm "1 (DCM) 3482, 3280, 2957, 1707, 1599, 1448, 1331, 1161, 1092, 668; 
5h 7.45 (2H, d, J 8.2,2 x Ar-H), 7.39 (2H, dd, J 7.1 and 2.4,2 x Ar-H), 7.15-7.11 (3H, m, 3 x Ar- 
H), 7.05 (2H, d, J 8.2, 2 x Ar-H), 4.63 (1H, d, J 9.0, NH), 4.50 (1H, dq, J 9.0 and 6.6, 2-H), 2.99 
(1H, bs, OH), 2.27 (3H, s, Ts-Me), 2.12 (2H, t, J 7.1, 6-CH2), 1.40 (2H, m, 7-CH2), 1.30 (2H, m, 
8-CH2), 1.01 (3H, d, J 6.6, 1-Me), 0.79 (3H, t, J 7.2, 9-Me); 5C (125MHz) 143.0 (C), 141.5 (C),
137.7 (C), 129.5 (2 x Ar-CH), 127.9 (2 x Ar-CH), 127.9 (Ar-CH), 127.0 (2 x Ar-CH), 126.5 (2 x
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Ar-CH), 88.6 (4-C), 80.3 (5-C), 75.2 (3-C), 58.8 (2-CH), 30.6 (6-CH2), 22.1 (7-CH2), 21.5 (Ts- 
Me), 18.4 (8-CH2), 17.3 (1-Me), 13.6 (9-Me); m/z (ES) 408 [M+Na]+ 55%, 368 (100), 213 (92), 
155(42).
5-ButyI-2-methyl-3-phenyI-l-tosyl-lH-pyrrole (239a)
NHTs
238a 239a
Using the general procedure (6 h), 10% AgNC>3.Si02 (0.041 g, 0.024 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238a (0.093 g, 0.241 mmol) in dichloromethane to 
yield pyrrole 239a as a yellow oil (0.084g, 94%): Rf 0.70 (30 : 70 ethyl acetate -  petroleum 
ether); tw /c m '1 (film) 2957,2929,2871, 1597, 1541, 1495, 1442, 1362, 1253, 1194, 1171, 1096, 
1032, 812, 764, 703; SH 7.51 (2H, d, J 8.3, 2 x Ar-H), 7.27 (2H, d, J 7.6, 2 x Ar-H), 7.2 (2H, d, J
8.3, 2 x Ar-H), 7.20-7.16 (3H, m, 3 x Ar-H), 6.01 (1H, s, 4-H), 2.78 (2H, t, J 7.7, l ’-CH2), 2.33 
(3H, s, Ts-Me), 2.31 (3H, s, 2-Me), 1.58 (2H, m, 2’-CH2), 1.33 (2H, m, 3’-CH2), 0.85 (3H, t, J
7.3, 4’-Me); 6C (125MHz) 144.4 (C), 137.6 (C), 137.2 (C), 135.4 (C), 130.0 (2 x Ar-CH), 128.7 
(2 x Ar-CH), 128.6 (2 x Ar-CH), 127.7 (C), 126.5 (Ar-CH), 126.1 (2 x Ar-CH), 126.0 (C), 112.4 
(4-C), 31.3 ( l ’-CH2), 28.7 (2’-CH2), 22.6 (3’-CH2), 21.6 (Ts-Me), 14.0 (2-Me), 13.6 (4’-Me); m/z 
(ES) 368 [M+H]+ 100%, [Found [M+Hf, 368.1697. C22H2«N02S requires M+H, 368.1684],
(2Ar3‘5)-13-Diphenyl-4-(tosylamino)pent-l-yn-3-ol (238b)
OhU£
NHTs NHTs
237a 238b
Using the general procedure (4 h), phenylacetylene (0.4 mL, 3.63 mmol) was added to the N- 
tosyl a-aminoketone 237a (0.5 g, 1.65 mmol) to give the 3-alkyne-2-hydroxy-l-sulfonamide 238b 
as a yellow solid (0.533g, 80%, mp = 138-140 °C) and as a single isomer: Rf 0.42 (30 : 70 ethyl
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acetate -  petroleum ether); Umax/cm'1 (DCM) 3410, 1598, 1325, 1150, 756, 665; 8h 7.55 (2H, d, J 
8.2, 2 x Ar-H), 7.54 (2H, d, J 7.8, 2 x Ar-H), 7.39 (2H, d, J 7.8, 2 x Ar-H), 7.34-7.24 (6H, m, 6 x 
Ar-H), 7.08 (2H, d, J 8.2, 2 x Ar-H), 4.52 (1H, d, J 9.3, NH), 3.69 (1H, dq, J 9.3 and 6.6, 4-H), 
2.88 (1H, bs, OH), 2.28 (3H, s, Ts-Me), 1.05 (3H, d, J 6.6, 5-Me); 5C (125MHz) 143.2 (C), 140.8 
(C), 137.6 (C), 131.9 (2 x Ar-CH), 129.6 (2 x Ar-CH), 128.9 (Ar-CH), 128.4 (2 x Ar-CH), 128.2 
(Ar-CH), 128.2 (2 x Ar-CH), 127.0 (2 x Ar-CH), 126.4 (2 x Ar-CH), 121.0 (C), 89.3 (1-C), 87.3 
(2-C), 75.7 (3-C), 58.8 (4-CH), 21.5 (Ts-Me), 17.3 (5-Me); m/z (ES) 428 [M+Na]+ 48%, 388 
(100), 233 (100), 155(19).
2-Methyl-3,5-diphenyI-l-tosyl-lH-pyrrole (239b)
Ts 
239b
Using the general procedure (3 h), 10% AgN0 3 .Si0 2  (0.054 g, 0.032 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238b (0.13 g, 0.321 mmol) in |dichloromethane to 
yield pyrrole 239b as a pale yellow-orange wax (0.120g, 97%): R f 0.60 (30 : 70 ethyl acetate -  
petroleum ether); Umax/cm*1 (film) 3062, 2965, 2927, 1643, 1598, 1537, 1495, 1443, 1365, 1306, 
1240, 1190, 1176, 1145, 1094, 1028,910,812, 734; 5h 7.35-7.15 (12H, m, 12 x Ar-H), 7.10 (2H, 
d, J 8.2, 2 x Ar-H), 6.20 (1H, s, 4-H), 2.51 (3H, s, 5-Me), 2.27 (3H, s, Ts-Me); 6C (125MHz)
144.7 (C), 137.4 (C), 136.3 (C), 134.9 (C), 133.1 (C), 130.5 (2 x Ar-CH), 129.7 (C), 129.5 (2 x 
Ar-CH), 128.8 (2 x Ar-CH), 128.4 (2 x Ar-CH), 128.0 (Ar-CH), 127.9 (C), 127.3 (2 x Ar-CH),
126.8 (Ar-CH), 126.6 (2 x Ar-CH), 117.1 (4-CH), 21.6 (Ts-Me), 14.2 (2-Me).
(2535)-l-(Trimethylsilyl)-3-phenyl-4-(tosylamino)pent-l-yn-3-ol (238c)
* Y °
^ N H T s
237a 238c 238d
NHTs NHTs
OH^
NHTs
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Using the general procedure (24 h), TMS-acetylene (0.5 mL, 3.63 mmol) was added to tosyl a- 
aminoketone 237a (0.5 g, 1.65 mmol) to yield a brown oil (0.357 g), containing a mixture of both 
silylated 238c and desilylated 238d alkynes. The two products were separated by column 
chromatography (10:90 and 20:80 ethyl acetate -  petroleum ether) to yield the silylated- 
sulfonamide 238c as a colourless solid (0.142 g, 22%, mp = 140-142 °C): Rf 0.30 (30 : 70 ethyl 
acetate -  petroleum ether): Umax/cm'1 (DCM) 3475, 3276, 2960, 2254, 2168, 1599, 1332, 1250, 
1163, 1092, 910, 846, 734; 6H 7.34 (2H, d, J 8.2, 2 x Ar-H), 7.29-7.25 (2H, m, 2 x Ar-H), 7.06-
7.01 (3H, m, 3 x Ar-H), 6.96 (2H, d, J 8.2, 2 x Ar-H), 4.35 (1H, d, J 9.2, NH), 3.41 (1H, dq, J 9.0 
and 6.6, 4-H), 2.91 (1H, bs, OH), 2.19 (3H, s, Ts-Me), 0.89 (3H, d, J 6.6, 5-Me), 0.0 (9H, s, 
SiMe3); 8C (125MHz) 143.2 (C), 140.4 (C), 137.5 (C), 129.6 (2 x Ar-CH), 128.1 (Ar-CH), 128.0 
(2 x Ar-CH), 127.0 (2 x Ar-CH), 126.6 (2 x Ar-CH), 105.2 (2-C), 92.8 (1-C), 75.5 (3-C), 58.5 (4- 
CH), 21.5 (Ts-Me), 17.3 (5-Me); m/z (ES) 440 [M+K]+ 30%, 424 (41), 384 (100), 229 (26), 
[Found [M+Kf, 440.1111. C2iH27KN03SiS requires M+K, 440.1118].
2-MethyI-3-phenyl-l-tosyl-lH-pyrrole (239c)
NHTs
238c 239c
Using the general procedure (24 h), 10% AgN03.Si02 (0.011 g, 0.007 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238c (0.027 g, 0.067 mmol) in dichloromethane to 
yield the pyrrole 239c as a pale yellow oil (0.020g, 95%): R f 0.56 (30 : 70 ethyl acetate -  
petroleum ether); Umax/cm'1 (film) 3148, 3059, 2925, 1597, 1501, 1443, 1365, 1270, 1175, 1121, 
1090, 1027, 814, 768, 703, 687; 8H; 7.65 (2H, d, J 8.3, 2 x Ar-H), 7.35-7.10 (8H, m, 8 x Ar-H),
6.30 (1H, d, J 3.5, 4-H), 2.35 (3H, s, Ts-Me), 2.30 (3H, s, 2-Me); 5C (125MHz) 144.9 (C), 136.3 
(C), 135.1 (C), 130.1 (2 x Ar-CH), 128.5 (2 x Ar-CH), 128.4 (2 x Ar-CH), 127.4 (C), 127.1 (2 x 
Ar-CH), 126.6 (Ar-CH), 126.2 (C), 121.4 (5-CH), 112.5 (4-CH), 21.7 (Ts-Me), 11.9 (2-Me); m/z 
(ES) 312 [M+H]+ 93%, 155 (100).
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O H ^
NHTs
TMS O H ^ H
NHTs
Ph Ph
+
NHTs
237a 238c 238d
Using the general procedure (24 h), TMS-acetylene (0.5 mL, 3.63 mmol) was added to the N- 
tosyl a-aminoketone 237a (0.5 g, 1.65 mmol) to yield a crude brown oil (0.357 g), containing a 
mixture of both silylated 238c and desilylated 238d alkynes. The two products were separated by 
column chromatography to yield the desilylated-sulfonamide 238d as a yellow oil (0.099g, 18%): 
R f 0.27 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3453, 3276, 2254, 2113, 1598, 
1325, 1158, 1091, 910, 733; 5H 7.36 (2H, d, J 8.2, 2 x Ar-H), 7.31-7.27 (2H, m, 2 x Ar-H), 7.08-
7.02 (3H, m, 3 x Ar-H), 6.99 (2H, d, J 8.2,2 x Ar-H), 4.60 (1H, bs, NH), 3.48 (1H, app. quintet, J
6.8, 4-H), 3.15 (1H, bs, OH), 2.48 (1H, s, 1-H), 2.17 (3H, s, Ts-Me), 0.83 (3H, d, J 6.8, 5-Me); 5C 
(125MHz) 143.2 (C), 140.3 (C), 137.6 (C), 129.6 (2 x Ar-CH), 128.2 (Ar-CH), 128.1 (2 x Ar- 
CH), 127.1 (2 x Ar-CH), 126.3 (2 x Ar-CH), 84.2 (1-CH), 75.5 (2-C), 75.0 (3-C), 58.7 (4-CH),
21.6 (Ts-Me), 17.0 (5-Me); m/z (ES) 352 [M+Na]+ 63%, 312 (100).
2-Methyl-3-phenyl-l-tosyl-lH-pyrrole (239d)
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.013 g, 0.008 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238d (0.025 g, 0.076 mmol) in dichloromethane 
to yield pyrrole 239d as a pale yellow oil (0.024g, 100%): 5h 7.65 (2H, d, J 8.3, 2 x Ar-H), 7.35-
O H ^
NHTs
238d 239d
7.10 (8H, m, 8 x Ar-H), 6.30 (1H, d, J 3.5, 4-H), 2.35 (3H, s, Ts-Me), 2.30 (3H, s, 2-Me), all 
other data was in agreement with the previously prepared compound.
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(l/f,2iS)-l-Phenyl-2-(4-nosylamino)propan-l-ol214 (236b)
Ph^OH Ph^OH
^ N H 2 ^ N H N s
236b
Using the general procedure, 4-nosyl chloride (1.3 g, 5.86 mmol) was added to (\R,2S)- 
norephedrine hydrochloride (1 g, 5.33 mmol) to yield the N-nosyI amino-alcohol 236b as a 
yellow solid (1.563g, 87%, mp = 147-148°C): R f 0.18 (30 : 70 ethyl acetate -  petroleum ether); 
Umax/cm'1 (DCM) 3512, 3243, 3105, 1606, 1529, 1445, 1290, 1222, 1159, 1085, 1066, 907, 854, 
736; 8h 8.26 (2H, d, J 8.8, 2 x Ar-H), 7.97 (2H, d, J 8.8, 2 x Ar-H), 7.30-7.15 (5H, m, 5 x Ar-H),
5.11 (1H, bs, NH), 4.72 (1H, d, J 3.5, 1-H), 3.61 (1H, bs, 2-H), 2.43 (1H, bs, OH), 0.87 (3H, d, J
6.8, 3-Me); 5C 147.0 (C), 139.9 (C), 131.9 (C), 128.6 (2 x Ar-CH), 128.2 (3 x Ar-CH), 126.0 (2 x 
Ar-CH), 124.4 (2 x Ar-CH), 76.1 (1-CH), 55.3 (2-CH), 15.4 (3-Me); m/z (APCI) 319 ([M+H]+ - 
H20 ) 32%, 186 (12), 133 (100).
(S)-l-Phenyl-2-(4-nosylamino)propan-l-one (237b)
Ph^O H  P h ^ O
^ tJHNs '^SlH N s
236b 237b
Using the general procedure, PCC (1.3 g, 6.04 mmol) and sodium acetate (0.1 g, 1.21 mmol) 
were added to A-nosyl amino-alcohol 236b (1.5 g, 4.46 mmol) to yield the N-nosyl-a- 
aminoketone 237b as a yellow solid (0.406g, 27%, mp = 154-155°C): Rf 0.70 (30 : 70 ethyl 
acetate -  petroleum ether); tw /c m '1 (DCM) 3289, 3107, 1694, 1608, 1526, 1454, 1351, 1318, 
1267, 1227, 1163,10%, %3, 861,739,703; 8H 8.17 (2H, d, J 8.8,2 x Ar-H), 7.93 (2H, d, J 8.8,2 
x Ar-H), 7.70 (2H, d, J 7.1, 2 x Ar-H), 7.55 (1H, t, J 7.4, Ar-H), 7.41-7.37 (2H, t, m, 2 x Ar-H), 
5.87 (1H, d, J 8.0, NH), 4.95 (1H, dq, J 8.0 and 7.2, 2-H), 1.39 (3H, d, J 7.2, 3-Me); Sc (125MHz)
197.2 (C), 146.0 (C), 140.3 (C), 134.6 (Ar-CH), 133.0 (C), 129.1 (2 x Ar-CH), 128.5 (2 x Ar- 
CH), 128.3 (2 x Ar-CH), 124.4 (2 x Ar-CH), 53.7 (2-CH), 21.2 (3-Me); m/z (ES) 335 [M+H]+ 
29%, 186(27), 149(100).
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NHNsNHNs
237b 238e
Using the general procedure (3 h), 1-hexyne (0.17 mL, 1.48 mmol) was added to the TV-nosyl-a- 
aminoketone 237b (0.25 g, 0.674 mmol) to give the 3-alkyne-2-hydroxy-l-sulfonamide 238e as a 
yellow solid (0.258g, 83%, mp = 144-145 °C) and as a single isomer: Rf 0.41 (30 : 70 ethyl 
acetate -  petroleum ether); Umax/cm'1 (DCM) 3492, 3318, 2931, 2361, 1524, 1443, 1338, 1265, 
1165, 1089, 1022, 855, 737; 5H 8.06 (2H, d, J 8.9, 2 x Ar-H), 7.64 (2H, d, J 8.9, 2 x Ar-H), 7.33-
7.31 (2H, m, 2 x Ar-H), 7.15-7.05 (3H, m, 3 x Ar-H), 4.58 (1H, d, J 9.5, NH), 3.60 (1H, dq, J 9.5 
and 6.4, 2-H), 2.20 (2H, t, J 7.2, 6-CH2), 1.49 (2H, m, 7- CH2), 1.35 (2H, m, 8-CH2), 1.27 (3H, d, 
J 6.4, 1-Me), 0.87 (3H, t, J 7.3, 9-Me); Sc (125MHz) 149.6 (C), 146.3 (C), 141.7 (C), 128.3 (Ar- 
CH), 128.2 (2 x Ar-CH), 128.0 (2 x Ar-CH), 126.2 (2 x Ar-CH), 124.0 (2 x Ar-CH), 89.9 (4-C),
79.2 (5-C), 75.3 (3-C), 59.3 (2-CH), 30.6 (6-CH2), 22.1 (7-CH2), 18.4 (8-CH2), 18.2 (1-Me), 13.6 
(9-Me); m/z (APCI) 399 ([M+H]+ - H20) 32%, 213 (73), 197 (39), 170 (73), 135 (100).
5-Butyl-2-methyl-3-phenyl-l-(4-nosyl)-lH-pyrrole (239e)
NHNs
238e 239e
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.026 g, 0.015 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238e (0.063 g, 0.151 mmol) in dichloromethane to 
yield the pyrrole 239e as a yellow oil (0.060g, 96%): Umax/cm*1 (film) 3100, 1607, 1532, 1349, 
1169, 1095, 741, 686; SH 8.29 (2H, d, J 8.9, 2 x Ar-H); 7.76 (2H, d, J 8.9, 2 x Ar-H), 7.27 (2H, t, 
J 7.5, 2 x Ar-H), 7.25-7.10 (3H, m, 3 x Ar-H), 6.08 (1H, s, 4-H), 2.80 (2H, t, J 7.7, l ’-CH2), 2.35 
(3H, s, 2-Me), 1.60 (2H, m, 7-CH2), 1.35 (2H, m, 8-CH2), 0.87 (3H, t, J 7.4, 9-Me); Sc (125MHz)
147.3 (C), 137.5 (C), 134.7 (C), 128.8 (C), 128.7 (2 x Ar-CH), 128.5 (2 x Ar-CH), 127.9 (C),
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127.4 (2 x Ar-CH), 127.0 (Ar-CH), 124.7 (2 x Ar-CH), 124.5 (C), 113.8 (4-CH), 31.3 ( l ’-CH2), 
28.8 (2’-CH2), 22.5 (3’-CH2), 14.0 (2-Me), 13.8 (4’-Me); m/z (ES) 399 [M+H]+ 28%, 228 (37), 
184 (100), [Found [M+H]+, 399.1376. C2iH23N20 4S requires M+H, 399.1379].
(253*S)-6,6-DimethyI-3-phenyl-2-(4-nosyIamino)hept-4-yn-3-ol (238h)
p^y 0
^ N H N s 
237b
Using the general procedure (3 h), 3,3-dimethyl-1 -butyne (0.12 mL, 0.990 mmol) was added to 
the /V-nosyl-a-aminoketone 237b (0.15 g, 0.450 mmol) to give the 3-alkyne-2-hydroxy-1 - 
sulfonamide 238h as a yellow solid (0.122g, 65%, mp = 151-153°C) and as a single isomer: Rf 
0.48 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (DCM) 3496, 3335, 2961, 2226, 1523, 
1416, 1338, 1164, 1042, 854, 736, 685; 8H 8.05 (2H, d, J 8.8, 2 x Ar-H); 7.64 (2H, d, J 8.8, 2 x 
Ar-H), 7.3 (2H, t, J 7.0, 2 x Ar-CH), 7.20-7.05 (3H, m, 3 x Ar-CH), 4.66 (1H, d, J 9.5, NH), 3.59 
(1H, dq, J 9.5 and 6.5, 2-H), 2.58 (1H, bs, OH), 1.22 (12H, bs, 1-Me and /-Bu); 8C 149.5 (C), 
146.3 (C), 141.6 (C), 128.3 (Ar-CH), 128.1 (2 x Ar-CH), 127.9 (2 x Ar-CH), 126.3 (2 x Ar-CH), 
124.1 (2 x Ar-CH), 98.2 (4-C), 77.6 (5-C), 75.2 (3-C), 59.1 (2-CH), 30.8 (/-Bu Me), 27.6 (/-Bu 
C), 18.2 (1-Me); m/z (APCI) 399 ([M+H]+ - H20) 22%, 229 (64), 213 (88), 198 (100), 186 (90).
5-/er/-Butyl-2-methy 1-3-phenyl-1 -(4-nosy 1)-1 H-py rrole (239h)
f
Using the general procedure (24 h), 10% AgNC>3.SiC)2 (0.02 g, 0.01 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-sulfonamide 238h (0.02 g, 0.05 mmol) in dichloromethane to 
give unreacted 3-alkyne-2-hydroxy-l-sulfonamide 239h as a yellow solid.
NHNs
Ph
-x- XIN:
239
Ph^ ! r
^ N H N s
238h
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(lJ?,25)-Methyl l-hydroxy-l-phenylpropan-2-ylcarbamate 215 (236c)
Ph^OH Ph^OH
^ N H 2 ^ N H C 0 2Me
236c
Using the general procedure, methyl chloroformate (0.82 mL, 10.7 mmol) was added to (\R,2S)- 
norephedrine hydrochloride (2 g, 10.7 mmol) to yield the Moc amino-alcohol 236c as a 
colourless oil (1.070g, 48%): tW o m '1 (film) 3414, 2983, 1698, 1519, 1452, 1346, 1253, 1064, 
911, 734, 702; SH 7.31-7.26 (4H, m, 4 x Ar-H), 7.21-7.18 (1H, m, Ar-H), 4.80 (2H, bs, NH and 1- 
H), 3.95 (1H, bs, 2-H), 3.63 (3H, s, OMe), 2.75 (1H, bs, OH), 0.9 (3H, d, J 6.9, 3-Me); 8C 157.2 
(C), 140.6 (C), 128.3 (3 x Ar-CH), 127.6 (Ar-CH), 126.2 (Ar-CH), 76.3 (1-CH), 52.3 (2-CH),
52.3 (OMe), 14.5 (3-Me); m/z (APCI) 192 ([M+H]+ - H20 ) 42%, 160 (91), 148 (56), 133 (49), 
117 (100). All data obtained matched that previously reported in the literature.
(S)-Methyl l-oxo-l-phenylpropan-2-ylcarbamate 216 (237c)
Ph^O H  P h ^ O
^ N H C 0 2Me ^ N H C 0 2Me
236c 237c
Using the general procedure, PCC (1.55 g, 7.17 mmol) and sodium acetate (0.12 g, 1.43 mmol) 
were added to Moc amino alcohol 236c (1 g, 4.78 mmol) to yield the Moc-a-aminoketone 237c as 
a colourless solid (0.693g, 70%, mp = 54-56°C): W c m '1 (DCM) 3339, 2984, 1705, 1692, 1526, 
1450, 1356, 1229, 1068, 972, 702; SH 7.9 (2H, d, J 7.6, 2 x Ar-H), 7.55 (1H, t, J 7.4, Ar-H), 7.40 
(2H, t, 7.7, 2 x Ar-H), 5.73 (1H, d, J 5.2, NH), 5.25 (1H, app. quintet, J 7.2, 2-H), 3.60 (3H, s, 
OMe), 1.37 (3H, d, J 7.2, 3-Me); 5C 199.0 (C), 156.3 (C), 133.9 (Ar-CH), 130.1 (C), 128.9 (3 x 
Ar-CH), 128.7 (Ar-CH), 52.3 (OMe), 51.6 (2-CH), 20.1 (3-Me); m/z (APCI) 208 [M+H]+ 5%, 
132 (100). All data obtained matched that previously reported in the literature.
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(253*S)-Methyl 3-hydroxy-3-phenylnon-4-yn-2-ylcarbamate (238f)
NHC02MeNHC02Me
237c 238f
Using the general procedure with the modified work-up, 1-hexyne (0.6 mL, 5.31 mmol) was 
added to Moc-a-aminoketone 237c (0.5 g, 2.41 mmol) to give the 3-alkyne-2-hydroxy-l- 
aminocarbonyl 238f as a colourless solid (0.579g, 83%) and as a single isomer: Rf 0.25 (30 : 70 
ethyl acetate -  petroleum ether); Umax/cm'1 (DCM) 3410, 2957, 1710, 1698, 1517, 1449, 1377, 
1236, 1068, 701; 6H 7.61 (2H, d, J 7.2, 2 x Ar-H), 7.35 (2H, t, J 7.3, 2 x Ar-H), 7.29 (1H, t, J 7.3, 
Ar-H), 4.80 (1H, bs, NH), 4.13 (1H, dq, J 6.7 and 6.1, 2-H), 3.62 (3H, s, OMe), 3.06 (1H, bs, 
OH), 2.29 (2H, t, J 7.0, 6-CH2), 1.54 (2H, m, 7-CH2), 1.44 (2H, m, 8-CH2), 1.11 (3H, d, J 6.1, 1- 
Me), 0.93 (3H, t, J 7.3, 9-Me); 5C (125MHz) 156.7 (C), 141.5 (C), 128.9 (Ar-CH), 127.9 (2 x Ar- 
CH), 127.9 (Ar-CH), 126.4 (Ar-CH), 87.5 (4-C), 81.4 (5-C), 75.9 (3-C), 56.1 (2-CH), 52.2 
(OMe), 30.7 (6-CH2), 22.0 (7-CH2), 18.4 (8- CH2), 16.3 (1-Me), 13.6 (9-Me); m/z (APCI) 272 
([M+Hf - H20 ) 14%, 197 (52), 155 (100), 141 (49), 132 (32).
Methyl 5-butyl-2-methyl-3-phenyl-lH-pyrrole-l-carboxylate (239f)
1 nV bu
C 02MeNHC02Me
238f 239f
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.088 g, 0.052 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-aminocarbonyl 238f (0.150 g, 0.518 mmol) in dichloromethane 
to yield the pyrrole 239f as a colourless oil (0.138g, 98%): aw/cm*1 (film) 2956, 2930, 2861, 
1744, 1598, 1547, 1509, 1442, 1332, 1263, 1193, 1141, 1110, 764, 701; 5H 7.35-7.20 (4H, m, 4 x 
Ar-H), 7.18 (1H, tt, J, 6.8 and 2.0, Ar-H), 5.98 (1H, s, 4-H), 3.88 (3H, s, OMe), 2.74 (2H, t, J 7.6, 
l ’-CH2), 2.38 (3H, s, 2-Me), 1.53 (2H, m, 2’-CH2), 1.35 (2H, m, 3’-CH2), 0.87 (3H, t, J 7.4, 4’- 
Me); 5C 152.7 (C), 136.0 (C), 135.8 (C), 128.7 (2 x Ar-CH), 128.3 (2 x Ar-CH), 126.8 (C), 126.2
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(Ar-CH), 125.1 (C), 111.4 (4-CH), 53.4 (OMe), 31.3 ( l ’-CH2), 29.1 (2’-CH2), 22.6 (3’-CH2),
14.2 (2-Me), 14.0 (4’-Me); m/z (ES) 272 [M+H]+ 100%, [Found [M+Hf, 272.1646. C,7H22N 02 
requires M+H, 272.1651 ].
{lRJSytert-Butyl l-hydroxy-l-phenylpropan-2-ylcarbamate 217 (236d)
Ph^JDH Ph^OH
^ N H 2 ^ N H B oc
236d
Using the general procedure, Boc anhydride (1.28 g, 5.86 mmol) was added to (li?,2iS)- 
norephedrine hydrochloride (1 g, 5.33 mmol) to yield the Boc-amino alcohol 236d as a colourless 
solid (1.338g, 100%, mp = 95-97°C (lit. mp = 90-92°C216)): tw /c m '1 (DCM) 3435, 3055, 2981, 
1700, 1505, 1453, 1368, 1166, 1051, 704; 5H 7.30-7.26 (3H, m, 3 x Ar-H), 7.22-7.18 (2H, m, 2 x 
Ar-H), 4.80 (1H, bs, NH), 4.54 (1H, bs, 1-H), 3.96 (1H, bs, 2-H), 3.16 (1H, bs, OH), 1.40 (9H, s, 
/-Bu), 0.93 (3H, d, J 6.8, 3-Me); 6C 156.3 (C), 141.0 (C), 128.1 (3 x Ar-CH), 127.3 (Ar-CH),
126.3 (Ar-CH), 79.7 (/-Bu C), 76.5 (1-CH), 52.0 (2-CH), 28.4 (/-Bu Me), 14.5 (3-Me); m/z 
(APCI) 274 [M+Na]+ 100%, 134 (70). All data obtained matched that previously reported in the 
literature.
(S)-tert-Butyl l-oxo-l-phenylpropan-2-yIcarbamate 216 (237d)
Ph^O H  P h ^ O
^ N H B o c  ^IMHBoc
236d 237d
Using the general procedure, PCC (0.65 g, 3.01 mmol) and sodium acetate (0.05 g, 0.60 mmol) 
were added to the Boc amino-alcohol 236d (0.5 g, 1.99 mmol) to yield the Boc-a-aminoketone 
237d as a colourless solid (0.324 g, 65%, mp = 82-83°C (lit. mp = 70-72°C216)): Rf 0.66 (30 : 70 
ethyl acetate-petroleum ether); iw /c m '1 (DCM) 3423, 1710, 1637, 1265, 738; 8h 7.92 (2H, d, J
7.5, 2 x Ar-H), 7.54 (1H, t, J 7.5, Ar-H), 7.42 (2H, t, J 7.5, 2 x Ar-H), 5.50 (1H, d, J 7.2, NH), 
5.23 (1H, app. quintet, J 7.2, 2-H), 1.38 (9H, s, /-Bu), 1.33 (3H, d, J 7.2, 3-Me); 6C 199.5 (C),
155.2 (C), 134.2 (C), 133.8 (Ar-CH), 128.9 (3 x Ar-CH), 128.7 (Ar-CH), 79.8 (/-Bu C), 51.1 (2-
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CH), 28.4 (/-Bu), 20.0 (3-Me); m/z (APCI) 250 [M+H]+ 18%, 194 (23), 150 (100). All data 
obtained matched that previously reported in the literature.
(2S£S)-tert-Buty\ 3-hydroxy-3-phenylnon-4-yn-2-ylcarbamate (238g)
NHBoc NHBoc
237d 238g
Using the general procedure, 1-hexyne (0.22 mL, 1.90 mmol) was added to Boc-a-aminoketone 
237d (0.2 g, 0.802 mmol) to give the 3-alkyne-2-hydroxy-l-aminocarbonyl 238g as a colourless 
solid (0.178g, 67%) and as a single isomer: Umax/cm'1 (DCM) 3432, 2962, 2933, 2873, 2248, 
1699, 1505, 1449, 1392, 1367, 1249, 1166, 1106, 1057, 1024, 909, 860, 735, 701; SH 7.51 (2H, d, 
J 7.2, 2 x Ar-H), 7.28-7.25 (2H, m, 2 x Ar-H), 7.20-7.17 (1H, m, Ar-H), 4.59 (1H, bs, NH), 4.00 
(1H, bs, 2-H), 2.22 (2H, t, J 7.0, 6-CH2), 2.02 (9H, s, /-Bu), 1.48 (2H, m, 7-CH2), 1.33 (2H, m, 8- 
CH2), 1.05 (3H, bs, 1-Me), 0.86 (3H, t, J 7.2, 9-Me).
tert- Butyl 5-butyI-2-methyl-3-phenyI-lH-pyrro!e-l-carboxyIate (239g)
NHBoc
238g 239g
Using the general procedure (24 h), 10% AgNC>3.Si02 (0.05 g, 0.003 mmol) was stirred with a 
solution of 3-alkyne-2-hydroxy-l-aminocarbonyl 238g (0.1 g, 0.030 mmol) in dichloromethane to 
yield pyrrole 239g as a colourless oil (0.09g, 90%): Rf 0.86 (30 : 70 ethyl acetate -  petroleum 
ether); tw /c m '1 (film) 2981,2253, 1733, 1457, 1370, 1330, 1140, 1115, 908, 733,650; 8H 7.35- 
7.15 (5H, m, 5 x Ar-H), 5.95 (1H, s, 4-H), 2.74 (2H, t, J 7.7, l ’-CH2), 2.37 (3H, s, 2-Me), 1.53 
(9H, s, r-Bu), 1.40-1.25 (4H, m, 2’- and 3’-CH2), 0.88 (3H, t, J 7.3, 4’-Me); 8C (125MHz) 150.6 
(C), 136.3 (C), 135.4 (C), 128.7 (2 x Ar-CH), 128.3 (2 x Ar-CH), 126.5 (C), 126.0 (Ar-CH),
124.5 (C), 110.7 (4-CH), 83.5 (/-Bu C), 31.4 ( l ’-CH2), 29.2 (2’-CH2), 28.1 (/-Bu), 22.6 (3’-CH2),
14.4 (2-Me), 14.1 (4’-Me).
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General procedure for the synthesis of pyrazole-JV-oxides 
General procedure for imine formation49
An amine (22-51 mmol, 1.1 eq) was added dropwise to a solution of aldehyde (20 - 47 mmol, 1 
eq) in diethyl ether (10 mL g'1). The solution was stirred overnight before being dried, filtered 
and evaporated to yield the desired imine as a yellow oil (>95%).
General procedure for propargvlamine formation49
w-BuLi (17-24 mmol of a 2.5M solution in hexanes, 1.3eq) was added dropwise to a solution of
1-alkyne (17-24 mmol, 1.3 eq) dissolved in THF (10 mL g'1) maintained at -78 °C. The solution 
was stirred for 0.5 h. Boron trifluoride-THF complex (17-24 mmol, 1.3 eq) was added slowly to 
the mixture which was then stirred for a further 0.25 h at -78 °C. The resulting solution was then 
added dropwise to a solution of imine (5.7 - 8 mmol, 1 eq) in THF (10 mL g '1) at -78 °C. After 
stirring for 3 h, the mixture was quenched by the addition of 0.1 M KH2PO4 pH 7 buffer (10 mL 
g '1). The product was then extracted into diethyl ether (3 x 25 mL g '1), and the combined extracts 
washed with water (1 x 50 mL g'1) and brine (1 x 50 mL g*1), then dried, filtered and evaporated 
to yield the propargyl amine. Any excess 1-alkyne, and other impurities, were removed through 
column chromatography when necessary.
General procedure for TV-nitrosation49
A propargylamine (0.9 -1 .1  mmol, 1 eq) was cooled to 0°C and treated with 32% hydrochloric 
acid (1.8 -  2.2 mmol, 2 eq) with stirring for 5 mins. The resulting mixture was diluted with 
diethyl ether (10 mL g'1), before a solution of sodium nitrite (1.1 -  1.3 mmol, 1.2 eq) in water (10 
mLg*1) was added and the resulting mixture stirred at ambient temperature for 3 h. The product 
was extracted with diethyl ether (3 x 25 mL g 1) and the combined organic extracts washed with 
water (1 x 25 mL g'1) and brine (1 x 25 mL g'1), then dried, filtered and evaporated to yield the N- 
nitroso propargylamine. No purification was usually required.
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In a foil wrapped NMR tube, 10% w/w silver nitrate on silica gel (0.02 - 0.04 mmol, 0.2eq) was 
added to a solution of a propargyl-A-nitrosoamine (0.1 -  0.2 mmol, leq) in deuteriochloroform (1 
mL), and the resulting suspension left for 6-24 h with occasional shaking. The solution was then 
analysed by *H NMR spectroscopy to show the formation of a pyrazole-N-oxide.
General procedure for Dvrazole-iV-oxide deoxveenation112,114
The pyrazole-iV-oxide (0.35 - 0.5 mmol, 1 eq) was dissolved in dry, ethanol free, chloroform (5 
mL) at ambient temperature. Phosphorus trichloride (1.9 -  2.7 mmol, 5.5eq) was added dropwise 
and the solution heated to reflux for 2 h. Upon cooling, water was added and the product 
extracted from the aqueous layer into chloroform (3 x 1 5  mL) and then washed with water (1 x 
25 mL) and brine (1 x 25 mL). The combined organic layers were then dried, filtered and 
evaporated to yield pyrazole.
(£>1 -Pheny I-2-aza-5-methy lhex-2-ene (291a)218
O
Using the general procedure, benzylamine (5.6 mL, 51.3 mmol) was added to isovaleraldehyde (5 
mL, 46.6 mmol) to give the imine 291a (7.928 g, 97%) as a clear oil: Sh 7.79 (1H, t, J 5.5, 3-H), 
7.40-7.20 (5H, m, 5 x Ar-H), 4.58 (2H, s, 1-CH2), 2.21 (2H, dd, J 6.6 and 5.5, 4-CH2), 1.95 (1H, 
app. nonet, J 6.6, 5-H), 0.98 (6H, d, J 6.6, 3- and 6-Me); 8C 166.0 (3-CH), 139.4 (C), 128.5 (2 x 
Ar-CH), 127.9 (2 x Ar-CH), 126.9 (Ar-CH), 65.3 (1-CH2), 44.8 (4-CH2), 26.4 (5-CH), 22.6 (6- 
Me). All data obtained matched that previously reported in the literature.
291a
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Ph'A ©P
294a
N-N
298a
Preparative Scale:
Using material provided by Pickering,790 and to test the true efficiency of these experiments prior 
to further investigation, one isolation experiment was performed. Thus, 10% AgN0 3 .SiC>2 
(0.059g, 0.035 mmol, 0.1 eq) was added to a stirred solution of N-nitroso propargylamine 294a 
(O.lg, 0.349 mmol) in dichloromethane (5mL) for 18 h. The resulting suspension was filtered 
through celite and the solvent removed to give the pyrazole-N-oxide 298a as a orange-yellow oil 
(0.090g, 96%): 5H 7.25-7.18 (3H, m, 3 x Ar-H), 7.10 (2H, d, J 7.0, 2 x Ar-H), 5.71 (1H, s, 4-H), 
5.30 (2H, s, r-C H 2), 2.63 (2H, t, J 7.8, r ” -CH2), 2.22 (2H, d, J 7.2, 1” -CH2), 1.72-1.62 (1H, m, 
1” -H), 1.59-1.50 (2H, m, 2” ’-CH2), 1.37-1.26 (2H, m, 3” ’-CH2), 0.90 (3H, t, J 7.5, 4” ’-Me), 
0.80 (6H, d, J 6.6,2” -Me); m/z (APCI) 287 [M+H]+ 100%.
N-Benzyl-3-butyl-5-isobutylpyrazoIe (297a)
Ph—\
©
©P
N-N
298a
Ph—\
N-N
297a
Using the general procedure, pyrazole-N-oxide 298a (O.lg, 0.350 mmol) was treated with 
phosphorus trichloride (0.17mL, 1.92 mmol) to yield the pyrazole 291si as a brown oil (0.093g, 
99%): Rf 0.69 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 2958, 1707, 1545, 1496, 
1455, 1388, 1076, 701; 8H 7.26-7.15 (3H, m, Ar-H), 6.98 (2H, d, J 7.4, Ar-H), 5.82 (1H, s, 4-H), 
5.21 (2H, s, l ’-CH2), 2.56 (2H, t, J 7.7, 1” -CH2), 2.27 (2H, d, J 7.2, 1” ’-CH2), 1.80-1.65 (1H, m, 
2” ’-H), 1.62-1.52 (2H, m, 2” -CH2), 1.38-1.27 (2H, m, 3” -CH2), 0.87 (3H, t, J 7.4, 4” -Me), 0.81 
(6H, d, J 6.6, 2” ’-Me); 5C 152.2 (C), 143.5 (C), 137.3 (C), 128.7 (2 x Ar-CH), 127.5 (Ar-CH),
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126.6 (2 x Ar-CH), 104.3 (4-CH), 52.5 ( l ’-CH2), 34.7 (1 ” ’-CH2), 31.9 (1” -CH2), 28.1 (2” ’-CH),
27.7 (2” -CH2), 22.5 (3” -CH2), 22.5 (2 x 2” ’-Me), 13.9 (4” -Me); m/z (APCI) 271 [M+H]+ 
100%.
A^(5-MethyI-l-phenyIhex-l-yn-3-yI)-^V-phenylmethyIamine (293b)
N Ph 
H
Ph NH
291a 293b
Using the general procedure, phenylacetylene (1.9 mL, 17.1 mmol) was added to imine 291a (1 
g, 5.70 mmol) to give a brown oil (2.126 g), which was purified by column chromatography to 
give the propargylamine 293b (0.72g, 45%) as a yellow oil. Umax/cm*1 (film) 3308, 3060, 2954, 
2866, 2226, 1946, 1874, 1804, 1666, 1598, 1490, 1452, 1364, 1168, 1070, 970, 756, 692; 8H 
7.50-7.20 (10H, m, 10 x Ar-H), 4.15 (1H, d, J 12.9, l ’-Ha), 3.90 (1H, d, J 12.9, l ’-Hb), 3.63 (1H, 
dd, J 7.8 and 7.2, 3-H), 2.04-1.92 (1H, m, 5-H), 1.64-1.58 (2H, m, 4-CH2), 1.40 (1H, bs, NH), 
0.93 (6H, d, J 6.7, 5-Me); 8C 140.2 (C), 131.7 (2 x Ar-CH), 128.4 (4 x Ar-CH), 128.3 (2 x Ar- 
CH), 127.9 (Ar-CH), 127.0 (Ar-CH), 123.5 (C), 91.2 (1-C), 83.9 (2-C), 51.5 (r-C H 2), 48.5 (3- 
CH), 45.3 (4-CH2), 25.3 (5-CH), 23.0 (5-Me), 22.3 (6-Me); m/z (APCI) 278 [M+H]+ 100%.
A-Nitroso-A-(5-methyl-l-phenylhex-l-yn-3-yI)-A-phenylmethylainine (294b)
Ph NH Ph N'N0
Using the general procedure, sodium nitrite (0.07 g, 1.08 mmol) was added to propargylamine 
293b (0.25 g, 0.90 mmol) to give the N-nitroso propargylamine 294b (0.127 g, 46%) as an 
orange oil, which showed a mixture of two rotamers in a ratio of 45 :55. 8h 7.40-7.15 (10H, m, 10 
x Ar-H), 5.93 (0.45H, dd, J 8.0 and 7.2, 3-H), 5.74 (0.55H, app. t, J 7.9, 3-H), 5.49 (0.45H, d, J 
14.9, l ’-Ha), 5.32 (0.45H, d, J 14.9, l ’-Hb), 4.93 (0.55H, d, J 14.7, l ’-Ha), 4.74 (0.55H, d, J 14.7,
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r -H b), 1.76-1.70 (1.1H, m, 4-CH2), 1.62-1.50 (0.55H, m, 5-H), 1.50-1.40 (0.45H, m, 5-H), 1.20- 
1.12 (0.9H, m, J 7.1, 4-CH2), 0.89 (1.65H, d, J 6.6, 5-Me), 0.87 (1.35H, d, J 6.6, 5-Me), 0.80 
(1.35H, d, J 6.6, 5-Me), 0.78 (1.65H, d, J 6.6, 5-Me); 5C (125MHz) 136.1 (C), 135.2 (C), 131.7 (2 
x Ar-CH), 131.7 (2 x Ar-CH), 128.8 (Ar-CH), 128.7 (2 x Ar-CH), 128.6 (2 x Ar-CH), 128.5 (3 x 
Ar-CH), 128.4 (Ar-CH), 128.3 (2 x Ar-CH), 128.2 (Ar-CH), 128.1 (2 x Ar-CH), 127.5 (2 x Ar- 
CH), 122.2 (C), 122.0 (C), 87.0 (1-C), 86.1 (1-C), 85.2 (2-C), 84.8 (2-C), 54.5 (3-CH), 53.7 (1*- 
CH2), 45.4 ( l ’-CH2), 44.4 (3-CH), 43.9 (4-CH2), 42.1 (4-CH2), 25.3 (5-CH), 24.8 (5-CH), 22.8 
(5-Me), 22.1 (5-Me), 22.0 (5-Me), 21.4 (5-Me).
A-Benzyl-3-isobutyl-5-phenylpyrazole-iV-oxide (298b)
©
Ph
298b
Ph'
Ph
294b
Using the general procedure, 10% AgNC>3.Si02 (0.055g, 0.033 mmol, 0.2 eq) was mixed with a 
solution of A-nitroso propargylamine 294b (~0.05g, 0.163 mmol) in deuteriochloroform 
(0.75mL). Analysis by *H NMR showed complete conversion to the pyrazole-N-oxide 298b in 
6 h. 5H 8.15 (2H, dd, J 8.5 and 1.3, 2 x Ar-H), 7.37 (2H, m, 2 x Ar-H), 7.31-7.19 (4H, m, 4 x Ar­
ty , 7.15 (2H, dd, J 8.0 and 1.4, 2 x Ar-H), 6.17 (1H, s, 4-H), 5.38 (2H, s, l ’-Cty), 2.32 (2H, d, J
7.3, 1” -CH2), 1.83-1.70 (1H, m, 2” -H), 0.85 (6H, d, J 6.7, 2” -Me); Sc 135.7 (C), 132.2 (C),
128.9 (2 x Ar-CH), 128.6 (2 x Ar-CH), 128.5 (C), 128.4 (Ar-CH), 128.4 (C), 127.9 (Ar-CH),
127.0 (2 x Ar-CH), 126.4 (2 x Ar-CH), 98.3 (4-CH), 45.5 ( l ’-Cty), 35.3 (1” -CH2), 27.6 (2” - 
CH), 22.3 (2 x 2” -Me); m/z (APCI) 307 [M+H]+ 100%, [Found [M+H]+, 307.1802. C20H23N2O 
requires M+H, 307.1810].
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0-(/-Butyldiphenylsilyl)-7-Methyl-5-phenylmethylaminooct-3-yn-l-ol (293c)
OTBDPS
Using the general procedure, 0-TBPDS 3-butyn-l-ol (5.28 g, 17.1 mmol) was added to imine 
291a (1 g, 5.70 mmol) to give a crude product (6.132 g) as an orange oil, which was purified by 
column chromatography (40:60 ethyl acetate -  petroleum ether) to give the propargylamine 293c 
(1.443 g, 52%) as a yellow oil: Rf 0.41 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm"1 (film) 
3306, 3070, 2954, 2928, 2224, 1958, 1886, 1820, 1590, 1472, 1428, 1384, 1362, 1262, 1104, 
916, 822, 736, 698; SH 7.69 (2H, d, J 7.9, 2 x Ar-H), 7.68 (2H, d, J 7.9, 2 x Ar-H), 7.46-7.26 
(11H, m, 11 x Ar-H), 3.99 (1H, d, J 12.9, l ’-Ha), 3.78 (2H, t, J 7.0, 1-CH2), 3.76 (1H, d, J 12.9, 
l ’-Hb), 3.37 (1H, dt, J 7.5 and 1.9, 5-H), 2.50 (2H, td, J 7.0 and 1.9, 2-CH2), 1.94-1.82 (1H, m, 7- 
H), 1.49-1.43 (2H, m, 6-CH2), 1.03 (9H, s, /-Bu Me), 0.89 (3H, d, J 6.6, 7-Me), 0.88 (3H, d, J 6.6,
7-Me); 6C 140.3 (C), 135.6 (4 x Ar-CH), 133.7 (C), 129.7 (2 x Ar-CH), 128.4 (2 x Ar-CH), 128.3 
(2 x Ar-CH), 128.3 (4 x Ar-CH), 126.9 (1 x Ar-CH), 82.7 (4-C), 80.7 (3-C), 62.8 (1-CH2), 51.4 
( l ’-CH2), 48.0 (5-CH), 45.5 (2-CH2), 26.8 (/-Bu Me), 25.1 (7-CH), 23.0 (6-CH2), 23.2 (7-Me),
22.9 (7-Me), 22.2 (/-Bu C); m/z (APCI) 484 [M+H]+ 100%, [Found [M+H]+, 484.3052. 
C32H42NOSi requires M+H, 484.3036].
0-(/-Butyldiphenylsilyl)-Ar-nitroso-7-Methyl-5-phenyImethylaminooct-3-yn-l-ol (294c)
Ph
OTBDPS
294c
OTBDPS
293c
Using the general procedure, sodium nitrite (0.09 g, 1.24 mmol) was added to propargylamine 
293c (0.5 g, 1.03 mmol) to give the N-nitroso propargylamine 294c (0.369 g, 70%) as a yellow 
oil, which showed a mixture of two rotamers in a ratio of 30:70. 5h 7.63-7.00 (15H, m, 15 x Ar­
ty , 5.68 (0.3H, app. t, J 6.7, 5-H), 5.47 (0.7H, app. tt, J 7.9 and 2.0, 5-H), 5.36 (0.3H, d, J 14.9,
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l ’-H8), 5.21 (0.3H, d, J 14.9, l ’-Hb), 4.85 (0.7H, d, J 14.7, l ’-Ha), 4.61 (0.7H, d, J 14.7, l ’-Hb), 
3.61 (2H, t, J 6.9, 1-CH2), 2.35 (1.4H, dt, J 6.9 and 2.0, 2-CH2), 2.33 (0.6H, dt, J 6.9 and 2.0, 2- 
CH2), 1.60-1.54 (1.4H, m, 6-CH2), 1.52-1.40 (1.3H, m, 6-CH2 and 7-H), 1.39-1.29 (0.3H, m, 7- 
H), 0.98 (9H, s, t-Bu CH3), 0.80 (1.8H, d, J 6.5, 7-Me), 0.69 (4.2H, d, J 6.7, 7-Me); 5C 135.6 (4 x 
Ar-CH), 135.3 (C), 133.4 (2 x C), 129.8 (2 x Ar-CH), 128.4 (2 x Ar-CH), 128.0 (2 x Ar-CH),
127.8 (4 x Ar-CH), 127.4 (Ar-CH), 84.8 (3-C), 83.8 (3-C), 77.3 (4-C), 76.7 (4-C), 62.2 (1-CH2),
62.1 (1-CH2), 54.3 (5-CH), 53.4 ( l ’-CH2), 45.2 ( l ’-CH2), 44.0 (5-CH), 43.9 (2-CH2), 42.1 (2- 
CH2), 26.8 (/-Bu Me), 25.0 (7-CH), 24.6 (7-CH), 22.9 (2 x 6-CH2), 22.0 (7-Me), 21.3 (7-Me),
15.3 (2 x C).
Ar-Benzyl-3-isobutyl-5-0-(/-ButyIdiphenylsilyl)ethan-2-ol-pyrazole-Ar-oxide (298c)
©
OTBDPS
298c
Ph
OTBDPS
294c
Using the general procedure, 10% AgN03.Si02 (0.033g, 0.019 mmol, 0.2 eq) was mixed with a 
solution of A-nitroso propargylamine 294c (~0.05g, 0.097 mmol) in deuteriochloroform 
(0.75mL). Analysis by *H NMR showed complete conversion to the pyrazole-N-oxide 298c in 
8 h. 5h 7.57 (2H, d, J 8.0, 2 x Ar-H), 7.56 (2H, d, J 8.0, 2 x Ar-H), 7.38-7.19 (9H, m, 9 x Ar-H),
7.08 (2H, dd, J 8.2 and 1.6, 2 x Ar-H), 5.86 (1H, s, 4-H), 5.32 (2H, s, l ’-CH2), 3.90 (2H, t, J 6.1, 
2” ’-CH2), 2.90 (2H, t, J 6.1, 1” ’-CH2), 2.25 (2H, d, J 7.2, 1” -CH2), 1.76-1.61 (1H, m, 2” -H), 
0.96 (9H, s, /-Bu Me), 0.80 (6H, d, J 6.7, 2” -Me); 8C 135.6 (C), 135.6 (4 x Ar-CH), 133.5 (C),
132.3 (C), 129.7 (2 x Ar-CH), 128.9 (2 x Ar-CH), 127.9 (Ar-CH), 127.7 (4 x Ar-CH), 127.7 (C),
126.9 (2 x Ar-CH), 101.0 (4-CH), 61.0 ( l ’-CH2), 45.9 (2” ’-CH2), 35.1 ( l ’” -CH2), 28.4 (1” - 
CH2), 27.6 (2” -CH), 26.8 (/-Bu Me), 22.3 (2 x 2” -Me), 19.2 (C).
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7V-Benzyl-5-isobutyl-3-0-(/-Butyldipheiiylsilyl)ethaii-2-ol-pyrazole (297b)
Ph—A. @P 
N-N
OTBDPS
298c
Ph-A
OTBDPS
297b
Using the general procedure, pyrazole-JV-oxide 298c (0.25g, 0.487 mmol) was treated with 
phosphorus trichloride (0.23mL, 2.68 mmol) to yield the pyrazole 297b as a yellow oil (0.222g, 
92%): Rf 0.67 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3340, 2959, 1710, 1589, 
1471, 1473, 1235, 1113, 1028, 859, 821, 703; 6H 7.65 (4H, dd, 7.6 and 1.6, 4 x Ar-H), 7.36-7.23 
(11H, m, 11 x Ar-H), 6.16 (1H, s, 4-H), 5.54 (2H, s, l ’-CH2), 3.92 (2H, t, J 4.5, 2” -CH2), 3.00 
(2H, t, J 4.5, 1” -CH2), 2.38 (2H, d, J 6.7, l ’” -CH2), 1.84-1.72 (1H, m, 2” ’-H), 0.99 (9H, s, /- 
Bu), 0.83 (6H, d, J 6.3, 2” ’-Me); 8C 147.0 (C), 135.5 (C), 135.3 (2 x C), 134.8 (6 x Ar-CH), 129.6 
(2 x Ar-CH), 129.3 (Ar-CH), 129.1 (C), 127.2 (6 x Ar-CH), 107.2 (4-CH), 59.4 ( l ’-CH2), 52.3 
(2” -CH2), 34.0 (1” -CH2), 29.2 (1” ’-CH2), 27.7 (2” ’-CH), 26.6 (/-Bu Me), 22.3 (2 x 2” ’-Me),
19.1 (C); m/z (ES) 497 [M+H]+ 34%, 259 (100), [Found [M+H]+, 497.2982. C32H4 iN2OSi 
requires M+H, 497.2988].
(£)-l-Phenyl-2-azapent-l-ene (291b)49,219
O N
A ------------------ A
Pi r"H PIT'H
291b
Using the general procedure, propylamine (1.8 mL, 21.8 mmol) was added to benzaldehyde (2 
mL, 19.8 mmol) to give the imine 291b (2.753 g, 94%) as a clear oil: Sh 8.26 (1H, app. s, 1-H ), 
7.78-7.75 (2H, m, 2 x Ar-H), 7.42-7.40 (3H, m, 3 x Ar-H), 3.59 (2H, td, J 6.9 and 1.2, 3-CH2), 
1.77 (2H, app. sext, J 7.2, 4-CH2), 0.99 (3H, t, J 7.4, 5-Me); 8C 160.3 (1-CH), 136.1 (C), 130.1 
(Ar-CH), 128.0 (2 x Ar-CH), 127.7 (2 x Ar-CH), 63.3 (3-CH2), 23.8 (4-CH2), 11.6 (5-Me). All 
data obtained matched that previously reported in the literature.
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291b 293d
Using the general procedure, 1-hexyne (2.4 mL, 20.9 mmol) was added to imine 291b (1 g, 6.98 
mmol) to give a crude mixture (1.426g) as a yellow oil, which was purified by column 
chromatography (20:80 ethyl acetate -  petroleum ether) to give the propargylamine 293d (1.204 
g, 77%) as a pale yellow oil: Rf 0.46 (30:70 ethyl acetate - petroleum ether): 6H 7.49 (2H, d, J 7.2, 
2 x Ar-H), 7.32-7.21 (3H, m, 3 x Ar-H), 4.57 (1H, s, 1-H), 2.64 (1H, ddd, J 11.2, 8.2 and 6.6, 1’- 
Ha), 2.59 (1H, dd, J 11.2, 8.2, 6.6, l ’-Hb), 2.20 (2H, dt, J 7.0 and 2.0, 4-CH2), 1.56-1.30 (6H, m, 
2’-, 5- and 6-CH2), 0.85 (3H, t, J 7.3, 3’-Me), 0.84 (3H, t, J 7.4, 7-Me); 5C 141.3 (C), 128.5 (3 x 
Ar-CH), 127.9 (2 x Ar-CH), 87.1 (2-C), 79.8 (3-C), 54.1 (1-CH), 48.5 ( l ’-CH2), 30.8 (4-CH2),
22.0 (2’-CH2), 18.5 (5- and 6-CH2), 13.6 (7-Me), 11.8 (3’-Me); m/z (ES) 230 [M+H]+ 22%, 171 
(100) [Found [M+H]+, 230.1909. Ci6H24N requires M+H, 230.1909]. All data obtained matched 
that previously reported in the literature.
N-Nitroso-A-(l-phenylhept-2-yn-l-yl)-A-propylamine (294d)49
293d 294d
Using the general procedure, sodium nitrite (0.09 g, 1.33 mmol) was added to propargylamine 
293d (0.25 g, 1.10 mmol) to give the N-nitroso propargylamine 294d (0.221 g, 78%) as a yellow 
oil, which showed a mixture of two rotamers in a ratio of 38:62: 8h 7.48-7.20 (5H, m, 5 x Ar-H), 
7.11 (0.38H, t, J 2.2, 1-H), 6.71 (0.62H, t, J 2.2, 1-H), 3.92 (0.38H, dt, J 13.9 and 7.5, l ’-Ha), 3.83 
(0.38H, dt, J 13.9 and 7.4, l ’-Hb), 3.35 (0.62H, ddd, J 13.1, 10.4 and 5.4, l ’-Ha), 3.15 (0.62H, 
ddd, J 13.1, 10.5 and 5.3, l ’-Hb), 2.29 (1.24H, dt, J 7.0 and 2.2, 4-CH2), 2.23 (0.76H, dt, J 7.0 and
2.2, 4-CH2), 1.70-1.58 (0.76H, m, J 7.5, 5-CH2), 1.56-1.44 (2H, m, 2’- and 6-CH2), 1.44-1.34 
(2.48H, m, 5- and 6-CH2), 1.20-1.07 (0.76H, m, 2’-CH2), 0.89 (1.86H, t, J 7.2, 3’-Me), 0.88
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(1.14H, t, J 7.2, 3’-Me), 0.78 (1.14H, t, J 7.4, 7-Me), 0.66 (1.86H, t, J 7.5, 7-Me); 8C 135.7 (C),
135.6 (C), 128.8 (2 x Ar-CH), 128.7 (2 x Ar-CH), 128.6 (Ar-CH), 128.3 (Ar-CH), 127.7 (2 x Ar- 
CH), 127,6 (2 x Ar-CH), 90.2 (2-C), 87.4 (2-C), 74.0 (3-C), 73.8 (3-C), 58.5 (1-CH), 51.2 (P- 
CH2), 46.1 (1-CH), 44.4 ( l ’-CH2), 30.6 (4-CH2), 30.5 (4-CH2), 22.9 (2’-CH2), 22.0 (2 x 5-CH2),
20.1 (2’-CH2), 18.5 (6-CH2), 18.4 (6-CH2), 13.6 (2 x 7-Me), 11.7 (3’-Me), 11.3 (3’-Me). All data 
obtained matched that previously reported in the literature.
Ar-Propyl-5-butyl-3-phenyIpyrazole-./V-oxide (298d)
294d 298d
Using the general procedure, 10% AgN0 3 .Si0 2 (0.066 g, 0.039 mmol, 0.2 eq) was mixed with a 
solution of iV-nitroso propargylamine 294d (~0.05g, 0.193 mmol) in deuteriochloroform 
(0.75mL). Analysis by *H NMR showed complete conversion to the pyrazole-N-oxide 298d in 
24 h: 5h 7.41-7.28 (5H, m, 5 x Ar-H), 5.96 (1H, s, 4-H), 4.11 (2H, t, J 7.5, l ’-CH2), 2.64 (2H, t, J 
7.8, 1” ’-CH2), 1.66 (2H, sextet, J 7.5, 2’-CH2), 1.64-1.56 (2H, m, 2” ’-CH2), 1.42-1.31 (2H, m, 
3” ’-CH2), 0.88 (3H, t, J 7.3, 4” ’-Me), 0.72 (3H, t, J 7.5, 3’-Me); 5C 132.6 (C), 132.5 (C), 129.8 
(C), 129.0 (2 x Ar-CH), 128.7 (Ar-CH), 128.2 (2 x Ar-CH), 100.4 (4-CH), 45.7 ( l ’-CH2), 29.0 
( P ” -CH2), 24.4 (2’-CH2), 22.5 (2” ’-CH2), 22.1 (3” ’-CH2), 13.9 (4” ’-Me), 10.9 (3’-Me); m/z 
(APCI) 259 [M+H]+ 100%, [Found [M+H]+, 259.1799. C16H23N20  requires M+H, 259.1810].
Ar-(13-I>iphenylprop-2-yn-l-yl)-A-propylamine (293e)49
291b 293e
Using the general procedure, phenylacetylene (2.3 mL, 20.9 mmol) was added to imine 291b (1 
g, 6.98 mmol) to give the propargylamine 293e (1.50g, 88%) as a yellow oil: Rf 0.52 (30:70 ethyl 
acetate - petroleum ether): 5H 7.59 (2H, d, J 7.2, 2 x Ar-H), 7.50-7.26 (8H, m, 8 x Ar-H), 4.80
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(1H, s, 1-H), 2.81 (1H, ddd, J 11.2, 8.0 and 6.8, l ’-Ha), 2.69 (1H, ddd, J 11.2, 8.0 and 6.4, l ’-Hb),
1.82 (1H, bs, NH), 1.62-1.50 (2H, m, 2’-CH2), 0.94 (3H, t, J 7.4, 3’-Me); 5C 140.6 (C), 131.8 (2 x 
Ar-CH), 128.6 (2 x Ar-CH), 128.3 (2 x Ar-CH), 128.2 (Ar-CH), 127.8 (Ar-CH), 127.7 (2 x Ar- 
CH), 123.2 (C), 89.6 (3-C), 85.3 (2-C), 54.7 (1-CH), 49.3 ( l ’-CH2), 23.2 (2’-CH2), 11.9 (3’-Me); 
m/z (APCI) 250 [M+H]+ 2%, 191 (100), 113 (28). All data obtained matched that previously 
reported in the literature.
Ar-Nitroso-Ar-(l,3-diphenylprop-2-yn-l-yI)-./V-propyIamine (294e)49
293e 294e
Using the general procedure, sodium nitrite (0.08 g, 1.22 mmol) was added to propargylamine 
293e (0.25 g, 1.02 mmol) to give the N-nitroso propargylamine 294e (0.243 g, 87%) as an orange 
oil, which showed a mixture of two rotamers in a ratio of 42:58: 8h 7.60-7.23 (10.42H, m, 10 x 
Ar-H and 1-H), 6.97 (0.58H, s, 1-H), 4.06-3.85 (0.84H, m, l ’-CH2), 3.45 (0.58H, ddd, J 13.2,
10.3 and 5.4, l ’-Ha), 3.22 (0.58H, ddd, J 13.2, 10.4 and 5.3, l ’-Hb), 1.71 (0.84H, app. sextet, J 
7.5, 2’-CH2), 1.50-1.34 (0.58H, m, 2’-Ha), 1.27-1.12 (0.58H, m, 2’-Hb), 0.82 (1.26H, t, J 7.4, 3’- 
Me), 0.69 (1.74H, t, J 7.4, 3’-Me); 8C 135.2 (C), 135.0 (C), 131.8 (Ar-CH), 131.8 (Ar-CH), 129.2 
(Ar-CH), 129.1 (Ar-CH), 128.9 (Ar-CH), 128.8 (Ar-CH), 128.6 (Ar-CH), 128.5 (Ar-CH), 127.7 
(Ar-CH), 127.6 (Ar-CH), 122.0 (C), 121.8 (C), 89.1 (3-C), 86.3 (3-C), 83.0 (2 x 2-C), 58.9 (1- 
CH), 51.4 ( l ’-CH2), 46.3 (1-CH), 44.6 ( l ’-CH2), 22.9 (2’-CH2), 20.2 (2’-CH2), 11.8 (3’-Me),
11.3 (3’-Me). All data obtained matched that previously reported in the literature.
A-PropyI-3,5-diphenylpyrazole-A-oxide (298e)
\  0 ^—\ ©P
N-N
Ph'^V ^'Ph
298e294e
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Using the general procedure, 10% AgN0 3 .SiC>2 (0.06 lg, 0.036 mmol, 0.2 eq) was mixed with a 
solution of JV-nitroso propargylamine 294e (~0.05g, 0.180 mmol) in deuteriochloroform 
(0.75mL). Analysis by *H NMR showed complete conversion to the pyrazole-N-oxide 298e in 
8 h. 8h 8.14 (2H, m, 2 x Ar-H), 7.43-7.36 (8H, m, 8 x Ar-H), 6.42 (1H, s, 4-H), 4.19 (2H, t, J 7.5, 
l ’-CH2), 1.73 (2H, sextet, 2’-CH2), 0.76 (3H, t, J 7.5, 3’-Me); 5C (125MHz) 133.8 (C), 132.3 (C),
129.1 (2 x Ar-CH), 128.6 (2 x Ar-CH), 128.5 (Ar-CH), 128.4 (2 x Ar-CH), 128.2 (C), 127.7 (C).
126.5 (Ar-CH), 126.4 (2 x Ar-CH), 99.1 (4-CH), 45.7 ( l ’-CH2), 22.2 (2’-CH2), 11.1 (3’-Me).
(Zs)-4-Aza-7-methylocta-l,4-diene (291c)49
O
291c
Using the general procedure, allylamine (5.6 mL, 51.3 mmol) was added to isovaleraldehyde (5 
mL, 46.6 mmol) to give the imine 291c (7.928 g, 97%) as a clear oil. The spectroscopic data 
obtained were in accord with those previously reported in the literature.
iV-(5-Methyl-l-phenylhex-l-yn-3-yl)-jV-allylainiiie (293f)
291c 293f
Using the general procedure, phenylacetylene (2.63 mL, 23.9 mmol) was added to imine 291c (1 
g, 7.98 mmol) to give a crude mixture (2.717 g) as an orange oil. The residue was purified by 
column chromatography (30:70 ethyl acetate -  petroleum ether) to give the propargylamine 293f 
(0.67g, 37%) as a pale yellow oil: Rf 0.59 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 
(film) 3315, 3080, 2956, 2869, 1643, 1599, 1490, 1467, 1385, 1366, 1315, 1102, 1069, 1028, 
993, 919, 756, 691; 5H 7.51-7.27 (5H, m, 5 x Ar-H), 5.95 (1H, dddd, J 17.0, 10.6, 6.3 and 5.7, 2’- 
H), 5.24 (1H, ddt, J 17.0, 3.1 and 1.4, 3’-Ha), 5.12 (1H, ddt, J 10.6, 3.1 and 1.4, 3’-Hb), 3.66 (1H,
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dd, J 8.7 and 6.5, 3-H), 3.57 (1H, ddt, J 13.8, 5.7 and 1.4, 1 ’-Ha), 3.35 (1H, ddt, J 13.8, 6.3 and
1.4, l ’-Hb), 2.04-1.89 (1H, m, 5-H), 1.67-1.51 (2H, m, 4-CH2), 1.27 (1H, bs, NH), 0.93 (3H, d, J 
6.7, 5-Me), 0.92 (3H, d, J 6.7, 5-Me); 8C 136.6 (Ar-CH), 132.1 (Ar-CH), 131.7 (Ar-CH), 128.3 
(Ar-CH), 128.3 (Ar-CH), 127.9 (2’-CH), 123.4 (C), 116.3 (3’-CH2), 91.0 (1-C), 83.8 (2-C), 50.1 
(P-CH2), 48.5 (3-CH), 45.3 (4-CH2), 25.3 (5-CH), 23.2 (5-Me), 22.1 (5-Me); m/z (APCI) 228 
[M+Hf 36%, 171 (100), [Found [M+H]+, 228.1763. requires M+H, 228.1752].
(V-N itroso-7V-(5-methyl-1 -phenylhex-l-yn-3-yl)-7V-aIlylaniine (294f)
P h
294f
P h
293f
Using the general procedure, sodium nitrite (0.09 g, 1.32 mmol) was added to propargylamine 
293f (0.5 g, 1.10 mmol) to give the N-nitroso propargylamine 294f (0.089 g, 32%) as a yellow 
oil, which showed a mixture of two rotamers in a ratio of 25:75: 5h 7.37-7.20 (5H, m, 5 x Ar-H), 
5.98 (0.25H, dddd, J 17.1, 10.0, 7.2 and 5.6, 2’-H), 5.91 (0.25H, dd, J 9.2 and 6.0, 3-H), 5.71 
(0.75H, app. t, J 8.0, 3-H), 5.68 (0.75H, dddd, J 17.1, 10.1, 6.6 and 5.4, 2’-H), 5.35 (0.25H, ddt, J
17.1, 2.5 and 1.3, 3’-Ha), 5.23 (0.25H, ddt, J 10.0, 2.5 and 1.1, 3’-Hb), 5.14 (0.75H, ddt, J 17.1,
2.6 and 1.4, 3’-Ha), 5.10 (0.75H, ddt, J 10.1, 2.6 and 1.1, 3’-Hb), 4.85 (0.25H, ddt, J 15.2, 5.6 and
1.3, l ’-Ha), 4.76 (0.25H, ddt, J 15.2, 7.2 and 1.1, l ’-Hb), 4.27 (0.75H, ddt, J 14.9, 5.4 and 1.4, P- 
Ha), 4.14 (0.75H, ddt, J 14.9, 6.6 and 1.2, P-Hb), 1.83-1.77 (1.50H, m, 4-CH2), 1.73-1.60 (1H, m, 
5-H), 1.55 (0.25H, ddd, J 13.0, 9.2 and 5.6, 4-Ha), 1.37 (0.25H, ddd, J 13.0, 8.3 and 6.0, 4-Hb), 
0.94 (2.25H, d, J 6.6, 5-Me), 0.90 (2.25H, d, J 6.7, 5-Me), 0.90 (0.75H, d, J 6.6, 5-Me), 0.87 
(0.75H, d, J 6.6, 5-Me); 8C 133.3 (2’-CH), 131.7 (2 x Ar-CH), 130.2 (Ar-CH), 128.9 (2’-CH),
128.8 (Ar-CH), 128.4 (6 x Ar-CH), 122.1 (C), 122.0 (C), 119.6 (3’-CH2), 118.8 (3’-CH2), 86.6 
(1-C), 85.7 (1-C), 84.9 (2-C), 84.5 (2-C), 54.5 (3-CH), 52.6 ( l ’-CH2), 45.2 (P-CH2), 44.1 (3- 
CH), 43.6 (4-CH2), 41.9 (4-CH2), 25.4 (5-CH), 24.8 (5-CH), 23.0 (5-Me), 22.1 (5-Me), 22.0 (5- 
Me), 21.5 (5-Me).
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294f 298f
Using the general procedure, 10% AgN0 3 .Si0 2  (0.068g, 0.040 mmol, 0.2 eq) was mixed with a 
solution of iV-nitroso propargylamine 294f (~0.05g, 0.201 mmol) in deuteriochloroform 
(0.75mL). Analysis by NMR showed complete conversion to the pyrazole-N-oxide 298f in 
24 h: 5h 8.08 (2H, m, 2 x Ar-H), 7.37-7.31 (2H, m, 2 x Ar-H), 7.27-7.21 (1H, m, Ar-H), 6.14 
(1H, s, 4-H), 5.84 (1H, ddt, J 17.1, 10.3 and 5.1, 2’-H), 5.14 (1H, ddt, J 10.3, 1.4 and 1.0, 3’-Ha), 
4.97 (1H, ddt, J 17.1, 1.4 and 1.0, 3’-Hb), 4.77 (2H, dt, J 5.1 and 1.4, l ’-CH2), 2.36 (2H, d, J 7.2, 
1” -CH2), 1.93-1.79 (1H, m, 2” -H), 0.90 (6H, d, J 6.7, 2” -Me); 5C 132.8 (C), 131.2 (Ar-CH),
130.0 (C), 128.6 (2 x Ar-CH), 128.2 (C), 126.5 (2 x Ar-CH), 117.8 (3’-CH2), 98.4 (2’-CH), 44.8 
(U-CH2), 35.1 (1” -CH2), 27.7 (2” -CH), 22.4 (2 x 2” -Me); m/z (APCI) 257 [M+H]+ 100%, 
[Found [M+H]+, 257.1643. Ci6H21N20  requires M+H, 257.1654].
Preparation of (J?)- and (51-334 and 336.
Both {R)~ and (5)-enantiomers were treated in an identical fashion. All ]H, 13C, IR and m/z data 
collected was seen to be identical for each enantiomerically pure intermediate. [a]o291 values 
were used to determine the optical activity of each enantiomer of the final furans 334 and 336.
8-Iodo-2,6-dimethyloct-2-ene (330)
330
Iodine (3.35g, 1.32 mmol, 1.2 eq) was added to a stirred solution of triphenylphosphine (3.46g, 
1.32 mmol, 1.2 eq) and imidazole (0.898g, 1.32 mmol, 1.2 eq) dichloromethane (30 mL). 
Citronellol (2 mL, 1.10 mmol, 1 eq) was added dropwise after 15 mins, and the resulting mixture
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stirred at room temperature overnight. The reaction was quenched with water (30 mL) and the 
product extracted into dichloromethane (3 x 50 mL), washed with water (100 mL) and brine (100 
mL), then dried, filtered and evaporated to yield a pale orange oil. Hexane (25 mL) was then 
added to crystallise the triphenylphosphine oxide, which was then removed by filtration through a 
sintered funnel. Evaporation of the solvent gave citronellyl iodide 330 (2.4 lg, 82%) as a pale 
orange oil: W o n '  (film) 3226, 2962, 2923, 1437, 1377, 1180, 1119, 972, 722, 694; 5H 5.10 
(1H, t heptet, J 6.4 and 1.2, 3-H), 3.18 (1H, ddd, J 9.5, 8.6 and 5.6, 8-Ha), 3.10 (1H, ddd, J 9.5,
8.2 and 7.1, 8-Hb), 2.00-1.85 (2H, m, 4-CH2), 1.60 (3H, d, J 1.2, 1-Me), 1.60-1.54 (1H, m, 6-H), 
1.54 (3H, d, J 1.2, 2-Me), 1.50-1.42 (2H, m, 7-CH2), 1.31-1.04 (2H, m, 5-CH2), 0.80 (3H, d, J 
6.5,6-Me); 8C 131.9 (2-C), 124.4 (3-CH), 40.9 (7-CH2), 36.4 (5-CH2), 33.5 (6-CH), 25.7 (6-Me),
25.3 (4-CH2), 18.6 (1-Me), 17.7 (2-Me), 5.2 (8-CH2).
5,9-DimethyIdec-8-en-l-yne (331)
A solution of lithium acetylide ethylene diamine complex (0.955g, 10.37 mmol, 1.2 eq) in 
DMSO (20 mL) was stirred at 0°C for 10 mins. Citronellyl iodide 330 (2.3g, 8.64 mmol, 1 eq) 
was then added dropwise and the reaction allowed to warm to room temperature with stirring for 
1 h. Water was added to quench the reaction, the product extracted into hexane (3 x 25 mL) and 
the combined organic extracts washed with water (100 mL) and brine (100 mL), then dried, 
filtered and evaporated to yield a pale orange oil, acetylene 331 (1.13g, 78%): Rf 0.65 (30 : 70 
ethyl acetate -  petroleum ether); Umax/cm*1 (film) 3304, 2929, 2358, 1668, 1531, 1436, 1377, 
1264, 1079, 895, 739; SH 5.00 (1H, t heptet, J 7.1 and 1.3, 8-H), 2.11 (2H, dt, J 6.1 and 1.8, 3- 
CH2), 1.90 (2H, m, 7-CH2), 1.85 (1H, t, J 1.8, 1-H), 1.61 (3H, d, J 1.3, 9-Me), 1.54 (3H, d, J 1.3, 
10-Me), 1.45 (2H, m, 4-CH2), 1.27 (2H, m, 6-CH2), 1.09 (1H, m, 5-H), 0.80 (3H, d, J 6.6, 5-Me); 
8C 131.2 (9-C), 124.7 (8-CH), 84.9 (2-C), 67.9 (1-CH), 36.6 (5-CH), 35.5 (3-CH2), 31.6 (7-CH2),
25.7 (5-CH2), 25.4 (4-CH2), 19.0 (9-Me), 17.6 (10-Me), 16.1 (6-CH2).
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0-TBDMS acetol220
^O H  OTBDMS
Imidazole (11.37g, 48.9 mmol, 3 eq), TBDMS-chloride (7.34g, 48.9, 3 eq) and DMAP (0.28g, 
2.24 mmol, 0.1 eq) were added to a solution of acetol (1.21g, 16.3 mmol, 1 eq) in 
dichloromethane (15 mL) and stirred overnight at ambient temperature. The reaction was 
quenched with water (25 mL), the product extracted into petroleum ether (3 x 50 mL) and the 
combined organic layers washed with water (100 mL) and brine (100 mL), then dried, filtered 
and evaporated to yield O-TBDMS acetol (2.98g, 97%) as a yellow oil. The product was 
subsequently distilled at 0.5mmHg (b.p. 28-32°C), to yield a colourless oil (2.67g, 87%): t>max/cm' 
1 (film) 3445, 2954, 2857, 1720, 1472, 1360, 1254, 1119, 1071, 1005, 837, 778, 669; 8H 4.06 
(2H, s, 1-CH2), 2.11 (3H, s, 3-Me), 0.84 (9H, s, r-Bu Me), 0.00 (6H, s, Si-Me); 8C 209.4 (C), 69.5 
(I-CH2), 25.9 (3-Me), 25.6 (/-Bu Me), 18.1 (C), -5.5 (Si-Me). All data obtained matched that 
previously reported in the literature.
2,7,11-T rimethyldodec-10-en-3-yne-l,2-diol (333a)
OTBDMS
332a331
Using the general procedure, citronellyl acetylene 331 (0.25g, 1.52 mmol, 1 eq) was added to O- 
TBDMS acetol (0.315g, 1.67 mmol, 1.1 eq) to give a crude yellow oil (0.419g) containing 
propargyl alcohol 332a. Key selected data: 5H 5.00-4.94 (1H, m, 10-H), 3.51-3.45 (2H, m, 1- 
CH2), 1.59 (3H, s, 11-Me), 1.51 (3H, s, 12-Me), 1.30 (3H, s, 2-Me), 0.82 (9H, s, /-Bu Me), 0.00 
(6H, s, Si-Me). The propargyl alcohol 332a was used without further purification.
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OH
3 3 3 a
OTBDMS
3 3 2 a
Tetrabutylammonium fluoride (3.54 mL of a 1M solution in THF, 3.54 mmol, 4 eq) was added to 
a solution of propargyl alcohol 3 3 2 a  (0.29 lg, 0.88 mmol, 1 eq) in dichloromethane (10 mL). The 
resulting solution was stirred overnight at ambient temperature, then diluted with water (25 mL) 
and extracted into dichloromethane (3 x 25 mL). The combined organic layers were washed with 
water (100 mL) and brine (100 mL), then dried, filtered and evaporated to give a thick yellow oil 
(0.31 lg), which was purified by column chromatography (30:70 ethyl acetate -  hexane) to yield 
the diol 3 3 3 a  (0.08g, 37%) as a colourless oil with a weak nondescript odour: R f 0.28 (30 : 70 
ethyl acetate -  hexane): W c m 1 (film) 3411, 2918, 2359, 2224, 1618, 1438, 1361, 1221, 1166; 
8h 5.09 (1H, t. heptet, J 7.1 and 1.4, 10-H), 3.61 (1H, dd, J 10.9 and 4.9, 1-Ha), 3.46 (1H, d, J
10.9 and 8.9, 1-Hb), 2.48 (1H, s, OH), 2.30-2.15 (2H, m, 5-CH2), 2.05-1.91 (2H, m, 9-CH2), 1.68 
(3H, s, 11-Me), 1.60 (3H, d, J 1.4, 12-Me), 1.60-1.48 (2H, m, 6-CH2), 1.41 (3H, d, J 1.4, 2-Me), 
1.39-1.29 (2H, m, 8-CH2), 1.20-1.10 (1H, m, 7-H), 0.88 (3H, d, J 6.5, 7-Me); 5C 131.4 (11-C),
124.6 (10-CH), 85.6 (3-C), 81.3 (4-C), 71.0 (1-CH2), 68.7 (2-C), 36.6 (5-CH2), 35.7 (9-CH2),
31.7 (7-CH), 25.8 (11-Me), 25.5 (12-Me), 25.4 (6-CH2), 19.1 (7-Me), 16.4 (8-CH2).
4-Methyl-2-(3,7-dimethyloct-6-enyl)furan (334)
334
OH
3 3 3 a
Using the general procedure (24 h), 10% AgN0 3 .Si0 2 (0.114g, 0.067 mmol) was stirred with a 
solution of diol 3 3 3 a  (0.08g, 0.336 mmol) in dichloromethane to yield the furan 33 4  (0.067g, 91 
and 90%) as a clear oil: \W c rn '1 (film) 3465, 2931, 2336, 1617, 1551, 1453, 1376, 1270, 1121, 
947, 884; 6H 6.98 (1H, s, 5-H), 5.77 (1H, s, 3-H), 5.02 (1H, t heptet, J 7.1 and 1.4, 6’-H), 2.55- 
2.35 (2H, m, l ’-CH2), 2.00-1.82 (2H, 5’-CH2), 1.91 (3H, s, 4-Me), 1.61 (3H, s, 7’-Me), 1.53 (3H, 
s, 8’-Me), 1.42-1.31 (4H, 2’- and 4’-CH2), 1.19-1.09 (1H, m, 3’-H), 0.83 (3H, d, J 6.3, 3’-Me); 5C
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156.8 (2-C), 137.2 (5-CH), 131.2 (7’-C), 124.9 (6’-CH), 120.4 (4-C), 107.3 (3-CH), 36.9 (P- 
CH2), 35.3 (5’-CH2), 32.0 (3’-CH), 25.7 (4-Me), 25.7 (2’-CH2), 25.4 (4’-CH2), 19.4 (7’-Me), 17.7 
(8’-Me), 9.8 (3’-Me). [a]o291 (R)-enantiomer -7.8° (oily scent). [a]o291 (S)-enantiomer +6.3° 
(some woody, earthy overtones).
0-TBDMS 3-hydroxybutan-2-one
X OH ^ O T B D M S
Imidazole (6.1g, 90.0 mmol, 4 eq), TBDMS-chloride (6.63g, 45.0 mmol, 2 eq) and DMAP 
(0.28g, 2.24 mmol, 0.1 eq) were added to a solution of 3-hydroxybutan-2-one (2g, 22.7 mmol, 1 
eq) in dichloromethane (20 mL) and stirred overnight at ambient temperature. The reaction was 
quenched with water (25 mL), the product extracted into petroleum ether (3 x 50 mL) and the 
combined organic layers washed with water (100 mL) and brine (100 mL), then dried, filtered 
and evaporated to yield O-TBDMS 3-hydroxybutan-2-one (4.59g, 99%) as a colourless oil: 
W c i tT 1 (film) 3306, 2929,2358, 1668, 1531, 1436, 1377, 1264, 1079, 895, 739; 8H 4.04 (1H, q, 
J 6.8, 2-H), 2.11 (3H, s, 4-Me), 1.20 (1H, d, J 6.8, 1-Me), 0.84 (9H, s, /-Bu Me), 0.00 (6H, s, Si- 
Me); 8C 208.5 (C), 75.0 (2-CH), 25.7 (4-Me), 24.8 (/-Bu Me), 20.7 (1-Me), 18.0 (C), -3.0 (Si- 
Me).
3,8,12-T rimethyltridec-l l-en-4-yne-2,3-dioI (333b)
OTBDMS
332b331
Using the general procedure, citronellyl acetylene 331 (0.33g, 2.01 mmol, 1 eq) was added to O- 
TBDMS 3-hydroxybutan-2-one (0.488g, 2.41 mmol, 1.2 eq) to give a crude yellow oil (0.652g) 
containing propargyl alcohol 332b. Key selected data: 5H 5.02 (1H, bt, J ca 7, 11-H), 3.58 (1H, 
q, J 6.0, 2-H), 2.64 (1H, bs, OH), 2.10 (3H, s, 3-Me), 1.60 (3H, s, 12-Me), 1.53 (3H, s, 13-Me), 
0.84 (9H, s, f-Bu Me), 0.00 (6H, s, Si-Me). The propargyl alcohol 332b was used without further 
purification.
230
Chapter 8: Experimental
OTBDMS
332b
OH
333b
Tetrabutylammonium fluoride (4.86 mL of a 1M solution in THF, 4.86 mmol, 4 eq) was added to 
a solution of propargyl alcohol 332b (0.440g, 1.22 mmol, 1 eq) in dichloromethane (10 mL). The 
resulting solution was stirred overnight at ambient temperature, then diluted with water (25 mL) 
and extracted into dichloromethane (3 x 25 mL). The combined organic layers were washed with 
water (100 mL) and brine (100 mL), then dried, filtered and evaporated to give a thick yellow oil 
(0.498g), which was purified by column chromatography (30:70 ethyl acetate -  hexane) to yield a 
colourless oil, the diol 333b (0.135g, 35%) as a mixture of two diastereoisomers in a ratio of 
89:11, which together displayed a weak nondescript odour: R f 0.40 (30 : 70 ethyl acetate -  
hexane): t j c m ' 1 (film) 3425, 2925, 2254, 1652, 1465, 1383, 1097, 911; 5h 5.01 (1H, bt, J ca
7.1, 11-H), 3.69 (0.11H, q J 6.6, 2-H), 3.58-3.51 (0.89H, m, 2-H), 2.65 (1H, bs, OH), 2.25-2.05 
(2H, m, 6-CH2), 2.00-1.80 (3H, m, 10-CH2 and OH), 1.62 (3H, s, 12-Me), 1.54 (3H, s, 13-Me), 
1.52-1.41 (2H, m, 7-CH2), 1.33 (2.67H, s, 3-Me), 1.32 (0.33H, s, 3-Me), 1.31-1.22 (2H, m, 9- 
CH2), 1.20 (2.67H, d, J 6.3, 1-Me), 1.15 (0.33H, d, J 6.6, 1-Me), 1.13-1.03 (1H, m, 8-H), 0.82 
(3H, d, J 6.7, 8-Me); 131.5 (C), 124.7 (11-CH), 86.4 (4-C), 80.4 (5-C), 77.3 (2-CH), 74.5 (2-CH),
72.1 (3-C), 36.7 (6-CH2), 35.8 (10-CH2), 31.7 (8-CH), 25.9 (1-Me), 25.8 (3-Me), 25.4 (7-CH2),
19.1 (12-Me), 18.5 (13-Me), 17.7 (8-Me), 16.4 (9-CH2).
23-Dimethyl-5-(3,7-dimethyloct-6-enyl)furan (336)
336
OH
333b
Using the general procedure (24 h), 10% AgN0 3 .SiC>2 (0.182g, 0.117 mmol) was stirred with a 
solution of diol 333b (0.135g, 0.535 mmol) in dichloromethane to yield the furan 334 (0.117g, 92 
and 95%) as a clear oil: \W c r n 1 (film) 3451, 2918, 2567, 2242, 1642, 1578, 1448, 1376, 1260,
231
Chapter 8: Experimental
1223, 1164, 1123, 992, 858; 8h 5.67 (1H, s, 4-H), 5.03 (1H, t heptet, J 7.0 and 1.3, 6’-H), 2.53- 
2.38 (2H, m, r-C H 2), 2.09 (3H, s, 2-Me), 2.00-1.82 (2H, 5’-CH2), 1.82 (3H, s, 3-Me), 1.68 (3H, 
s, 7’-Me), 1.60 (3H, s, 8’-Me), 1.46-1.35 (4H, 2’- and 4’-CH2), 1.21-1.05 (1H, m, 3’-H), 0.83 
(3H, d, J 6.4, 3’-Me); 8C 153.7 (5-C), 145.1 (2-C), 131.2 (7’-C), 124.9 (6’-CH), 114.1 (3-C),
107.6 (4-CH), 36.9 ( l ’-CH2), 35.2 (5’-CH2), 32.0 (3’-CH), 25.8 (3-Me), 25.6 (2’-CH2), 25.5 (4’- 
CH2), 19.4 (7’-Me), 17.7 (8’-Me), 11.3 (2-Me), 9.9 (3’-Me). [<x]D291 (R)-enantiomer -8.9° (oily 
scent). [a]r>291 (S)-enantiomer i l !.4° (fruity flowery scent).
Towards the synthesis of Plakorsin A and B
(£)-l-Iodooctadec-l-ene (365)
365
Catecholborane (0.42 mL, 3.99 mmol, 1 eq) was added dropwise to 1-octadecyne (lg, 3.99 
mmol, 1 eq) and the mixture heated to 70°C for 2 h, then cooled to ambient temperature and 
stirred with water (5 mL) for a further 2 h. The resulting white solid was collected by filtration 
and washed free of catechol with ice-cold water (5 mL). Next, 3M sodium hydroxide (5 mL) was 
added slowly to a solution of the white solid, (E)-1 -octadecenylboronic acid, in diethyl ether (10 
mL), which was maintained at 0 °C. After stirring for 0.25 h, iodine (1.2g, 4.79 mmol, 1.2 eq) in 
diethyl ether (10 mL) was added with stirring for 0.5 h. Saturated aqueous sodium thiosulfate 
(few mL) was added and the product extracted with diethyl ether (2 x 20 mL). The combined 
organic layers were washed with water (2 x 50 mL) and brine (1 x 50 mL) then dried, filtered and 
evaporated to yield a pale yellow wax, (E)-l-iodooctadec-l-ene 365 (0.679g, 45%): Umax/cm'1 
(DCM) 3419, 2926, 2854, 2305, 1639, 1466, 1377, 1264, 1099, 947, 896, 740; 8H 6.43 (1H, dt, J
14.4 and 7.3, 2-H), 5.89 (1H, dt, J 14.4 and 1.3, 1-H), 1.97 (2H, app. dt, J 7.3 and 1.3, 3-CH2), 
1.49-1.41 (2H, m, 4-CH2), 1.24-1.14 (26H, m, 5 17-CH2), 0.81 (3H, t, J 6.9, 18-Me); 5C 146.8
(2-CH), 74.3 (1-CH), 36.1 (3-CH2), 32.0 (4-CH2), 30.0-28.3 (12 x CH2), 22.7 (17-CH2), 14.2 (18- 
Me).
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(j?$J?*^-Docos-5,6-dihydroxy-3-ynyloxytributylsiIane (367)
.OTBS
H33C16"
366
359
Using the general procedure, O-TBS-3-butyn-1 -ol 359 (0.35g, 1.32 mmol, 1 eq) was added to 
(E)-1 -iodooctadecene 365 (0.5g, 1.32 mmol, 1 eq) to give the enyne 366 as a crude yellow solid 
(0.542g), which was immediately dihydroxylated to give diol 367.
H33C16 ^ H33C16"
Using the general procedure, enyne 366 (0.5g, 0.96 mmol) was dihydroxylated with potassium 
osmate (VI) dihydrate (5mg, 20 pmol) to give crude diol 367 as a yellow wax (0.450g). The 
product was purified by column chromatography to give the syn-diol 367 as a pure yellow wax 
(0.037g): Umax/cm1 (film) 3438, 2960, 2237, 1724, 1404, 1266, 1163, 1066, 978, 933, 738, 703; 
8h 4.06 (1H, d, J 6.1, 5-H), 3.63 (2H, t, J 7.2, 1-CH2), 3.51 (1H, ddt, J 8.1, 6.1 and 3.6, 6-H), 2.37 
(2H, dt, J 7.2 and 1.9, 2-CH2), 1.64-1.52 (2H, m, 7-CH2), 1.48-1.35 (2H, m, 8-CH2), 1.27-1.21 
(6H, m, Si l ’-CH2), 1.20-1.14 (26H, m, 9 -> 21-CH2), 0.86-0.78 (15H, m, 22-Me, Si 2’- and 3’- 
CH2), 0.57-0.50 (9H, m, Si 4’-Me); 5C 84.1 (4-C), 79.9 (3-C), 75.1 (5-CH), 66.4 (6-CH), 61.3 (1- 
CH2), 32.4 (2-CH2), 32.0 (2 x CH2), 29.7 (7 x CH2), 29.4 (2 x CH2), 26.6 (3 x Si l ’-CH2), 25.6 
(CH2), 26.4 (3 x 2’-CH2), 23.1 (CH2), 22.7 (2 x CH2), 14.2 (22-Me), 13.8 (Si 3 x 4’-Me), 13.2 (Si 
3 x 3’-CH2); m/z (El) 534 ([M] - H20) 2%.
(2-(5-Hexadecylfuran-2-yl)ethoxy)tributylsilane (368)
^33^16 H 3 3 C 1 6 '
OH
367 368
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Using the general procedure (24 h), 10% AgN0 3 .SiC>2 (0.018g, 0.010 mmol, 0.2 eq) was added to 
a solution of diol 367 (0.03g, 0.054 mmol) in DCM to yield furan 368 as a yellow oil (0.025g, 
86%): 5h 5.91 (1H, d, J 2.8, 3-H), 5.81 (1H, d, J 2.8, 4-H), 3.78 (2H, t, J 6.7, 2’-CH2), 2.77 (2H, t, 
J 6.7, l ’-CH2), 2.50 (2H, t, J 7.2, 1” -CH2), 1.55 (6 H, m, Si l ’-CH2), 1.22 (31H, m, 14 x CH2 and 
16” -Me), 0.81 (18H, m, 9 x CH2), 0.50 (9H, m, Si 4’-Me); 6C 154.9 (C), 151.2 (C), 106.4 (3-CH),
105.0 (4-CH), 61.5 (2’-CH2), 31.9 (1’-, 1” -CH2 and CH2), 29.7 (6  x CH2), 29.3 (2 x CH2), 26.5 
(3 x CH2), 25.3 (3 x CH2), 22.7 (2 x CH2), 14.8 (3 x CH2), 14.1 (16” -Me), 13.8 (3 x Si 4’-Me),
13.3 (2 x CH2).
Preparation of 7- and 8 -membered cyclic ethers 
23-Dihydro-7-phenyIoxepin-4(5H)-one (372)
371 372
Method 1:
In an open flask, furan 371 (1 g, 5.32 mmol, 1 eq) was dissolved in acetone (10 mL) at ambient 
temperature. Jones reagent178 (3 mL, 6.38 mmol, 1.2 eq) was added dropwise and the solution 
stirred for 0.5 - 1 h. Sufficient sodium sulfite was added to quench the reaction and the slurry 
filtered through silica with ethyl acetate (200 mL). The solvent was removed to yield the oxepin- 
4-one 372 as an orange oil (0.497 g, 50%). In a slight modification to this procedure, the reaction 
was run at 0 °C and basified by the addition of sufficient saturated aqueous potassium carbonate 
solution after 0.5 h, and the product extracted into ethyl acetate (3 x 25 mL). The combined 
organic layers were washed with water (50 mL) and brine (50 mL) then dried, filtered and 
evaporated to yield the oxepin-4-one 372 as an orange oil (0.812g, 81%). Recrystallisation from 
methanol: water yielded orange crystals (0.653 g, mp = 48-50 °C): Rf 0.56 (30 : 70 ethyl acetate -  
petroleum ether); W c irT 1 (DCM) 1756, 1686, 1597, 1449, 1370, 1268, 1219, 1150, 1092, 736, 
689; SH 7.86 (2H, d, J 7.2, 2 x Ar-H), 7.51 (1H, t, J 7.3, Ar-H), 7.42-7.38 (2H, m, 2 x Ar-H), 4.34 
(1H, dt, J 9.2 and 4.2, 2-H„), 4.13-4.05 (2H, m, 2-Hb and 6 -H), 3.55 (1H, dd, J 18.0 and 3.4, 5-
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Ha), 3.31 (1H, dd, J 18.0 and 5.5, 5-Hb), 2.82 (1H, dt, J 18.0 and 9.0, 3-Ha), 2.51 (1H, ddd, J 18.0,
7.5 and 4.2, 3-Hb); 8C (125MHz) 215.8 (C), 196.1 (C), 136.2 (C), 133.6 (Ar-CH), 128.7 (2 x Ar- 
CH), 128.2 (2 x Ar-CH), 75.5 (6-CH), 65.3 (2-CH2), 40.6 (5-CH2), 36.6 (3-CH2); m/z (ES) 227 
[M+K]+ 100%.
Method 2:
In an open flask, furan 371 (0.2g, 1.06 mmol) was dissolved in acetone (10 mL) and the solution 
cooled to 0 °C. Chromium trioxide (0.128g, 1.28 mmol) was added and the solution stirred for 1 
h. Sodium sulfite (1 g) was used to quench the reaction and the slurry filtered through silica with 
ethyl acetate (25 mL). Saturated aqueous potassium carbonate solution (10 mL) was added to 
neautralise the reaction mixture and the product extracted into ethyl acetate (3 x 25 mL). The 
combined organic layers were washed with water (50 mL) and brine (50 mL) then dried, filtered 
and evaporated to yield a 1:1 mixture of oxepin-4-one 372 and furan 371 (0.162g). All data 
obtained was in accord with that previously obtained from our conventional approach.
Method 3:
Furan 371 (0.2g, 1.06 mmol) was dissolved in DMF (2 mL) and cooled to 0 °C. Pyridinium 
dichromate (1.4g, 3.72 mmol) in DMF (4 mL) was added and the solution stirred at ambient 
temperature overnight. Sodium sulfite (1 g) was used to quench the reaction and the slurry 
filtered through silica with ethyl acetate (25 mL). Saturated aqueous potassium carbonate 
solution (few mL) was added to neautralise the reaction mixture and the product extracted into 
ethyl acetate (3 x 25 mL). The combined organic layers were washed with water (50 mL) and 
brine (50 mL) then dried, filtered and evaporated to yield a crude product containing primarily 
furan 371 together with trace amounts of oxepin-4-one 372 (0.037g). All data obtained was in 
accord with that previously obtained from our conventional approach.
Method 4:
Dimethyl sulfoxide (0.2 lmL, 2.93 mmol) was added carefully to a solution of oxalyl chloride 
(0.13mL, 1.46 mmol) in dichloromethane, cooled to -78 °C and stirred for 10 mins. Furan 371 
(0.25g, 1.33 mmol) was added dropwise and the mixture stirred for 15 mins. Finally
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triethylamine (0.93mL, 6.65 mmol) was added with further 15 mins, at which point the solution 
was allowed to warm to 0 °C. The reaction mixture was then filtered through a plug of silica and 
washed with 30:70 ethyl acetate: hexane. The organic solution was then dried, filtered and 
evaporated to yield a crude yellow oil (0.123g). The data obtained showed the formation of 
oxepin-4-one 372 (5%) amongst other products.
Method 5:
^  , -OTBDMS
P f f O  pirv
392 372
In an open flask, furan 392 (0.1 g, 0.314 mmol, 1 eq) was dissolved in acetone (10 mL) and 
cooled to 0 °C. Jones reagent (0.15 mL, 0.314 mmol, 1 eq) was added dropwise and the solution 
stirred for 1 h. Sufficient sodium sulfite was added to quench the reaction and the slurry filtered 
through silica with ethyl acetate (200 mL). The solvent was removed to yield oxepin-4-one 372 
as an orange oil (0.045 g, 76%). All data obtained was in accord with that previously obtained 
from our conventional approach.
2-(2-(2-Hydroxyethyl)-5-phenylfuran-3-yl)propan-2-ol (393a)
w  ' - ° H
HO,
OH
Ph
393a
PIT O 
371
In an open flask, furan 371 (0.42 g, 2.13 mmol, 1 eq) was dissolved in acetone (10 mL) and 
cooled to 0 °C. Concentrated sulfuric acid (5 mL) was added dropwise and the solution stirred 
for 8 h at ambient temperature. Upon re-cooling to 0°C, sufficient aqueous saturated K2CO3 was 
added carefully to neautralise the solution. Next, 2M hydrochloric acid was added dropwise to 
acidify the solution to pH 4, and the product extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were washed with water (100 mL) and brine (100 mL) then dried, 
filtered and evaporated to yield a crude brown oil (0.654g). The residue was purified by column
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chromatography (30:70 ethyl acetate -  petroleum ether) to yield the furan 393a as a yellow oil 
(0.246 g, 47%): R f 0.22 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3344, 2972, 
1632, 1553, 1486, 1448, 1405, 1379, 1335, 1250, 1224, 1170, 1114, 1092, 1053, 947, 930, 869, 
817, 760, 724, 691, 671, 654; SH 7.55 (2H, d, J 7.1, 2 x Ar-H), 7.32-7.25 (2H, m, 2 x Ar-H), 7.15 
(IH, t, J 7.5, Ar-H), 6.37 (1H, s,4-H), 3.95 (2H, t, J 5.5, 2’-CH2), 2.69 (2H, t, J 5.5, l ’-CH2), 1.39 
(6H, s, 1” -Me); 5C (125MHz) 152.2 (C), 146.4 (C), 131.0 (C), 128.7 (2 x Ar-CH), 127.0 (Ar- 
CH), 126.4 (C), 123.4 (2 x Ar-CH), 102.5 (4-CH), 73.0 (C), 59.6 (2’-CH2), 28.1 (2 x 1” -Me),
24.7 ( l ’-CH2); m/z (ES) 269 [M+Na]+ 100%.
7-Hydroxy-5-(2-hydroxypropan-2-yl)-7-phenyIoxepan-4-one (394)
393a 394
In an open flask, furan 393a (0.1 g, 0.406 mmol, 1 eq) was dissolved in acetone (10 mL) and 
cooled to 0°C. Jones reagent (0.23 mL, 0.487 mmol, 1.2 eq) was added dropwise and the solution 
stirred for 1 h. Sufficient sodium sulfite was added to quench the reaction and the slurry filtered 
through silica with ethyl acetate (100 mL). The solvent was removed to a crude yellow oil (0.09 
g) containing the desired oxepane-4-one 394 together with oxepin-4-one 372, formed from 
previous trace impurities of furan 371. The product was purified by column chromatography 
(30:70 ethyl acetate -  petroleum ether) to yield the oxepan-4-one 394 as a yellow oil (0.029 g, 
27%): R f 0.46 (30 : 70 ethyl acetate -  petroleum ether); Umax/cm'1 (film) 3450, 2977, 2926, 1715, 
1687, 1598, 1581, 1449, 1372, 1330, 1281, 1216, 1173, 1148, 1095, 1071, 1003, 912, 851, 734, 
690, 648; 6H 7.92 (2H, d, J 7.3,2 x Ar-H), 7.50 (1H, t, J 7.3, Ar-H), 7.43-7.38 (2H, m, 2 x Ar-H), 
4.10 (1H, ddd, J 11.9, 7.9 and 1.5, 2-Ha), 3.85 (1H, app. dt, J 11.9 and 3.1, 2-Hb), 3.52 (1H, dd, J
17.3 and 9.7, 6-Ha), 3.38 (1H, dd, J 9.7 and 2.3, 5-H), 2.75 (1H, dddd, J 13.5, 11.9, 7.9 and 0.8, 3- 
Ha), 2.51 (1H, dd, J 17.3 and 2.3, 6-Hb), 2.27 (1H, ddd, J 13.5, 3.1 and 1.5, 3-Hb), 1.33 (3H, s, 2’- 
Me), 1.08 (3H, s, 2’-Me); 8C (125MHz) 207.4 (C), 197.7 (C), 136.9 (C), 133.1 (Ar-CH), 128.6 (2 
x Ar-CH), 128.1 (2 x Ar-CH), 79.4 (C), 61.6 (2-CH2), 56.2 (5-CH), 42.2 (3-CH2), 33.8 (6-CH2),
28.9 (2’-Me), 20.6 (2’-Me); m/z (El) 246 ([M] -  H20 ) 2%, 231 (8), 187 (8), 141 (40), 122 (36), 
105 (100), 83 (38), 77 (70), [Found [M-H20], 246.1265. Ci5H180 3 requires M-H20 , 246.1256].
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3.4-Dihydro-8-phenyl-2H-oxocin-5(6H)-one (397) and (£)-7-hydroxy-l-phenylhept-2-ene-
1.4-dione (398)
0
OTBDMS
396
Ph o
398
In an open flask, furan 396 (0.2 g, 0.630 mmol, 1 eq) was dissolved in acetone (10 mL) and 
cooled to 0 °C. Jones reagent (0.3 mL, 0.756 mmol, 1.2 eq) was added dropwise and the solution 
stirred for 1 h. Sufficient sodium sulfite was added to quench the reaction and the slurry filtered 
through silica with ethyl acetate (200 mL). The solvent was removed to yield a residue (0.129 g), 
which was purified by column chromatography (20:80 ethyl acetate -  petroleum ether) to give a 
yellow oil (0.020g), which contained oxecin-5-one 397 (10%) and dione 398 (6%): Rf 0.35 and 
0.26 (30 : 70 ethyl acetate -  petroleum ether); rw /c m '1 (film) 2928, 1748, 1639, 1577, 1448, 
1210, 1110, 1002, 751, 691; 8h oxecin-5-one 7.90 (1.26H, dd, J 7.2 and 1.4, Ar-H), 7.53-7.48 
(0.63H, m, Ar-H), 7.42-7.37 (1.26H, m, Ar-H), 4.45 (0.63H, dd, J 6.0 and 4.7, 7-H), 4.01 (0.63H, 
ddd, 11.6, 7.1 and 2.1, 2-CHa), 3.78 (0.63H, app. dd, 11.6 and 2.9, 2-CHb), 3.52 (0.63H, dd, J
17.6 and 4.7, 6-H.), 3.23 (0.63H, dd, J 17.6 and 6 .0 ,6-Hb), 2.64 (0.63H, ddd, J 16.1, 7.5 and 2.8, 
4-Ha), 2.48 (0.63H, app. dd, J 16.1 and 6.7,4-Hb), 2.18 (0.63H, m, 3-H,), 2.04 (0.63H, m, 3-Hb); 
8h dione 7.77 (0.74H, dd, J 7.4 and 1.3, 2 x Ar-H), 7.32-7.25 (0.74H, m, 2 x Ar-H), 7.24-7.20 
(0.37H, m, Ar-H), 6.50 (0.37H, d, J 12.0, 2-H), 5.62 (0.37H, dt, J 12.0 and 2.5, 3-H), 3.73 
(0.74H, t, J 6.2, 7-CH2), 2.50 (0.74H, dt, J 6.7 and 2.5, 5-CH2), 1.83-1.75 (0.74H, m, 6-CH2); 8C 
(125MHz) oxecin-5-one 207.7 (C), 196.8 (C), 136.6 (C), 128.6 (2 x Ar-CH), 128.4 (Ar-CH),
128.2 (2 x Ar-CH), 79.5 (7-CH), 66.6 (2-CH2), 39.3 (6-CH2), 38.0 (4-CH2), 26.5 (3-CH2); 8C 
(125MHz) dione 188.2 (C), 180.7 (C), 144.0 (C), 137.7 (2-CH), 133.3 (3 x Ar-CH), 128.3 (2 x 
Ar-CH), 123.3 (3-CH), 61.8 (7-CH2), 31.2 (5-CH2), 16.5 (6-CH2); m/z (ES) 203 [M+H]+ 5% and 
219 [Dione M+H]+ 100%.
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General procedure for the operation of the resin bound flow system
Catalyst Preparation and Formal Priming:
Amberlyst 200C was suspended in water and then packed into a stainless steel column (8 x 0.5 
inches), plugged lightly at both ends with cotton wool, using positive pressure. A t-piece joint 
was fitted to the top of the column so as to allow the introduction of reagent and nitrogen inlets. 
A saturated aqueous solution of silver nitrate was then passed through the column five times 
using positive pressure. Water (1L) was then used to wash of any unbound silver from the 
column. Acetone (250mL), methanol (250mL), hexane (250mL) and dichloromethane (250mL) 
were then passed through the column to condition it for use.
Continuous cyclisation reaction:
A heterocyclic precursor (e.g. diols 100,126) was dissolved in dichloromethane (typically 10 mL 
g 1). The resulting solution was passed through the column at a flow rate of lmL/min, and the 
output collected into a round- bottomed flask. The solvent was removed to yield product in 
excellent purity and yield (>95%). The column was then washed and re-primed.
Washing:
Methanol (50mL), hexane (50mL) and dichloromethane were passed sequentially through the 
column (5mL/min) to remove any organics. The flow rate was then adjusted to O.lmL/min in 
preparation for additional runs.
General procedure for the operation of the scCQ;: IL flow system
Catalyst Preparation:
Silver triflate was dissolved in the required ionic liquid (lOg/g) and stirred in a foil-wrapped flask 
at 40°C until dissolved {ca. lh). The solution was then transferred to the autoclave chamber and, 
with stirring, heated to the desired reaction temperature and placed under pressure.
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SCCO2 Cyclisation Reaction:
Once at temperature and pressure, the output pressure regulator was adjusted to maintain a 
continuous flow of CO2 (lmL/min). Diol 100a was then added at a steady flow rate (0.05-
0.2mL/min). Samples were collected every 30mins by shutting the output pressure regulator 
momentarily and then releasing the pressure in the decompression chamber. Pure furan 101a was 
then collected into a small vial, via a tap at the bottom of the decompression chamber, and then 
the flow of CO2 restored. Once finished, CO2 was used to flush the system and the catalyst used 
again, if desired.
General procedure for the use of the microwave reactor
Diol lOOe was dissolved in dichloromethane (10ml g"1) and placed inside a microwave tube fitted 
with a stirrer bar. 10% w/w silver nitrate on silica gel (0.1 - 0.5eq) was then added to the stirred 
solution, which was then immeadiately irradiated with microwave radiation for lh. The resulting 
suspension was then filtered through celite and the solvent evaporated to yield furan lOle in 
excellent yield (>95%).
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Appendix A: X-Ray Data for Chelation Control Diol lOOf.
University of Southampton School of Chemistry
EPSRC National Crystallography Service
Table 1. Crystal data and structure refinement.
f M M l  Physical 'xw txr* 
ftvw anti Council
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F(000)
Crystal 
Crystal size
Grange for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to 8= 27.49° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [.F2 > 20(1*)] 
R indices (all data)
Largest diff. peak and hole
2007src0348 (MG002)
314.36 
120(2) K 
0.71073 A 
Monoclinic 
P2\ln
a  =15.5139(3) A a  =90°
b  =  5.63200(10) A /?=  93.0380(10)°
c  —  18.7366(4) A ^ = 90°
1634.80(6) A3 
4
1.277 M g/ m3 
0.081 mm'1 
664
Prism; colourless 
0.50 x 0.20 x 0.20 mm3 
3.32-27.49°
-18 £ /»£ 20, -7 £ it £ 7, -2 4 S /S 2 1  
18952
3754 [/?*, = 0.0757]
99.7 %
Semi-empirical from equivalents 
0.9841 and 0.9608 
Full-matrix least-squares on F 2 
3754/0/219  
1.124
R l = 0.0598, = 0.1408
R1 =  0.0879, w/?2 = 0.1548 
0.242 and-0.344 e A"3
Diffractometer Nonius KappaCCD area detector (^  scans and to scans to fill asymmetric unit sphere). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius B.V., 
1998). Data redaction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307-326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption correction: 
SADABS Version 2.10. (G. M. Sheldrick (2003)) Bruker AXS Inc., Madison, Wisconsin, USA. Structure solution: SHELXS97 (G. M. 
Sheldrick, Acta Cryst. (1990) A46 467-473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), University of Gottingen, 
Germany). Graphics: PLATON (A.L. Spek, J Appl. Crystallogr. 2003,36,7).
Special details:
Cl =C2 = S Chirality
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Table 2. Atomic coordinates [x 104], equivalent isotropic displacement parameters [A2 x 103] and site occupancy factors. 
Ueq is defined as one third of the trace of the orthogonal ized lfj tensor.
Atom X y z ueq S.o.f.
Cl 1006(1) 1949(3) 9373(1) 19(1) 1
C2 1554(1) 3415(3) 9938(1) 20(1) 1
C3 1097(1) 2803(3) 8616(1) 19(1) 1
C4 1601(1) 1509(4) 8163(1) 23(1) 1
C5 1700(1) 2262(4) 7465(1) 29(1) 1
C6 1294(1) 4303(4) 7216(1) 29(1) 1
C7 783(1) 5604(4) 7661(1) 26(1) 1
C8 686(1) 4860(3) 8359(1) 22(1) 1
C9 2505(1) 3207(3) 9775(1) 19(1) 1
CIO 2962(1) 1156(4) 9965(1) 24(1) 1
C ll 3826(1) 941(4) 9813(1) 29(1) 1
C12 4237(1) 2745(4) 9463(1) 28(1) 1
C13 3785(1) 4774(4) 9265(1) 28(1) 1
C14 2921(1) 5004(4) 9419(1) 24(1) 1
C15 1421(1) 2507(4) 10666(1) 23(1) 1
C16 1355(1) 1912(4) 11277(1) 23(1) 1
C17 1325(1) 1384(3) 12027(1) 20(1) 1
C18 1695(1) 2990(4) 12522(1) 26(1) 1
C19 1689(2) 2516(4) 13246(1) 33(1) 1
C20 1314(2) 460(4) 13489(1) 32(1) 1
C21 942(2) -1141(4) 13000(1) 33(1) 1
C22 952(1) -695(4) 12274(1) 27(1) 1
01 121(1) 2103(2) 9568(1) 24(1) 1
02 1326(1) 5865(2) 9896(1) 24(1) 1
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T a b le  3 .  Bond lengths [A] and angles [°].
C l-O l 1.442(2)
C1-C3 1.511(3)
C1-C2 1.559(3)
C2-02 1.425(2)
C2-C15 1.481(3)
C2-C9 1.528(3)
C3-C4 1.391(3)
C3-C8 1.396(3)
C4-C5 1.391(3)
C5-C6 1.381(3)
C6-C7 1.390(3)
C7-C8 1.388(3)
C9-C14 1.390(3)
01-C1-C3 110.86(15)
01-C1-C2 106.79(15)
C3-C1-C2 113.22(15)
02-C2-C15 109.82(15)
02-C2-C9 107.61(15)
C15-C2-C9 109.97(16)
02-C2-C1 110.50(15)
C15-C2-C1 110.17(16)
C9-C2-C1 108.74(15)
C4-C3-C8 118.98(18)
C4-C3-C1 119.39(17)
C8-C3-C1 121.63(17)
C3-C4-C5 120.59(19)
C6-C5-C4 120.04(19)
C5-C6-C7 119.98(19)
C8-C7-C6 120.05(19)
C7-C8-C3 120.36(18)
C14-C9-C10 118.93(18)
C14-C9-C2 121.25(17)
C10-C9-C2 119.79(17)
C11-C10-C9 120.22(19)
C12-C11-C10 120.48(19)
C13-C12-C11 119.65(19)
C12-C13-C14 120.1(2)
C9-C14-C13 120.57(19)
C16-C15-C2 174.8(2)
C15-C16-C17 174.8(2)
C22-C17-C18 119.09(18)
C22-C17-C16 122.18(18)
C18-C17-C16 118.73(18)
C19-C18-C17 120.1(2)
C20-C19-C18 120.6(2)
C19-C20-C21 119.6(2)
C22-C21-C20 120.3(2)
C21-C22-C17 120.3(2)
C9-C10 1.392(3)
C10-C11 1.390(3)
Cl 1-C12 1.383(3)
C12-C13 1.382(3)
C13-C14 1.391(3)
C15-C16 1.202(3)
C16-C17 1.440(3)
C17-C22 1.395(3)
C17-C18 1.398(3)
C18-C19 1.384(3)
C19-C20 1.383(3)
C20-C21 1.388(3)
C21-C22 1.385(3)
Symmetry transformations used to generate equivalent 
atoms:
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Tabic 4. Anisotropic displacement parameters [A2x 103]. The anisotropic displacement 
factor exponent takes the form: - 2 z 2[h2a*2Uu + ••• + 2 h ka* b* U'2 ].
Atom Uil U22 i f 3 U23 Un i f 2
Cl 18(1) 15(1) 23(1) 2(1) 3(1) KD
C2 23(1) 14(1) 22(1) 0(1) 2(1) 1(1)
C3 18(1) 18(1) 20(1) 10) -1(1) -3(1)
C4 23(1) 23(1) 23(1) 10) -1(1) 2(1)
C5 29(1) 36(1) 22(1) -2(1) 4(1) 3(1)
C6 30(1) 36(1) 21(1) 7(1) 1(1) -5(1)
C7 26(1) 23(1) 27(1) 7(1) -4(1) -2(1)
C8 24(1) 19(1) 25(1) 0(1) 1(1) 0(1)
C9 21(1) 19(1) 16(1) -1(1) -1(1) -K D
CIO 28(1) 22(1) 21(1) 2(1) 0(1) 2(1)
C ll 27(1) 28(1) 30(1) 3(1) -3(1) 7(1)
C12 20(1) 35(1) 29(1) -2(1) -1(1) -1(1)
C13 24(1) 29(1) 31(1) 4(1) I d ) -5(1)
C14 24(1) 20(1) 27(1) 3(1) -1(1) 0(1)
C15 24(1) 21(1) 24(1) -2(1) 2(1) 2(1)
C16 22(1) 23(1) 24(1) -2(1) KD 2(1)
C17 19(1) 22(1) 19(1) -1(1) KD 3(1)
C18 28(1) 23(1) 26(1) -3(1) 2(1) -2(1)
C19 39(1) 36(1) 23(1) -7(1) -1(1) 0(1)
C20 33(1) 43(1) 20(1) 6(1) 5(1) 9(1)
C21 31(1) 32(1) 36(1) 10(1) 7(1) 2(1)
C22 26(1) 27(1) 28(1) -1(1) -1(1) -2(1)
Ol 21(1) 20(1) 30(1) 0(1) 7(1) -5(1)
02 25(1) 15(1) 32(1) -1(1) 5(1) 2(1)
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Appendix B: JH NMR profile o f 3-alkyne-l ,2-diol 100k cyclisation.
OH^
100k 101k
9-5 9.0 8.5 8.0 7S  7 0  6.5 6 0  5.5 5-0 4.5 4.0 l ! s  t!o  0.5 o !7
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Appendix C: NMR profile o f 3-alkyne-l,2-diol lOOi cyclisation.
10Oi 101 i
73 6.0 33 23 23 138.0 53 53 43 3.0
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Appendix P: A Flow System for Heterocyclic Synthesis.
